data_2lw6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lw6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.647 ' HD1' ' HA ' ' A' ' 68' ' ' VAL . 28.6 m-85 -53.89 131.32 39.81 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 110.301 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 t -111.14 130.99 63.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.135 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.825 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -93.15 141.08 28.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.648 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 92.8 m -151.72 144.36 24.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.782 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.802 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -74.7 109.72 8.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.019 0.438 . . . . 0.0 109.861 176.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.69 12.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 86' ' ' THR . 9.8 m-70 -84.46 130.8 34.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.332 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.602 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -99.04 127.8 45.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -98.35 122.76 41.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.613 . . . . 0.0 110.846 -176.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.042 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 1.8 t80 -100.39 152.7 20.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.42 99.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.526 0.516 . . . . 0.0 111.857 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.96 -19.74 42.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.379 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -163.82 156.89 18.27 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.458 1.129 . . . . 0.0 112.909 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -48.54 119.34 3.0 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.704 171.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 1.042 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.5 t90 -87.71 -56.52 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.503 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.01 -177.92 42.63 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.2 t -156.0 146.53 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.086 0.443 . . . . 0.0 111.391 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.15 126.73 71.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.769 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 16.1 mtm180 -75.94 122.1 23.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.656 0.741 . . . . 0.0 110.803 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.83 149.78 31.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.262 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 50.6 mtpt -69.92 155.1 41.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 110.858 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.43 142.3 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.445 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 88.44 -34.29 3.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.348 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 89.7 m95 -78.13 132.8 37.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.08 0.467 . . . . 0.0 110.451 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.44 141.59 52.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.741 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 62' ' ' CYS . 9.5 p -124.35 157.63 31.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.4 136.45 40.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.377 . . . . 0.0 111.484 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.602 ' CG ' HD21 ' A' ' 27' ' ' LEU . 67.8 m-85 -128.37 133.74 48.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -150.77 154.04 36.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 17.0 pt-20 -101.46 126.56 48.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.06 102.49 9.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.604 0.716 . . . . 0.0 109.905 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.76 131.41 35.75 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.975 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.83 116.46 3.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.569 2.179 . . . . 0.0 112.351 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.41 -10.18 57.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.123 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -122.05 154.69 61.5 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.406 0.282 . . . . 0.0 110.569 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.23 155.6 51.57 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.6 2.2 . . . . 0.0 111.359 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -72.33 140.09 48.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.216 0.531 . . . . 0.0 110.903 -177.171 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.33 129.8 55.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.464 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.14 123.74 17.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 110.484 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -110.37 -18.27 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.1 134.87 1.29 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.623 0.725 . . . . 0.0 111.394 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.68 111.6 36.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.9 t -131.18 144.05 51.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.269 -167.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.658 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -144.8 161.13 40.02 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -80.53 141.79 34.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.825 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.83 -62.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.015 0.822 . . . . 0.0 112.258 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.7 t -90.23 138.53 27.21 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.249 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.753 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -78.23 -2.41 12.49 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.521 2.147 . . . . 0.0 111.632 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HA ' ' HD1' ' A' ' 20' ' ' PHE . 12.5 t -105.04 -74.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.336 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.91 163.64 12.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.1 t -98.22 131.69 44.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.85 0.357 . . . . 0.0 110.298 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -132.54 -84.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.953 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -131.57 164.24 26.28 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.186 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.765 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 25.9 mt -103.54 122.94 45.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.988 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -102.78 106.21 16.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.619 ' HB2' HD23 ' A' ' 78' ' ' LEU . 1.8 m -110.01 146.56 35.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.599 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -124.16 157.48 34.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.708 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.54 55.84 3.28 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.609 0.568 . . . . 0.0 110.987 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 75' ' ' CYS . 92.1 mt -73.62 148.21 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.153 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -105.22 67.89 0.79 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.026 0.441 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.8 -91.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.258 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.04 60.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.008 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 90.2 m-85 -79.51 108.23 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.401 . . . . 0.0 110.74 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 m -149.68 163.31 38.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -98.67 159.98 14.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.34 -64.0 0.19 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.335 -170.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 11.6 t -160.16 -165.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.943 0.372 . . . . 0.0 110.423 -171.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.648 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 14.3 t -144.5 148.04 34.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.8 p -140.01 -153.21 0.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.276 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.802 ' HB3' HD22 ' A' ' 24' ' ' ASN . 7.9 t70 61.34 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 173.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -69.28 -42.38 81.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.967 0.413 . . . . 0.0 111.31 -176.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.401 HD22 ' SG ' ' A' ' 23' ' ' CYS . 4.1 pp -89.68 -33.93 16.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.552 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.554 -172.612 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.622 0.248 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.3 m-85 -81.24 140.67 34.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.85 140.18 48.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.851 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -112.41 144.87 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.325 176.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.455 ' HB3' HD13 ' A' ' 91' ' ' LEU . 19.8 p -153.49 157.05 39.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 0.0 111.54 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.963 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -78.11 112.52 15.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.602 174.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -81.97 115.3 21.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.651 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -83.94 129.01 34.93 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.017 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 28' ' ' LEU . 1.3 tm? -101.36 132.57 46.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.31 122.57 44.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.374 0.607 . . . . 0.0 111.037 -178.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 56.7 t80 -106.09 143.99 33.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -53.07 104.96 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.039 0.447 . . . . 0.0 110.792 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 -50.59 0.88 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.964 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 33' ' ' HIS . 30.7 tpt180 -172.75 167.37 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.41 ' N ' ' HG3' ' A' ' 32' ' ' ARG . 11.0 t-80 -36.3 131.37 0.63 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.985 0.914 . . . . 0.0 112.221 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.808 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 32.8 t-105 -99.56 -56.69 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.264 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -178.71 39.57 Favored Glycine 0 C--O 1.234 0.143 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.906 ' HG1' ' HB2' ' A' ' 24' ' ' ASN . 9.7 t -151.77 141.76 22.11 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.187 0.518 . . . . 0.0 111.664 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.88 130.04 58.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.827 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.851 ' HD2' HE22 ' A' ' 22' ' ' GLN . 29.7 mtm180 -87.68 124.78 33.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.325 0.583 . . . . 0.0 111.539 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HE3' HG11 ' A' ' 45' ' ' VAL . 36.6 ttmt -153.53 152.35 30.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.575 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.794 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 47.1 mtpt -76.15 155.07 34.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.924 0.392 . . . . 0.0 111.044 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.78 142.45 55.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.564 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 104.65 -36.32 4.46 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.139 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -90.29 146.92 23.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.927 0.394 . . . . 0.0 110.614 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -85.63 131.37 34.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -101.12 152.54 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -94.43 140.12 30.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.88 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.467 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 94.2 m-85 -136.54 132.5 35.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.5 p90 -147.62 157.76 43.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 0.0 111.377 -173.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 16.9 pt-20 -95.33 130.03 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.143 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 16.4 pt-20 -126.25 112.21 15.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.443 0.64 . . . . 0.0 109.96 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -136.4 121.82 13.29 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.592 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -48.58 116.88 2.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.686 2.924 . . . . 0.0 113.417 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.04 -19.26 12.02 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.274 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -126.67 149.26 67.76 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.807 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 162.33 42.44 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.822 2.348 . . . . 0.0 111.403 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 24.3 mttm -86.29 118.28 25.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.532 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -103.99 133.33 49.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.292 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -65.85 113.25 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.244 0.34 . . . . 0.0 110.172 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 33.2 m -92.76 -24.04 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB3' HD22 ' A' ' 78' ' ' LEU . . . 178.91 146.68 0.17 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.288 0.565 . . . . 0.0 111.29 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.7 mp -105.42 117.31 50.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 170.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 6.2 t -125.44 144.74 50.39 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.514 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.0 ptpt -143.1 163.0 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -84.59 136.35 33.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.261 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.43 -54.68 3.74 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.052 0.845 . . . . 0.0 112.322 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.493 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 34.5 t -89.33 141.03 28.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.294 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.564 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 3.5 Cg_exo -81.62 2.79 8.31 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.25 2.633 . . . . 0.0 112.107 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.2 t -122.99 -70.38 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.664 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -86.25 165.02 16.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.1 126.05 44.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.879 0.371 . . . . 0.0 110.223 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -124.16 -81.55 0.64 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.293 0.568 . . . . 0.0 110.016 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.44 168.91 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 24.0 mt -102.52 120.34 40.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.251 0.548 . . . . 0.0 110.784 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.9 mmpt? -102.26 105.65 16.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.809 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.666 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.7 m -104.58 149.77 25.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.956 0.408 . . . . 0.0 110.769 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -127.27 155.36 43.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.517 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.48 50.82 4.39 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.491 0.494 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 75' ' ' CYS . 87.7 mt -68.24 140.36 56.03 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 59' ' ' VAL . . . -89.51 89.62 7.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.575 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.54 -88.16 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.01 0.82 11.77 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.993 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -82.42 126.17 31.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 m -146.81 -177.74 5.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.923 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -100.72 171.28 7.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.415 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -123.04 -140.79 5.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.256 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 178.85 5.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.844 0.354 . . . . 0.0 110.531 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 42.4 m -110.6 142.61 42.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 24.6 p -141.27 -159.32 0.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.963 ' HB3' HD22 ' A' ' 24' ' ' ASN . 22.2 t70 63.06 -82.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.948 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.419 ' H ' HG21 ' A' ' 90' ' ' VAL . 10.3 m -70.97 -36.02 61.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.211 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 23' ' ' CYS . 12.9 mt -89.46 -55.32 3.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.23 0.538 . . . . 0.0 111.729 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.62 -171.329 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.641 0.258 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.555 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.3 m-85 -64.39 113.99 4.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.45 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.9 p -101.26 139.75 21.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.322 -172.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.993 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.0 pt20 -96.08 144.81 26.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 10.8 p -150.07 142.43 24.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 111.796 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.965 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -73.43 110.59 7.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.016 175.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.83 116.11 16.21 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 11.4 m-70 -86.62 131.18 34.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.873 0.368 . . . . 0.0 111.132 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.453 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -98.51 125.46 43.73 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.12 125.67 50.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.366 0.603 . . . . 0.0 111.235 -172.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -98.53 150.79 21.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -53.38 100.38 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.662 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.91 -58.85 0.58 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.684 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -142.58 170.81 15.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.369 0.604 . . . . 0.0 112.317 -171.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 134.48 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.866 172.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -101.59 -55.85 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.897 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.99 175.14 42.28 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 t -154.28 145.79 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.278 0.539 . . . . 0.0 111.424 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.568 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.0 mp -126.78 125.1 66.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.88 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 47.2 ttp180 -88.67 98.07 11.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.49 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.5 mmtp -126.05 153.8 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.993 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 32.9 mtpt -66.24 161.93 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.228 0.537 . . . . 0.0 111.482 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 66' ' ' SER . . . -59.92 142.78 53.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.763 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.586 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 89.78 -28.19 7.35 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.465 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 55.1 m95 -75.87 115.27 15.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.572 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.933 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.11 115.43 16.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.042 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG21 ' HB ' ' A' ' 37' ' ' ILE . 8.2 p -103.75 154.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.34 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.415 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.53 134.09 37.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 111.346 -177.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.701 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 88.7 m-85 -120.37 128.38 53.18 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' HB3' HD21 ' A' ' 58' ' ' LEU . 36.7 p90 -143.78 152.1 40.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.299 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 7.1 pt-20 -94.72 137.53 33.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.354 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -126.78 100.37 6.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 31.8 mttp -95.66 154.08 39.26 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.02 116.36 3.12 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 121.994 1.796 . . . . 0.0 111.639 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 -11.59 66.39 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.873 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -110.12 126.34 29.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.769 -0.254 . . . . 0.0 110.474 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 31.7 Cg_exo -63.06 154.87 64.44 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.041 2.494 . . . . 0.0 112.765 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -62.11 126.92 29.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.181 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -130.39 142.74 50.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.816 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.802 HD11 HD13 ' A' ' 61' ' ' ILE . 16.6 mt -70.32 130.07 41.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 -175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.09 -18.0 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.393 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -176.63 138.29 0.28 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.514 0.673 . . . . 0.0 111.633 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.802 HD13 HD11 ' A' ' 58' ' ' LEU . 4.5 mp -108.81 111.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.7 t -132.39 146.12 51.73 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.687 -168.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.933 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 27.5 pttt -145.6 164.56 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.651 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 9.0 t30 -77.33 134.37 38.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.75 -56.78 1.67 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.455 1.097 . . . . 0.0 112.706 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 40.6 t -92.0 136.75 25.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 69.3 Cg_endo -75.42 -1.52 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.404 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.9 t -112.42 -72.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' A' ' 66' ' ' SER . 39.6 m80 -98.01 164.47 12.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.411 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.0 t -97.63 132.72 43.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -132.1 -81.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -138.26 175.7 9.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.498 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.778 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 31.3 mt -103.72 129.5 51.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.69 109.95 21.25 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.6 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.9 m -114.44 149.15 36.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.53 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -124.76 159.99 29.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.174 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 68.36 40.13 2.1 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.407 0.442 . . . . 0.0 111.642 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 75' ' ' CYS . 96.5 mt -66.73 126.69 29.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.887 0.375 . . . . 0.0 110.971 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -95.41 68.79 3.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.585 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.47 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.366 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.3 -16.32 64.77 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.971 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 99.2 m-85 -86.99 109.29 19.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.085 0.469 . . . . 0.0 110.39 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.4 m -147.72 168.29 22.48 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.585 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -98.76 161.53 13.6 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.472 -175.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.31 -79.28 0.76 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.218 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.9 t -155.77 -169.52 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.611 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 30.1 m -130.58 144.75 51.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.645 0.259 . . . . 0.0 110.309 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 58.3 p -138.34 -154.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.936 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.965 ' HB3' HD22 ' A' ' 24' ' ' ASN . 36.2 t70 63.58 -78.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.25 1.02 . . . . 0.0 112.548 173.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 23' ' ' CYS . 0.9 OUTLIER -68.03 -42.84 85.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.793 0.33 . . . . 0.0 111.662 -175.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.66 -31.39 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.597 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.027 -175.249 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -57.09 142.08 43.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.402 174.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.29 141.33 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.709 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.2 pt20 -94.39 143.0 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.709 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 20.0 p -147.53 145.5 29.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.037 0.446 . . . . 0.0 110.901 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.937 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.02 113.05 11.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 174.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.485 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 1.3 m80 -78.4 117.63 19.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -85.42 134.69 34.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.019 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.57 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -101.09 122.9 44.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.07 122.04 42.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.697 0.76 . . . . 0.0 110.862 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 65.9 t80 -94.24 150.95 19.83 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.75 100.15 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.47 -58.45 0.71 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.255 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -159.71 179.96 8.4 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -52.44 131.51 33.66 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.764 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.786 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.4 t90 -101.57 -55.84 2.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.314 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.23 179.03 38.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.1 t -154.32 143.74 21.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.187 0.493 . . . . 0.0 111.164 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.551 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.5 mp -123.42 122.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.798 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 42.3 ttp180 -83.44 105.65 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.17 0.509 . . . . 0.0 110.741 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 37' ' ' ILE . 70.1 mmtt -127.11 152.96 46.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.536 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 38.9 mtpt -80.22 149.97 30.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.631 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.09 136.18 57.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 111.297 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.47 -17.76 46.16 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -91.38 130.93 37.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.73 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.93 122.89 26.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.5 p -107.58 147.81 12.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.873 0.368 . . . . 0.0 110.483 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.501 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -98.44 135.95 39.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.0 111.154 -177.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CG ' HD21 ' A' ' 27' ' ' LEU . 74.8 m-85 -123.89 131.02 53.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.193 173.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HD2' ' HB3' ' A' ' 56' ' ' LYS . 36.0 p90 -143.74 149.64 37.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.194 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -95.21 142.97 27.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 10.4 pt-20 -130.07 102.2 6.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.726 0.774 . . . . 0.0 110.199 172.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.5 124.84 56.07 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.45 117.82 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.583 2.855 . . . . 0.0 113.303 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.77 22.51 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.377 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.49 148.32 34.37 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.592 0.357 . . . . 0.0 110.735 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.0 151.84 82.9 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.903 2.402 . . . . 0.0 112.153 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 48' ' ' TYR . 26.9 mttm -76.63 136.06 39.17 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.899 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -123.89 135.92 54.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.613 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.82 118.8 12.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.2 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 16.1 m -104.7 -19.16 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.39 136.21 0.59 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.651 0.739 . . . . 0.0 112.349 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.588 HD11 HD21 ' A' ' 77' ' ' ASN . 4.6 mp -108.28 112.87 42.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.8 t -132.14 150.46 52.15 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 -168.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -150.1 163.59 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.827 HD22 ' HA ' ' A' ' 70' ' ' CYS . 32.6 t30 -73.02 150.55 42.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.989 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.41 -52.5 28.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.542 0.526 . . . . 0.0 111.692 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -108.78 139.12 20.57 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.066 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.23 12.74 1.21 Allowed 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.772 2.315 . . . . 0.0 113.149 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.01 -78.8 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.762 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -90.59 156.94 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.827 ' HA ' HD22 ' A' ' 64' ' ' ASN . 31.5 t -97.74 137.03 37.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.854 0.359 . . . . 0.0 110.992 -172.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -133.49 -76.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -134.28 164.75 26.69 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.461 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.3 mt -103.82 124.32 48.7 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.13 105.75 16.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.17 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 19.0 m -102.93 155.18 18.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.816 -175.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.9 t -136.37 154.71 50.75 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.588 HD21 HD11 ' A' ' 61' ' ' ILE . 90.8 m-20 65.81 46.35 2.33 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.736 0.648 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.9 mt -64.3 155.62 31.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 111.425 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' A' ' 82' ' ' PHE . . . -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.193 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.39 -90.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.287 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.49 -15.1 78.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.76 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 98.1 m-85 -89.12 120.44 30.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 110.332 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.42 ' HA ' HD22 ' A' ' 78' ' ' LEU . 22.9 m -147.34 172.75 13.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.605 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -109.87 174.93 5.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.158 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.52 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -142.48 -175.35 15.64 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.068 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -66.57 172.45 4.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.0 111.495 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 15.5 p -110.33 144.0 39.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.71 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.455 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.5 p -140.7 -154.84 0.54 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 111.461 -174.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.937 ' HB3' HD22 ' A' ' 24' ' ' ASN . 19.4 t70 69.9 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.032 169.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' H ' HG21 ' A' ' 90' ' ' VAL . 6.8 m -72.64 -38.05 57.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.616 -176.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.87 -30.03 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 p . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.606 -179.228 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.479 0.181 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -79.05 140.58 37.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.592 HG11 ' HG ' ' A' ' 70' ' ' CYS . 2.3 p -145.4 136.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.245 -175.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.656 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -100.87 155.14 18.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.516 175.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 16.9 p -154.85 152.44 29.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.212 0.53 . . . . 0.0 111.681 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -75.05 111.19 10.02 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 109.503 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.814 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 9.7 m80 -72.19 121.03 18.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.403 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -84.17 136.54 33.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.584 -174.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.581 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -109.89 122.98 48.78 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 165.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 122.08 45.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.287 0.565 . . . . 0.0 110.504 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.13 143.94 26.17 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -50.43 101.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.537 0.523 . . . . 0.0 110.463 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.6 -53.34 0.81 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.146 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 22.8 tpt180 -165.09 160.02 18.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.085 0.442 . . . . 0.0 111.77 -175.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -42.83 127.83 4.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -99.51 -56.72 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.323 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.63 178.32 39.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.975 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.517 ' HB ' ' HD2' ' A' ' 26' ' ' HIS . 5.8 t -153.8 138.41 16.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.951 0.375 . . . . 0.0 110.704 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.31 135.98 55.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.199 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.656 ' HD2' HE22 ' A' ' 22' ' ' GLN . 3.3 tpp85 -73.81 110.21 7.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.776 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 16.7 tppt? -143.89 128.57 18.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.563 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 18.6 ptmt -72.3 153.64 41.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.222 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 66' ' ' SER . . . -63.66 142.75 58.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 94.26 -17.27 59.23 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.645 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.454 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 44.3 m95 -105.36 142.91 34.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 0.0 110.66 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -80.17 140.63 36.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.63 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.776 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.9 p -126.89 148.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.85 0.357 . . . . 0.0 110.543 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.76 143.55 27.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.814 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 63.5 m-85 -128.35 135.88 50.19 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 53.0 p90 -151.1 156.49 41.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.869 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' OE1' ' HE2' ' A' ' 51' ' ' LYS . 14.9 pt-20 -107.38 134.93 49.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 168.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.0 102.25 10.74 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.229 0.537 . . . . 0.0 110.67 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HE2' ' OE1' ' A' ' 49' ' ' GLU . 67.6 mttm -85.23 125.48 69.96 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.672 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.02 117.64 2.63 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.332 2.688 . . . . 0.0 113.573 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.37 -14.24 62.37 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.559 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -113.05 158.11 38.85 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.543 0.211 . . . . 0.0 110.438 -176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.55 161.9 41.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.665 2.243 . . . . 0.0 111.118 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -74.71 138.38 42.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.056 0.455 . . . . 0.0 110.728 -176.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 20.4 tpp180 -99.52 123.55 43.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.069 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.34 107.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.997 0.427 . . . . 0.0 110.55 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.477 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -95.16 -18.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.57 138.7 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.505 0.669 . . . . 0.0 111.904 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.62 112.13 38.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 12.0 t -134.9 154.02 51.83 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.982 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.628 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -150.21 162.36 40.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -83.85 135.86 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.718 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.33 -51.9 6.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.079 0.862 . . . . 0.0 112.868 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 46.0 t -94.77 139.18 22.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.265 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 80.1 Cg_endo -79.13 2.69 8.08 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 111.744 173.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.2 -79.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.589 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' A' ' 66' ' ' SER . 67.5 m80 -89.65 165.38 14.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.472 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.592 ' HG ' HG11 ' A' ' 21' ' ' VAL . 74.8 m -98.72 124.92 43.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.29 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.406 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 61.5 m-20 -124.22 -85.52 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 110.227 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.406 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 93.9 m-85 -130.43 174.14 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.949 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.832 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.6 mt -109.36 132.21 54.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.626 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -101.19 104.51 15.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.744 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.562 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 1.6 m -116.41 144.87 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.967 0.413 . . . . 0.0 110.597 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -126.46 159.63 32.8 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.2 t30 59.83 71.59 0.57 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 -175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 83' ' ' SER . 96.4 mt -91.66 128.79 37.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 59' ' ' VAL . . . -92.33 73.92 5.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.674 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.62 -93.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.468 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.07 0.85 73.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.923 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 96.5 m-85 -101.16 108.89 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 0.0 110.474 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.465 ' HA ' HD23 ' A' ' 78' ' ' LEU . 41.7 m -138.39 169.35 17.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -101.24 163.76 12.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.283 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.83 -175.68 14.8 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.669 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 13.6 t -61.77 159.02 14.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.567 0.698 . . . . 0.0 111.234 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.632 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 7.0 p -91.17 144.67 25.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.479 -168.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.61 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 40.0 p -131.64 -158.45 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.803 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.2 t70 70.83 -85.04 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.411 1.084 . . . . 0.0 111.707 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.414 ' H ' HG21 ' A' ' 90' ' ' VAL . 1.7 m -67.45 -46.94 82.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.94 -27.8 20.7 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.725 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 88' ' ' THR . 5.9 t . . . . . 0 C--N 1.329 -0.284 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.069 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 82.5 m-85 -78.9 139.94 38.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.46 138.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.398 0.618 . . . . 0.0 111.819 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.79 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.47 145.84 31.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.421 176.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.624 ' HA ' HG22 ' A' ' 90' ' ' VAL . 18.0 p -148.66 150.44 33.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.501 0.667 . . . . 0.0 112.314 -174.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.956 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -72.24 112.84 8.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.958 174.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.826 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 14.6 m80 -80.68 108.81 14.64 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.615 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.699 ' HA ' ' HG1' ' A' ' 36' ' ' THR . 43.5 m-70 -83.72 125.33 31.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.774 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 28' ' ' LEU . 1.7 tm? -98.2 134.08 41.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -104.73 116.7 32.49 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.563 0.697 . . . . 0.0 110.903 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.709 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 71.6 t80 -95.19 145.42 25.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.954 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -57.75 99.76 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.856 0.36 . . . . 0.0 110.287 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.76 -43.57 1.26 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.68 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -175.06 166.06 3.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.092 0.446 . . . . 0.0 111.337 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -43.42 127.03 4.54 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.553 0.741 . . . . 0.0 111.596 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 48.9 t-105 -99.68 -57.65 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.636 -175.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.73 177.49 39.56 Favored Glycine 0 C--N 1.328 0.137 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.278 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.699 ' HG1' ' HA ' ' A' ' 26' ' ' HIS . 0.8 OUTLIER -152.85 133.11 13.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.143 0.497 . . . . 0.0 111.328 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -120.33 134.6 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.53 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -80.05 104.93 10.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 3.7 tppp? -138.85 145.01 39.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.79 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.5 mtpt -68.32 148.94 50.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.854 ' HB3' HD21 ' A' ' 64' ' ' ASN . . . -65.55 136.61 56.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.9 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.839 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 97.14 -26.18 23.85 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.068 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -89.19 130.83 35.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.924 0.392 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.74 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.99 126.64 30.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.201 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.553 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.2 p -116.41 145.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.41 145.21 30.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.148 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.826 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 76.7 m-85 -134.79 145.33 48.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -148.61 163.39 37.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.199 0.523 . . . . 0.0 111.585 -173.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.32 134.53 51.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.381 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -109.57 113.79 26.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.391 0.615 . . . . 0.0 110.399 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 33.6 mmtp -108.31 125.51 31.75 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.432 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.53 126.87 23.93 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.32 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.5 -9.56 64.35 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.297 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 40.8 mt-30 -122.38 159.12 53.87 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.365 0.266 . . . . 0.0 110.733 -175.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.25 156.65 58.79 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.765 2.31 . . . . 0.0 111.967 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -88.21 138.86 31.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.495 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -117.45 123.63 46.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.929 -172.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.45 106.6 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.44 -30.08 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -174.07 144.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.199 0.523 . . . . 0.0 111.338 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -102.07 113.72 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.687 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -118.96 148.69 42.69 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.187 -171.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.74 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 13.9 pttp -157.1 164.32 38.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.341 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.854 HD21 ' HB3' ' A' ' 41' ' ' ALA . 30.7 t30 -81.83 152.02 27.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.408 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.23 -48.88 67.82 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.552 0.532 . . . . 0.0 111.362 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -105.57 137.54 19.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.818 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.839 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 78.1 Cg_endo -80.96 10.37 3.41 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.742 2.294 . . . . 0.0 112.518 175.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.0 t -113.98 -82.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.11 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.413 ' H ' ' HB ' ' A' ' 68' ' ' VAL . 79.0 m-70 -90.28 158.45 17.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.736 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.6 t -98.5 127.32 44.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -116.39 -87.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -134.53 171.79 13.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.648 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 39.2 mt -103.43 120.54 41.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.105 0.479 . . . . 0.0 112.056 -173.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -102.91 109.29 20.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.155 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.75 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.9 m -103.21 146.53 28.28 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.481 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -120.45 155.29 33.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.152 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 56.68 55.24 6.51 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.664 0.603 . . . . 0.0 110.184 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.6 mt -67.74 149.48 49.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.76 94.67 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.51 -85.56 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.628 0.58 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.45 4.64 6.26 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.02 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.88 120.71 25.06 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.9 t -151.84 178.17 9.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.469 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . . . -100.71 159.84 14.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.199 -177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.55 -64.38 0.38 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.006 -171.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 t -164.91 -169.62 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.006 0.403 . . . . 0.0 110.586 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 5.0 p -143.73 144.25 31.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.263 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 37.6 p -139.61 -155.22 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.731 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.956 ' HB3' HD22 ' A' ' 24' ' ' ASN . 16.7 t70 64.61 -76.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.465 0.706 . . . . 0.0 112.377 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -70.94 -44.36 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.15 -23.34 22.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.095 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.77 179.593 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -64.18 149.14 48.44 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.529 HG22 ' SG ' ' A' ' 23' ' ' CYS . 2.6 p -133.67 135.23 55.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.402 0.62 . . . . 0.0 111.488 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.713 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -109.6 140.94 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.388 176.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 58.6 m -145.1 157.58 44.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.088 0.47 . . . . 0.0 111.994 -168.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.889 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -83.43 111.84 19.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 166.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -77.61 124.02 27.39 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.32 137.6 32.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.403 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.501 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -98.96 116.4 31.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 166.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.72 124.05 41.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.928 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -110.7 150.62 28.79 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -52.86 101.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.346 0.404 . . . . 0.0 110.492 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.17 -59.01 0.69 Allowed Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.32 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -162.58 166.76 24.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -49.87 119.58 3.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.767 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.522 ' HH2' ' H ' ' A' ' 50' ' ' GLU . 10.1 t90 -92.84 -55.57 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.968 0.413 . . . . 0.0 110.598 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.73 163.26 28.56 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.0 t -154.26 140.22 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.224 0.512 . . . . 0.0 110.699 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.455 HD13 ' C ' ' A' ' 36' ' ' THR . 2.5 mp -124.39 126.97 72.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.714 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.9 mtm180 -79.13 110.31 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.502 . . . . 0.0 111.819 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -146.52 137.29 24.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.155 175.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.0 ptmt -62.12 156.91 20.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.28 142.15 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.935 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.38 -40.7 2.33 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.523 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.479 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 56.9 m95 -75.14 141.94 43.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.137 0.494 . . . . 0.0 111.142 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.621 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.93 131.33 41.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.399 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.8 p -121.63 140.08 46.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.059 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.694 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -101.33 139.41 37.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.998 0.427 . . . . 0.0 110.541 -178.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CG ' HD21 ' A' ' 27' ' ' LEU . 82.9 m-85 -120.43 139.08 53.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.301 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 30.5 p90 -147.44 154.04 40.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.934 0.397 . . . . 0.0 111.335 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -103.69 142.66 33.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.495 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.522 ' H ' ' HH2' ' A' ' 34' ' ' TRP . 7.6 pt-20 -93.89 104.16 16.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 73.1 mmtt -119.45 135.47 24.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.055 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 23.3 Cg_exo -63.9 117.51 4.5 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.028 2.485 . . . . 0.0 112.834 -175.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.45 64.76 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -107.69 149.96 39.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.942 0.401 . . . . 0.0 110.696 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.24 153.4 78.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.943 1.762 . . . . 0.0 109.323 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.583 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 34.7 mmtm -67.37 109.53 3.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.181 0.515 . . . . 0.0 109.899 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 18.7 tpp180 -80.67 126.11 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.817 -167.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' A' ' 46' ' ' ARG . 11.1 mt -58.9 109.12 0.76 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.599 0.562 . . . . 0.0 110.649 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -93.78 -15.43 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.862 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.53 135.19 0.53 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.598 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.537 HG13 HD23 ' A' ' 58' ' ' LEU . 4.7 mp -107.7 113.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 166.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.2 t -133.63 159.54 40.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.998 -168.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.621 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -158.97 162.82 36.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 10.4 t30 -87.4 138.4 31.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.383 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -55.4 4.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.093 0.87 . . . . 0.0 112.655 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -99.89 146.41 31.84 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.049 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 94.7 Cg_endo -87.98 20.54 1.15 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.053 2.502 . . . . 0.0 112.714 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.57 -76.77 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.103 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.469 ' HA ' HG12 ' A' ' 21' ' ' VAL . 36.5 m-70 -92.22 164.28 13.61 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.54 122.43 44.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -116.51 -78.74 0.58 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.484 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.26 165.49 25.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.213 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.4 mt -105.03 124.74 50.06 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.457 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.57 105.37 15.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 2.1 m -111.54 151.46 28.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.364 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -128.95 161.74 29.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.521 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.39 41.09 5.98 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.567 0.542 . . . . 0.0 111.484 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -65.55 147.03 54.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.975 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -110.46 67.42 0.64 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.408 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.71 -89.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.859 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.85 -16.66 69.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.734 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.43 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.0 m-85 -85.17 107.05 17.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.234 0.54 . . . . 0.0 110.475 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.516 ' HA ' HD23 ' A' ' 78' ' ' LEU . 11.1 m -134.08 165.54 24.83 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.487 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -101.44 161.7 13.44 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.1 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 -164.04 9.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.846 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -69.34 -177.39 1.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.833 0.453 . . . . 0.0 111.338 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.2 p -122.03 151.75 40.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.928 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.535 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 68.8 p -139.78 -157.4 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 110.739 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.889 ' HB3' HD22 ' A' ' 24' ' ' ASN . 35.3 t70 66.11 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.919 0.888 . . . . 0.0 112.111 172.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.598 HG21 HD22 ' A' ' 91' ' ' LEU . 5.7 m -67.83 -41.47 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.598 HD22 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -89.87 -40.97 12.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' A' ' 88' ' ' THR . 9.3 m . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -172.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 34.6 p90 -61.23 135.35 57.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.419 0.628 . . . . 0.0 110.921 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.4 142.71 40.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.869 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.809 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -95.15 142.34 27.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 5.1 m -142.94 140.54 31.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.377 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.93 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -72.51 111.7 7.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 170.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 36' ' ' THR . 5.1 m80 -80.77 122.98 27.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.892 -177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.614 ' HA ' ' HG1' ' A' ' 36' ' ' THR . 12.1 m170 -90.61 123.64 34.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.589 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 28' ' ' LEU . 1.1 tm? -98.1 126.81 43.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.37 128.62 53.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.158 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.428 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.7 t80 -103.78 144.78 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -56.1 100.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.2 -56.6 0.63 Allowed Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.658 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.514 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 11.5 tpp180 -172.02 172.08 4.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.514 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 39.5 t-80 -47.62 135.92 10.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.194 0.598 . . . . 0.0 111.524 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.487 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 58.3 t90 -107.43 -55.76 2.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.119 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.12 164.02 30.76 Favored Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.282 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.614 ' HG1' ' HA ' ' A' ' 26' ' ' HIS . 1.0 OUTLIER -146.53 130.69 17.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.984 0.421 . . . . 0.0 111.313 -177.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.44 130.47 74.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.809 ' HD2' HE22 ' A' ' 22' ' ' GLN . 24.1 mtm180 -76.42 128.53 35.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.216 0.531 . . . . 0.0 110.671 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -148.86 152.15 35.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.654 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.5 mtpt -87.19 148.13 25.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.42 -174.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.84 136.42 58.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.971 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 95.58 -20.9 47.47 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.992 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.452 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 65.1 m95 -101.63 137.51 39.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 110.227 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.604 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -81.21 145.6 30.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -112.9 156.3 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.0 177.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.25 130.23 50.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.138 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.518 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 97.5 m-85 -122.73 126.83 48.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -145.78 156.68 43.75 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.483 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 14.3 pt-20 -104.47 123.68 47.91 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.7 102.08 10.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.826 0.822 . . . . 0.0 109.937 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.3 121.64 52.8 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.666 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.82 116.38 2.13 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.029 2.486 . . . . 0.0 112.519 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.46 -28.13 14.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.21 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -107.92 148.78 38.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.85 152.49 77.22 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.382 2.055 . . . . 0.0 111.293 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.638 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -77.82 137.6 38.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.537 -175.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -112.93 137.49 51.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.989 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.82 109.07 5.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.456 0.473 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 15.7 m -94.05 -19.64 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.808 -176.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.28 142.18 0.59 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 112.139 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.91 112.35 40.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 165.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.3 t -130.78 150.02 52.15 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.955 -167.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 ptpt -145.03 163.03 35.47 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -77.1 138.22 39.39 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.557 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -40.62 -58.73 1.54 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.125 0.891 . . . . 0.0 112.628 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.0 t -94.04 138.2 22.72 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.201 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.416 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 58.9 Cg_endo -73.2 -1.75 11.05 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.675 2.25 . . . . 0.0 111.701 172.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.3 t -103.37 -81.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.296 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -107.25 165.98 10.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.122 0.487 . . . . 0.0 111.204 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.27 124.24 38.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.099 -168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -128.46 -83.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.092 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -130.44 173.82 10.47 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.202 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.781 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 29.0 mt -110.07 127.71 55.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.952 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.82 107.92 19.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.519 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.8 m -113.41 152.15 30.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -175.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -126.2 159.43 33.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 62.46 40.32 10.98 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.935 0.494 . . . . 0.0 111.301 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.9 mt -62.04 135.12 57.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.78 ' HB1' ' HB2' ' A' ' 82' ' ' PHE . . . -92.68 41.81 1.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.227 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.31 -84.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.22 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.89 -18.6 76.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.758 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.78 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 96.9 m-85 -96.38 109.48 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.472 ' HA ' HD23 ' A' ' 78' ' ' LEU . 14.8 m -139.85 167.15 22.77 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.537 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -103.47 159.77 15.29 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.311 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.81 -95.08 1.85 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.929 -174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -138.97 -167.44 2.22 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 49.4 m -134.43 144.97 48.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 61.3 p -139.35 -157.03 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.815 -174.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.93 ' HB3' HD22 ' A' ' 24' ' ' ASN . 31.9 t70 61.68 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.431 1.092 . . . . 0.0 112.277 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.8 -20.91 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.745 0.307 . . . . 0.0 111.141 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.401 HD21 ' SG ' ' A' ' 23' ' ' CYS . 13.6 mt -89.1 -56.04 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.505 0.669 . . . . 0.0 111.201 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.317 -0.831 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.418 -174.139 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 48.5 p90 -88.8 143.2 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.85 137.76 21.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.358 0.599 . . . . 0.0 111.798 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.813 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 8.6 pt20 -102.95 150.13 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.467 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.2 p -151.04 136.4 17.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.366 0.603 . . . . 0.0 111.936 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.837 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -76.63 106.28 8.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 172.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.41 ' CB ' ' HZ ' ' A' ' 47' ' ' PHE . 4.6 m80 -72.86 122.26 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.122 -174.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -82.21 126.46 32.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.037 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -98.33 119.5 37.11 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.03 123.22 44.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.681 0.753 . . . . 0.0 111.425 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -101.63 148.38 25.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -57.27 99.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.26 0.35 . . . . 0.0 110.089 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.39 -57.58 0.59 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.484 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -168.84 170.62 9.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.153 0.477 . . . . 0.0 111.346 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -46.26 114.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.395 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.493 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 70.4 t90 -90.26 -55.92 3.41 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.825 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.24 169.67 36.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.669 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 t -154.55 147.81 24.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 111.551 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.08 128.13 70.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.837 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.9 ttp180 -87.62 116.0 25.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.705 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -150.29 149.04 29.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 40.4 mtpt -66.62 145.94 55.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.37 141.58 58.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.77 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 108.37 -28.03 12.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.832 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -96.42 145.98 25.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.011 0.434 . . . . 0.0 110.409 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -75.85 131.96 40.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -105.79 131.49 55.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 129.42 34.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.101 0.477 . . . . 0.0 110.199 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.422 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 87.8 m-85 -121.27 123.69 42.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.8 p90 -144.57 150.35 37.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.991 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.493 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 15.6 pt-20 -95.51 142.2 28.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.689 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.621 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 6.4 pt-20 -118.72 102.51 8.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.472 0.653 . . . . 0.0 110.451 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -110.23 122.73 37.88 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.93 116.72 2.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.78 2.32 . . . . 0.0 112.532 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.83 13.71 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.023 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.77 140.26 20.9 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 159.52 31.5 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.827 2.352 . . . . 0.0 111.602 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 24.8 mmtp -71.05 119.93 15.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.87 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -112.97 129.25 56.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.186 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 61' ' ' ILE . 12.9 mt -62.49 126.63 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.974 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -113.46 -17.19 8.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.532 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.13 140.65 1.2 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.542 0.687 . . . . 0.0 111.873 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.471 HD13 HD11 ' A' ' 58' ' ' LEU . 4.7 mp -117.49 111.93 36.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 167.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.632 ' O ' HG22 ' A' ' 45' ' ' VAL . 6.8 t -129.03 147.52 50.9 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.552 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.9 ptpt -148.18 163.22 37.64 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.65 137.88 32.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.447 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -48.72 8.15 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.085 0.866 . . . . 0.0 112.538 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 38.5 t -97.45 140.69 22.16 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.77 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 98.5 Cg_endo -81.65 5.21 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.876 2.384 . . . . 0.0 112.532 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.2 t -123.94 -62.33 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.378 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 66' ' ' SER . 36.7 m-70 -95.29 156.29 16.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.812 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.7 t -99.03 121.55 41.11 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -119.13 -78.73 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -135.56 172.48 12.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 11.5 mt -102.93 120.56 40.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 0.0 110.532 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.634 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.2 mmpt? -100.87 103.67 14.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 8.4 m -106.51 155.51 19.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.67 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -142.57 165.91 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 55.22 45.71 25.25 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.763 0.664 . . . . 0.0 111.487 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 83' ' ' SER . 85.0 mt -68.19 144.98 54.73 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -99.18 58.53 1.11 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.931 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.3 -86.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.103 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.54 -22.89 68.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.632 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.8 m-85 -86.29 112.02 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.51 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.465 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.1 m -136.97 169.2 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.639 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -103.19 167.58 9.73 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.003 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.16 -108.35 1.07 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.18 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -115.32 -169.04 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.633 0.254 . . . . 0.0 110.531 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.6 m -135.7 143.52 45.45 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 12.1 p -139.83 -144.06 0.17 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -172.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.635 ' HB3' HD22 ' A' ' 24' ' ' ASN . 33.0 t70 53.48 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.201 1.0 . . . . 0.0 113.498 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.472 ' H ' HG21 ' A' ' 90' ' ' VAL . 3.2 m -70.42 -45.08 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.53 ' H ' HD22 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -89.84 -37.75 14.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.671 0.272 . . . . 0.0 111.33 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.898 -175.138 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 68' ' ' VAL . 15.4 m . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.579 0.228 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.7 m-85 -87.49 148.46 24.92 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.021 0.439 . . . . 0.0 110.247 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -144.75 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.819 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.736 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.99 143.38 44.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.692 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 8.1 p -152.76 155.45 37.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.106 0.479 . . . . 0.0 112.091 -173.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.84 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -80.88 113.34 19.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.816 175.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -79.76 121.12 24.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 12.4 m170 -90.53 132.2 35.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.918 0.39 . . . . 0.0 111.492 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.94 129.27 46.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.44 123.45 48.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.282 0.563 . . . . 0.0 110.543 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -102.2 149.78 23.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.59 100.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.69 -56.91 0.72 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.364 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -159.8 178.49 9.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 111.452 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -61.47 129.56 41.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.323 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -90.83 -55.75 3.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.88 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.21 -179.4 44.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.831 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.0 t -153.69 146.0 23.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.16 0.48 . . . . 0.0 111.348 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 45' ' ' VAL . 3.7 mp -129.0 127.35 65.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.7 ttp180 -86.6 111.98 21.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.015 0.436 . . . . 0.0 110.413 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HG2' HG23 ' A' ' 37' ' ' ILE . 37.9 mmtm -141.02 153.76 45.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.792 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.736 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 50.3 mtpt -69.98 155.91 39.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.744 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.16 141.39 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.831 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.877 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 89.73 -22.14 26.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.964 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.57 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 92.1 m95 -91.86 130.71 37.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.461 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -68.11 130.66 43.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.8 p -113.8 151.04 15.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.351 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -104.67 137.38 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.195 0.522 . . . . 0.0 111.407 -175.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.11 120.76 32.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.608 ' HE2' ' HD3' ' A' ' 56' ' ' LYS . 49.3 p90 -151.19 146.12 25.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -87.0 129.0 35.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 109.973 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.763 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -106.3 132.67 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.501 177.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 32.9 mmtm -131.82 113.3 15.08 Favored Pre-proline 0 C--N 1.315 -0.932 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.03 117.52 3.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.177 2.585 . . . . 0.0 113.053 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.32 -4.21 86.23 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.453 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -118.88 158.32 48.05 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 122.666 0.387 . . . . 0.0 109.976 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.29 154.69 65.41 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.437 2.091 . . . . 0.0 112.342 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.763 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 74.9 mttt -106.55 150.61 25.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.471 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -130.4 137.17 49.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.529 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.574 HD12 HD13 ' A' ' 61' ' ' ILE . 8.5 mt -69.85 115.44 9.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.529 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.629 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 20.8 m -85.7 -21.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.99 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.517 ' HB3' HD22 ' A' ' 78' ' ' LEU . . . 176.85 140.81 0.07 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-O 121.589 0.709 . . . . 0.0 111.794 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.574 HD13 HD12 ' A' ' 58' ' ' LEU . 4.6 mp -102.07 115.37 43.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.5 t -131.93 152.76 50.88 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.388 -169.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.645 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.3 ptpp? -153.14 163.27 40.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -81.04 135.56 35.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.4 -59.25 2.2 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.048 0.843 . . . . 0.0 112.624 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.7 t -87.17 135.22 35.12 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.213 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.877 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 4.0 Cg_exo -78.78 2.12 8.49 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.385 2.723 . . . . 0.0 112.059 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.0 t -119.06 -64.48 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.035 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 66' ' ' SER . 44.1 m80 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.039 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t -100.01 128.29 46.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -123.06 -82.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.298 0.57 . . . . 0.0 109.689 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.35 178.26 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.005 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.738 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 26.7 mt -103.48 124.56 48.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.894 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -109.19 107.21 17.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.297 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.559 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.8 m -110.4 149.74 29.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.075 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -124.27 155.51 38.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.6 t30 60.74 53.53 3.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.526 0.679 . . . . 0.0 110.152 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 75' ' ' CYS . 85.1 mt -72.95 139.34 46.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.298 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.859 ' HB1' ' HB2' ' A' ' 82' ' ' PHE . . . -91.56 45.29 1.22 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.583 0.23 . . . . 0.0 110.946 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 56.77 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.666 0.786 . . . . 0.0 112.054 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.72 -15.29 61.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.137 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.859 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 96.5 m-85 -99.64 106.69 18.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.015 0.436 . . . . 0.0 110.253 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.46 ' HA ' HD23 ' A' ' 78' ' ' LEU . 15.8 m -129.02 167.03 18.07 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.528 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -108.33 154.56 21.64 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.198 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.09 -126.57 3.42 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.06 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 p -96.82 -168.41 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.391 0.615 . . . . 0.0 111.814 -174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 49.7 m -136.33 141.53 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.024 172.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 25.4 p -142.28 -156.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.331 -174.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.762 ' HB3' HD22 ' A' ' 24' ' ' ASN . 32.6 t70 63.86 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.615 0.766 . . . . 0.0 112.157 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -66.88 -41.55 87.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.601 ' H ' HD22 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.32 -24.88 20.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.77 0.319 . . . . 0.0 111.056 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.762 -176.309 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 51.6 p90 -89.91 146.25 24.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.72 140.04 21.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.335 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.763 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 12.4 pt20 -104.43 150.12 24.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.613 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' HA ' HG22 ' A' ' 90' ' ' VAL . 9.2 p -154.48 155.56 35.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.356 0.598 . . . . 0.0 111.399 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.924 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -76.74 108.98 10.14 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.437 ' C ' ' HG1' ' A' ' 36' ' ' THR . 0.4 OUTLIER -76.62 118.69 19.52 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 14.4 m-70 -88.41 126.4 35.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.473 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 1.1 tm? -99.87 121.21 40.96 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 130.01 54.02 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.554 0.692 . . . . 0.0 111.497 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -106.95 151.17 25.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.743 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.33 100.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.313 0.383 . . . . 0.0 110.16 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 32' ' ' ARG . . . 138.58 -51.69 0.76 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.941 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.679 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 7.5 tpp180 176.49 179.56 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.452 0.301 . . . . 0.0 110.249 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.679 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.6 t-80 -41.05 130.98 2.64 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.722 0.809 . . . . 0.0 111.966 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.584 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 39.4 t90 -104.61 -53.9 2.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.75 164.88 34.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.189 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 25' ' ' HIS . 7.1 t -153.95 137.26 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.506 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.521 ' HB ' HG21 ' A' ' 45' ' ' VAL . 2.3 mp -115.65 132.38 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.67 98.74 4.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.78 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.24 148.95 43.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 110.407 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 51.3 mtpt -64.52 153.36 39.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.47 139.56 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.564 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 1.016 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 92.49 -38.85 3.09 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.023 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -66.58 125.39 25.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.912 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.5 122.58 22.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.51 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.521 HG21 ' HB ' ' A' ' 37' ' ' ILE . 8.4 p -109.39 147.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.085 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 134.35 40.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.354 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.473 ' CD1' ' HB2' ' A' ' 27' ' ' LEU . 90.2 m-85 -122.05 127.3 50.05 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.7 147.98 30.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.584 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 9.4 pt-20 -86.94 130.36 34.49 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.913 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 47.5 mt-10 -108.23 102.29 11.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.266 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.828 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 34.4 mmtp -99.36 129.69 28.66 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.415 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 116.36 3.27 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.349 2.033 . . . . 0.0 112.265 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.65 90.42 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.828 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 53.8 mt-30 -125.71 157.36 68.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 C-N-CA 122.381 0.272 . . . . 0.0 110.343 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.26 160.69 48.13 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.393 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 55.1 mttt -103.55 136.64 42.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.337 -173.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -132.91 135.77 45.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.677 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.5 119.93 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.558 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 32.2 m -92.69 -27.01 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.466 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.517 ' CB ' HD22 ' A' ' 78' ' ' LEU . . . 177.7 144.25 0.1 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.727 0.642 . . . . 0.0 111.261 173.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.1 mp -102.93 111.93 34.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.492 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.7 m -116.96 146.49 42.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.932 0.396 . . . . 0.0 111.136 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.912 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.5 pttm -155.13 161.56 41.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.491 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 9.0 t30 -80.19 143.21 33.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.301 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.2 -57.04 3.14 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.062 0.852 . . . . 0.0 112.044 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.7 m -94.74 138.77 22.12 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.406 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 1.016 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.5 Cg_endo -82.98 23.52 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.143 2.562 . . . . 0.0 112.008 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 4.0 t -136.34 -73.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.68 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -85.13 159.92 20.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.13 125.71 48.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.985 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -123.64 -79.34 0.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.27 174.45 10.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 85' ' ' GLY . 50.1 mt -101.28 122.51 43.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.464 0.65 . . . . 0.0 111.381 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.733 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.6 mmpt? -93.59 106.91 18.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.356 172.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 8.1 t -121.58 166.1 14.71 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.298 -177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.56 HG21 HD21 ' A' ' 77' ' ' ASN . 11.4 t -159.94 162.19 34.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.073 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.56 HD21 HG21 ' A' ' 76' ' ' THR . 50.3 m-80 68.67 33.56 3.78 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.78 0.675 . . . . 0.0 110.256 -176.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 83' ' ' SER . 93.1 mt -59.86 139.58 57.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -97.55 65.09 1.87 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.0 111.484 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.84 -88.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.151 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.19 -21.8 77.38 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.898 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.8 m-85 -88.43 109.66 20.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.937 0.398 . . . . 0.0 110.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.865 ' HA ' HD23 ' A' ' 78' ' ' LEU . 17.0 m -128.54 173.62 10.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.58 158.79 19.53 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.69 -0.631 . . . . 0.0 110.667 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.486 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -123.11 -151.14 8.22 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.19 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -84.15 -176.69 6.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.855 0.359 . . . . 0.0 110.186 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.1 m -120.72 142.94 49.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 66.7 p -139.55 -156.04 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.731 0.301 . . . . 0.0 111.75 -170.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.924 ' HB3' HD22 ' A' ' 24' ' ' ASN . 21.9 t70 63.61 -77.03 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.99 0.916 . . . . 0.0 112.547 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 23' ' ' CYS . 2.5 m -68.08 -46.61 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 23' ' ' CYS . 3.8 pp -90.7 -41.35 11.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.712 0.291 . . . . 0.0 111.648 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.403 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 79.7 m-85 -76.37 134.21 39.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 p -135.57 136.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.388 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.735 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -101.99 141.54 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.58 ' HA ' HG22 ' A' ' 90' ' ' VAL . 7.1 p -144.09 148.86 35.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.416 0.627 . . . . 0.0 112.105 -170.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.857 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -74.77 106.61 6.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.169 175.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.51 121.74 21.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.2 130.81 37.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.29 -174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.504 HD21 ' CG ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -100.2 124.13 45.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.409 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.98 125.65 49.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.253 0.549 . . . . 0.0 110.686 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 50.9 t80 -113.32 151.27 31.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -53.34 100.92 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.715 0.634 . . . . 0.0 110.379 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -52.16 0.82 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.241 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 20.9 tpt180 -172.74 171.77 4.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.743 0.272 . . . . 0.0 110.822 -175.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.626 ' HE2' ' HB ' ' A' ' 36' ' ' THR . 23.7 t-80 -46.31 121.38 3.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.325 0.65 . . . . 0.0 111.289 172.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 57.9 t90 -89.93 -56.14 3.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.99 170.8 34.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.563 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.626 ' HB ' ' HE2' ' A' ' 33' ' ' HIS . 6.6 t -154.42 143.92 21.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.09 0.445 . . . . 0.0 110.758 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.11 130.23 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.614 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.2 mtm180 -82.32 117.83 22.7 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.362 0.601 . . . . 0.0 110.726 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HG3' HG22 ' A' ' 45' ' ' VAL . 72.6 mmtt -142.52 152.61 42.82 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.3 mtpt -69.16 156.74 38.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.023 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 140.3 58.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.418 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 89.98 -25.1 12.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.228 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.524 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 49.8 m95 -83.13 130.05 35.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 0.0 110.634 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.897 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -79.03 123.38 27.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.705 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.7 p -106.15 154.26 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.981 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.8 140.99 29.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CG ' HD21 ' A' ' 27' ' ' LEU . 75.6 m-85 -131.33 123.68 28.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -142.14 149.85 40.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.933 0.397 . . . . 0.0 111.265 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 11.1 pt-20 -87.41 130.04 34.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.728 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 56' ' ' LYS . 29.8 mt-10 -114.04 101.91 9.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.152 0.501 . . . . 0.0 109.827 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 71.6 mmtt -82.9 134.74 46.24 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.896 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.55 117.05 3.53 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.54 2.16 . . . . 0.0 112.358 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.06 80.55 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.482 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.765 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 33.3 mt-30 -115.67 162.04 27.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 122.498 0.319 . . . . 0.0 110.772 -175.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 54' ' ' GLN . 57.5 Cg_endo -70.95 159.2 53.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.88 2.387 . . . . 0.0 112.803 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.778 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.4 146.39 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 -178.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -137.63 131.65 31.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.49 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.494 HD23 HG13 ' A' ' 61' ' ' ILE . 9.1 mt -58.22 119.6 7.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.012 0.434 . . . . 0.0 112.046 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.4 m -100.09 -15.71 7.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.396 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.32 135.77 0.58 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.581 0.705 . . . . 0.0 111.821 176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.494 HG13 HD23 ' A' ' 58' ' ' LEU . 5.0 mp -107.74 112.29 39.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.1 t -131.53 149.72 52.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.728 -169.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.897 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 pttp -155.39 163.43 40.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.42 139.22 34.13 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.318 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.38 -55.71 4.78 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.818 0.698 . . . . 0.0 112.179 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.9 t -95.86 146.64 31.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.212 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 3.5 Cg_exo -82.45 -1.19 10.54 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.157 2.572 . . . . 0.0 111.972 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.7 t -103.96 -79.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -94.27 165.04 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.155 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.1 121.97 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -119.55 -85.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.275 0.56 . . . . 0.0 109.593 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -126.31 166.34 17.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.914 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.763 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 14.2 mt -102.99 123.39 46.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.0 110.638 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -98.88 104.65 16.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.808 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 m -112.84 146.1 39.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.427 . . . . 0.0 110.658 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -129.23 155.45 45.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.874 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.4 60.2 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.691 0.619 . . . . 0.0 110.37 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 83' ' ' SER . 91.3 mt -77.6 157.91 30.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.364 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -115.46 71.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.743 0.306 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.96 -92.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.171 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.16 55.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.994 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 96.6 m-85 -72.65 109.56 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.314 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.562 ' HA ' HD23 ' A' ' 78' ' ' LEU . 19.6 m -140.97 166.71 24.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.53 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -103.56 168.49 9.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.045 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -139.0 -171.49 12.19 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.049 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -69.16 169.77 11.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.463 0.649 . . . . 0.0 111.622 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.4 m -105.76 153.84 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.669 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.5 p -139.88 -156.44 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.047 -175.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.857 ' HB3' HD22 ' A' ' 24' ' ' ASN . 4.1 t70 62.61 -80.17 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 23' ' ' CYS . 1.3 m -66.06 -41.62 89.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.222 -175.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.569 ' H ' HD22 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.464 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.387 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 17.8 p90 -58.5 131.15 49.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.284 0.564 . . . . 0.0 110.589 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.35 139.78 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.92 -170.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.656 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -99.7 143.34 30.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.659 175.083 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' HD22 ' A' ' 91' ' ' LEU . 7.5 p -151.72 159.19 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.886 0.374 . . . . 0.0 111.463 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.815 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -82.16 117.25 22.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -85.16 119.44 25.55 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -90.57 130.37 36.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.829 0.347 . . . . 0.0 111.206 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.534 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -98.1 126.1 43.39 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -110.02 116.53 31.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.575 0.703 . . . . 0.0 110.68 -175.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -94.95 135.12 36.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.8 101.92 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.446 0.641 . . . . 0.0 110.281 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.73 -56.29 0.61 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.607 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -175.4 161.69 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.492 0.317 . . . . 0.0 110.727 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -37.86 132.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.908 0.883 . . . . 0.0 112.195 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -100.79 -54.8 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.593 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.99 -179.33 40.49 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.338 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -153.83 147.7 25.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.031 0.416 . . . . 0.0 111.354 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.4 mp -134.02 136.6 53.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 46.0 mtm180 -77.71 130.17 36.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.294 0.568 . . . . 0.0 111.36 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -150.39 148.22 28.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.542 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.656 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 46.6 mtpt -73.97 149.94 41.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.069 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 66' ' ' SER . . . -61.6 138.92 58.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.59 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 93.75 -23.7 29.53 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.143 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -101.44 136.16 41.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.817 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -82.57 155.07 24.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.495 0.664 . . . . 0.0 111.117 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.6 p -126.92 150.19 32.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.585 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 135.77 33.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.421 . . . . 0.0 111.301 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.693 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.2 m-85 -125.9 128.27 47.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 169.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 49.9 p90 -146.18 153.75 40.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.396 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -100.04 136.64 39.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -115.68 110.85 19.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.567 0.699 . . . . 0.0 111.474 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.2 105.28 42.39 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -44.29 121.63 3.24 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.324 2.682 . . . . 0.0 112.683 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.27 -24.15 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.65 151.43 57.08 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.004 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.72 149.25 54.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.227 1.952 . . . . 0.0 111.049 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 51.8 mttt -77.24 119.0 20.29 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.823 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 19.5 tpp180 -94.1 133.77 37.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.356 -168.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.445 HD23 HG13 ' A' ' 61' ' ' ILE . 6.8 mt -62.29 107.78 0.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.195 0.522 . . . . 0.0 110.28 174.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.2 m -91.56 -22.71 6.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.295 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -168.68 135.53 1.9 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 111.684 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.445 HG13 HD23 ' A' ' 58' ' ' LEU . 4.7 mp -105.11 111.18 33.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.7 t -132.88 146.45 51.82 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.899 -168.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.817 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 29.6 pttt -145.25 164.92 29.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.955 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -78.27 136.81 37.83 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.799 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.67 -37.77 19.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.474 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 22.1 t -105.62 140.74 21.48 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.06 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.59 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 4.2 Cg_exo -77.83 4.35 6.16 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.022 2.482 . . . . 0.0 111.943 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.1 t -121.4 -77.33 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.68 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 66' ' ' SER . 52.8 m80 -94.06 163.75 13.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 p -96.7 125.38 41.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.415 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 50.6 m-20 -123.21 -87.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.415 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 33.9 m-85 -129.24 177.56 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.018 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.747 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.3 mt -103.17 125.12 49.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.153 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -106.85 106.26 16.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.034 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -115.56 150.44 36.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.022 -174.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -119.68 150.57 40.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 7.2 t30 64.74 103.84 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.705 0.628 . . . . 0.0 110.722 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 83' ' ' SER . 98.1 mt -117.98 127.63 54.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -91.26 76.8 5.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.633 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.06 -88.52 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.456 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.36 -6.36 61.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.061 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.3 m-85 -94.24 115.84 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.893 0.378 . . . . 0.0 110.809 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.494 ' HA ' HD23 ' A' ' 78' ' ' LEU . 17.2 m -144.98 168.64 19.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.485 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -99.86 154.77 18.08 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -110.67 -58.97 0.49 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.603 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.26 -178.32 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.9 m -126.9 141.36 51.83 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.45 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.7 p -142.32 -155.96 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.16 0.505 . . . . 0.0 111.812 -172.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.815 ' HB3' HD22 ' A' ' 24' ' ' ASN . 26.8 t70 66.95 -83.45 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.113 168.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 7.3 m -71.07 -33.36 51.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.843 0.354 . . . . 0.0 111.027 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.526 HD22 ' CB ' ' A' ' 23' ' ' CYS . 4.1 pp -88.73 -31.94 18.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 CA--C 1.532 0.287 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.84 -175.542 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 18.2 p90 -86.79 131.41 34.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 70' ' ' CYS . 1.8 p -121.43 142.11 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.895 -168.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 1.033 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.28 147.53 25.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 10.6 p -149.49 147.91 28.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.454 0.645 . . . . 0.0 112.405 -175.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 1.014 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -72.39 110.66 6.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.753 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 5.4 m80 -75.85 107.28 7.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.802 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.489 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 12.3 m-70 -79.68 126.63 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.106 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.506 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -99.33 125.26 44.96 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.55 125.42 51.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.472 0.653 . . . . 0.0 110.978 -176.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -100.14 151.13 21.77 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -48.29 101.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.458 0.474 . . . . 0.0 111.009 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.5 -53.03 0.68 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.235 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -147.85 160.95 42.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.457 0.646 . . . . 0.0 112.67 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -48.78 133.05 17.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.177 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -102.91 -55.48 2.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.127 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -177.9 38.01 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.459 ' HG1' ' C ' ' A' ' 25' ' ' HIS . 5.6 t -153.92 141.44 19.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.204 0.502 . . . . 0.0 110.037 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.31 123.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 6.1 tpp85 -75.84 99.4 4.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.841 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -145.02 145.76 31.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.133 0.492 . . . . 0.0 111.365 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 1.033 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 12.7 ptmt -64.69 151.82 43.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.002 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.93 142.57 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.866 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.88 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.62 -30.61 10.01 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.316 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.565 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 76.2 m95 -90.17 139.68 30.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.21 130.59 40.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.957 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.3 p -121.46 153.43 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.141 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.73 142.39 28.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 111.059 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.753 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 77.3 m-85 -127.89 133.81 49.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 170.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.581 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 45.6 p90 -148.92 151.05 33.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.706 0.289 . . . . 0.0 110.689 -175.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.29 143.78 27.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.611 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.923 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 11.3 pt-20 -126.67 102.02 6.89 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.933 0.873 . . . . 0.0 111.158 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.17 128.15 41.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.02 116.94 2.71 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.57 2.18 . . . . 0.0 112.487 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.53 -29.27 12.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.372 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -96.54 153.09 38.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.24 153.4 74.59 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.588 2.192 . . . . 0.0 111.732 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.923 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 21.1 mmtp -70.57 117.7 12.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.43 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -105.81 125.67 51.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.598 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mt -57.02 120.83 8.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 110.784 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.1 m -107.74 -17.74 7.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.35 138.41 0.94 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.48 0.657 . . . . 0.0 111.62 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.8 mp -108.26 112.38 40.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 168.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -130.69 150.89 51.67 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.953 -168.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.1 ptpp? -151.28 162.74 40.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.44 144.61 31.27 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.43 -56.96 5.13 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.767 0.667 . . . . 0.0 111.918 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -97.05 143.06 25.48 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.585 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.88 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 Cg_endo -83.81 22.19 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.25 2.633 . . . . 0.0 112.343 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.0 t -136.03 -76.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -81.28 159.55 24.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.413 ' HB2' HG11 ' A' ' 21' ' ' VAL . 23.7 t -98.81 122.32 41.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.998 0.427 . . . . 0.0 109.957 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -112.09 -83.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.591 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -145.76 179.99 7.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.838 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.721 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 16.3 mt -101.75 121.78 42.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -100.6 104.87 16.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.013 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 m -116.57 149.22 40.0 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.91 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -128.17 156.32 43.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 63.74 59.34 1.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.752 0.658 . . . . 0.0 110.286 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 83' ' ' SER . 94.6 mt -77.84 131.63 37.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.428 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -90.33 66.65 6.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 111.538 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.2 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.107 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.47 -10.15 83.85 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.089 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.7 m-85 -96.43 114.14 25.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.612 ' HA ' HD23 ' A' ' 78' ' ' LEU . 38.6 m -143.98 172.82 12.34 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -106.98 162.64 13.66 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.55 -126.91 3.95 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.02 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 14.1 t -104.4 -176.37 3.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.642 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 3.9 p -132.52 141.82 48.93 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.41 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 28.8 p -142.67 -157.58 0.79 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.962 0.41 . . . . 0.0 111.967 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 1.014 ' HB3' HD22 ' A' ' 24' ' ' ASN . 21.1 t70 72.21 -62.43 0.46 Allowed 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.799 168.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.626 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 1.5 m -85.07 -31.89 7.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.481 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 23' ' ' CYS . 4.1 pp -89.77 -34.66 16.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.667 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.1 p . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.37 -178.736 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.717 0.294 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.661 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 39.1 p90 -88.8 139.59 30.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -120.71 138.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.571 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.766 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -98.71 142.36 30.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.689 175.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.56 ' HA ' HG22 ' A' ' 90' ' ' VAL . 7.6 p -155.68 159.45 39.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 111.613 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.965 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -80.38 111.78 17.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.099 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HD2' HG11 ' A' ' 45' ' ' VAL . 3.3 m-70 -81.82 115.95 21.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -87.85 129.65 35.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.5 tm? -98.6 127.78 44.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -103.64 121.72 43.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.71 -175.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 85.4 t80 -94.31 141.29 28.73 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -54.78 101.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 110.699 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.57 -42.9 1.39 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.361 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -168.86 153.09 5.62 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.018 0.437 . . . . 0.0 111.672 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -38.55 126.22 1.43 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.07 0.948 . . . . 0.0 112.538 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.6 t90 -94.25 -55.77 3.07 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.98 -175.07 37.42 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.781 -0.724 . . . . 0.0 111.899 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.6 t -154.39 147.89 25.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.055 0.428 . . . . 0.0 110.882 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.441 HD13 ' CE1' ' A' ' 47' ' ' PHE . 3.3 mp -124.4 126.22 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 2.9 tpp180 -77.84 93.7 4.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -127.7 144.54 51.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.766 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 36.4 mtpt -70.72 151.86 44.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.65 142.05 57.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.47 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 91.88 -27.94 9.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.157 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 27.1 m95 -84.52 128.28 34.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.696 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.08 135.07 46.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.475 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' A' ' 25' ' ' HIS . 7.3 p -121.56 142.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.841 0.353 . . . . 0.0 110.764 -176.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.14 141.81 28.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 73.9 m-85 -130.65 134.98 47.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.46 167.75 21.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.733 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 15.5 pt-20 -107.54 125.39 51.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.422 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.542 ' HG2' ' HZ2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -117.52 121.67 41.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -129.73 149.97 74.47 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.24 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.13 117.81 3.96 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.447 2.765 . . . . 0.0 112.737 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.29 -13.43 45.64 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.888 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.75 142.38 25.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.965 0.412 . . . . 0.0 111.549 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.1 155.49 67.95 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.834 2.356 . . . . 0.0 111.568 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.604 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.487 -176.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -130.52 144.16 51.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.54 130.85 48.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.465 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' A' ' 49' ' ' GLU . 33.5 m -117.2 -20.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -166.73 137.67 3.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.433 0.635 . . . . 0.0 111.137 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.6 mp -109.54 110.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 169.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.688 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.9 t -130.52 168.16 17.5 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.863 -167.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.696 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 19.5 pttp -174.45 163.83 3.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.606 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.1 133.42 44.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.59 -41.9 10.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 114.009 -1.451 . . . . 0.0 113.177 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.9 t -102.15 138.15 19.66 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.191 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.547 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.3 Cg_endo -75.89 1.43 8.16 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.642 2.228 . . . . 0.0 111.792 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.5 t -118.81 -78.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.555 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.526 ' O ' ' HB3' ' A' ' 66' ' ' SER . 45.7 m-70 -89.91 162.53 15.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.2 t -97.25 129.12 44.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.067 0.46 . . . . 0.0 110.446 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -125.49 -81.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -139.67 174.82 10.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.828 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.632 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.9 mt -103.6 120.57 41.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.721 0.296 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -106.54 110.53 22.75 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 1.9 m -112.81 149.78 32.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.357 -173.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -111.8 150.61 30.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 9.5 t30 59.62 90.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.675 0.61 . . . . 0.0 110.473 -174.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.0 117.4 34.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -84.21 61.74 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.046 0.451 . . . . 0.0 111.352 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.57 -91.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.265 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 5.31 84.73 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.41 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 98.6 m-85 -114.43 108.84 17.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 0.0 110.139 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 m -147.29 166.52 26.84 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -100.32 153.78 19.02 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.321 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.66 -63.82 0.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.486 -171.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 t -175.91 -169.94 0.36 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 m -129.09 143.39 50.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 49.0 p -140.23 -152.51 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.995 -0.093 . . . . 0.0 110.97 -174.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.965 ' HB3' HD22 ' A' ' 24' ' ' ASN . 16.6 t70 63.0 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.962 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -69.12 -45.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.723 0.297 . . . . 0.0 111.778 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.02 -24.33 22.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 111.259 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.4 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -175.647 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.7 m-85 -47.82 130.01 14.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.309 0.576 . . . . 0.0 110.799 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.75 143.77 34.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.266 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.911 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -99.3 142.43 30.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.14 177.14 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 6.0 p -148.84 146.21 27.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.512 . . . . 0.0 111.846 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.993 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -77.27 115.52 17.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 110.302 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.4 124.49 29.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.281 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.662 ' HA ' ' HG1' ' A' ' 36' ' ' THR . 10.8 m170 -94.25 126.27 39.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.92 0.39 . . . . 0.0 111.533 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.475 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -97.89 127.89 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -105.07 128.86 53.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.929 -175.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.611 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 73.3 t80 -104.26 148.22 26.6 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.05 99.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.0 109.756 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -49.83 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.626 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -173.99 175.35 2.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.526 0.203 . . . . 0.0 110.619 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.693 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 44.9 t-80 -54.3 139.14 37.36 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.794 0.438 . . . . 0.0 110.945 176.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 60.9 t90 -107.42 -56.01 2.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.736 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.78 167.45 33.16 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.035 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.662 ' HG1' ' HA ' ' A' ' 26' ' ' HIS . 0.9 OUTLIER -151.89 136.78 17.2 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 120.99 0.424 . . . . 0.0 112.025 -176.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.401 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.5 mp -126.2 132.78 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.957 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.843 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 34.9 ttp180 -94.21 113.92 25.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 37' ' ' ILE . 73.9 mmtt -138.1 153.95 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.298 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.911 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.9 mtpt -68.06 157.84 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 111.251 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 66' ' ' SER . . . -69.87 142.47 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.41 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.24 10.98 81.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.487 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -116.75 156.44 27.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . . . -90.55 120.44 31.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.407 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 62' ' ' CYS . 14.7 p -105.38 141.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.569 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 133.61 39.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.182 0.515 . . . . 0.0 110.671 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CG ' HD21 ' A' ' 27' ' ' LEU . 66.5 m-85 -125.65 125.14 42.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.681 ' HB3' HD21 ' A' ' 58' ' ' LEU . 42.6 p90 -147.32 148.03 30.96 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.998 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.6 125.19 34.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.57 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 8.8 pt-20 -128.54 102.78 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.02 0.914 . . . . 0.0 110.019 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -104.13 118.24 57.48 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.572 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -42.92 117.34 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.694 2.929 . . . . 0.0 113.067 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.18 -20.83 32.4 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.012 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 47.5 mt-30 -115.84 143.4 30.69 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.654 0.264 . . . . 0.0 110.91 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 24.4 Cg_exo -64.56 161.99 32.98 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.215 2.61 . . . . 0.0 111.93 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 27.9 mttm -90.93 143.43 26.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.116 -169.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.595 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -134.53 133.29 40.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 48' ' ' TYR . 13.3 mt -64.09 126.67 28.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 0.0 111.052 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 20.5 m -113.02 -17.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -171.18 135.53 0.99 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.484 0.659 . . . . 0.0 111.799 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.589 HD13 HD11 ' A' ' 58' ' ' LEU . 4.5 mp -113.17 112.13 39.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 167.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -120.56 146.12 46.64 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.356 -166.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.509 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 24.9 mmtm -120.01 164.67 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 70' ' ' CYS . 9.9 t30 -93.66 137.06 33.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.6 -55.28 1.89 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.115 0.884 . . . . 0.0 112.679 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 39.9 t -103.12 141.62 22.86 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.823 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.48 -10.55 13.3 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.591 2.194 . . . . 0.0 111.649 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 16.2 t -100.32 -59.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.497 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -104.96 164.52 11.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.407 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.421 ' HA ' HD22 ' A' ' 64' ' ' ASN . 5.9 p -100.87 122.02 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.302 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.87 -90.09 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.111 0.481 . . . . 0.0 110.709 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -131.37 176.52 8.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.448 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.792 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.7 mt -105.79 128.41 53.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -170.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -109.41 105.26 14.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.772 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 1.7 m -119.94 152.68 37.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.973 -171.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 t -124.45 174.1 8.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.18 34.49 21.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.636 0.585 . . . . 0.0 111.606 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.614 HD23 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -66.08 131.01 45.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.795 -176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -100.92 68.15 1.26 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.674 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.07 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.538 0.735 . . . . 0.0 112.821 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.12 -14.05 83.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.966 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 98.1 m-85 -96.92 111.42 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.994 0.426 . . . . 0.0 110.753 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.614 ' HA ' HD23 ' A' ' 78' ' ' LEU . 45.1 m -148.51 168.53 22.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.718 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -112.1 154.61 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.872 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -106.31 -79.22 1.23 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.895 -171.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 13.4 t -161.1 -174.91 4.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 27.8 m -116.06 144.04 44.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 39.9 p -139.75 -155.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.103 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.993 ' HB3' HD22 ' A' ' 24' ' ' ASN . 20.9 t70 66.67 -81.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.593 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -65.23 -40.91 90.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.813 0.339 . . . . 0.0 111.591 -175.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.8 -30.24 19.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.668 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.661 -178.699 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.611 ' HD1' ' H ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -85.32 125.81 33.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -132.93 139.44 49.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.865 -172.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.67 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -101.51 142.15 33.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.844 ' HA ' HG22 ' A' ' 90' ' ' VAL . 26.1 p -143.69 150.14 38.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.316 -172.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.911 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -74.31 114.4 12.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 175.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.504 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -83.18 113.79 20.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.601 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -85.39 127.37 34.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.173 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 28' ' ' LEU . 1.5 tm? -100.06 132.44 45.42 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -99.46 124.67 44.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.599 -178.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.921 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.8 t80 -93.61 150.0 20.78 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -53.74 99.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 110.309 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.85 -68.32 0.46 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.189 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -142.89 179.19 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 112.128 -171.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -47.71 133.85 13.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.801 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.921 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 83.8 t90 -103.15 -56.62 2.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.17 -178.57 42.49 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.022 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.687 ' HG1' ' HB2' ' A' ' 24' ' ' ASN . 13.3 t -153.11 138.7 17.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.631 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.2 mp -116.11 129.89 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.571 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.663 HH11 HG12 ' A' ' 90' ' ' VAL . 2.3 tpp180 -80.84 99.84 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.419 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.0 mmtm -140.9 152.95 45.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.224 0.535 . . . . 0.0 111.385 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.4 mtpt -67.18 154.97 39.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.826 -176.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 54.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.187 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 91.94 -26.63 12.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.177 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -81.14 134.73 35.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.007 0.432 . . . . 0.0 110.842 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.654 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -78.21 121.75 24.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.972 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.1 p -111.87 147.31 15.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 141.72 28.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 -176.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.727 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.0 m-85 -127.56 138.29 52.84 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 22.4 p90 -153.33 159.63 42.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 -172.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.48 137.37 44.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 56' ' ' LYS . 22.9 mt-10 -112.5 102.0 10.13 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -90.56 143.59 29.38 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.57 116.51 3.34 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.512 2.141 . . . . 0.0 111.788 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.07 -17.74 57.68 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.292 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -101.56 148.43 35.22 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.63 153.41 59.82 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 110.615 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.54 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 15.6 mttp -62.61 127.85 33.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.08 -173.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -103.82 119.97 40.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.89 115.53 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.638 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 25.9 m -96.88 -22.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.614 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 47' ' ' PHE . . . 176.27 144.61 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.612 0.57 . . . . 0.0 111.315 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.4 mp -101.73 116.98 46.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.727 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.6 t -128.63 149.42 50.66 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.321 -171.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.2 ptpt -144.26 162.29 36.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -85.71 133.69 34.0 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.166 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.29 -53.51 5.17 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.092 0.87 . . . . 0.0 112.959 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 33.2 t -93.46 139.59 22.93 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.318 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 71.7 Cg_endo -78.87 -3.51 13.28 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.594 2.196 . . . . 0.0 111.827 173.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -111.33 -69.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.423 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 66' ' ' SER . 35.6 m80 -94.79 161.8 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.004 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.0 p -98.51 121.17 40.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -121.41 -88.48 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 0.0 109.707 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.04 171.23 12.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.47 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.673 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 37.8 mt -103.71 119.93 39.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.869 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.9 mmpt? -96.05 104.47 16.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 30.7 m -100.87 152.88 20.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.033 0.444 . . . . 0.0 111.361 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -133.39 157.86 44.48 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.553 173.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.463 HD21 HD11 ' A' ' 61' ' ' ILE . 90.6 m-20 59.43 49.57 8.56 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.469 0.481 . . . . 0.0 111.066 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.87 140.81 58.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 59' ' ' VAL . . . -96.91 79.0 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.944 0.402 . . . . 0.0 110.76 -178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 67.67 -77.7 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.798 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.83 -13.1 6.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.955 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 50.6 m-85 -71.22 118.09 13.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -151.2 171.59 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.705 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . . . -92.24 163.24 13.99 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.752 0.311 . . . . 0.0 110.56 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.24 -62.64 0.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.511 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.11 -171.44 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.8 m -129.83 143.18 50.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.424 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 41.6 p -141.66 -160.74 1.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.698 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.911 ' HB3' HD22 ' A' ' 24' ' ' ASN . 19.5 t70 64.51 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.388 171.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.844 HG22 ' HA ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -62.25 -38.29 80.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.901 0.382 . . . . 0.0 111.206 -176.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.22 -37.91 15.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.733 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.53 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.03 -179.45 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.6 m-85 -53.32 141.22 24.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.941 0.4 . . . . 0.0 110.419 173.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.661 HG11 ' HG ' ' A' ' 70' ' ' CYS . 1.5 p -142.39 133.7 25.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.606 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -96.52 145.66 25.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 21.6 p -150.23 149.1 29.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.486 0.66 . . . . 0.0 111.876 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.884 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.53 114.37 14.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.857 173.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.447 ' C ' ' HG1' ' A' ' 36' ' ' THR . 0.3 OUTLIER -80.04 117.96 21.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -87.06 134.09 33.53 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.804 0.335 . . . . 0.0 111.895 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.564 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -99.55 123.59 43.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.78 122.29 45.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.475 0.655 . . . . 0.0 110.858 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -95.35 146.66 24.22 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -60.8 100.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.0 -52.61 0.68 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.825 -174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.551 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 17.6 tpt180 -174.94 177.9 1.9 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.744 0.272 . . . . 0.0 111.428 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.551 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.5 t-80 -51.23 128.13 21.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.516 0.727 . . . . 0.0 111.631 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.695 ' HZ2' ' H ' ' A' ' 50' ' ' GLU . 57.2 t90 -95.65 -56.8 2.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.56 173.71 44.97 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 8.8 t -155.24 146.6 22.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.206 0.503 . . . . 0.0 111.497 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.81 133.85 66.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.405 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.604 HH11 ' HB3' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -76.09 113.55 13.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.156 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 11.9 tppt? -143.72 150.72 39.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 21.0 ttmt -83.25 147.42 28.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.86 139.59 33.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.966 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.577 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 98.2 -39.6 2.72 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.447 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -81.2 137.19 35.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 110.608 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.647 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -76.34 136.66 39.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.646 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 62' ' ' CYS . 10.0 p -118.39 148.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.679 ' HE ' ' HE1' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -89.01 143.32 26.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.407 . . . . 0.0 110.899 -177.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 55.0 m-85 -128.31 143.28 51.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.679 ' HE1' ' HE ' ' A' ' 46' ' ' ARG . 36.7 p90 -152.51 156.48 39.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.814 0.34 . . . . 0.0 110.58 -174.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 8.5 pt-20 -100.17 130.07 46.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.743 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -120.32 101.08 7.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.963 0.887 . . . . 0.0 110.497 175.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -85.19 141.53 37.38 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.816 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.19 116.39 2.22 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.847 2.365 . . . . 0.0 112.894 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.73 -30.52 6.48 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.171 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -83.15 153.33 66.27 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.719 0.295 . . . . 0.0 111.228 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 153.9 76.15 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 111.186 171.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.743 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 32.2 mttm -94.54 126.1 39.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.99 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 7.2 ttm-85 -94.58 123.53 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.261 -174.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.15 102.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.59 -19.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.79 146.92 0.35 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.158 0.504 . . . . 0.0 111.51 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.6 mp -107.89 118.64 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.697 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 9.1 t -133.82 150.88 51.42 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.289 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.647 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.4 ptpt -146.32 162.75 37.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.21 138.65 36.87 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.439 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.93 -57.53 2.37 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.38 1.05 . . . . 0.0 112.677 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.7 t -93.54 138.3 23.0 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.156 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.577 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -76.25 -0.76 10.7 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.641 2.228 . . . . 0.0 111.879 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -115.34 -66.45 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.73 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' ' 66' ' ' SER . 53.5 m-70 -98.21 163.89 12.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.661 ' HG ' HG11 ' A' ' 21' ' ' VAL . 97.9 m -99.23 122.33 42.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.398 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -125.04 -79.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.305 0.574 . . . . 0.0 110.218 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.53 174.18 10.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.827 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.696 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 28.3 mt -104.51 127.44 52.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.235 0.541 . . . . 0.0 111.387 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -104.69 105.66 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.35 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 5.9 m -106.14 163.64 12.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.244 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -144.22 157.91 44.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.3 46.61 5.9 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.664 0.603 . . . . 0.0 111.34 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.5 mt -67.28 147.89 52.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.691 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -107.57 69.85 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 111.465 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.22 -93.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.8 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.91 -5.87 88.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.184 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.8 m-85 -98.71 112.98 24.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.233 0.539 . . . . 0.0 110.485 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.426 ' HA ' HD22 ' A' ' 78' ' ' LEU . 20.1 m -140.02 169.12 18.29 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.661 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -108.0 156.78 18.85 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.569 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -121.07 3.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.896 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -110.35 -169.6 1.49 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.594 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 18.9 p -125.24 142.74 51.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.2 p -140.4 -155.86 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.538 0.208 . . . . 0.0 111.046 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.884 ' HB3' HD22 ' A' ' 24' ' ' ASN . 16.3 t70 67.25 -72.9 0.08 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.828 0.851 . . . . 0.0 112.33 170.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 91' ' ' LEU . 12.3 m -78.63 -42.76 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.604 ' H ' HD22 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -89.51 -45.6 9.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.377 -178.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.43 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 15.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.579 0.228 . . . . 0.0 110.66 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.7 p90 -58.19 136.56 57.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.23 139.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.463 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.573 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -116.88 141.6 48.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.432 ' HA ' HG22 ' A' ' 90' ' ' VAL . 20.5 p -147.33 164.12 34.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.111 0.481 . . . . 0.0 111.373 -171.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.851 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.3 p30 -79.35 115.61 19.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.585 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m-70 -83.22 121.53 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -89.53 138.69 31.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.477 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.585 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -109.65 130.32 55.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 170.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -100.43 123.5 44.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.385 0.612 . . . . 0.0 111.032 -178.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.943 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 21.4 t80 -95.72 151.63 19.19 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -57.44 100.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.079 0.466 . . . . 0.0 110.514 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.2 -57.28 0.69 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.62 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -147.38 178.47 8.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.193 0.52 . . . . 0.0 111.87 -171.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -62.5 133.7 55.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.044 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.943 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 84.3 t90 -101.25 -57.61 2.05 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.218 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.31 -179.5 40.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.118 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 12.1 t -154.68 148.75 25.82 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.65 0.262 . . . . 0.0 110.892 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.654 HG23 ' HG2' ' A' ' 39' ' ' LYS . 4.6 mp -128.15 125.54 64.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -75.97 99.5 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.952 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.654 ' HG2' HG23 ' A' ' 37' ' ' ILE . 67.5 mmtt -135.15 153.12 52.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.0 mtpt -72.11 153.0 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 142.39 58.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 90.96 -25.86 12.77 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 -178.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.546 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 86.0 m95 -86.02 133.7 33.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.605 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.649 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.91 135.64 48.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 62' ' ' CYS . 11.2 p -122.54 148.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.1 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.6 147.88 23.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.705 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.626 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 61.1 m-85 -136.38 137.28 40.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.0 p90 -145.55 154.29 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.515 0.198 . . . . 0.0 110.549 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -95.51 135.43 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.073 0.463 . . . . 0.0 110.577 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HB2' ' HZ2' ' A' ' 34' ' ' TRP . 1.6 mm-40 -94.84 106.39 18.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.418 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 75.9 mmtt -106.81 123.46 38.48 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.48 117.26 3.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.848 2.366 . . . . 0.0 112.339 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.46 -6.68 75.91 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.479 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.619 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 28.3 mt-30 -113.25 158.63 37.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 122.664 0.385 . . . . 0.0 110.69 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.85 155.53 62.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.529 2.153 . . . . 0.0 111.944 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 1.9 mptp? -80.82 130.01 34.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.299 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.4 tpm_? -108.19 124.09 49.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.354 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.497 HD22 ' O ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -61.0 106.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.077 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.5 m -94.2 -17.06 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.927 -172.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.34 138.08 2.47 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.376 0.608 . . . . 0.0 112.238 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.81 111.93 38.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.6 t -130.93 155.11 47.33 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.193 -168.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.7 ptpt -157.59 158.56 35.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -77.95 131.09 37.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 74' ' ' LYS . . . -55.2 -28.3 52.03 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.022 0.826 . . . . 0.0 112.958 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 34.0 t -104.64 131.65 21.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.713 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 77.6 Cg_endo -80.1 2.54 8.37 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.65 2.233 . . . . 0.0 112.415 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 13.2 t -121.31 -65.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.667 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.581 ' O ' ' HB3' ' A' ' 66' ' ' SER . 69.5 t60 -97.94 160.37 14.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 110.025 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.3 p -100.94 128.62 46.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.071 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -129.13 -86.63 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.036 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -132.14 169.72 16.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.544 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.733 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 19.0 mt -102.76 120.1 39.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.157 0.503 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.673 ' HD3' ' HB3' ' A' ' 65' ' ' ALA . 4.1 mptp? -100.79 106.27 17.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.479 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.594 ' HB2' HD23 ' A' ' 78' ' ' LEU . 2.5 m -108.81 152.49 24.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.776 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -125.73 156.1 39.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.729 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 61.9 47.45 6.0 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.611 0.57 . . . . 0.0 111.773 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 75' ' ' CYS . 81.2 mt -66.77 145.91 55.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 82' ' ' PHE . . . -88.8 72.95 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.2 -93.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.15 -17.13 30.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.642 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 40.4 m-85 -72.38 109.37 6.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.166 0.507 . . . . 0.0 109.885 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 p -139.14 175.93 9.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.017 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.485 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -98.34 169.1 9.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.768 0.318 . . . . 0.0 110.652 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.417 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -127.82 -159.24 10.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.861 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 t -77.29 -178.09 4.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 91' ' ' LEU . 41.2 m -116.8 144.75 44.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.5 p -139.67 -157.92 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.525 0.202 . . . . 0.0 111.335 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.851 ' HB3' HD22 ' A' ' 24' ' ' ASN . 27.9 t70 65.14 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.955 0.902 . . . . 0.0 112.43 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 23' ' ' CYS . 2.6 m -71.4 -47.67 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.3 pp -88.97 -30.34 18.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.688 0.28 . . . . 0.0 111.079 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -176.574 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 41.1 p90 -58.81 142.06 51.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.93 0.395 . . . . 0.0 110.059 175.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.42 139.37 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.322 0.582 . . . . 0.0 111.802 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.722 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.71 140.93 47.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.577 173.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 7.7 p -148.44 151.58 35.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.951 0.405 . . . . 0.0 111.842 -171.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.909 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -73.01 102.63 3.55 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.414 0.626 . . . . 0.0 110.573 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.771 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 4.7 m80 -69.95 116.55 10.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.382 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.9 m-70 -93.57 128.98 39.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.439 . . . . 0.0 111.43 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -91.85 123.63 35.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.487 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.538 ' HB2' ' CB ' ' A' ' 34' ' ' TRP . 37.2 t80 -94.18 149.59 21.1 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -52.04 99.45 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.475 0.484 . . . . 0.0 110.038 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.14 -70.86 0.51 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.954 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -149.15 178.97 8.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.087 0.47 . . . . 0.0 112.031 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -53.62 132.7 41.05 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.856 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 29' ' ' TYR . 8.1 t-105 -128.34 -57.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.073 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' HIS . . . -98.93 150.62 19.34 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.314 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 36' ' ' THR . 1.3 m -151.39 108.07 3.51 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.73 113.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.832 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 21.9 ttp180 -77.87 93.56 4.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 109.768 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 15.6 tppt? -116.34 153.0 32.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.036 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.722 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.5 mtpt -79.94 149.33 30.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.673 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.05 137.31 56.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 97.08 -20.24 51.61 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.031 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 84.6 m95 -95.9 133.11 40.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.769 0.319 . . . . 0.0 110.223 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.48 130.42 40.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.162 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.569 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 14.8 p -116.09 143.18 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.906 0.384 . . . . 0.0 110.382 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.511 ' HB2' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -95.94 143.27 27.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.226 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.771 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 86.7 m-85 -120.93 137.96 54.35 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.8 p90 -144.51 157.96 43.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.399 0.619 . . . . 0.0 111.371 -173.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 21.8 pt-20 -97.78 126.42 43.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.939 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.766 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 7.7 pt-20 -121.93 102.09 7.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.715 0.769 . . . . 0.0 109.824 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -116.15 151.77 47.05 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.237 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.95 116.14 2.45 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.957 2.438 . . . . 0.0 112.759 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.57 50.07 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.312 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -102.14 143.81 27.35 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.196 0.522 . . . . 0.0 112.105 -173.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.23 166.11 29.26 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.214 2.609 . . . . 0.0 110.429 169.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.766 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 50.3 mttt -94.16 110.67 22.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.36 -168.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 9.5 ttp180 -100.7 144.2 29.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.579 -174.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 46' ' ' ARG . 14.1 mt -64.94 125.35 24.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.137 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.484 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 29.8 m -111.3 -18.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.535 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -172.47 140.6 1.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.446 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -113.31 113.28 43.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.662 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -133.73 162.64 31.42 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.595 -169.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.3 ptpt -158.21 163.39 37.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.91 132.88 35.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.34 -54.7 3.66 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.155 0.909 . . . . 0.0 112.795 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -95.22 146.77 31.91 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 83.4 Cg_endo -86.57 10.99 3.42 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.769 2.313 . . . . 0.0 112.485 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 10.8 t -122.64 -73.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.638 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -95.58 163.47 13.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.1 t -98.08 125.91 43.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -120.07 -80.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.672 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -139.52 176.36 8.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.75 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.8 mt -106.72 120.43 41.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.828 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -100.22 104.02 15.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 22.1 m -105.62 150.32 25.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 112.074 -172.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 t -132.26 156.23 46.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.458 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.6 t30 57.14 77.7 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.758 0.661 . . . . 0.0 111.102 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 83' ' ' SER . 92.0 mt -94.8 137.31 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.268 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 59' ' ' VAL . . . -87.08 80.71 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 110.685 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.61 -94.26 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.686 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.99 -5.29 53.58 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.37 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 33.6 m-85 -83.39 113.58 20.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.988 0.423 . . . . 0.0 110.116 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.593 ' HA ' HD23 ' A' ' 78' ' ' LEU . 12.3 m -142.44 166.44 24.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.623 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -89.47 162.89 15.5 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.91 -63.28 0.24 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.884 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -175.85 -167.83 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 19.7 m -135.0 144.08 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 62.6 p -140.11 -152.15 0.4 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.909 ' HB3' HD22 ' A' ' 24' ' ' ASN . 27.8 t70 66.07 -70.11 0.1 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.018 0.927 . . . . 0.0 112.533 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 23' ' ' CYS . 4.5 m -80.14 -42.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.746 0.308 . . . . 0.0 111.651 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.9 -33.2 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.745 0.307 . . . . 0.0 111.443 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 120.679 0.276 . . . . 0.0 110.716 -177.271 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.647 ' HD1' ' HA ' ' A' ' 68' ' ' VAL . 28.6 m-85 -53.89 131.32 39.81 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 110.301 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 t -111.14 130.99 63.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.135 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.825 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -93.15 141.08 28.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.648 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 92.8 m -151.72 144.36 24.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.782 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.802 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -74.7 109.72 8.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.019 0.438 . . . . 0.0 109.861 176.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.69 12.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 86' ' ' THR . 9.8 m-70 -84.46 130.8 34.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.332 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.602 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -99.04 127.8 45.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -98.35 122.76 41.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.613 . . . . 0.0 110.846 -176.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.042 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 1.8 t80 -100.39 152.7 20.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.42 99.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.526 0.516 . . . . 0.0 111.857 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.96 -19.74 42.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.379 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -163.82 156.89 18.27 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.458 1.129 . . . . 0.0 112.909 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -48.54 119.34 3.0 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.704 171.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 1.042 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.5 t90 -87.71 -56.52 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.503 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.01 -177.92 42.63 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.2 t -156.0 146.53 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.086 0.443 . . . . 0.0 111.391 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.15 126.73 71.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.769 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 16.1 mtm180 -75.94 122.1 23.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.656 0.741 . . . . 0.0 110.803 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.83 149.78 31.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.262 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 50.6 mtpt -69.92 155.1 41.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 110.858 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.43 142.3 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.445 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 88.44 -34.29 3.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.348 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 89.7 m95 -78.13 132.8 37.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.08 0.467 . . . . 0.0 110.451 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.44 141.59 52.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.741 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 62' ' ' CYS . 9.5 p -124.35 157.63 31.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.4 136.45 40.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.377 . . . . 0.0 111.484 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' CG ' HD21 ' A' ' 27' ' ' LEU . 67.8 m-85 -128.37 133.74 48.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -150.77 154.04 36.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 17.0 pt-20 -101.46 126.56 48.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.06 102.49 9.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.604 0.716 . . . . 0.0 109.905 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.76 131.41 35.75 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.975 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.83 116.46 3.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.569 2.179 . . . . 0.0 112.351 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.41 -10.18 57.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.123 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -122.05 154.69 61.5 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.406 0.282 . . . . 0.0 110.569 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.23 155.6 51.57 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.6 2.2 . . . . 0.0 111.359 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -72.33 140.09 48.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.216 0.531 . . . . 0.0 110.903 -177.171 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.33 129.8 55.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.464 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.14 123.74 17.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 110.484 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -110.37 -18.27 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.1 134.87 1.29 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.623 0.725 . . . . 0.0 111.394 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.68 111.6 36.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.765 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.9 t -131.18 144.05 51.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.269 -167.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.658 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -144.8 161.13 40.02 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -80.53 141.79 34.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.825 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.83 -62.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.015 0.822 . . . . 0.0 112.258 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.7 t -90.23 138.53 27.21 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.249 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.753 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -78.23 -2.41 12.49 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.521 2.147 . . . . 0.0 111.632 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HA ' ' HD1' ' A' ' 20' ' ' PHE . 12.5 t -105.04 -74.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.336 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.91 163.64 12.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.1 t -98.22 131.69 44.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.85 0.357 . . . . 0.0 110.298 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -132.54 -84.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.953 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -131.57 164.24 26.28 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.186 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.765 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 25.9 mt -103.54 122.94 45.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.988 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -102.78 106.21 16.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.619 ' HB2' HD23 ' A' ' 78' ' ' LEU . 1.8 m -110.01 146.56 35.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.599 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -124.16 157.48 34.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.708 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.54 55.84 3.28 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.609 0.568 . . . . 0.0 110.987 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 75' ' ' CYS . 92.1 mt -73.62 148.21 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.153 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -105.22 67.89 0.79 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.026 0.441 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.8 -91.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.258 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.04 60.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.008 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 90.2 m-85 -79.51 108.23 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.401 . . . . 0.0 110.74 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 m -149.68 163.31 38.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -98.67 159.98 14.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.34 -64.0 0.19 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.335 -170.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 11.6 t -160.16 -165.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.943 0.372 . . . . 0.0 110.423 -171.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.648 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 14.3 t -144.5 148.04 34.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.485 ' HB ' HG23 ' A' ' 95' ' ' THR . 73.8 p -140.01 -153.21 0.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.276 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.802 ' HB3' HD22 ' A' ' 24' ' ' ASN . 7.9 t70 61.34 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 173.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -69.28 -42.38 81.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.967 0.413 . . . . 0.0 111.31 -176.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.401 HD22 ' SG ' ' A' ' 23' ' ' CYS . 4.1 pp -89.68 -33.93 16.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.552 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t -94.67 -37.73 11.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.554 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 t 66.35 114.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.122 0.569 . . . . 0.0 111.694 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.9 66.12 1.32 Allowed Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.643 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.485 HG23 ' HB ' ' A' ' 88' ' ' THR . 11.6 p -144.42 160.02 41.77 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.708 -0.29 . . . . 0.0 110.758 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 m -82.14 79.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.887 0.851 . . . . 0.0 110.482 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.49 -86.04 1.81 Allowed Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.051 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.88 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.622 0.248 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.3 m-85 -81.24 140.67 34.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.85 140.18 48.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.851 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -112.41 144.87 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.325 176.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.455 ' HB3' HD13 ' A' ' 91' ' ' LEU . 19.8 p -153.49 157.05 39.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 0.0 111.54 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.963 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -78.11 112.52 15.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.602 174.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -81.97 115.3 21.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.651 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -83.94 129.01 34.93 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.017 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 28' ' ' LEU . 1.3 tm? -101.36 132.57 46.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.31 122.57 44.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.374 0.607 . . . . 0.0 111.037 -178.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 56.7 t80 -106.09 143.99 33.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -53.07 104.96 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.039 0.447 . . . . 0.0 110.792 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 -50.59 0.88 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.964 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 33' ' ' HIS . 30.7 tpt180 -172.75 167.37 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.41 ' N ' ' HG3' ' A' ' 32' ' ' ARG . 11.0 t-80 -36.3 131.37 0.63 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.985 0.914 . . . . 0.0 112.221 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.808 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 32.8 t-105 -99.56 -56.69 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.264 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -178.71 39.57 Favored Glycine 0 C--O 1.234 0.143 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.906 ' HG1' ' HB2' ' A' ' 24' ' ' ASN . 9.7 t -151.77 141.76 22.11 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.187 0.518 . . . . 0.0 111.664 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.88 130.04 58.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.827 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.851 ' HD2' HE22 ' A' ' 22' ' ' GLN . 29.7 mtm180 -87.68 124.78 33.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.325 0.583 . . . . 0.0 111.539 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HE3' HG11 ' A' ' 45' ' ' VAL . 36.6 ttmt -153.53 152.35 30.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.575 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.794 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 47.1 mtpt -76.15 155.07 34.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.924 0.392 . . . . 0.0 111.044 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.78 142.45 55.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.564 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 104.65 -36.32 4.46 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.139 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -90.29 146.92 23.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.927 0.394 . . . . 0.0 110.614 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -85.63 131.37 34.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -101.12 152.54 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -94.43 140.12 30.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.88 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.467 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 94.2 m-85 -136.54 132.5 35.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.5 p90 -147.62 157.76 43.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 0.0 111.377 -173.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 16.9 pt-20 -95.33 130.03 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.143 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 16.4 pt-20 -126.25 112.21 15.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.443 0.64 . . . . 0.0 109.96 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -136.4 121.82 13.29 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.592 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -48.58 116.88 2.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.686 2.924 . . . . 0.0 113.417 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.04 -19.26 12.02 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.274 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -126.67 149.26 67.76 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.807 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 162.33 42.44 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.822 2.348 . . . . 0.0 111.403 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 24.3 mttm -86.29 118.28 25.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.532 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -103.99 133.33 49.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.292 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -65.85 113.25 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.244 0.34 . . . . 0.0 110.172 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 33.2 m -92.76 -24.04 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB3' HD22 ' A' ' 78' ' ' LEU . . . 178.91 146.68 0.17 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.288 0.565 . . . . 0.0 111.29 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.7 mp -105.42 117.31 50.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 170.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 6.2 t -125.44 144.74 50.39 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.514 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.0 ptpt -143.1 163.0 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -84.59 136.35 33.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.261 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.43 -54.68 3.74 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.052 0.845 . . . . 0.0 112.322 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.493 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 34.5 t -89.33 141.03 28.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.294 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.564 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 3.5 Cg_exo -81.62 2.79 8.31 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.25 2.633 . . . . 0.0 112.107 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.2 t -122.99 -70.38 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.664 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -86.25 165.02 16.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.1 126.05 44.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.879 0.371 . . . . 0.0 110.223 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -124.16 -81.55 0.64 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.293 0.568 . . . . 0.0 110.016 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.44 168.91 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 24.0 mt -102.52 120.34 40.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.251 0.548 . . . . 0.0 110.784 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.9 mmpt? -102.26 105.65 16.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.809 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.666 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.7 m -104.58 149.77 25.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.956 0.408 . . . . 0.0 110.769 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -127.27 155.36 43.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.517 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.48 50.82 4.39 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.491 0.494 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 75' ' ' CYS . 87.7 mt -68.24 140.36 56.03 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 59' ' ' VAL . . . -89.51 89.62 7.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.575 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.54 -88.16 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.01 0.82 11.77 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.993 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -82.42 126.17 31.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 m -146.81 -177.74 5.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.923 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -100.72 171.28 7.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.415 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -123.04 -140.79 5.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.256 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 178.85 5.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.844 0.354 . . . . 0.0 110.531 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 42.4 m -110.6 142.61 42.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 24.6 p -141.27 -159.32 0.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.963 ' HB3' HD22 ' A' ' 24' ' ' ASN . 22.2 t70 63.06 -82.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.948 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.419 ' H ' HG21 ' A' ' 90' ' ' VAL . 10.3 m -70.97 -36.02 61.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.211 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 23' ' ' CYS . 12.9 mt -89.46 -55.32 3.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.23 0.538 . . . . 0.0 111.729 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -73.38 -76.99 0.11 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.62 -171.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 m -152.57 -61.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.262 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 89' ' ' ASP . . . -178.15 172.62 45.14 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.5 p -141.1 -87.31 0.17 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.831 0.824 . . . . 0.0 110.59 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.7 p 174.12 -15.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.171 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.46 35.75 3.01 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.212 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' HG22 ' A' ' 36' ' ' THR . 31.0 t . . . . . 0 C--O 1.252 1.221 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -173.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.641 0.258 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.555 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.3 m-85 -64.39 113.99 4.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.9 p -101.26 139.75 21.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.322 -172.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.993 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.0 pt20 -96.08 144.81 26.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 10.8 p -150.07 142.43 24.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 111.796 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.965 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -73.43 110.59 7.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.016 175.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.83 116.11 16.21 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 11.4 m-70 -86.62 131.18 34.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.873 0.368 . . . . 0.0 111.132 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.453 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -98.51 125.46 43.73 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.12 125.67 50.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.366 0.603 . . . . 0.0 111.235 -172.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -98.53 150.79 21.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -53.38 100.38 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.662 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.91 -58.85 0.58 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.684 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -142.58 170.81 15.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.369 0.604 . . . . 0.0 112.317 -171.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 134.48 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.866 172.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -101.59 -55.85 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.897 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.99 175.14 42.28 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 t -154.28 145.79 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.278 0.539 . . . . 0.0 111.424 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.568 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.0 mp -126.78 125.1 66.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.88 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 47.2 ttp180 -88.67 98.07 11.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.5 mmtp -126.05 153.8 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.993 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 32.9 mtpt -66.24 161.93 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.228 0.537 . . . . 0.0 111.482 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 66' ' ' SER . . . -59.92 142.78 53.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.763 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.586 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 89.78 -28.19 7.35 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.465 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 55.1 m95 -75.87 115.27 15.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.572 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.933 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.11 115.43 16.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.042 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG21 ' HB ' ' A' ' 37' ' ' ILE . 8.2 p -103.75 154.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.34 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.415 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.53 134.09 37.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 111.346 -177.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.701 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 88.7 m-85 -120.37 128.38 53.18 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' HB3' HD21 ' A' ' 58' ' ' LEU . 36.7 p90 -143.78 152.1 40.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.299 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 7.1 pt-20 -94.72 137.53 33.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.354 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -126.78 100.37 6.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 31.8 mttp -95.66 154.08 39.26 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.02 116.36 3.12 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 121.994 1.796 . . . . 0.0 111.639 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 -11.59 66.39 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.873 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -110.12 126.34 29.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.769 -0.254 . . . . 0.0 110.474 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 31.7 Cg_exo -63.06 154.87 64.44 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.041 2.494 . . . . 0.0 112.765 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -62.11 126.92 29.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.181 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -130.39 142.74 50.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.816 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.802 HD11 HD13 ' A' ' 61' ' ' ILE . 16.6 mt -70.32 130.07 41.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 -175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.09 -18.0 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.393 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -176.63 138.29 0.28 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.514 0.673 . . . . 0.0 111.633 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.802 HD13 HD11 ' A' ' 58' ' ' LEU . 4.5 mp -108.81 111.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.7 t -132.39 146.12 51.73 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.687 -168.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.933 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 27.5 pttt -145.6 164.56 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.651 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 9.0 t30 -77.33 134.37 38.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.75 -56.78 1.67 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.455 1.097 . . . . 0.0 112.706 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 40.6 t -92.0 136.75 25.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 69.3 Cg_endo -75.42 -1.52 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.404 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.9 t -112.42 -72.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' A' ' 66' ' ' SER . 39.6 m80 -98.01 164.47 12.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.411 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.0 t -97.63 132.72 43.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -132.1 -81.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -138.26 175.7 9.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.498 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.778 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 31.3 mt -103.72 129.5 51.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.69 109.95 21.25 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.6 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.9 m -114.44 149.15 36.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.53 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -124.76 159.99 29.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.174 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 68.36 40.13 2.1 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.407 0.442 . . . . 0.0 111.642 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 75' ' ' CYS . 96.5 mt -66.73 126.69 29.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.887 0.375 . . . . 0.0 110.971 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -95.41 68.79 3.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.585 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.47 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.366 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.3 -16.32 64.77 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.971 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 99.2 m-85 -86.99 109.29 19.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.085 0.469 . . . . 0.0 110.39 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.4 m -147.72 168.29 22.48 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.585 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -98.76 161.53 13.6 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.472 -175.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.31 -79.28 0.76 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.218 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.9 t -155.77 -169.52 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.611 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 30.1 m -130.58 144.75 51.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.645 0.259 . . . . 0.0 110.309 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 58.3 p -138.34 -154.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.936 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.965 ' HB3' HD22 ' A' ' 24' ' ' ASN . 36.2 t70 63.58 -78.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.25 1.02 . . . . 0.0 112.548 173.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 23' ' ' CYS . 0.9 OUTLIER -68.03 -42.84 85.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.793 0.33 . . . . 0.0 111.662 -175.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.0 pp -89.66 -31.39 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.597 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 t -87.44 -40.28 14.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.027 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.3 t 60.54 90.38 0.06 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.236 0.541 . . . . 0.0 111.061 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.56 43.66 0.53 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.184 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.9 p -133.38 -179.34 5.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -118.41 134.5 61.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.967 172.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -100.56 -89.54 2.04 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.253 1.248 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.307 173.526 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -57.09 142.08 43.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.402 174.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.29 141.33 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.709 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.2 pt20 -94.39 143.0 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.709 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 20.0 p -147.53 145.5 29.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.037 0.446 . . . . 0.0 110.901 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.937 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.02 113.05 11.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 174.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.485 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 1.3 m80 -78.4 117.63 19.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -85.42 134.69 34.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.019 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.57 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -101.09 122.9 44.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.07 122.04 42.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.697 0.76 . . . . 0.0 110.862 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 65.9 t80 -94.24 150.95 19.83 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.75 100.15 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.47 -58.45 0.71 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.255 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -159.71 179.96 8.4 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -52.44 131.51 33.66 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.764 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.786 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.4 t90 -101.57 -55.84 2.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.314 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.23 179.03 38.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.1 t -154.32 143.74 21.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.187 0.493 . . . . 0.0 111.164 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.551 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.5 mp -123.42 122.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.798 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 42.3 ttp180 -83.44 105.65 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.17 0.509 . . . . 0.0 110.741 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 37' ' ' ILE . 70.1 mmtt -127.11 152.96 46.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.536 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 38.9 mtpt -80.22 149.97 30.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.631 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.09 136.18 57.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 111.297 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.47 -17.76 46.16 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -91.38 130.93 37.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.73 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.93 122.89 26.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.5 p -107.58 147.81 12.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.873 0.368 . . . . 0.0 110.483 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.501 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -98.44 135.95 39.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.0 111.154 -177.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CG ' HD21 ' A' ' 27' ' ' LEU . 74.8 m-85 -123.89 131.02 53.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.193 173.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HD2' ' HB3' ' A' ' 56' ' ' LYS . 36.0 p90 -143.74 149.64 37.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.194 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -95.21 142.97 27.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 10.4 pt-20 -130.07 102.2 6.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.726 0.774 . . . . 0.0 110.199 172.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.5 124.84 56.07 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.45 117.82 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.583 2.855 . . . . 0.0 113.303 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.77 22.51 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.377 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.49 148.32 34.37 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.592 0.357 . . . . 0.0 110.735 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.0 151.84 82.9 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.903 2.402 . . . . 0.0 112.153 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 48' ' ' TYR . 26.9 mttm -76.63 136.06 39.17 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.899 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -123.89 135.92 54.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.613 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.82 118.8 12.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.2 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 16.1 m -104.7 -19.16 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.39 136.21 0.59 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.651 0.739 . . . . 0.0 112.349 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.588 HD11 HD21 ' A' ' 77' ' ' ASN . 4.6 mp -108.28 112.87 42.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.8 t -132.14 150.46 52.15 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 -168.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -150.1 163.59 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.827 HD22 ' HA ' ' A' ' 70' ' ' CYS . 32.6 t30 -73.02 150.55 42.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.989 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.41 -52.5 28.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.542 0.526 . . . . 0.0 111.692 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -108.78 139.12 20.57 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.066 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.23 12.74 1.21 Allowed 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.772 2.315 . . . . 0.0 113.149 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 t -128.01 -78.8 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.762 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -90.59 156.94 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.827 ' HA ' HD22 ' A' ' 64' ' ' ASN . 31.5 t -97.74 137.03 37.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.854 0.359 . . . . 0.0 110.992 -172.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -133.49 -76.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -134.28 164.75 26.69 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.461 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.3 mt -103.82 124.32 48.7 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.13 105.75 16.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.17 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 19.0 m -102.93 155.18 18.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.816 -175.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.9 t -136.37 154.71 50.75 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.588 HD21 HD11 ' A' ' 61' ' ' ILE . 90.8 m-20 65.81 46.35 2.33 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.736 0.648 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.9 mt -64.3 155.62 31.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 111.425 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' A' ' 82' ' ' PHE . . . -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.193 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.39 -90.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.287 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.49 -15.1 78.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.76 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 98.1 m-85 -89.12 120.44 30.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 110.332 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.42 ' HA ' HD22 ' A' ' 78' ' ' LEU . 22.9 m -147.34 172.75 13.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.605 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -109.87 174.93 5.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.158 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.52 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -142.48 -175.35 15.64 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.068 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -66.57 172.45 4.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.0 111.495 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 15.5 p -110.33 144.0 39.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.71 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.455 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.5 p -140.7 -154.84 0.54 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 111.461 -174.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.937 ' HB3' HD22 ' A' ' 24' ' ' ASN . 19.4 t70 69.9 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.032 169.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' H ' HG21 ' A' ' 90' ' ' VAL . 6.8 m -72.64 -38.05 57.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.616 -176.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.87 -30.03 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 p -94.73 -76.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.606 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 t -158.4 -54.54 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.669 0.271 . . . . 0.0 110.589 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 89' ' ' ASP . . . 173.4 138.66 2.69 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.47 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.545 ' OG1' ' HB2' ' A' ' 89' ' ' ASP . 7.7 p -140.04 21.77 2.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.957 0.408 . . . . 0.0 110.492 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.6 t 68.48 -72.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.418 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.55 -131.64 4.92 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.874 178.043 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.479 0.181 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -79.05 140.58 37.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.592 HG11 ' HG ' ' A' ' 70' ' ' CYS . 2.3 p -145.4 136.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.245 -175.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.656 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -100.87 155.14 18.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.516 175.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 16.9 p -154.85 152.44 29.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.212 0.53 . . . . 0.0 111.681 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -75.05 111.19 10.02 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 109.503 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.814 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 9.7 m80 -72.19 121.03 18.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.403 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -84.17 136.54 33.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.584 -174.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.581 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -109.89 122.98 48.78 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 165.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 122.08 45.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.287 0.565 . . . . 0.0 110.504 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.13 143.94 26.17 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -50.43 101.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.537 0.523 . . . . 0.0 110.463 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.6 -53.34 0.81 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.146 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 22.8 tpt180 -165.09 160.02 18.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.085 0.442 . . . . 0.0 111.77 -175.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -42.83 127.83 4.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -99.51 -56.72 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.323 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.63 178.32 39.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.975 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.517 ' HB ' ' HD2' ' A' ' 26' ' ' HIS . 5.8 t -153.8 138.41 16.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.951 0.375 . . . . 0.0 110.704 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.31 135.98 55.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.199 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.656 ' HD2' HE22 ' A' ' 22' ' ' GLN . 3.3 tpp85 -73.81 110.21 7.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.776 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 16.7 tppt? -143.89 128.57 18.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.563 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 18.6 ptmt -72.3 153.64 41.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.222 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 66' ' ' SER . . . -63.66 142.75 58.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 94.26 -17.27 59.23 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.645 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.454 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 44.3 m95 -105.36 142.91 34.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 0.0 110.66 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -80.17 140.63 36.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.63 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.776 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.9 p -126.89 148.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.85 0.357 . . . . 0.0 110.543 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.76 143.55 27.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.814 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 63.5 m-85 -128.35 135.88 50.19 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 53.0 p90 -151.1 156.49 41.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.869 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' OE1' ' HE2' ' A' ' 51' ' ' LYS . 14.9 pt-20 -107.38 134.93 49.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 168.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.0 102.25 10.74 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.229 0.537 . . . . 0.0 110.67 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HE2' ' OE1' ' A' ' 49' ' ' GLU . 67.6 mttm -85.23 125.48 69.96 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.672 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.02 117.64 2.63 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.332 2.688 . . . . 0.0 113.573 -173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.37 -14.24 62.37 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.559 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -113.05 158.11 38.85 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.543 0.211 . . . . 0.0 110.438 -176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.55 161.9 41.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.665 2.243 . . . . 0.0 111.118 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -74.71 138.38 42.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.056 0.455 . . . . 0.0 110.728 -176.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 20.4 tpp180 -99.52 123.55 43.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.069 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.34 107.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.997 0.427 . . . . 0.0 110.55 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.477 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -95.16 -18.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.57 138.7 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.505 0.669 . . . . 0.0 111.904 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.62 112.13 38.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.832 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 12.0 t -134.9 154.02 51.83 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.982 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.628 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -150.21 162.36 40.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -83.85 135.86 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.718 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.33 -51.9 6.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.079 0.862 . . . . 0.0 112.868 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 46.0 t -94.77 139.18 22.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.265 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 80.1 Cg_endo -79.13 2.69 8.08 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 111.744 173.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.2 -79.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.589 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.511 ' O ' ' HB3' ' A' ' 66' ' ' SER . 67.5 m80 -89.65 165.38 14.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.472 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.592 ' HG ' HG11 ' A' ' 21' ' ' VAL . 74.8 m -98.72 124.92 43.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.29 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.406 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 61.5 m-20 -124.22 -85.52 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 110.227 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.406 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 93.9 m-85 -130.43 174.14 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.949 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.832 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.6 mt -109.36 132.21 54.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.626 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -101.19 104.51 15.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.744 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.562 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 1.6 m -116.41 144.87 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.967 0.413 . . . . 0.0 110.597 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -126.46 159.63 32.8 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.2 t30 59.83 71.59 0.57 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 -175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 83' ' ' SER . 96.4 mt -91.66 128.79 37.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 59' ' ' VAL . . . -92.33 73.92 5.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.674 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.62 -93.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.468 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.07 0.85 73.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.923 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 96.5 m-85 -101.16 108.89 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 0.0 110.474 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.465 ' HA ' HD23 ' A' ' 78' ' ' LEU . 41.7 m -138.39 169.35 17.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -101.24 163.76 12.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.283 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.83 -175.68 14.8 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.669 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 13.6 t -61.77 159.02 14.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.567 0.698 . . . . 0.0 111.234 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.632 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 7.0 p -91.17 144.67 25.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.479 -168.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.61 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 40.0 p -131.64 -158.45 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.803 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.465 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 25.2 t70 70.83 -85.04 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.411 1.084 . . . . 0.0 111.707 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.414 ' H ' HG21 ' A' ' 90' ' ' VAL . 1.7 m -67.45 -46.94 82.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.94 -27.8 20.7 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.725 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 88' ' ' THR . 5.9 t -76.96 -54.03 7.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.069 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 t 68.12 115.0 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.422 0.63 . . . . 0.0 110.372 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.86 35.15 5.2 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -173.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -144.33 148.81 35.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.699 -0.75 . . . . 0.0 110.445 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.28 114.47 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 89' ' ' ASP . . . -136.21 178.31 18.88 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.851 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.793 178.561 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 82.5 m-85 -78.9 139.94 38.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.46 138.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.398 0.618 . . . . 0.0 111.819 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.79 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.47 145.84 31.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.421 176.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.624 ' HA ' HG22 ' A' ' 90' ' ' VAL . 18.0 p -148.66 150.44 33.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.501 0.667 . . . . 0.0 112.314 -174.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.956 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -72.24 112.84 8.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.958 174.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.826 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 14.6 m80 -80.68 108.81 14.64 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.615 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.699 ' HA ' ' HG1' ' A' ' 36' ' ' THR . 43.5 m-70 -83.72 125.33 31.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.774 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 28' ' ' LEU . 1.7 tm? -98.2 134.08 41.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -104.73 116.7 32.49 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.563 0.697 . . . . 0.0 110.903 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.709 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 71.6 t80 -95.19 145.42 25.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.954 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -57.75 99.76 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.856 0.36 . . . . 0.0 110.287 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.76 -43.57 1.26 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.68 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -175.06 166.06 3.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.092 0.446 . . . . 0.0 111.337 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -43.42 127.03 4.54 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.553 0.741 . . . . 0.0 111.596 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 48.9 t-105 -99.68 -57.65 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.636 -175.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.73 177.49 39.56 Favored Glycine 0 C--N 1.328 0.137 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.278 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.699 ' HG1' ' HA ' ' A' ' 26' ' ' HIS . 0.8 OUTLIER -152.85 133.11 13.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.143 0.497 . . . . 0.0 111.328 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -120.33 134.6 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.53 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -80.05 104.93 10.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 3.7 tppp? -138.85 145.01 39.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.79 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.5 mtpt -68.32 148.94 50.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.854 ' HB3' HD21 ' A' ' 64' ' ' ASN . . . -65.55 136.61 56.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.9 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.839 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 97.14 -26.18 23.85 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.068 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -89.19 130.83 35.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.924 0.392 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.74 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.99 126.64 30.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.201 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.553 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.2 p -116.41 145.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.41 145.21 30.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.148 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.826 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 76.7 m-85 -134.79 145.33 48.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -148.61 163.39 37.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.199 0.523 . . . . 0.0 111.585 -173.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.32 134.53 51.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.381 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -109.57 113.79 26.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.391 0.615 . . . . 0.0 110.399 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 33.6 mmtp -108.31 125.51 31.75 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.432 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.53 126.87 23.93 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.32 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.5 -9.56 64.35 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.297 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 40.8 mt-30 -122.38 159.12 53.87 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.365 0.266 . . . . 0.0 110.733 -175.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.25 156.65 58.79 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.765 2.31 . . . . 0.0 111.967 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -88.21 138.86 31.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.495 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -117.45 123.63 46.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.929 -172.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.45 106.6 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.44 -30.08 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -174.07 144.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.199 0.523 . . . . 0.0 111.338 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -102.07 113.72 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.687 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -118.96 148.69 42.69 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.187 -171.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.74 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 13.9 pttp -157.1 164.32 38.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.341 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.854 HD21 ' HB3' ' A' ' 41' ' ' ALA . 30.7 t30 -81.83 152.02 27.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.408 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.23 -48.88 67.82 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.552 0.532 . . . . 0.0 111.362 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -105.57 137.54 19.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.818 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.839 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 78.1 Cg_endo -80.96 10.37 3.41 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.742 2.294 . . . . 0.0 112.518 175.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.0 t -113.98 -82.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.11 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.413 ' H ' ' HB ' ' A' ' 68' ' ' VAL . 79.0 m-70 -90.28 158.45 17.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.736 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.6 t -98.5 127.32 44.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -116.39 -87.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -134.53 171.79 13.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.648 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 39.2 mt -103.43 120.54 41.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.105 0.479 . . . . 0.0 112.056 -173.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -102.91 109.29 20.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.155 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.75 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.9 m -103.21 146.53 28.28 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.481 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -120.45 155.29 33.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.152 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 56.68 55.24 6.51 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.664 0.603 . . . . 0.0 110.184 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.6 mt -67.74 149.48 49.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.76 94.67 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.51 -85.56 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.628 0.58 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.45 4.64 6.26 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.02 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.88 120.71 25.06 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.9 t -151.84 178.17 9.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.469 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . . . -100.71 159.84 14.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.199 -177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.55 -64.38 0.38 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.006 -171.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 t -164.91 -169.62 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.006 0.403 . . . . 0.0 110.586 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 5.0 p -143.73 144.25 31.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.263 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 37.6 p -139.61 -155.22 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.731 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.956 ' HB3' HD22 ' A' ' 24' ' ' ASN . 16.7 t70 64.61 -76.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.465 0.706 . . . . 0.0 112.377 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -70.94 -44.36 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.15 -23.34 22.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.095 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.5 t -84.53 -77.24 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.77 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.2 t 174.88 -60.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.97 131.33 2.45 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.526 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.0 p -144.73 124.9 13.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.629 0.215 . . . . 0.0 110.476 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.9 m -79.44 87.28 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.66 0.743 . . . . 0.0 110.546 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.06 -152.91 11.97 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.734 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.502 ' OXT' ' HB ' ' A' ' 36' ' ' THR . 11.5 p . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -64.18 149.14 48.44 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.529 HG22 ' SG ' ' A' ' 23' ' ' CYS . 2.6 p -133.67 135.23 55.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.402 0.62 . . . . 0.0 111.488 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.713 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -109.6 140.94 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.388 176.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 58.6 m -145.1 157.58 44.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.088 0.47 . . . . 0.0 111.994 -168.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.889 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -83.43 111.84 19.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 166.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -77.61 124.02 27.39 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.32 137.6 32.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.403 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -98.96 116.4 31.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 166.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.72 124.05 41.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.928 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -110.7 150.62 28.79 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -52.86 101.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.346 0.404 . . . . 0.0 110.492 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.17 -59.01 0.69 Allowed Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.32 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -162.58 166.76 24.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -49.87 119.58 3.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.767 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.522 ' HH2' ' H ' ' A' ' 50' ' ' GLU . 10.1 t90 -92.84 -55.57 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.968 0.413 . . . . 0.0 110.598 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.73 163.26 28.56 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.0 t -154.26 140.22 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.224 0.512 . . . . 0.0 110.699 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.455 HD13 ' C ' ' A' ' 36' ' ' THR . 2.5 mp -124.39 126.97 72.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.714 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.9 mtm180 -79.13 110.31 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.502 . . . . 0.0 111.819 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -146.52 137.29 24.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.155 175.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.0 ptmt -62.12 156.91 20.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.28 142.15 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.935 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.38 -40.7 2.33 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.523 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.479 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 56.9 m95 -75.14 141.94 43.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.137 0.494 . . . . 0.0 111.142 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.621 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.93 131.33 41.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.399 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.8 p -121.63 140.08 46.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.059 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.694 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -101.33 139.41 37.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.998 0.427 . . . . 0.0 110.541 -178.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CG ' HD21 ' A' ' 27' ' ' LEU . 82.9 m-85 -120.43 139.08 53.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.301 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 30.5 p90 -147.44 154.04 40.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.934 0.397 . . . . 0.0 111.335 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -103.69 142.66 33.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.495 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.522 ' H ' ' HH2' ' A' ' 34' ' ' TRP . 7.6 pt-20 -93.89 104.16 16.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 73.1 mmtt -119.45 135.47 24.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.055 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 23.3 Cg_exo -63.9 117.51 4.5 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.028 2.485 . . . . 0.0 112.834 -175.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.45 64.76 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -107.69 149.96 39.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.942 0.401 . . . . 0.0 110.696 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.24 153.4 78.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.943 1.762 . . . . 0.0 109.323 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.583 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 34.7 mmtm -67.37 109.53 3.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.181 0.515 . . . . 0.0 109.899 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 18.7 tpp180 -80.67 126.11 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.817 -167.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' A' ' 46' ' ' ARG . 11.1 mt -58.9 109.12 0.76 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.599 0.562 . . . . 0.0 110.649 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -93.78 -15.43 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.862 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.53 135.19 0.53 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.598 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.537 HG13 HD23 ' A' ' 58' ' ' LEU . 4.7 mp -107.7 113.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 166.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.2 t -133.63 159.54 40.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.998 -168.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.621 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -158.97 162.82 36.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 10.4 t30 -87.4 138.4 31.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.383 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -55.4 4.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.093 0.87 . . . . 0.0 112.655 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -99.89 146.41 31.84 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.049 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 94.7 Cg_endo -87.98 20.54 1.15 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.053 2.502 . . . . 0.0 112.714 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.57 -76.77 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.103 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.469 ' HA ' HG12 ' A' ' 21' ' ' VAL . 36.5 m-70 -92.22 164.28 13.61 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.54 122.43 44.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -116.51 -78.74 0.58 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.484 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.26 165.49 25.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.213 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.4 mt -105.03 124.74 50.06 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.457 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.57 105.37 15.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 2.1 m -111.54 151.46 28.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.364 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -128.95 161.74 29.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.521 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.39 41.09 5.98 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.567 0.542 . . . . 0.0 111.484 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -65.55 147.03 54.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.975 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -110.46 67.42 0.64 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.408 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.71 -89.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.859 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.85 -16.66 69.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.734 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.43 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.0 m-85 -85.17 107.05 17.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.234 0.54 . . . . 0.0 110.475 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.516 ' HA ' HD23 ' A' ' 78' ' ' LEU . 11.1 m -134.08 165.54 24.83 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.487 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -101.44 161.7 13.44 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.1 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 -164.04 9.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.846 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -69.34 -177.39 1.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.833 0.453 . . . . 0.0 111.338 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.59 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.2 p -122.03 151.75 40.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.928 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.56 ' HB ' ' CB ' ' A' ' 95' ' ' THR . 68.8 p -139.78 -157.4 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 110.739 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.889 ' HB3' HD22 ' A' ' 24' ' ' ASN . 35.3 t70 66.11 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.919 0.888 . . . . 0.0 112.111 172.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.598 HG21 HD22 ' A' ' 91' ' ' LEU . 5.7 m -67.83 -41.47 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.598 HD22 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -89.87 -40.97 12.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' A' ' 88' ' ' THR . 9.3 m -77.13 -40.69 44.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -172.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.9 m 62.24 96.39 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.224 0.535 . . . . 0.0 111.145 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.13 36.65 2.29 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.56 ' CB ' ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -138.16 163.73 30.95 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.76 118.4 35.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.319 0.581 . . . . 0.0 111.231 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.88 85.75 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.338 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.978 -177.54 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 34.6 p90 -61.23 135.35 57.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.419 0.628 . . . . 0.0 110.921 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.4 142.71 40.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.869 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.809 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -95.15 142.34 27.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 5.1 m -142.94 140.54 31.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.377 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.93 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -72.51 111.7 7.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 170.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 36' ' ' THR . 5.1 m80 -80.77 122.98 27.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.892 -177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.614 ' HA ' ' HG1' ' A' ' 36' ' ' THR . 12.1 m170 -90.61 123.64 34.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.589 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 28' ' ' LEU . 1.1 tm? -98.1 126.81 43.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.37 128.62 53.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.158 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.428 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.7 t80 -103.78 144.78 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -56.1 100.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.2 -56.6 0.63 Allowed Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.658 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.514 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 11.5 tpp180 -172.02 172.08 4.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.514 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 39.5 t-80 -47.62 135.92 10.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.194 0.598 . . . . 0.0 111.524 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.487 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 58.3 t90 -107.43 -55.76 2.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.119 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.12 164.02 30.76 Favored Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.282 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.614 ' HG1' ' HA ' ' A' ' 26' ' ' HIS . 1.0 OUTLIER -146.53 130.69 17.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.984 0.421 . . . . 0.0 111.313 -177.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.44 130.47 74.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.809 ' HD2' HE22 ' A' ' 22' ' ' GLN . 24.1 mtm180 -76.42 128.53 35.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.216 0.531 . . . . 0.0 110.671 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -148.86 152.15 35.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.654 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.715 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.5 mtpt -87.19 148.13 25.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.42 -174.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.84 136.42 58.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.971 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 95.58 -20.9 47.47 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.992 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.452 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 65.1 m95 -101.63 137.51 39.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 110.227 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.604 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -81.21 145.6 30.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -112.9 156.3 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.0 177.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.25 130.23 50.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.138 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.518 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 97.5 m-85 -122.73 126.83 48.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -145.78 156.68 43.75 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.483 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 14.3 pt-20 -104.47 123.68 47.91 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.7 102.08 10.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.826 0.822 . . . . 0.0 109.937 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.3 121.64 52.8 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.666 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.82 116.38 2.13 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.029 2.486 . . . . 0.0 112.519 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.46 -28.13 14.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.21 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -107.92 148.78 38.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.85 152.49 77.22 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.382 2.055 . . . . 0.0 111.293 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.638 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -77.82 137.6 38.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.537 -175.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -112.93 137.49 51.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.989 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.82 109.07 5.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.456 0.473 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 15.7 m -94.05 -19.64 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.808 -176.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.28 142.18 0.59 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 112.139 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.91 112.35 40.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 165.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.3 t -130.78 150.02 52.15 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.955 -167.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 ptpt -145.03 163.03 35.47 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -77.1 138.22 39.39 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.557 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -40.62 -58.73 1.54 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.125 0.891 . . . . 0.0 112.628 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.0 t -94.04 138.2 22.72 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.201 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.416 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 58.9 Cg_endo -73.2 -1.75 11.05 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.675 2.25 . . . . 0.0 111.701 172.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.3 t -103.37 -81.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.296 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -107.25 165.98 10.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.122 0.487 . . . . 0.0 111.204 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.27 124.24 38.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.099 -168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -128.46 -83.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.092 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -130.44 173.82 10.47 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.202 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.781 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 29.0 mt -110.07 127.71 55.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.952 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.82 107.92 19.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.519 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.8 m -113.41 152.15 30.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -175.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -126.2 159.43 33.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 62.46 40.32 10.98 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.935 0.494 . . . . 0.0 111.301 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.9 mt -62.04 135.12 57.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.78 ' HB1' ' HB2' ' A' ' 82' ' ' PHE . . . -92.68 41.81 1.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.227 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.31 -84.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.22 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.89 -18.6 76.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.758 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.78 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 96.9 m-85 -96.38 109.48 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.472 ' HA ' HD23 ' A' ' 78' ' ' LEU . 14.8 m -139.85 167.15 22.77 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.537 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -103.47 159.77 15.29 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.311 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.81 -95.08 1.85 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.929 -174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -138.97 -167.44 2.22 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 49.4 m -134.43 144.97 48.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.567 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 61.3 p -139.35 -157.03 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.815 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.93 ' HB3' HD22 ' A' ' 24' ' ' ASN . 31.9 t70 61.68 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.431 1.092 . . . . 0.0 112.277 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.8 -20.91 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.745 0.307 . . . . 0.0 111.141 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.401 HD21 ' SG ' ' A' ' 23' ' ' CYS . 13.6 mt -89.1 -56.04 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.505 0.669 . . . . 0.0 111.201 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p -91.18 -32.07 15.94 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.418 -174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.3 m 69.37 -0.46 2.55 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.198 0.599 . . . . 0.0 112.045 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.58 23.35 20.23 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.567 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.7 OUTLIER -129.71 163.76 25.45 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.223 -0.489 . . . . 0.0 109.866 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.8 t -98.84 104.52 16.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.794 0.33 . . . . 0.0 110.83 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.92 144.75 43.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.958 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.784 -0.627 . . . . 0.0 110.291 -176.07 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 48.5 p90 -88.8 143.2 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.85 137.76 21.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.358 0.599 . . . . 0.0 111.798 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.813 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 8.6 pt20 -102.95 150.13 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.467 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.2 p -151.04 136.4 17.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.366 0.603 . . . . 0.0 111.936 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.837 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -76.63 106.28 8.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 172.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.41 ' CB ' ' HZ ' ' A' ' 47' ' ' PHE . 4.6 m80 -72.86 122.26 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.122 -174.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -82.21 126.46 32.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.037 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -98.33 119.5 37.11 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.03 123.22 44.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.681 0.753 . . . . 0.0 111.425 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -101.63 148.38 25.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -57.27 99.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.26 0.35 . . . . 0.0 110.089 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.39 -57.58 0.59 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.484 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -168.84 170.62 9.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.153 0.477 . . . . 0.0 111.346 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -46.26 114.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.395 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.493 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 70.4 t90 -90.26 -55.92 3.41 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.825 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.24 169.67 36.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.669 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.55 ' CG2' ' HB2' ' A' ' 98' ' ' SER . 15.1 t -154.55 147.81 24.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 111.551 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.08 128.13 70.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.837 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.9 ttp180 -87.62 116.0 25.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.705 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -150.29 149.04 29.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 40.4 mtpt -66.62 145.94 55.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.37 141.58 58.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.77 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 108.37 -28.03 12.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.832 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -96.42 145.98 25.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.011 0.434 . . . . 0.0 110.409 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -75.85 131.96 40.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -105.79 131.49 55.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 129.42 34.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.101 0.477 . . . . 0.0 110.199 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.422 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 87.8 m-85 -121.27 123.69 42.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.8 p90 -144.57 150.35 37.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.991 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.493 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 15.6 pt-20 -95.51 142.2 28.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.689 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.621 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 6.4 pt-20 -118.72 102.51 8.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.472 0.653 . . . . 0.0 110.451 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -110.23 122.73 37.88 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.93 116.72 2.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.78 2.32 . . . . 0.0 112.532 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.83 13.71 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.023 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.77 140.26 20.9 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 159.52 31.5 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.827 2.352 . . . . 0.0 111.602 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.621 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 24.8 mmtp -71.05 119.93 15.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.87 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -112.97 129.25 56.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.186 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 61' ' ' ILE . 12.9 mt -62.49 126.63 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.974 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -113.46 -17.19 8.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.532 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.13 140.65 1.2 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.542 0.687 . . . . 0.0 111.873 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.471 HD13 HD11 ' A' ' 58' ' ' LEU . 4.7 mp -117.49 111.93 36.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 167.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.632 ' O ' HG22 ' A' ' 45' ' ' VAL . 6.8 t -129.03 147.52 50.9 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.552 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.9 ptpt -148.18 163.22 37.64 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.65 137.88 32.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.447 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -48.72 8.15 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.085 0.866 . . . . 0.0 112.538 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 38.5 t -97.45 140.69 22.16 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.77 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 98.5 Cg_endo -81.65 5.21 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.876 2.384 . . . . 0.0 112.532 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.2 t -123.94 -62.33 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.378 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 66' ' ' SER . 36.7 m-70 -95.29 156.29 16.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.812 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.7 t -99.03 121.55 41.11 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -119.13 -78.73 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -135.56 172.48 12.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 11.5 mt -102.93 120.56 40.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 0.0 110.532 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.634 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.2 mmpt? -100.87 103.67 14.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 8.4 m -106.51 155.51 19.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.67 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -142.57 165.91 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 55.22 45.71 25.25 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.763 0.664 . . . . 0.0 111.487 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 83' ' ' SER . 85.0 mt -68.19 144.98 54.73 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -99.18 58.53 1.11 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.931 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.3 -86.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.103 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.54 -22.89 68.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.632 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.8 m-85 -86.29 112.02 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.51 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.465 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.1 m -136.97 169.2 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.639 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -103.19 167.58 9.73 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.003 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.16 -108.35 1.07 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.18 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -115.32 -169.04 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.633 0.254 . . . . 0.0 110.531 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.6 m -135.7 143.52 45.45 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.493 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 12.1 p -139.83 -144.06 0.17 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -172.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.635 ' HB3' HD22 ' A' ' 24' ' ' ASN . 33.0 t70 53.48 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.201 1.0 . . . . 0.0 113.498 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.472 ' H ' HG21 ' A' ' 90' ' ' VAL . 3.2 m -70.42 -45.08 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' H ' HD22 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -89.84 -37.75 14.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.671 0.272 . . . . 0.0 111.33 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t -90.02 -55.81 3.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.898 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.6 t 70.14 153.54 0.11 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.594 0.559 . . . . 0.0 111.058 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.69 19.13 66.5 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.493 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 1.3 m -97.41 137.65 36.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.267 -0.467 . . . . 0.0 110.629 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.54 115.38 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.077 0.465 . . . . 0.0 110.209 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.88 -132.85 14.3 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.55 ' HB2' ' CG2' ' A' ' 36' ' ' THR . 19.4 m . . . . . 0 C--O 1.246 0.903 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 68' ' ' VAL . 15.4 m . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.579 0.228 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.7 m-85 -87.49 148.46 24.92 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.021 0.439 . . . . 0.0 110.247 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -144.75 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.819 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.736 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.99 143.38 44.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.692 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 8.1 p -152.76 155.45 37.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.106 0.479 . . . . 0.0 112.091 -173.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.84 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -80.88 113.34 19.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.816 175.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -79.76 121.12 24.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 12.4 m170 -90.53 132.2 35.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.918 0.39 . . . . 0.0 111.492 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.94 129.27 46.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.44 123.45 48.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.282 0.563 . . . . 0.0 110.543 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -102.2 149.78 23.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.59 100.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.69 -56.91 0.72 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.364 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -159.8 178.49 9.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 111.452 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -61.47 129.56 41.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.323 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -90.83 -55.75 3.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.88 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.21 -179.4 44.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.831 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.0 t -153.69 146.0 23.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.16 0.48 . . . . 0.0 111.348 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 45' ' ' VAL . 3.7 mp -129.0 127.35 65.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.7 ttp180 -86.6 111.98 21.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.015 0.436 . . . . 0.0 110.413 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HG2' HG23 ' A' ' 37' ' ' ILE . 37.9 mmtm -141.02 153.76 45.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.792 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.736 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 50.3 mtpt -69.98 155.91 39.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.744 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.16 141.39 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.831 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.877 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 89.73 -22.14 26.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.964 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.57 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 92.1 m95 -91.86 130.71 37.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.461 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -68.11 130.66 43.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.8 p -113.8 151.04 15.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.351 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -104.67 137.38 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.195 0.522 . . . . 0.0 111.407 -175.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.11 120.76 32.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.608 ' HE2' ' HD3' ' A' ' 56' ' ' LYS . 49.3 p90 -151.19 146.12 25.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -87.0 129.0 35.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 109.973 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.763 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -106.3 132.67 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.501 177.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 32.9 mmtm -131.82 113.3 15.08 Favored Pre-proline 0 C--N 1.315 -0.932 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.03 117.52 3.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.177 2.585 . . . . 0.0 113.053 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.32 -4.21 86.23 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.453 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -118.88 158.32 48.05 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 122.666 0.387 . . . . 0.0 109.976 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.29 154.69 65.41 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.437 2.091 . . . . 0.0 112.342 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.763 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 74.9 mttt -106.55 150.61 25.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.471 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -130.4 137.17 49.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.529 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.574 HD12 HD13 ' A' ' 61' ' ' ILE . 8.5 mt -69.85 115.44 9.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.529 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.629 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 20.8 m -85.7 -21.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.99 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.517 ' HB3' HD22 ' A' ' 78' ' ' LEU . . . 176.85 140.81 0.07 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-O 121.589 0.709 . . . . 0.0 111.794 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.574 HD13 HD12 ' A' ' 58' ' ' LEU . 4.6 mp -102.07 115.37 43.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.5 t -131.93 152.76 50.88 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.388 -169.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.645 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.3 ptpp? -153.14 163.27 40.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -81.04 135.56 35.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.4 -59.25 2.2 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.048 0.843 . . . . 0.0 112.624 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.7 t -87.17 135.22 35.12 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.213 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.877 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 4.0 Cg_exo -78.78 2.12 8.49 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.385 2.723 . . . . 0.0 112.059 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.0 t -119.06 -64.48 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.035 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 66' ' ' SER . 44.1 m80 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.039 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t -100.01 128.29 46.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -123.06 -82.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.298 0.57 . . . . 0.0 109.689 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.35 178.26 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.005 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.738 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 26.7 mt -103.48 124.56 48.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.894 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -109.19 107.21 17.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.297 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.559 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.8 m -110.4 149.74 29.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.075 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -124.27 155.51 38.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.6 t30 60.74 53.53 3.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.526 0.679 . . . . 0.0 110.152 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 75' ' ' CYS . 85.1 mt -72.95 139.34 46.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.298 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.859 ' HB1' ' HB2' ' A' ' 82' ' ' PHE . . . -91.56 45.29 1.22 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.583 0.23 . . . . 0.0 110.946 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 56.77 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.666 0.786 . . . . 0.0 112.054 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.72 -15.29 61.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.137 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.859 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 96.5 m-85 -99.64 106.69 18.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.015 0.436 . . . . 0.0 110.253 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.46 ' HA ' HD23 ' A' ' 78' ' ' LEU . 15.8 m -129.02 167.03 18.07 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.528 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -108.33 154.56 21.64 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.198 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.09 -126.57 3.42 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.06 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 p -96.82 -168.41 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.391 0.615 . . . . 0.0 111.814 -174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 49.7 m -136.33 141.53 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.024 172.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 25.4 p -142.28 -156.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.331 -174.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.762 ' HB3' HD22 ' A' ' 24' ' ' ASN . 32.6 t70 63.86 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.615 0.766 . . . . 0.0 112.157 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -66.88 -41.55 87.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.601 ' H ' HD22 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.32 -24.88 20.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.77 0.319 . . . . 0.0 111.056 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.1 t -86.53 -77.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.762 -176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.3 p -173.85 -69.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.147 0.499 . . . . 0.0 110.119 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.06 96.79 0.12 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p -120.62 33.45 5.58 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.388 -0.125 . . . . 0.0 111.297 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 t 61.0 70.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.762 0.791 . . . . 0.0 109.608 -173.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.0 146.68 18.35 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.246 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.06 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 51.6 p90 -89.91 146.25 24.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.72 140.04 21.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.335 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.763 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 12.4 pt20 -104.43 150.12 24.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.613 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' HA ' HG22 ' A' ' 90' ' ' VAL . 9.2 p -154.48 155.56 35.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.356 0.598 . . . . 0.0 111.399 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.924 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -76.74 108.98 10.14 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.437 ' C ' ' HG1' ' A' ' 36' ' ' THR . 0.4 OUTLIER -76.62 118.69 19.52 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 14.4 m-70 -88.41 126.4 35.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.473 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 1.1 tm? -99.87 121.21 40.96 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 130.01 54.02 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.554 0.692 . . . . 0.0 111.497 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -106.95 151.17 25.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.743 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.33 100.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.313 0.383 . . . . 0.0 110.16 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 32' ' ' ARG . . . 138.58 -51.69 0.76 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.941 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.679 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 7.5 tpp180 176.49 179.56 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.452 0.301 . . . . 0.0 110.249 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.679 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.6 t-80 -41.05 130.98 2.64 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.722 0.809 . . . . 0.0 111.966 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.584 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 39.4 t90 -104.61 -53.9 2.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.75 164.88 34.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.189 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 25' ' ' HIS . 7.1 t -153.95 137.26 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.506 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.521 ' HB ' HG21 ' A' ' 45' ' ' VAL . 2.3 mp -115.65 132.38 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.67 98.74 4.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.78 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.24 148.95 43.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 110.407 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 51.3 mtpt -64.52 153.36 39.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.47 139.56 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.564 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 1.016 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 92.49 -38.85 3.09 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.023 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -66.58 125.39 25.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.912 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.5 122.58 22.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.51 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.521 HG21 ' HB ' ' A' ' 37' ' ' ILE . 8.4 p -109.39 147.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.085 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 134.35 40.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.354 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.473 ' CD1' ' HB2' ' A' ' 27' ' ' LEU . 90.2 m-85 -122.05 127.3 50.05 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.7 147.98 30.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.584 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 9.4 pt-20 -86.94 130.36 34.49 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.913 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 47.5 mt-10 -108.23 102.29 11.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.266 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.828 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 34.4 mmtp -99.36 129.69 28.66 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.415 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 116.36 3.27 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.349 2.033 . . . . 0.0 112.265 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.65 90.42 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.828 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 53.8 mt-30 -125.71 157.36 68.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 C-N-CA 122.381 0.272 . . . . 0.0 110.343 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.26 160.69 48.13 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.393 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 55.1 mttt -103.55 136.64 42.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.337 -173.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -132.91 135.77 45.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.677 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.5 119.93 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.558 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 32.2 m -92.69 -27.01 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.466 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.517 ' CB ' HD22 ' A' ' 78' ' ' LEU . . . 177.7 144.25 0.1 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.727 0.642 . . . . 0.0 111.261 173.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.1 mp -102.93 111.93 34.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.492 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.7 m -116.96 146.49 42.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.932 0.396 . . . . 0.0 111.136 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.912 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.5 pttm -155.13 161.56 41.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.491 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 9.0 t30 -80.19 143.21 33.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.301 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.2 -57.04 3.14 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.062 0.852 . . . . 0.0 112.044 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.7 m -94.74 138.77 22.12 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.406 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 1.016 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.5 Cg_endo -82.98 23.52 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.143 2.562 . . . . 0.0 112.008 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 4.0 t -136.34 -73.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.68 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -85.13 159.92 20.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.13 125.71 48.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.985 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -123.64 -79.34 0.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.27 174.45 10.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 85' ' ' GLY . 50.1 mt -101.28 122.51 43.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.464 0.65 . . . . 0.0 111.381 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.733 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.6 mmpt? -93.59 106.91 18.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.356 172.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 8.1 t -121.58 166.1 14.71 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.298 -177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.56 HG21 HD21 ' A' ' 77' ' ' ASN . 11.4 t -159.94 162.19 34.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.073 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.56 HD21 HG21 ' A' ' 76' ' ' THR . 50.3 m-80 68.67 33.56 3.78 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.78 0.675 . . . . 0.0 110.256 -176.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 83' ' ' SER . 93.1 mt -59.86 139.58 57.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -97.55 65.09 1.87 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.0 111.484 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.84 -88.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.151 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.19 -21.8 77.38 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.898 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.8 m-85 -88.43 109.66 20.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.937 0.398 . . . . 0.0 110.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.865 ' HA ' HD23 ' A' ' 78' ' ' LEU . 17.0 m -128.54 173.62 10.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.58 158.79 19.53 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.69 -0.631 . . . . 0.0 110.667 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.486 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -123.11 -151.14 8.22 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.19 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -84.15 -176.69 6.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.855 0.359 . . . . 0.0 110.186 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.1 m -120.72 142.94 49.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 66.7 p -139.55 -156.04 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.731 0.301 . . . . 0.0 111.75 -170.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.924 ' HB3' HD22 ' A' ' 24' ' ' ASN . 21.9 t70 63.61 -77.03 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.99 0.916 . . . . 0.0 112.547 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 23' ' ' CYS . 2.5 m -68.08 -46.61 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 23' ' ' CYS . 3.8 pp -90.7 -41.35 11.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.712 0.291 . . . . 0.0 111.648 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.403 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 t -78.08 -42.8 31.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -174.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.2 t 60.94 88.56 0.08 Allowed 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.514 0.509 . . . . 0.0 110.441 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 141.12 53.75 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.161 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -148.41 178.71 8.37 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.375 0.27 . . . . 0.0 110.277 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.0 t -70.71 -73.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.43 177.37 48.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.251 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.248 0.99 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.475 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 79.7 m-85 -76.37 134.21 39.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 p -135.57 136.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.388 -173.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.735 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -101.99 141.54 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.58 ' HA ' HG22 ' A' ' 90' ' ' VAL . 7.1 p -144.09 148.86 35.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.416 0.627 . . . . 0.0 112.105 -170.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.857 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -74.77 106.61 6.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.169 175.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.51 121.74 21.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.2 130.81 37.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.29 -174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.504 HD21 ' CG ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -100.2 124.13 45.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.409 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.98 125.65 49.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.253 0.549 . . . . 0.0 110.686 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 50.9 t80 -113.32 151.27 31.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -53.34 100.92 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.715 0.634 . . . . 0.0 110.379 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -52.16 0.82 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.241 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 20.9 tpt180 -172.74 171.77 4.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.743 0.272 . . . . 0.0 110.822 -175.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.626 ' HE2' ' HB ' ' A' ' 36' ' ' THR . 23.7 t-80 -46.31 121.38 3.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.325 0.65 . . . . 0.0 111.289 172.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 57.9 t90 -89.93 -56.14 3.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.99 170.8 34.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.563 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.626 ' HB ' ' HE2' ' A' ' 33' ' ' HIS . 6.6 t -154.42 143.92 21.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.09 0.445 . . . . 0.0 110.758 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.11 130.23 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.614 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.2 mtm180 -82.32 117.83 22.7 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.362 0.601 . . . . 0.0 110.726 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' HG3' HG22 ' A' ' 45' ' ' VAL . 72.6 mmtt -142.52 152.61 42.82 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.3 mtpt -69.16 156.74 38.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.023 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 140.3 58.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.418 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 89.98 -25.1 12.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.228 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.524 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 49.8 m95 -83.13 130.05 35.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 0.0 110.634 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.897 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -79.03 123.38 27.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.705 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.7 p -106.15 154.26 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.981 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.8 140.99 29.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CG ' HD21 ' A' ' 27' ' ' LEU . 75.6 m-85 -131.33 123.68 28.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -142.14 149.85 40.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.933 0.397 . . . . 0.0 111.265 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 11.1 pt-20 -87.41 130.04 34.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.728 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 56' ' ' LYS . 29.8 mt-10 -114.04 101.91 9.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.152 0.501 . . . . 0.0 109.827 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 71.6 mmtt -82.9 134.74 46.24 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.896 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.55 117.05 3.53 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.54 2.16 . . . . 0.0 112.358 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.06 80.55 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.482 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.765 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 33.3 mt-30 -115.67 162.04 27.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 122.498 0.319 . . . . 0.0 110.772 -175.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 54' ' ' GLN . 57.5 Cg_endo -70.95 159.2 53.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.88 2.387 . . . . 0.0 112.803 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.778 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.4 146.39 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 -178.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -137.63 131.65 31.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.49 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.494 HD23 HG13 ' A' ' 61' ' ' ILE . 9.1 mt -58.22 119.6 7.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.012 0.434 . . . . 0.0 112.046 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.4 m -100.09 -15.71 7.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.396 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.32 135.77 0.58 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.581 0.705 . . . . 0.0 111.821 176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.494 HG13 HD23 ' A' ' 58' ' ' LEU . 5.0 mp -107.74 112.29 39.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.1 t -131.53 149.72 52.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.728 -169.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.897 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 pttp -155.39 163.43 40.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.42 139.22 34.13 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.318 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.38 -55.71 4.78 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.818 0.698 . . . . 0.0 112.179 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.9 t -95.86 146.64 31.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.212 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 3.5 Cg_exo -82.45 -1.19 10.54 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.157 2.572 . . . . 0.0 111.972 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.7 t -103.96 -79.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -94.27 165.04 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.155 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.1 121.97 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -119.55 -85.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.275 0.56 . . . . 0.0 109.593 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -126.31 166.34 17.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.914 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.763 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 14.2 mt -102.99 123.39 46.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.0 110.638 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -98.88 104.65 16.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.808 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 m -112.84 146.1 39.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.427 . . . . 0.0 110.658 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -129.23 155.45 45.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.874 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.4 60.2 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.691 0.619 . . . . 0.0 110.37 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 83' ' ' SER . 91.3 mt -77.6 157.91 30.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.364 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -115.46 71.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.743 0.306 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.96 -92.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.171 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.16 55.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.994 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 96.6 m-85 -72.65 109.56 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.314 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.562 ' HA ' HD23 ' A' ' 78' ' ' LEU . 19.6 m -140.97 166.71 24.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.53 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -103.56 168.49 9.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.045 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -139.0 -171.49 12.19 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.049 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -69.16 169.77 11.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.463 0.649 . . . . 0.0 111.622 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.4 m -105.76 153.84 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.669 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.5 p -139.88 -156.44 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.047 -175.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.857 ' HB3' HD22 ' A' ' 24' ' ' ASN . 4.1 t70 62.61 -80.17 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 23' ' ' CYS . 1.3 m -66.06 -41.62 89.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.222 -175.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.569 ' H ' HD22 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.464 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m -95.53 -77.46 0.47 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.8 t -159.29 -59.31 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 110.824 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.542 ' N ' ' HA ' ' A' ' 89' ' ' ASP . . . 167.68 136.17 2.0 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.0 p -135.58 137.71 42.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.916 0.358 . . . . 0.0 111.21 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.38 164.75 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.003 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.89 -41.03 1.49 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.608 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.168 177.707 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 17.8 p90 -58.5 131.15 49.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.284 0.564 . . . . 0.0 110.589 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.35 139.78 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.92 -170.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.656 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -99.7 143.34 30.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.659 175.083 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' HD22 ' A' ' 91' ' ' LEU . 7.5 p -151.72 159.19 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.886 0.374 . . . . 0.0 111.463 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.815 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -82.16 117.25 22.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -85.16 119.44 25.55 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -90.57 130.37 36.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.829 0.347 . . . . 0.0 111.206 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.534 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -98.1 126.1 43.39 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -110.02 116.53 31.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.575 0.703 . . . . 0.0 110.68 -175.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -94.95 135.12 36.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.8 101.92 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.446 0.641 . . . . 0.0 110.281 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.73 -56.29 0.61 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.607 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -175.4 161.69 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.492 0.317 . . . . 0.0 110.727 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -37.86 132.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.908 0.883 . . . . 0.0 112.195 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -100.79 -54.8 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.593 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.99 -179.33 40.49 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.338 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.542 HG22 ' HG ' ' A' ' 98' ' ' SER . 10.4 t -153.83 147.7 25.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.031 0.416 . . . . 0.0 111.354 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.4 mp -134.02 136.6 53.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 46.0 mtm180 -77.71 130.17 36.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.294 0.568 . . . . 0.0 111.36 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -150.39 148.22 28.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.542 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.656 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 46.6 mtpt -73.97 149.94 41.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.069 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 66' ' ' SER . . . -61.6 138.92 58.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.59 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 93.75 -23.7 29.53 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.143 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -101.44 136.16 41.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.817 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -82.57 155.07 24.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.495 0.664 . . . . 0.0 111.117 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.6 p -126.92 150.19 32.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.585 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 135.77 33.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.421 . . . . 0.0 111.301 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.693 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.2 m-85 -125.9 128.27 47.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 169.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 49.9 p90 -146.18 153.75 40.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.396 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -100.04 136.64 39.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -115.68 110.85 19.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.567 0.699 . . . . 0.0 111.474 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.2 105.28 42.39 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -44.29 121.63 3.24 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.324 2.682 . . . . 0.0 112.683 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.27 -24.15 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.65 151.43 57.08 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.004 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.72 149.25 54.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.227 1.952 . . . . 0.0 111.049 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 51.8 mttt -77.24 119.0 20.29 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.823 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 19.5 tpp180 -94.1 133.77 37.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.356 -168.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.445 HD23 HG13 ' A' ' 61' ' ' ILE . 6.8 mt -62.29 107.78 0.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.195 0.522 . . . . 0.0 110.28 174.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.2 m -91.56 -22.71 6.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.295 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -168.68 135.53 1.9 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 111.684 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.445 HG13 HD23 ' A' ' 58' ' ' LEU . 4.7 mp -105.11 111.18 33.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.747 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.7 t -132.88 146.45 51.82 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.899 -168.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.817 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 29.6 pttt -145.25 164.92 29.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.955 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -78.27 136.81 37.83 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.799 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.67 -37.77 19.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.474 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 22.1 t -105.62 140.74 21.48 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.06 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.59 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 4.2 Cg_exo -77.83 4.35 6.16 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.022 2.482 . . . . 0.0 111.943 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.1 t -121.4 -77.33 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.68 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 66' ' ' SER . 52.8 m80 -94.06 163.75 13.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 p -96.7 125.38 41.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.415 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 50.6 m-20 -123.21 -87.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.415 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 33.9 m-85 -129.24 177.56 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.018 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.747 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.3 mt -103.17 125.12 49.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.153 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -106.85 106.26 16.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.034 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -115.56 150.44 36.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.022 -174.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -119.68 150.57 40.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 7.2 t30 64.74 103.84 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.705 0.628 . . . . 0.0 110.722 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 83' ' ' SER . 98.1 mt -117.98 127.63 54.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -91.26 76.8 5.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.633 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.06 -88.52 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.456 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.36 -6.36 61.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.061 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.3 m-85 -94.24 115.84 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.893 0.378 . . . . 0.0 110.809 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.494 ' HA ' HD23 ' A' ' 78' ' ' LEU . 17.2 m -144.98 168.64 19.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.485 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -99.86 154.77 18.08 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -110.67 -58.97 0.49 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.603 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.26 -178.32 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.9 m -126.9 141.36 51.83 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.45 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.7 p -142.32 -155.96 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.16 0.505 . . . . 0.0 111.812 -172.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.815 ' HB3' HD22 ' A' ' 24' ' ' ASN . 26.8 t70 66.95 -83.45 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.113 168.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 7.3 m -71.07 -33.36 51.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.843 0.354 . . . . 0.0 111.027 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.526 HD22 ' CB ' ' A' ' 23' ' ' CYS . 4.1 pp -88.73 -31.94 18.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.4 t -95.27 -77.56 0.47 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.84 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -159.64 -59.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.995 0.426 . . . . 0.0 110.417 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.71 141.37 5.61 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.25 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 89' ' ' ASP . 7.2 p -137.41 167.3 21.89 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m -61.92 129.96 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.092 0.472 . . . . 0.0 110.512 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.74 106.91 2.59 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.829 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.542 ' HG ' HG22 ' A' ' 36' ' ' THR . 64.4 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.951 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 18.2 p90 -86.79 131.41 34.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 70' ' ' CYS . 1.8 p -121.43 142.11 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.895 -168.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 1.033 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.28 147.53 25.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 10.6 p -149.49 147.91 28.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.454 0.645 . . . . 0.0 112.405 -175.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 1.014 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -72.39 110.66 6.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.753 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 5.4 m80 -75.85 107.28 7.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.802 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.489 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 12.3 m-70 -79.68 126.63 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.106 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.506 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -99.33 125.26 44.96 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.55 125.42 51.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.472 0.653 . . . . 0.0 110.978 -176.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -100.14 151.13 21.77 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -48.29 101.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.458 0.474 . . . . 0.0 111.009 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.5 -53.03 0.68 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.235 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -147.85 160.95 42.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.457 0.646 . . . . 0.0 112.67 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -48.78 133.05 17.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.177 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -102.91 -55.48 2.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.127 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -177.9 38.01 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.459 ' HG1' ' C ' ' A' ' 25' ' ' HIS . 5.6 t -153.92 141.44 19.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.204 0.502 . . . . 0.0 110.037 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.31 123.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.54 HH21 ' HA ' ' A' ' 98' ' ' SER . 6.1 tpp85 -75.84 99.4 4.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.841 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -145.02 145.76 31.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.133 0.492 . . . . 0.0 111.365 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 1.033 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 12.7 ptmt -64.69 151.82 43.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.002 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.93 142.57 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.866 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.88 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.62 -30.61 10.01 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.316 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.565 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 76.2 m95 -90.17 139.68 30.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.21 130.59 40.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.957 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.3 p -121.46 153.43 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.141 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.73 142.39 28.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 111.059 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.753 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 77.3 m-85 -127.89 133.81 49.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 170.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.581 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 45.6 p90 -148.92 151.05 33.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.706 0.289 . . . . 0.0 110.689 -175.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.29 143.78 27.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.611 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.923 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 11.3 pt-20 -126.67 102.02 6.89 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.933 0.873 . . . . 0.0 111.158 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.17 128.15 41.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.02 116.94 2.71 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.57 2.18 . . . . 0.0 112.487 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.53 -29.27 12.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.372 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -96.54 153.09 38.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.24 153.4 74.59 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.588 2.192 . . . . 0.0 111.732 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.923 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 21.1 mmtp -70.57 117.7 12.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.43 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -105.81 125.67 51.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.598 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mt -57.02 120.83 8.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 110.784 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.1 m -107.74 -17.74 7.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.35 138.41 0.94 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.48 0.657 . . . . 0.0 111.62 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.8 mp -108.26 112.38 40.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 168.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -130.69 150.89 51.67 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.953 -168.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.1 ptpp? -151.28 162.74 40.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.44 144.61 31.27 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.43 -56.96 5.13 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.767 0.667 . . . . 0.0 111.918 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 m -97.05 143.06 25.48 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.585 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.88 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 Cg_endo -83.81 22.19 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.25 2.633 . . . . 0.0 112.343 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.0 t -136.03 -76.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -81.28 159.55 24.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.413 ' HB2' HG11 ' A' ' 21' ' ' VAL . 23.7 t -98.81 122.32 41.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.998 0.427 . . . . 0.0 109.957 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -112.09 -83.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.591 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -145.76 179.99 7.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.838 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.721 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 16.3 mt -101.75 121.78 42.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -100.6 104.87 16.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.013 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 m -116.57 149.22 40.0 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.91 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -128.17 156.32 43.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 63.74 59.34 1.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.752 0.658 . . . . 0.0 110.286 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 83' ' ' SER . 94.6 mt -77.84 131.63 37.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.428 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -90.33 66.65 6.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 111.538 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.2 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.107 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.47 -10.15 83.85 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.089 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.7 m-85 -96.43 114.14 25.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.612 ' HA ' HD23 ' A' ' 78' ' ' LEU . 38.6 m -143.98 172.82 12.34 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -106.98 162.64 13.66 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.55 -126.91 3.95 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.02 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 14.1 t -104.4 -176.37 3.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.642 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 3.9 p -132.52 141.82 48.93 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.53 ' HB ' HG23 ' A' ' 95' ' ' THR . 28.8 p -142.67 -157.58 0.79 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.962 0.41 . . . . 0.0 111.967 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 1.014 ' HB3' HD22 ' A' ' 24' ' ' ASN . 21.1 t70 72.21 -62.43 0.46 Allowed 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.799 168.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.626 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 1.5 m -85.07 -31.89 7.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.481 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 23' ' ' CYS . 4.1 pp -89.77 -34.66 16.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.667 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.1 p -99.97 -14.96 18.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.37 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 5.3 t 82.2 86.67 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.074 171.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.9 94.72 0.89 Allowed Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.63 -0.714 . . . . 0.0 114.046 173.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.561 ' HG1' ' HB2' ' A' ' 89' ' ' ASP . 41.6 p -137.64 -127.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.662 0.268 . . . . 0.0 110.977 174.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.2 m -123.61 149.46 27.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.632 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.5 162.3 21.51 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.274 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.54 ' HA ' HH21 ' A' ' 38' ' ' ARG . 20.7 t . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.355 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.717 0.294 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.661 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 39.1 p90 -88.8 139.59 30.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -120.71 138.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.571 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.766 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -98.71 142.36 30.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.689 175.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.56 ' HA ' HG22 ' A' ' 90' ' ' VAL . 7.6 p -155.68 159.45 39.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 111.613 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.965 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -80.38 111.78 17.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.099 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HD2' HG11 ' A' ' 45' ' ' VAL . 3.3 m-70 -81.82 115.95 21.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -87.85 129.65 35.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.5 tm? -98.6 127.78 44.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -103.64 121.72 43.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.71 -175.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 85.4 t80 -94.31 141.29 28.73 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -54.78 101.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 110.699 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.57 -42.9 1.39 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.361 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -168.86 153.09 5.62 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.018 0.437 . . . . 0.0 111.672 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -38.55 126.22 1.43 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.07 0.948 . . . . 0.0 112.538 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.582 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.6 t90 -94.25 -55.77 3.07 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.98 -175.07 37.42 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.781 -0.724 . . . . 0.0 111.899 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.497 HG22 ' HB2' ' A' ' 98' ' ' SER . 6.6 t -154.39 147.89 25.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.055 0.428 . . . . 0.0 110.882 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.441 HD13 ' CE1' ' A' ' 47' ' ' PHE . 3.3 mp -124.4 126.22 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 2.9 tpp180 -77.84 93.7 4.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -127.7 144.54 51.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.766 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 36.4 mtpt -70.72 151.86 44.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.65 142.05 57.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.47 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 91.88 -27.94 9.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.157 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 27.1 m95 -84.52 128.28 34.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.696 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.08 135.07 46.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.475 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' A' ' 25' ' ' HIS . 7.3 p -121.56 142.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.841 0.353 . . . . 0.0 110.764 -176.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.14 141.81 28.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 73.9 m-85 -130.65 134.98 47.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.46 167.75 21.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.733 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 15.5 pt-20 -107.54 125.39 51.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.422 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.542 ' HG2' ' HZ2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -117.52 121.67 41.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -129.73 149.97 74.47 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.24 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.13 117.81 3.96 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.447 2.765 . . . . 0.0 112.737 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.29 -13.43 45.64 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.888 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.75 142.38 25.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.965 0.412 . . . . 0.0 111.549 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.1 155.49 67.95 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.834 2.356 . . . . 0.0 111.568 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.604 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.487 -176.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -130.52 144.16 51.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.54 130.85 48.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.465 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' A' ' 49' ' ' GLU . 33.5 m -117.2 -20.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -166.73 137.67 3.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.433 0.635 . . . . 0.0 111.137 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.6 mp -109.54 110.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 169.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.688 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.9 t -130.52 168.16 17.5 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.863 -167.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.696 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 19.5 pttp -174.45 163.83 3.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.606 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.1 133.42 44.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -45.59 -41.9 10.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 114.009 -1.451 . . . . 0.0 113.177 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.9 t -102.15 138.15 19.66 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.191 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.547 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.3 Cg_endo -75.89 1.43 8.16 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.642 2.228 . . . . 0.0 111.792 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.5 t -118.81 -78.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.555 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.526 ' O ' ' HB3' ' A' ' 66' ' ' SER . 45.7 m-70 -89.91 162.53 15.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.2 t -97.25 129.12 44.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.067 0.46 . . . . 0.0 110.446 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -125.49 -81.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -139.67 174.82 10.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.828 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.632 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.9 mt -103.6 120.57 41.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.721 0.296 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -106.54 110.53 22.75 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 1.9 m -112.81 149.78 32.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.357 -173.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -111.8 150.61 30.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 9.5 t30 59.62 90.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.675 0.61 . . . . 0.0 110.473 -174.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.0 117.4 34.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -84.21 61.74 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.046 0.451 . . . . 0.0 111.352 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.57 -91.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.265 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 5.31 84.73 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.41 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 98.6 m-85 -114.43 108.84 17.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 0.0 110.139 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 m -147.29 166.52 26.84 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -100.32 153.78 19.02 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.321 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.66 -63.82 0.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.486 -171.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 t -175.91 -169.94 0.36 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 m -129.09 143.39 50.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 49.0 p -140.23 -152.51 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.995 -0.093 . . . . 0.0 110.97 -174.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.965 ' HB3' HD22 ' A' ' 24' ' ' ASN . 16.6 t70 63.0 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.962 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -69.12 -45.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.723 0.297 . . . . 0.0 111.778 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.02 -24.33 22.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 111.259 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.4 t -88.04 -71.68 0.57 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.7 p 179.8 -68.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.527 0.68 . . . . 0.0 109.663 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.05 -53.55 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.427 ' HB ' ' H ' ' A' ' 96' ' ' VAL . 34.8 p 50.44 -157.42 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.631 0.772 . . . . 0.0 112.34 176.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.427 ' H ' ' HB ' ' A' ' 95' ' ' THR . 29.0 m -94.23 148.33 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.83 -154.91 6.54 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.425 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.497 ' HB2' HG22 ' A' ' 36' ' ' THR . 15.9 m . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.338 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.7 m-85 -47.82 130.01 14.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.309 0.576 . . . . 0.0 110.799 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.75 143.77 34.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.266 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.911 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -99.3 142.43 30.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.14 177.14 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 6.0 p -148.84 146.21 27.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.512 . . . . 0.0 111.846 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.993 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -77.27 115.52 17.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 110.302 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.4 124.49 29.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.281 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.662 ' HA ' ' HG1' ' A' ' 36' ' ' THR . 10.8 m170 -94.25 126.27 39.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.92 0.39 . . . . 0.0 111.533 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.475 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -97.89 127.89 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -105.07 128.86 53.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.929 -175.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.611 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 73.3 t80 -104.26 148.22 26.6 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.05 99.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.0 109.756 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -49.83 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.626 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -173.99 175.35 2.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.526 0.203 . . . . 0.0 110.619 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.745 ' HE1' ' HA ' ' A' ' 98' ' ' SER . 44.9 t-80 -54.3 139.14 37.36 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.794 0.438 . . . . 0.0 110.945 176.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 60.9 t90 -107.42 -56.01 2.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.736 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.78 167.45 33.16 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.035 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.662 ' HG1' ' HA ' ' A' ' 26' ' ' HIS . 0.9 OUTLIER -151.89 136.78 17.2 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 120.99 0.424 . . . . 0.0 112.025 -176.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.401 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.5 mp -126.2 132.78 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.957 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.843 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 34.9 ttp180 -94.21 113.92 25.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 37' ' ' ILE . 73.9 mmtt -138.1 153.95 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.298 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.911 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.9 mtpt -68.06 157.84 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 111.251 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 66' ' ' SER . . . -69.87 142.47 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.41 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.24 10.98 81.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.487 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -116.75 156.44 27.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . . . -90.55 120.44 31.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.407 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 62' ' ' CYS . 14.7 p -105.38 141.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.569 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 133.61 39.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.182 0.515 . . . . 0.0 110.671 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CG ' HD21 ' A' ' 27' ' ' LEU . 66.5 m-85 -125.65 125.14 42.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.681 ' HB3' HD21 ' A' ' 58' ' ' LEU . 42.6 p90 -147.32 148.03 30.96 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.998 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.6 125.19 34.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.57 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 8.8 pt-20 -128.54 102.78 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.02 0.914 . . . . 0.0 110.019 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -104.13 118.24 57.48 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.572 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -42.92 117.34 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.694 2.929 . . . . 0.0 113.067 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.18 -20.83 32.4 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.012 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 47.5 mt-30 -115.84 143.4 30.69 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.654 0.264 . . . . 0.0 110.91 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 24.4 Cg_exo -64.56 161.99 32.98 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.215 2.61 . . . . 0.0 111.93 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 27.9 mttm -90.93 143.43 26.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.116 -169.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.595 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -134.53 133.29 40.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 48' ' ' TYR . 13.3 mt -64.09 126.67 28.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 0.0 111.052 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 20.5 m -113.02 -17.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -171.18 135.53 0.99 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.484 0.659 . . . . 0.0 111.799 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.589 HD13 HD11 ' A' ' 58' ' ' LEU . 4.5 mp -113.17 112.13 39.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 167.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -120.56 146.12 46.64 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.356 -166.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.509 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 24.9 mmtm -120.01 164.67 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 70' ' ' CYS . 9.9 t30 -93.66 137.06 33.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.6 -55.28 1.89 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.115 0.884 . . . . 0.0 112.679 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 39.9 t -103.12 141.62 22.86 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.823 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.48 -10.55 13.3 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.591 2.194 . . . . 0.0 111.649 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 16.2 t -100.32 -59.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.497 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -104.96 164.52 11.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.407 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.421 ' HA ' HD22 ' A' ' 64' ' ' ASN . 5.9 p -100.87 122.02 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.302 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.87 -90.09 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.111 0.481 . . . . 0.0 110.709 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -131.37 176.52 8.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.448 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.792 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.7 mt -105.79 128.41 53.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -170.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -109.41 105.26 14.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.772 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 1.7 m -119.94 152.68 37.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.973 -171.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 t -124.45 174.1 8.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.18 34.49 21.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.636 0.585 . . . . 0.0 111.606 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.614 HD23 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -66.08 131.01 45.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.795 -176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -100.92 68.15 1.26 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.674 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.07 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.538 0.735 . . . . 0.0 112.821 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.12 -14.05 83.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.966 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 98.1 m-85 -96.92 111.42 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.994 0.426 . . . . 0.0 110.753 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.614 ' HA ' HD23 ' A' ' 78' ' ' LEU . 45.1 m -148.51 168.53 22.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.718 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -112.1 154.61 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.872 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -106.31 -79.22 1.23 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.895 -171.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 13.4 t -161.1 -174.91 4.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 27.8 m -116.06 144.04 44.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.463 ' HG1' HG23 ' A' ' 95' ' ' THR . 39.9 p -139.75 -155.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.103 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.993 ' HB3' HD22 ' A' ' 24' ' ' ASN . 20.9 t70 66.67 -81.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.593 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -65.23 -40.91 90.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.813 0.339 . . . . 0.0 111.591 -175.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.8 -30.24 19.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.668 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -86.29 -75.55 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.661 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.4 t -166.95 -58.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.636 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.39 142.46 5.74 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.363 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' A' ' 89' ' ' ASP . 31.4 p -136.38 -170.87 2.76 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.89 26.92 3.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.903 0.382 . . . . 0.0 111.398 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.0 -115.04 6.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.085 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.745 ' HA ' ' HE1' ' A' ' 33' ' ' HIS . 50.1 m . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.839 -0.601 . . . . 0.0 110.199 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.611 ' HD1' ' H ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -85.32 125.81 33.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -132.93 139.44 49.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.865 -172.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.67 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -101.51 142.15 33.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.844 ' HA ' HG22 ' A' ' 90' ' ' VAL . 26.1 p -143.69 150.14 38.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.316 -172.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.911 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -74.31 114.4 12.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 175.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.504 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -83.18 113.79 20.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.601 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -85.39 127.37 34.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.173 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 28' ' ' LEU . 1.5 tm? -100.06 132.44 45.42 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -99.46 124.67 44.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.599 -178.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.921 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.8 t80 -93.61 150.0 20.78 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -53.74 99.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 110.309 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.85 -68.32 0.46 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.189 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -142.89 179.19 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 112.128 -171.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -47.71 133.85 13.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.801 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.921 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 83.8 t90 -103.15 -56.62 2.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.17 -178.57 42.49 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.022 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.687 ' HG1' ' HB2' ' A' ' 24' ' ' ASN . 13.3 t -153.11 138.7 17.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.631 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.2 mp -116.11 129.89 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.571 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.663 HH11 HG12 ' A' ' 90' ' ' VAL . 2.3 tpp180 -80.84 99.84 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.419 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.0 mmtm -140.9 152.95 45.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.224 0.535 . . . . 0.0 111.385 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.4 mtpt -67.18 154.97 39.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.826 -176.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 54.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.187 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 91.94 -26.63 12.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.177 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -81.14 134.73 35.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.007 0.432 . . . . 0.0 110.842 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.654 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -78.21 121.75 24.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.972 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.1 p -111.87 147.31 15.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 141.72 28.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 -176.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.727 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.0 m-85 -127.56 138.29 52.84 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 22.4 p90 -153.33 159.63 42.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 -172.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.48 137.37 44.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 56' ' ' LYS . 22.9 mt-10 -112.5 102.0 10.13 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -90.56 143.59 29.38 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.57 116.51 3.34 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.512 2.141 . . . . 0.0 111.788 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.07 -17.74 57.68 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.292 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -101.56 148.43 35.22 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.63 153.41 59.82 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 110.615 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.54 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 15.6 mttp -62.61 127.85 33.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.08 -173.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -103.82 119.97 40.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.89 115.53 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.638 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 25.9 m -96.88 -22.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.614 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 47' ' ' PHE . . . 176.27 144.61 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.612 0.57 . . . . 0.0 111.315 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.4 mp -101.73 116.98 46.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.727 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.6 t -128.63 149.42 50.66 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.321 -171.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.2 ptpt -144.26 162.29 36.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -85.71 133.69 34.0 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.166 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.29 -53.51 5.17 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.092 0.87 . . . . 0.0 112.959 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 33.2 t -93.46 139.59 22.93 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.318 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 71.7 Cg_endo -78.87 -3.51 13.28 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.594 2.196 . . . . 0.0 111.827 173.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -111.33 -69.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.423 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 66' ' ' SER . 35.6 m80 -94.79 161.8 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.004 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.0 p -98.51 121.17 40.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -121.41 -88.48 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 0.0 109.707 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.04 171.23 12.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.47 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.673 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 37.8 mt -103.71 119.93 39.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.869 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.9 mmpt? -96.05 104.47 16.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 30.7 m -100.87 152.88 20.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.033 0.444 . . . . 0.0 111.361 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -133.39 157.86 44.48 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.553 173.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.463 HD21 HD11 ' A' ' 61' ' ' ILE . 90.6 m-20 59.43 49.57 8.56 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.469 0.481 . . . . 0.0 111.066 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.87 140.81 58.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 59' ' ' VAL . . . -96.91 79.0 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.944 0.402 . . . . 0.0 110.76 -178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 67.67 -77.7 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.798 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.83 -13.1 6.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.955 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 50.6 m-85 -71.22 118.09 13.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -151.2 171.59 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.705 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . . . -92.24 163.24 13.99 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.752 0.311 . . . . 0.0 110.56 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.24 -62.64 0.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.511 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.11 -171.44 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.8 m -129.83 143.18 50.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.424 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 41.6 p -141.66 -160.74 1.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.698 -176.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.911 ' HB3' HD22 ' A' ' 24' ' ' ASN . 19.5 t70 64.51 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.388 171.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.844 HG22 ' HA ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -62.25 -38.29 80.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.901 0.382 . . . . 0.0 111.206 -176.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.22 -37.91 15.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.733 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m -87.96 -77.06 0.36 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.03 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.5 t -162.43 -66.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.37 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.416 ' HA2' ' OD1' ' A' ' 89' ' ' ASP . . . -170.58 137.49 4.47 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.131 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.5 p -136.44 123.69 21.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.718 0.259 . . . . 0.0 111.287 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.5 m -86.26 129.02 38.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.94 -57.82 0.17 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.589 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.555 -1.212 . . . . 0.0 109.623 -178.785 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.6 m-85 -53.32 141.22 24.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.941 0.4 . . . . 0.0 110.419 173.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.661 HG11 ' HG ' ' A' ' 70' ' ' CYS . 1.5 p -142.39 133.7 25.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.606 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -96.52 145.66 25.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 21.6 p -150.23 149.1 29.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.486 0.66 . . . . 0.0 111.876 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.884 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.53 114.37 14.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.857 173.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.447 ' C ' ' HG1' ' A' ' 36' ' ' THR . 0.3 OUTLIER -80.04 117.96 21.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.434 ' CE1' ' HA3' ' A' ' 97' ' ' GLY . 11.5 m170 -87.06 134.09 33.53 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.804 0.335 . . . . 0.0 111.895 -174.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.564 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -99.55 123.59 43.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.78 122.29 45.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.475 0.655 . . . . 0.0 110.858 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -95.35 146.66 24.22 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -60.8 100.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.0 -52.61 0.68 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.825 -174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.551 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 17.6 tpt180 -174.94 177.9 1.9 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.744 0.272 . . . . 0.0 111.428 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.551 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.5 t-80 -51.23 128.13 21.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.516 0.727 . . . . 0.0 111.631 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.695 ' HZ2' ' H ' ' A' ' 50' ' ' GLU . 57.2 t90 -95.65 -56.8 2.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.56 173.71 44.97 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 8.8 t -155.24 146.6 22.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.206 0.503 . . . . 0.0 111.497 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.81 133.85 66.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.405 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.604 HH11 ' HB3' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -76.09 113.55 13.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.156 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 11.9 tppt? -143.72 150.72 39.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 21.0 ttmt -83.25 147.42 28.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.86 139.59 33.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.966 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.577 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 98.2 -39.6 2.72 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.447 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -81.2 137.19 35.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 110.608 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.647 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -76.34 136.66 39.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.646 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 62' ' ' CYS . 10.0 p -118.39 148.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.679 ' HE ' ' HE1' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -89.01 143.32 26.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.407 . . . . 0.0 110.899 -177.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.697 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 55.0 m-85 -128.31 143.28 51.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.679 ' HE1' ' HE ' ' A' ' 46' ' ' ARG . 36.7 p90 -152.51 156.48 39.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.814 0.34 . . . . 0.0 110.58 -174.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 8.5 pt-20 -100.17 130.07 46.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.743 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -120.32 101.08 7.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.963 0.887 . . . . 0.0 110.497 175.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -85.19 141.53 37.38 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.816 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.19 116.39 2.22 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.847 2.365 . . . . 0.0 112.894 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.73 -30.52 6.48 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.171 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -83.15 153.33 66.27 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.719 0.295 . . . . 0.0 111.228 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 153.9 76.15 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 111.186 171.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.743 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 32.2 mttm -94.54 126.1 39.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.99 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 7.2 ttm-85 -94.58 123.53 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.261 -174.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.15 102.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.59 -19.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.79 146.92 0.35 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.158 0.504 . . . . 0.0 111.51 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.6 mp -107.89 118.64 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.697 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 9.1 t -133.82 150.88 51.42 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.289 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.647 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.4 ptpt -146.32 162.75 37.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.21 138.65 36.87 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.439 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.93 -57.53 2.37 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.38 1.05 . . . . 0.0 112.677 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.7 t -93.54 138.3 23.0 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.156 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.577 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -76.25 -0.76 10.7 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.641 2.228 . . . . 0.0 111.879 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -115.34 -66.45 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.73 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' ' 66' ' ' SER . 53.5 m-70 -98.21 163.89 12.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.661 ' HG ' HG11 ' A' ' 21' ' ' VAL . 97.9 m -99.23 122.33 42.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.398 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -125.04 -79.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.305 0.574 . . . . 0.0 110.218 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.53 174.18 10.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.827 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.696 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 28.3 mt -104.51 127.44 52.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.235 0.541 . . . . 0.0 111.387 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -104.69 105.66 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.35 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 5.9 m -106.14 163.64 12.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.244 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -144.22 157.91 44.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.3 46.61 5.9 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.664 0.603 . . . . 0.0 111.34 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.5 mt -67.28 147.89 52.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.691 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . . . -107.57 69.85 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 111.465 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.22 -93.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.8 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.91 -5.87 88.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.184 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 97.8 m-85 -98.71 112.98 24.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.233 0.539 . . . . 0.0 110.485 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.426 ' HA ' HD22 ' A' ' 78' ' ' LEU . 20.1 m -140.02 169.12 18.29 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.661 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -108.0 156.78 18.85 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.569 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -121.07 3.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.896 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -110.35 -169.6 1.49 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.594 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 18.9 p -125.24 142.74 51.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.513 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 75.2 p -140.4 -155.86 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.538 0.208 . . . . 0.0 111.046 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.884 ' HB3' HD22 ' A' ' 24' ' ' ASN . 16.3 t70 67.25 -72.9 0.08 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.828 0.851 . . . . 0.0 112.33 170.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 91' ' ' LEU . 12.3 m -78.63 -42.76 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -176.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.604 ' H ' HD22 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -89.51 -45.6 9.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.377 -178.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.43 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 15.2 t -83.82 -16.74 43.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.579 0.228 . . . . 0.0 110.66 -175.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 62.9 m 62.74 -82.44 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.324 0.649 . . . . 0.0 112.409 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -71.7 74.89 0.73 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.339 -0.457 . . . . 0.0 112.817 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.513 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -154.58 152.37 29.95 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 122.665 0.386 . . . . 0.0 110.427 -177.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.86 102.64 14.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' A' ' 26' ' ' HIS . . . -159.17 101.06 0.2 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.891 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 18.6 t . . . . . 0 C--O 1.254 1.303 0 CA-C-O 117.89 -1.052 . . . . 0.0 108.422 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.7 p90 -58.19 136.56 57.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.23 139.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.463 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.573 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -116.88 141.6 48.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.432 ' HA ' HG22 ' A' ' 90' ' ' VAL . 20.5 p -147.33 164.12 34.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.111 0.481 . . . . 0.0 111.373 -171.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.851 HD22 ' HB3' ' A' ' 89' ' ' ASP . 1.3 p30 -79.35 115.61 19.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.585 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m-70 -83.22 121.53 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -89.53 138.69 31.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.477 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.585 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -109.65 130.32 55.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 170.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -100.43 123.5 44.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.385 0.612 . . . . 0.0 111.032 -178.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.943 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 21.4 t80 -95.72 151.63 19.19 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -57.44 100.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.079 0.466 . . . . 0.0 110.514 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.2 -57.28 0.69 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.62 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -147.38 178.47 8.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.193 0.52 . . . . 0.0 111.87 -171.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -62.5 133.7 55.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.044 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.943 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 84.3 t90 -101.25 -57.61 2.05 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.218 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.31 -179.5 40.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.118 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 12.1 t -154.68 148.75 25.82 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.65 0.262 . . . . 0.0 110.892 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.654 HG23 ' HG2' ' A' ' 39' ' ' LYS . 4.6 mp -128.15 125.54 64.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.528 HH12 ' HA ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -75.97 99.5 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.952 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' HG2' HG23 ' A' ' 37' ' ' ILE . 67.5 mmtt -135.15 153.12 52.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.0 mtpt -72.11 153.0 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 142.39 58.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 90.96 -25.86 12.77 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 -178.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.546 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 86.0 m95 -86.02 133.7 33.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.605 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.649 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.91 135.64 48.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 62' ' ' CYS . 11.2 p -122.54 148.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.1 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.6 147.88 23.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.705 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.626 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 61.1 m-85 -136.38 137.28 40.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.0 p90 -145.55 154.29 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.515 0.198 . . . . 0.0 110.549 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -95.51 135.43 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.073 0.463 . . . . 0.0 110.577 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HB2' ' HZ2' ' A' ' 34' ' ' TRP . 1.6 mm-40 -94.84 106.39 18.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.418 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.619 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 75.9 mmtt -106.81 123.46 38.48 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.48 117.26 3.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.848 2.366 . . . . 0.0 112.339 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.46 -6.68 75.91 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.479 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.619 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 28.3 mt-30 -113.25 158.63 37.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 122.664 0.385 . . . . 0.0 110.69 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.85 155.53 62.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.529 2.153 . . . . 0.0 111.944 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 1.9 mptp? -80.82 130.01 34.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.299 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.4 tpm_? -108.19 124.09 49.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.354 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.497 HD22 ' O ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -61.0 106.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.077 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.5 m -94.2 -17.06 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.927 -172.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.34 138.08 2.47 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.376 0.608 . . . . 0.0 112.238 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.81 111.93 38.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.6 t -130.93 155.11 47.33 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.193 -168.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.7 ptpt -157.59 158.56 35.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -77.95 131.09 37.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 74' ' ' LYS . . . -55.2 -28.3 52.03 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.022 0.826 . . . . 0.0 112.958 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 34.0 t -104.64 131.65 21.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.713 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 77.6 Cg_endo -80.1 2.54 8.37 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.65 2.233 . . . . 0.0 112.415 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 13.2 t -121.31 -65.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.667 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.581 ' O ' ' HB3' ' A' ' 66' ' ' SER . 69.5 t60 -97.94 160.37 14.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 110.025 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.3 p -100.94 128.62 46.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.071 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -129.13 -86.63 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.036 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -132.14 169.72 16.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.544 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.733 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 19.0 mt -102.76 120.1 39.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.157 0.503 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.673 ' HD3' ' HB3' ' A' ' 65' ' ' ALA . 4.1 mptp? -100.79 106.27 17.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.479 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.594 ' HB2' HD23 ' A' ' 78' ' ' LEU . 2.5 m -108.81 152.49 24.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.776 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -125.73 156.1 39.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.729 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 61.9 47.45 6.0 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.611 0.57 . . . . 0.0 111.773 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 75' ' ' CYS . 81.2 mt -66.77 145.91 55.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 82' ' ' PHE . . . -88.8 72.95 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.2 -93.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.15 -17.13 30.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.642 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 40.4 m-85 -72.38 109.37 6.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.166 0.507 . . . . 0.0 109.885 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 p -139.14 175.93 9.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.017 -175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.485 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -98.34 169.1 9.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.768 0.318 . . . . 0.0 110.652 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' O ' HD13 ' A' ' 73' ' ' LEU . . . -127.82 -159.24 10.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.861 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 t -77.29 -178.09 4.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 91' ' ' LEU . 41.2 m -116.8 144.75 44.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.595 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 69.5 p -139.67 -157.92 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.525 0.202 . . . . 0.0 111.335 -173.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.851 ' HB3' HD22 ' A' ' 24' ' ' ASN . 27.9 t70 65.14 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.955 0.902 . . . . 0.0 112.43 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 23' ' ' CYS . 2.6 m -71.4 -47.67 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.3 pp -88.97 -30.34 18.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.688 0.28 . . . . 0.0 111.079 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.6 t -85.03 -58.67 2.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.7 t 69.47 133.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.32 0.581 . . . . 0.0 110.03 -171.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.4 -1.37 72.65 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.595 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.8 OUTLIER -116.36 155.87 27.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.726 -0.737 . . . . 0.0 109.979 177.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.6 m -97.56 144.03 11.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.925 0.393 . . . . 0.0 110.609 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.65 172.11 39.42 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.772 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.528 ' HA ' HH12 ' A' ' 38' ' ' ARG . 22.1 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.57 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 41.1 p90 -58.81 142.06 51.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.93 0.395 . . . . 0.0 110.059 175.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.42 139.37 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.322 0.582 . . . . 0.0 111.802 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.722 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.71 140.93 47.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.577 173.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 7.7 p -148.44 151.58 35.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.951 0.405 . . . . 0.0 111.842 -171.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.909 HD22 ' HB3' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -73.01 102.63 3.55 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.414 0.626 . . . . 0.0 110.573 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.771 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 4.7 m80 -69.95 116.55 10.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.382 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.9 m-70 -93.57 128.98 39.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.439 . . . . 0.0 111.43 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -91.85 123.63 35.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.487 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.538 ' HB2' ' CB ' ' A' ' 34' ' ' TRP . 37.2 t80 -94.18 149.59 21.1 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -52.04 99.45 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.475 0.484 . . . . 0.0 110.038 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.14 -70.86 0.51 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.954 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -149.15 178.97 8.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.087 0.47 . . . . 0.0 112.031 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -53.62 132.7 41.05 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.856 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 29' ' ' TYR . 8.1 t-105 -128.34 -57.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.073 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' HIS . . . -98.93 150.62 19.34 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.314 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 36' ' ' THR . 1.3 m -151.39 108.07 3.51 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.73 113.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.832 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 21.9 ttp180 -77.87 93.56 4.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 109.768 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 15.6 tppt? -116.34 153.0 32.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.036 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.722 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.5 mtpt -79.94 149.33 30.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.673 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.05 137.31 56.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 97.08 -20.24 51.61 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.031 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 84.6 m95 -95.9 133.11 40.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.769 0.319 . . . . 0.0 110.223 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.48 130.42 40.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.162 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.569 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 14.8 p -116.09 143.18 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.906 0.384 . . . . 0.0 110.382 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.511 ' HB2' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -95.94 143.27 27.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.226 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.771 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 86.7 m-85 -120.93 137.96 54.35 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.8 p90 -144.51 157.96 43.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.399 0.619 . . . . 0.0 111.371 -173.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 21.8 pt-20 -97.78 126.42 43.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.939 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.766 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 7.7 pt-20 -121.93 102.09 7.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.715 0.769 . . . . 0.0 109.824 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -116.15 151.77 47.05 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.237 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.95 116.14 2.45 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.957 2.438 . . . . 0.0 112.759 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.57 50.07 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.312 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -102.14 143.81 27.35 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.196 0.522 . . . . 0.0 112.105 -173.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.23 166.11 29.26 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.214 2.609 . . . . 0.0 110.429 169.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.766 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 50.3 mttt -94.16 110.67 22.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.36 -168.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 9.5 ttp180 -100.7 144.2 29.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.579 -174.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 46' ' ' ARG . 14.1 mt -64.94 125.35 24.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.137 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.484 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 29.8 m -111.3 -18.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.535 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -172.47 140.6 1.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.446 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -113.31 113.28 43.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.662 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -133.73 162.64 31.42 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.595 -169.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.3 ptpt -158.21 163.39 37.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.91 132.88 35.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.34 -54.7 3.66 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.155 0.909 . . . . 0.0 112.795 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -95.22 146.77 31.91 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.47 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 83.4 Cg_endo -86.57 10.99 3.42 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.769 2.313 . . . . 0.0 112.485 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 10.8 t -122.64 -73.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.638 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -95.58 163.47 13.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.1 t -98.08 125.91 43.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -120.07 -80.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.672 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -139.52 176.36 8.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.75 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.8 mt -106.72 120.43 41.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.828 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -100.22 104.02 15.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 22.1 m -105.62 150.32 25.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 112.074 -172.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 t -132.26 156.23 46.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.458 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.6 t30 57.14 77.7 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.758 0.661 . . . . 0.0 111.102 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 83' ' ' SER . 92.0 mt -94.8 137.31 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.268 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 59' ' ' VAL . . . -87.08 80.71 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 110.685 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.61 -94.26 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.686 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.99 -5.29 53.58 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.37 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 33.6 m-85 -83.39 113.58 20.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.988 0.423 . . . . 0.0 110.116 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.593 ' HA ' HD23 ' A' ' 78' ' ' LEU . 12.3 m -142.44 166.44 24.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.623 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . . . -89.47 162.89 15.5 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.91 -63.28 0.24 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.884 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -175.85 -167.83 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 19.7 m -135.0 144.08 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.475 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 62.6 p -140.11 -152.15 0.4 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.909 ' HB3' HD22 ' A' ' 24' ' ' ASN . 27.8 t70 66.07 -70.11 0.1 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.018 0.927 . . . . 0.0 112.533 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 23' ' ' CYS . 4.5 m -80.14 -42.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.746 0.308 . . . . 0.0 111.651 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.9 -33.2 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.745 0.307 . . . . 0.0 111.443 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -93.44 -16.13 24.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.679 0.276 . . . . 0.0 110.716 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 t 68.01 -81.19 0.03 OUTLIER 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.24 66.97 3.7 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.521 -176.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -141.38 138.35 32.94 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.911 -0.17 . . . . 0.0 110.592 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.8 t -72.74 119.14 18.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.029 0.442 . . . . 0.0 110.494 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.33 -155.49 13.35 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.641 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.246 0.898 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.071 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.671 ' HD1' ' HA ' ' A' ' 68' ' ' VAL . 28.6 m-85 -53.89 131.32 39.81 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 110.301 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 t -111.14 130.99 63.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.135 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 1.5 pp0? -93.15 141.08 28.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.662 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 92.8 m -151.72 144.36 24.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.782 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.822 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -74.7 109.72 8.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.019 0.438 . . . . 0.0 109.861 176.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.69 12.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' THR . 9.8 m-70 -84.46 130.8 34.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.332 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.598 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -99.04 127.8 45.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -98.35 122.76 41.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.613 . . . . 0.0 110.846 -176.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.054 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 1.8 t80 -100.39 152.7 20.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.42 99.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.526 0.516 . . . . 0.0 111.857 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.96 -19.74 42.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.379 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -163.82 156.89 18.27 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.458 1.129 . . . . 0.0 112.909 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -48.54 119.34 3.0 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.704 171.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 1.054 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.5 t90 -87.71 -56.52 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.503 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.01 -177.92 42.63 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.2 t -156.0 146.53 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.086 0.443 . . . . 0.0 111.391 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.2 mp -125.15 126.73 71.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 16.1 mtm180 -75.94 122.1 23.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.656 0.741 . . . . 0.0 110.803 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.83 149.78 31.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.262 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 50.6 mtpt -69.92 155.1 41.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 110.858 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.43 142.3 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.445 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 88.44 -34.29 3.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.348 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 89.7 m95 -78.13 132.8 37.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.08 0.467 . . . . 0.0 110.451 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.661 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.44 141.59 52.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.741 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 62' ' ' CYS . 9.5 p -124.35 157.63 31.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.4 136.45 40.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.377 . . . . 0.0 111.484 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.598 ' CG ' HD23 ' A' ' 27' ' ' LEU . 67.8 m-85 -128.37 133.74 48.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -150.77 154.04 36.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 17.0 pt-20 -101.46 126.56 48.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.06 102.49 9.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.604 0.716 . . . . 0.0 109.905 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.76 131.41 35.75 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.975 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.83 116.46 3.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.569 2.179 . . . . 0.0 112.351 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.41 -10.18 57.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.123 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -122.05 154.69 61.5 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.406 0.282 . . . . 0.0 110.569 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.23 155.6 51.57 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.6 2.2 . . . . 0.0 111.359 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.707 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -72.33 140.09 48.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.216 0.531 . . . . 0.0 110.903 -177.171 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.33 129.8 55.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.464 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 58' ' ' LEU . 3.7 mm? -59.14 123.74 17.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 110.484 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -110.37 -18.27 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.1 134.87 1.29 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.623 0.725 . . . . 0.0 111.394 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.68 111.6 36.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.9 t -131.18 144.05 51.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.269 -167.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -144.8 161.13 40.02 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -80.53 141.79 34.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.825 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.83 -62.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.015 0.822 . . . . 0.0 112.258 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.7 t -90.23 138.53 27.21 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.249 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.699 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -78.23 -2.41 12.49 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.521 2.147 . . . . 0.0 111.632 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.671 ' HA ' ' HD1' ' A' ' 20' ' ' PHE . 12.5 t -105.04 -74.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.336 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.91 163.64 12.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.1 t -98.22 131.69 44.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.85 0.357 . . . . 0.0 110.298 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -132.54 -84.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.953 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -131.57 164.24 26.28 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.186 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.776 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 25.9 mt -103.54 122.94 45.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.988 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -102.78 106.21 16.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.698 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.8 m -110.01 146.56 35.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.599 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -124.16 157.48 34.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.708 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m120 60.54 55.84 3.28 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.609 0.568 . . . . 0.0 110.987 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 75' ' ' CYS . 92.1 mt -73.62 148.21 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.153 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -105.22 67.89 0.79 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.026 0.441 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.8 -91.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.258 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.04 60.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.008 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 90.2 m-85 -79.51 108.23 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.401 . . . . 0.0 110.74 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 m -149.68 163.31 38.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.67 159.98 14.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.34 -64.0 0.19 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.335 -170.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 11.6 t -160.16 -165.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.943 0.372 . . . . 0.0 110.423 -171.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.662 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 14.3 t -144.5 148.04 34.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.8 p -140.01 -153.21 0.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.276 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.822 ' HB3' HD21 ' A' ' 24' ' ' ASN . 7.9 t70 61.34 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 173.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -69.28 -42.38 81.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.967 0.413 . . . . 0.0 111.31 -176.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.414 HD23 ' SG ' ' A' ' 23' ' ' CYS . 4.1 pp -89.68 -33.93 16.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.552 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.554 -172.612 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.622 0.248 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.3 m-85 -81.24 140.67 34.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.85 140.18 48.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.816 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 4.7 pp0? -112.41 144.87 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.325 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HB3' HD11 ' A' ' 91' ' ' LEU . 19.8 p -153.49 157.05 39.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 0.0 111.54 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.643 ' HB2' ' OG1' ' A' ' 36' ' ' THR . 0.6 OUTLIER -78.11 112.52 15.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.602 174.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -81.97 115.3 21.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.651 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -83.94 129.01 34.93 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.017 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.3 tm? -101.36 132.57 46.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.542 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.31 122.57 44.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.374 0.607 . . . . 0.0 111.037 -178.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.828 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 56.7 t80 -106.09 143.99 33.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -53.07 104.96 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.039 0.447 . . . . 0.0 110.792 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 -50.59 0.88 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.964 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -172.75 167.37 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -36.3 131.37 0.63 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.985 0.914 . . . . 0.0 112.221 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.828 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 32.8 t-105 -99.56 -56.69 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.264 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -178.71 39.57 Favored Glycine 0 C--O 1.234 0.143 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.643 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 9.7 t -151.77 141.76 22.11 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.187 0.518 . . . . 0.0 111.664 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.88 130.04 58.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.827 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.489 HH11 HE22 ' A' ' 22' ' ' GLN . 29.7 mtm180 -87.68 124.78 33.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.325 0.583 . . . . 0.0 111.539 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.425 ' HE3' HG13 ' A' ' 45' ' ' VAL . 36.6 ttmt -153.53 152.35 30.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.575 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.816 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 47.1 mtpt -76.15 155.07 34.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.924 0.392 . . . . 0.0 111.044 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.78 142.45 55.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 104.65 -36.32 4.46 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.139 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -90.29 146.92 23.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.927 0.394 . . . . 0.0 110.614 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -85.63 131.37 34.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -101.12 152.54 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -94.43 140.12 30.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.88 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.476 ' O ' HD23 ' A' ' 58' ' ' LEU . 94.2 m-85 -136.54 132.5 35.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.5 p90 -147.62 157.76 43.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 0.0 111.377 -173.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 16.9 pt-20 -95.33 130.03 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.143 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.557 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 16.4 pt-20 -126.25 112.21 15.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.443 0.64 . . . . 0.0 109.96 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 49.2 mtmt -136.4 121.82 13.29 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.592 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 8.0 Cg_endo -48.58 116.88 2.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.686 2.924 . . . . 0.0 113.417 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.04 -19.26 12.02 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.274 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -126.67 149.26 67.76 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.807 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 162.33 42.44 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.822 2.348 . . . . 0.0 111.403 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.557 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 24.3 mttm -86.29 118.28 25.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.532 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -103.99 133.33 49.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.292 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -65.85 113.25 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.244 0.34 . . . . 0.0 110.172 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 33.2 m -92.76 -24.04 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.4 ' CB ' HD23 ' A' ' 78' ' ' LEU . . . 178.91 146.68 0.17 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.288 0.565 . . . . 0.0 111.29 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.408 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 4.7 mp -105.42 117.31 50.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 170.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 6.2 t -125.44 144.74 50.39 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.514 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.0 ptpt -143.1 163.0 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -84.59 136.35 33.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.261 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.43 -54.68 3.74 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.052 0.845 . . . . 0.0 112.322 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.507 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 34.5 t -89.33 141.03 28.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.294 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 3.5 Cg_exo -81.62 2.79 8.31 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.25 2.633 . . . . 0.0 112.107 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.2 t -122.99 -70.38 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.664 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -86.25 165.02 16.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.1 126.05 44.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.879 0.371 . . . . 0.0 110.223 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -124.16 -81.55 0.64 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.293 0.568 . . . . 0.0 110.016 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.44 168.91 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.69 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 24.0 mt -102.52 120.34 40.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.251 0.548 . . . . 0.0 110.784 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.67 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.9 mmpt? -102.26 105.65 16.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.809 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.666 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.7 m -104.58 149.77 25.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.956 0.408 . . . . 0.0 110.769 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -127.27 155.36 43.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.517 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.48 50.82 4.39 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.491 0.494 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 75' ' ' CYS . 87.7 mt -68.24 140.36 56.03 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.51 89.62 7.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.575 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.54 -88.16 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.01 0.82 11.77 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.993 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -82.42 126.17 31.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 m -146.81 -177.74 5.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.923 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.499 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.72 171.28 7.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.04 -140.79 5.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.256 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 178.85 5.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.844 0.354 . . . . 0.0 110.531 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 42.4 m -110.6 142.61 42.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 24.6 p -141.27 -159.32 0.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.501 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 22.2 t70 63.06 -82.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.948 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -70.97 -36.02 61.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.211 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 23' ' ' CYS . 12.9 mt -89.46 -55.32 3.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.23 0.538 . . . . 0.0 111.729 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.62 -171.329 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.641 0.258 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.3 m-85 -64.39 113.99 4.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 69' ' ' HIS . 1.9 p -101.26 139.75 21.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.322 -172.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 1.01 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.0 pt20 -96.08 144.81 26.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HA ' HG21 ' A' ' 90' ' ' VAL . 10.8 p -150.07 142.43 24.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 111.796 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.887 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.6 OUTLIER -73.43 110.59 7.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.016 175.511 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.83 116.11 16.21 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.412 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 11.4 m-70 -86.62 131.18 34.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.873 0.368 . . . . 0.0 111.132 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -98.51 125.46 43.73 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -104.12 125.67 50.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.366 0.603 . . . . 0.0 111.235 -172.38 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -98.53 150.79 21.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -53.38 100.38 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.662 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.91 -58.85 0.58 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.684 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -142.58 170.81 15.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.369 0.604 . . . . 0.0 112.317 -171.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 134.48 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.866 172.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -101.59 -55.85 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.897 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.99 175.14 42.28 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.7 t -154.28 145.79 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.278 0.539 . . . . 0.0 111.424 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.507 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.0 mp -126.78 125.1 66.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 47.2 ttp180 -88.67 98.07 11.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.5 mmtp -126.05 153.8 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 1.01 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 32.9 mtpt -66.24 161.93 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.228 0.537 . . . . 0.0 111.482 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -59.92 142.78 53.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.763 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 89.78 -28.19 7.35 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.465 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.529 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 55.1 m95 -75.87 115.27 15.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.572 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.929 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.11 115.43 16.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.042 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.2 p -103.75 154.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.34 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.53 134.09 37.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 111.346 -177.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.72 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 88.7 m-85 -120.37 128.38 53.18 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HB3' HD23 ' A' ' 58' ' ' LEU . 36.7 p90 -143.78 152.1 40.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.299 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 7.1 pt-20 -94.72 137.53 33.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.354 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -126.78 100.37 6.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 31.8 mttp -95.66 154.08 39.26 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.02 116.36 3.12 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 121.994 1.796 . . . . 0.0 111.639 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 -11.59 66.39 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.873 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -110.12 126.34 29.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.769 -0.254 . . . . 0.0 110.474 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 31.7 Cg_exo -63.06 154.87 64.44 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.041 2.494 . . . . 0.0 112.765 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -62.11 126.92 29.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.181 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -130.39 142.74 50.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.816 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.785 HD13 HD11 ' A' ' 61' ' ' ILE . 16.6 mt -70.32 130.07 41.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 -175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.09 -18.0 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.393 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -176.63 138.29 0.28 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.514 0.673 . . . . 0.0 111.633 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -108.81 111.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.7 t -132.39 146.12 51.73 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.687 -168.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.929 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 27.5 pttt -145.6 164.56 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.651 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 9.0 t30 -77.33 134.37 38.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.75 -56.78 1.67 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.455 1.097 . . . . 0.0 112.706 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 40.6 t -92.0 136.75 25.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 69.3 Cg_endo -75.42 -1.52 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.404 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.9 t -112.42 -72.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 66' ' ' SER . 39.6 m80 -98.01 164.47 12.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.424 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.0 t -97.63 132.72 43.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -132.1 -81.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -138.26 175.7 9.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.498 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 31.3 mt -103.72 129.5 51.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.69 109.95 21.25 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m -114.44 149.15 36.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.53 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -124.76 159.99 29.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.174 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 68.36 40.13 2.1 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.407 0.442 . . . . 0.0 111.642 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' A' ' 75' ' ' CYS . 96.5 mt -66.73 126.69 29.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.887 0.375 . . . . 0.0 110.971 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -95.41 68.79 3.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.585 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.47 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.366 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.3 -16.32 64.77 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.971 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 99.2 m-85 -86.99 109.29 19.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.085 0.469 . . . . 0.0 110.39 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.4 m -147.72 168.29 22.48 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.611 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.76 161.53 13.6 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.472 -175.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.31 -79.28 0.76 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.218 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.9 t -155.77 -169.52 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 30.1 m -130.58 144.75 51.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.645 0.259 . . . . 0.0 110.309 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 58.3 p -138.34 -154.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.936 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.542 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 36.2 t70 63.58 -78.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.25 1.02 . . . . 0.0 112.548 173.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.9 OUTLIER -68.03 -42.84 85.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.793 0.33 . . . . 0.0 111.662 -175.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.0 pp -89.66 -31.39 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.597 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.027 -175.249 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.1 p90 -57.09 142.08 43.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.402 174.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.29 141.33 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.709 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.2 pt20 -94.39 143.0 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.709 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 20.0 p -147.53 145.5 29.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.037 0.446 . . . . 0.0 110.901 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.981 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.02 113.05 11.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 174.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.505 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 1.3 m80 -78.4 117.63 19.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -85.42 134.69 34.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.019 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -101.09 122.9 44.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -101.07 122.04 42.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.697 0.76 . . . . 0.0 110.862 -177.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 65.9 t80 -94.24 150.95 19.83 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.75 100.15 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.47 -58.45 0.71 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.255 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -159.71 179.96 8.4 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -52.44 131.51 33.66 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.764 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.808 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.4 t90 -101.57 -55.84 2.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.314 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.23 179.03 38.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.1 t -154.32 143.74 21.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.187 0.493 . . . . 0.0 111.164 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.586 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.5 mp -123.42 122.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 42.3 ttp180 -83.44 105.65 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.17 0.509 . . . . 0.0 110.741 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.586 ' HG2' HG22 ' A' ' 37' ' ' ILE . 70.1 mmtt -127.11 152.96 46.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.536 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 38.9 mtpt -80.22 149.97 30.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.631 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.09 136.18 57.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 111.297 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.47 -17.76 46.16 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -91.38 130.93 37.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.73 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.93 122.89 26.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.5 p -107.58 147.81 12.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.873 0.368 . . . . 0.0 110.483 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -98.44 135.95 39.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.0 111.154 -177.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CG ' HD23 ' A' ' 27' ' ' LEU . 74.8 m-85 -123.89 131.02 53.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.193 173.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HD2' ' HB3' ' A' ' 56' ' ' LYS . 36.0 p90 -143.74 149.64 37.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.194 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.4 ' HB3' HG11 ' A' ' 59' ' ' VAL . 9.0 pt-20 -95.21 142.97 27.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 10.4 pt-20 -130.07 102.2 6.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.726 0.774 . . . . 0.0 110.199 172.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.5 124.84 56.07 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.45 117.82 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.583 2.855 . . . . 0.0 113.303 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.77 22.51 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.377 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.49 148.32 34.37 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.592 0.357 . . . . 0.0 110.735 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.0 151.84 82.9 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.903 2.402 . . . . 0.0 112.153 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 26.9 mttm -76.63 136.06 39.17 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.899 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -123.89 135.92 54.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.613 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.82 118.8 12.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.2 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 16.1 m -104.7 -19.16 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.39 136.21 0.59 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.651 0.739 . . . . 0.0 112.349 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.28 112.87 42.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 166.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.8 t -132.14 150.46 52.15 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 -168.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -150.1 163.59 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.838 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 32.6 t30 -73.02 150.55 42.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.989 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.41 -52.5 28.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.542 0.526 . . . . 0.0 111.692 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -108.78 139.12 20.57 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.066 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.23 12.74 1.21 Allowed 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.772 2.315 . . . . 0.0 113.149 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.7 t -128.01 -78.8 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.762 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -90.59 156.94 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.838 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 31.5 t -97.74 137.03 37.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.854 0.359 . . . . 0.0 110.992 -172.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -133.49 -76.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -134.28 164.75 26.69 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.461 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.67 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.3 mt -103.82 124.32 48.7 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.13 105.75 16.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.17 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 19.0 m -102.93 155.18 18.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.816 -175.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.9 t -136.37 154.71 50.75 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.5 m120 65.81 46.35 2.33 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.736 0.648 . . . . 0.0 111.279 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.9 mt -64.3 155.62 31.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 111.425 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.193 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.39 -90.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.287 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.49 -15.1 78.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.769 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.1 m-85 -89.12 120.44 30.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 110.332 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.47 ' HA ' HD22 ' A' ' 78' ' ' LEU . 22.9 m -147.34 172.75 13.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.622 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -109.87 174.93 5.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.158 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -142.48 -175.35 15.64 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.068 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -66.57 172.45 4.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.0 111.495 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 15.5 p -110.33 144.0 39.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.71 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.5 p -140.7 -154.84 0.54 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 111.461 -174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.981 ' HB3' HD21 ' A' ' 24' ' ' ASN . 19.4 t70 69.9 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.032 169.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.64 -38.05 57.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.616 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.87 -30.03 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 p . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.606 -179.228 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.479 0.181 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -79.05 140.58 37.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 70' ' ' CYS . 2.3 p -145.4 136.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.245 -175.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.667 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -100.87 155.14 18.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.516 175.349 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 16.9 p -154.85 152.44 29.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.212 0.53 . . . . 0.0 111.681 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.05 111.19 10.02 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 109.503 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.83 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 9.7 m80 -72.19 121.03 18.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.403 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -84.17 136.54 33.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.584 -174.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.596 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -109.89 122.98 48.78 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 165.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -106.02 122.08 45.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.287 0.565 . . . . 0.0 110.504 -176.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.13 143.94 26.17 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -50.43 101.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.537 0.523 . . . . 0.0 110.463 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.6 -53.34 0.81 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.146 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 22.8 tpt180 -165.09 160.02 18.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.085 0.442 . . . . 0.0 111.77 -175.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -42.83 127.83 4.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -99.51 -56.72 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.323 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.63 178.32 39.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.975 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 26' ' ' HIS . 5.8 t -153.8 138.41 16.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.951 0.375 . . . . 0.0 110.704 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.31 135.98 55.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.199 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.3 tpp85 -73.81 110.21 7.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.788 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 16.7 tppt? -143.89 128.57 18.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.563 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 18.6 ptmt -72.3 153.64 41.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.222 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -63.66 142.75 58.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 94.26 -17.27 59.23 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.645 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 44.3 m95 -105.36 142.91 34.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 0.0 110.66 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.64 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -80.17 140.63 36.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.63 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.788 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.9 p -126.89 148.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.85 0.357 . . . . 0.0 110.543 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.76 143.55 27.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.83 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 63.5 m-85 -128.35 135.88 50.19 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 53.0 p90 -151.1 156.49 41.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.869 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' ' 51' ' ' LYS . 14.9 pt-20 -107.38 134.93 49.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 168.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.0 102.25 10.74 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.229 0.537 . . . . 0.0 110.67 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HE2' ' OE1' ' A' ' 49' ' ' GLU . 67.6 mttm -85.23 125.48 69.96 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.672 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 86.9 Cg_exo -48.02 117.64 2.63 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.332 2.688 . . . . 0.0 113.573 -173.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.37 -14.24 62.37 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.559 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -113.05 158.11 38.85 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.543 0.211 . . . . 0.0 110.438 -176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.55 161.9 41.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.665 2.243 . . . . 0.0 111.118 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -74.71 138.38 42.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.056 0.455 . . . . 0.0 110.728 -176.115 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 20.4 tpp180 -99.52 123.55 43.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.069 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.34 107.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.997 0.427 . . . . 0.0 110.55 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -95.16 -18.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -173.57 138.7 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.505 0.669 . . . . 0.0 111.904 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.62 112.13 38.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.845 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 12.0 t -134.9 154.02 51.83 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.982 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -150.21 162.36 40.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -83.85 135.86 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.718 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.33 -51.9 6.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.079 0.862 . . . . 0.0 112.868 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 46.0 t -94.77 139.18 22.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.265 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 80.1 Cg_endo -79.13 2.69 8.08 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 111.744 173.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.2 -79.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.589 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' ' 66' ' ' SER . 67.5 m80 -89.65 165.38 14.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.472 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 21' ' ' VAL . 74.8 m -98.72 124.92 43.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.29 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 61.5 m-20 -124.22 -85.52 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 110.227 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 93.9 m-85 -130.43 174.14 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.949 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.845 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.6 mt -109.36 132.21 54.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.626 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -101.19 104.51 15.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.744 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.6 m -116.41 144.87 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.967 0.413 . . . . 0.0 110.597 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -126.46 159.63 32.8 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 6.2 t30 59.83 71.59 0.57 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 -175.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 83' ' ' SER . 96.4 mt -91.66 128.79 37.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -92.33 73.92 5.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.674 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.62 -93.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.468 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.07 0.85 73.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.923 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 96.5 m-85 -101.16 108.89 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 0.0 110.474 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 78' ' ' LEU . 41.7 m -138.39 169.35 17.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -101.24 163.76 12.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.283 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.83 -175.68 14.8 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.669 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 13.6 t -61.77 159.02 14.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.567 0.698 . . . . 0.0 111.234 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 7.0 p -91.17 144.67 25.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.479 -168.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.613 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 40.0 p -131.64 -158.45 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.803 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 88' ' ' THR . 25.2 t70 70.83 -85.04 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.411 1.084 . . . . 0.0 111.707 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 90' ' ' VAL . 1.7 m -67.45 -46.94 82.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.94 -27.8 20.7 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.725 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' A' ' 88' ' ' THR . 5.9 t . . . . . 0 C--N 1.329 -0.284 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.069 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 82.5 m-85 -78.9 139.94 38.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.46 138.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.398 0.618 . . . . 0.0 111.819 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.821 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 3.8 pp0? -106.47 145.84 31.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.421 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.707 ' HA ' HG21 ' A' ' 90' ' ' VAL . 18.0 p -148.66 150.44 33.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.501 0.667 . . . . 0.0 112.314 -174.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.602 ' ND2' ' H ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -72.24 112.84 8.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.958 174.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.832 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 14.6 m80 -80.68 108.81 14.64 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.615 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.562 ' HD2' ' HA ' ' A' ' 87' ' ' SER . 43.5 m-70 -83.72 125.33 31.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.774 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.7 tm? -98.2 134.08 41.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.589 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -104.73 116.7 32.49 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.563 0.697 . . . . 0.0 110.903 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.728 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 71.6 t80 -95.19 145.42 25.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.954 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -57.75 99.76 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.856 0.36 . . . . 0.0 110.287 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.76 -43.57 1.26 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.68 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -175.06 166.06 3.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.092 0.446 . . . . 0.0 111.337 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -43.42 127.03 4.54 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.553 0.741 . . . . 0.0 111.596 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.728 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 48.9 t-105 -99.68 -57.65 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.636 -175.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.73 177.49 39.56 Favored Glycine 0 C--N 1.328 0.137 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.278 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -152.85 133.11 13.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.143 0.497 . . . . 0.0 111.328 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.6 mp -120.33 134.6 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.53 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -80.05 104.93 10.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.562 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 3.7 tppp? -138.85 145.01 39.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.821 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.5 mtpt -68.32 148.94 50.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.424 ' HB1' ' OD1' ' A' ' 64' ' ' ASN . . . -65.55 136.61 56.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.9 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.797 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 97.14 -26.18 23.85 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.068 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -89.19 130.83 35.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.924 0.392 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.736 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.99 126.64 30.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.201 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.2 p -116.41 145.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.41 145.21 30.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.148 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.832 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 76.7 m-85 -134.79 145.33 48.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 56' ' ' LYS . 31.5 p90 -148.61 163.39 37.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.199 0.523 . . . . 0.0 111.585 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.32 134.53 51.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.381 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' H ' ' HZ2' ' A' ' 34' ' ' TRP . 10.8 pt-20 -109.57 113.79 26.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.391 0.615 . . . . 0.0 110.399 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 33.6 mmtp -108.31 125.51 31.75 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.432 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.53 126.87 23.93 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.32 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.5 -9.56 64.35 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.297 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 40.8 mt-30 -122.38 159.12 53.87 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.365 0.266 . . . . 0.0 110.733 -175.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.25 156.65 58.79 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.765 2.31 . . . . 0.0 111.967 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . 9.7 pttp -88.21 138.86 31.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -117.45 123.63 46.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.929 -172.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.45 106.6 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.44 -30.08 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . . . -174.07 144.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.199 0.523 . . . . 0.0 111.338 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.413 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 4.6 mp -102.07 113.72 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.71 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -118.96 148.69 42.69 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.187 -171.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 13.9 pttp -157.1 164.32 38.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.341 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.64 HD22 ' H ' ' A' ' 71' ' ' ASN . 4.6 t-20 -81.83 152.02 27.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.408 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.23 -48.88 67.82 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.552 0.532 . . . . 0.0 111.362 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -105.57 137.54 19.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.818 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.797 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 78.1 Cg_endo -80.96 10.37 3.41 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.742 2.294 . . . . 0.0 112.518 175.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.0 t -113.98 -82.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.11 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -90.28 158.45 17.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.593 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 38.6 t -98.5 127.32 44.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.64 ' H ' HD22 ' A' ' 64' ' ' ASN . 31.5 m-80 -116.39 -87.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -134.53 171.79 13.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 39.2 mt -103.43 120.54 41.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.105 0.479 . . . . 0.0 112.056 -173.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -102.91 109.29 20.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.155 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.678 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.9 m -103.21 146.53 28.28 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.481 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -120.45 155.29 33.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.152 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 56.68 55.24 6.51 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.664 0.603 . . . . 0.0 110.184 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.6 mt -67.74 149.48 49.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.76 94.67 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.51 -85.56 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.628 0.58 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.45 4.64 6.26 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.02 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.88 120.71 25.06 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.9 t -151.84 178.17 9.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.469 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.71 159.84 14.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.199 -177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.55 -64.38 0.38 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.006 -171.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 t -164.91 -169.62 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.006 0.403 . . . . 0.0 110.586 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 5.0 p -143.73 144.25 31.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.263 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.602 ' H ' ' ND2' ' A' ' 24' ' ' ASN . 37.6 p -139.61 -155.22 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.731 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 16.7 t70 64.61 -76.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.465 0.706 . . . . 0.0 112.377 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -70.94 -44.36 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.15 -23.34 22.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.095 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.77 179.593 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -64.18 149.14 48.44 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 69' ' ' HIS . 2.6 p -133.67 135.23 55.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.402 0.62 . . . . 0.0 111.488 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.767 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 3.3 pp0? -109.6 140.94 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.388 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 58.6 m -145.1 157.58 44.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.088 0.47 . . . . 0.0 111.994 -168.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.963 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -83.43 111.84 19.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 166.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -77.61 124.02 27.39 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.32 137.6 32.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.403 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -98.96 116.4 31.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 166.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.72 124.05 41.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.928 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -110.7 150.62 28.79 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -52.86 101.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.346 0.404 . . . . 0.0 110.492 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.17 -59.01 0.69 Allowed Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.32 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -162.58 166.76 24.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -49.87 119.58 3.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.767 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.538 ' HH2' ' H ' ' A' ' 50' ' ' GLU . 10.1 t90 -92.84 -55.57 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.968 0.413 . . . . 0.0 110.598 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.73 163.26 28.56 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.509 ' C ' HD12 ' A' ' 37' ' ' ILE . 6.0 t -154.26 140.22 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.224 0.512 . . . . 0.0 110.699 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 36' ' ' THR . 2.5 mp -124.39 126.97 72.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.745 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.9 mtm180 -79.13 110.31 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.502 . . . . 0.0 111.819 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HG3' HG22 ' A' ' 37' ' ' ILE . 62.2 mttm -146.52 137.29 24.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.155 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.0 ptmt -62.12 156.91 20.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.28 142.15 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.935 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.38 -40.7 2.33 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.523 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 56.9 m95 -75.14 141.94 43.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.137 0.494 . . . . 0.0 111.142 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.93 131.33 41.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.399 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.8 p -121.63 140.08 46.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.059 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.672 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -101.33 139.41 37.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.998 0.427 . . . . 0.0 110.541 -178.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.508 ' CG ' HD23 ' A' ' 27' ' ' LEU . 82.9 m-85 -120.43 139.08 53.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.301 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 30.5 p90 -147.44 154.04 40.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.934 0.397 . . . . 0.0 111.335 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -103.69 142.66 33.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.495 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.538 ' H ' ' HH2' ' A' ' 34' ' ' TRP . 7.6 pt-20 -93.89 104.16 16.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 73.1 mmtt -119.45 135.47 24.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.055 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 23.3 Cg_exo -63.9 117.51 4.5 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.028 2.485 . . . . 0.0 112.834 -175.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.45 64.76 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -107.69 149.96 39.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.942 0.401 . . . . 0.0 110.696 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.24 153.4 78.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.943 1.762 . . . . 0.0 109.323 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.594 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 34.7 mmtm -67.37 109.53 3.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.181 0.515 . . . . 0.0 109.899 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 18.7 tpp180 -80.67 126.11 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.817 -167.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 46' ' ' ARG . 11.1 mt -58.9 109.12 0.76 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.599 0.562 . . . . 0.0 110.649 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -93.78 -15.43 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.862 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.53 135.19 0.53 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.598 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.522 HD11 HD13 ' A' ' 58' ' ' LEU . 4.7 mp -107.7 113.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 166.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.2 t -133.63 159.54 40.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.998 -168.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.637 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -158.97 162.82 36.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 10.4 t30 -87.4 138.4 31.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.383 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -55.4 4.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.093 0.87 . . . . 0.0 112.655 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -99.89 146.41 31.84 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.049 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 94.7 Cg_endo -87.98 20.54 1.15 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.053 2.502 . . . . 0.0 112.714 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.57 -76.77 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.103 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.496 ' HA ' HG12 ' A' ' 21' ' ' VAL . 36.5 m-70 -92.22 164.28 13.61 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.54 122.43 44.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -116.51 -78.74 0.58 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.484 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.26 165.49 25.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.213 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.797 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.4 mt -105.03 124.74 50.06 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.457 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.57 105.37 15.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 2.1 m -111.54 151.46 28.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.364 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -128.95 161.74 29.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.521 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.39 41.09 5.98 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.567 0.542 . . . . 0.0 111.484 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -65.55 147.03 54.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.975 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -110.46 67.42 0.64 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.408 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.71 -89.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.859 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.85 -16.66 69.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.734 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.0 m-85 -85.17 107.05 17.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.234 0.54 . . . . 0.0 110.475 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.542 ' HA ' HD22 ' A' ' 78' ' ' LEU . 11.1 m -134.08 165.54 24.83 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.512 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -101.44 161.7 13.44 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.1 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 -164.04 9.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.846 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -69.34 -177.39 1.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.833 0.453 . . . . 0.0 111.338 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.61 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.2 p -122.03 151.75 40.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.928 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.528 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 68.8 p -139.78 -157.4 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 110.739 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.963 ' HB3' HD21 ' A' ' 24' ' ' ASN . 35.3 t70 66.11 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.919 0.888 . . . . 0.0 112.111 172.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.83 -41.47 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -89.87 -40.97 12.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 88' ' ' THR . 9.3 m . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -172.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 34.6 p90 -61.23 135.35 57.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.419 0.628 . . . . 0.0 110.921 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.4 142.71 40.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.869 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 1.6 pp0? -95.15 142.34 27.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 5.1 m -142.94 140.54 31.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.377 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.994 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -72.51 111.7 7.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 170.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 36' ' ' THR . 5.1 m80 -80.77 122.98 27.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.892 -177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -90.61 123.64 34.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.589 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.1 tm? -98.1 126.81 43.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.37 128.62 53.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.158 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.7 t80 -103.78 144.78 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -56.1 100.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.2 -56.6 0.63 Allowed Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.658 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.503 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 11.5 tpp180 -172.02 172.08 4.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.503 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 39.5 t-80 -47.62 135.92 10.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.194 0.598 . . . . 0.0 111.524 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.501 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 58.3 t90 -107.43 -55.76 2.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.119 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.12 164.02 30.76 Favored Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.282 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -146.53 130.69 17.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.984 0.421 . . . . 0.0 111.313 -177.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.7 mp -122.44 130.47 74.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.703 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 24.1 mtm180 -76.42 128.53 35.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.216 0.531 . . . . 0.0 110.671 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 45' ' ' VAL . 12.3 tppt? -148.86 152.15 35.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.654 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.5 mtpt -87.19 148.13 25.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.42 -174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.84 136.42 58.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.971 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.58 -20.9 47.47 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.992 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 65.1 m95 -101.63 137.51 39.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 110.227 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.608 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -81.21 145.6 30.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -112.9 156.3 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.0 177.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.25 130.23 50.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.138 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 97.5 m-85 -122.73 126.83 48.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -145.78 156.68 43.75 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.483 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.501 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 14.3 pt-20 -104.47 123.68 47.91 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.7 102.08 10.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.826 0.822 . . . . 0.0 109.937 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.3 121.64 52.8 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.666 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.82 116.38 2.13 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.029 2.486 . . . . 0.0 112.519 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.46 -28.13 14.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.21 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -107.92 148.78 38.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.85 152.49 77.22 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.382 2.055 . . . . 0.0 111.293 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.714 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -77.82 137.6 38.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.537 -175.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -112.93 137.49 51.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.989 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.82 109.07 5.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.456 0.473 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 15.7 m -94.05 -19.64 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.808 -176.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.28 142.18 0.59 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 112.139 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.91 112.35 40.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 165.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.795 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.3 t -130.78 150.02 52.15 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.955 -167.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 ptpt -145.03 163.03 35.47 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -77.1 138.22 39.39 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.557 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -40.62 -58.73 1.54 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.125 0.891 . . . . 0.0 112.628 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 30.0 t -94.04 138.2 22.72 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.201 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.2 -1.75 11.05 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.675 2.25 . . . . 0.0 111.701 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.3 t -103.37 -81.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.296 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 66' ' ' SER . 7.4 p80 -107.25 165.98 10.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.122 0.487 . . . . 0.0 111.204 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.405 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 1.6 p -94.27 124.24 38.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.099 -168.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -128.46 -83.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.092 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -130.44 173.82 10.47 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.202 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.795 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 29.0 mt -110.07 127.71 55.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.952 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.82 107.92 19.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.519 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -113.41 152.15 30.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -175.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -126.2 159.43 33.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.6 m120 62.46 40.32 10.98 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.935 0.494 . . . . 0.0 111.301 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.9 mt -62.04 135.12 57.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.859 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -92.68 41.81 1.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.227 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.31 -84.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.22 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.89 -18.6 76.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.758 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.859 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.9 m-85 -96.38 109.48 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' HD22 ' A' ' 78' ' ' LEU . 14.8 m -139.85 167.15 22.77 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.47 159.77 15.29 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.311 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.81 -95.08 1.85 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.929 -174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -138.97 -167.44 2.22 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 49.4 m -134.43 144.97 48.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 61.3 p -139.35 -157.03 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.815 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.994 ' HB3' HD21 ' A' ' 24' ' ' ASN . 31.9 t70 61.68 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.431 1.092 . . . . 0.0 112.277 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 90' ' ' VAL . 3.1 m -70.8 -20.91 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.745 0.307 . . . . 0.0 111.141 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.528 HD21 ' SG ' ' A' ' 23' ' ' CYS . 13.6 mt -89.1 -56.04 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.505 0.669 . . . . 0.0 111.201 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.317 -0.831 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.418 -174.139 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 48.5 p90 -88.8 143.2 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.85 137.76 21.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.358 0.599 . . . . 0.0 111.798 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.844 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 8.6 pt20 -102.95 150.13 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.467 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.2 p -151.04 136.4 17.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.366 0.603 . . . . 0.0 111.936 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.854 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -76.63 106.28 8.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 172.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.41 ' CB ' ' HZ ' ' A' ' 47' ' ' PHE . 4.6 m80 -72.86 122.26 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.122 -174.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -82.21 126.46 32.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.037 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 27' ' ' LEU . 1.1 tm? -98.33 119.5 37.11 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.03 123.22 44.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.681 0.753 . . . . 0.0 111.425 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -101.63 148.38 25.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -57.27 99.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.26 0.35 . . . . 0.0 110.089 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.39 -57.58 0.59 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.484 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -168.84 170.62 9.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.153 0.477 . . . . 0.0 111.346 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -46.26 114.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.395 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.504 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 70.4 t90 -90.26 -55.92 3.41 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.825 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.24 169.67 36.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.669 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 t -154.55 147.81 24.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 111.551 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.9 mp -127.08 128.13 70.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.854 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.9 ttp180 -87.62 116.0 25.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.705 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -150.29 149.04 29.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.844 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 40.4 mtpt -66.62 145.94 55.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.37 141.58 58.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 108.37 -28.03 12.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.832 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -96.42 145.98 25.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.011 0.434 . . . . 0.0 110.409 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -75.85 131.96 40.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -105.79 131.49 55.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 129.42 34.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.101 0.477 . . . . 0.0 110.199 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 87.8 m-85 -121.27 123.69 42.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.8 p90 -144.57 150.35 37.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.991 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 15.6 pt-20 -95.51 142.2 28.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.689 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 6.4 pt-20 -118.72 102.51 8.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.472 0.653 . . . . 0.0 110.451 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -110.23 122.73 37.88 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.93 116.72 2.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.78 2.32 . . . . 0.0 112.532 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.83 13.71 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.023 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -104.77 140.26 20.9 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 159.52 31.5 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.827 2.352 . . . . 0.0 111.602 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.65 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 24.8 mmtp -71.05 119.93 15.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.87 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -112.97 129.25 56.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.186 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.485 HD13 HD11 ' A' ' 61' ' ' ILE . 12.9 mt -62.49 126.63 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.974 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -113.46 -17.19 8.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.532 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.13 140.65 1.2 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.542 0.687 . . . . 0.0 111.873 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.485 HD11 HD13 ' A' ' 58' ' ' LEU . 4.7 mp -117.49 111.93 36.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 167.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.648 ' O ' HG23 ' A' ' 45' ' ' VAL . 6.8 t -129.03 147.52 50.9 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.552 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.9 ptpt -148.18 163.22 37.64 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.65 137.88 32.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.447 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -48.72 8.15 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.085 0.866 . . . . 0.0 112.538 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 38.5 t -97.45 140.69 22.16 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.751 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 98.5 Cg_endo -81.65 5.21 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.876 2.384 . . . . 0.0 112.532 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.2 t -123.94 -62.33 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.378 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 66' ' ' SER . 36.7 m-70 -95.29 156.29 16.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.812 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.7 t -99.03 121.55 41.11 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -119.13 -78.73 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -135.56 172.48 12.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.58 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 11.5 mt -102.93 120.56 40.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 0.0 110.532 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.2 mmpt? -100.87 103.67 14.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 8.4 m -106.51 155.51 19.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.67 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -142.57 165.91 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 55.22 45.71 25.25 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.763 0.664 . . . . 0.0 111.487 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 83' ' ' SER . 85.0 mt -68.19 144.98 54.73 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -99.18 58.53 1.11 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.931 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.3 -86.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.103 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.54 -22.89 68.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.632 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -86.29 112.02 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.51 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.1 m -136.97 169.2 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.635 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.19 167.58 9.73 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.003 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.16 -108.35 1.07 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.18 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -115.32 -169.04 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.633 0.254 . . . . 0.0 110.531 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.6 m -135.7 143.52 45.45 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.1 p -139.83 -144.06 0.17 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.48 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.201 1.0 . . . . 0.0 113.498 174.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.596 HG23 HD23 ' A' ' 91' ' ' LEU . 3.2 m -70.42 -45.08 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 HG23 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -89.84 -37.75 14.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.671 0.272 . . . . 0.0 111.33 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.898 -175.138 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 68' ' ' VAL . 15.4 m . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.579 0.228 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.7 m-85 -87.49 148.46 24.92 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.021 0.439 . . . . 0.0 110.247 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -144.75 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.819 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.765 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 3.5 pp0? -113.99 143.38 44.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.692 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.671 ' HA ' HG21 ' A' ' 90' ' ' VAL . 8.1 p -152.76 155.45 37.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.106 0.479 . . . . 0.0 112.091 -173.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -80.88 113.34 19.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.816 175.685 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.416 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 32.3 m170 -79.76 121.12 24.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.53 132.2 35.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.918 0.39 . . . . 0.0 111.492 -174.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -99.94 129.27 46.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.443 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -108.44 123.45 48.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.282 0.563 . . . . 0.0 110.543 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 29.9 t80 -102.2 149.78 23.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.59 100.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.69 -56.91 0.72 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.364 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -159.8 178.49 9.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 111.452 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -61.47 129.56 41.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.323 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.1 t90 -90.83 -55.75 3.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.88 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.21 -179.4 44.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.831 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.0 t -153.69 146.0 23.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.16 0.48 . . . . 0.0 111.348 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.484 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.7 mp -129.0 127.35 65.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.7 ttp180 -86.6 111.98 21.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.015 0.436 . . . . 0.0 110.413 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HG2' HG22 ' A' ' 37' ' ' ILE . 37.9 mmtm -141.02 153.76 45.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.792 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.765 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 50.3 mtpt -69.98 155.91 39.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.744 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.16 141.39 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.831 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.847 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 89.73 -22.14 26.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.964 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 92.1 m95 -91.86 130.71 37.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.461 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -68.11 130.66 43.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.8 p -113.8 151.04 15.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.351 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -104.67 137.38 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.195 0.522 . . . . 0.0 111.407 -175.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.11 120.76 32.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.609 ' HE2' ' HD3' ' A' ' 56' ' ' LYS . 49.3 p90 -151.19 146.12 25.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -87.0 129.0 35.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 109.973 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.792 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -106.3 132.67 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.501 177.022 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 32.9 mmtm -131.82 113.3 15.08 Favored Pre-proline 0 C--N 1.315 -0.932 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.03 117.52 3.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.177 2.585 . . . . 0.0 113.053 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.32 -4.21 86.23 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.453 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -118.88 158.32 48.05 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 122.666 0.387 . . . . 0.0 109.976 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.29 154.69 65.41 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.437 2.091 . . . . 0.0 112.342 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.792 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 74.9 mttt -106.55 150.61 25.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.471 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -130.4 137.17 49.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.529 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 61' ' ' ILE . 8.5 mt -69.85 115.44 9.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.529 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 20.8 m -85.7 -21.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.99 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.498 ' HB2' HD23 ' A' ' 78' ' ' LEU . . . 176.85 140.81 0.07 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-O 121.589 0.709 . . . . 0.0 111.794 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 58' ' ' LEU . 4.6 mp -102.07 115.37 43.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.5 t -131.93 152.76 50.88 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.388 -169.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.662 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.3 ptpp? -153.14 163.27 40.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -81.04 135.56 35.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.4 -59.25 2.2 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.048 0.843 . . . . 0.0 112.624 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.7 t -87.17 135.22 35.12 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.213 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.847 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 4.0 Cg_exo -78.78 2.12 8.49 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.385 2.723 . . . . 0.0 112.059 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.0 t -119.06 -64.48 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.035 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' SER . 44.1 m80 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.039 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t -100.01 128.29 46.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -123.06 -82.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.298 0.57 . . . . 0.0 109.689 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.35 178.26 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.005 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.746 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 26.7 mt -103.48 124.56 48.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.894 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -109.19 107.21 17.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.297 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -110.4 149.74 29.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.075 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -124.27 155.51 38.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.6 t30 60.74 53.53 3.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.526 0.679 . . . . 0.0 110.152 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 75' ' ' CYS . 85.1 mt -72.95 139.34 46.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.298 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.893 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -91.56 45.29 1.22 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.583 0.23 . . . . 0.0 110.946 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 56.77 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.666 0.786 . . . . 0.0 112.054 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.72 -15.29 61.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.137 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.893 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.5 m-85 -99.64 106.69 18.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.015 0.436 . . . . 0.0 110.253 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.504 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.8 m -129.02 167.03 18.07 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.624 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -108.33 154.56 21.64 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.198 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.09 -126.57 3.42 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.06 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 p -96.82 -168.41 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.391 0.615 . . . . 0.0 111.814 -174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 49.7 m -136.33 141.53 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.024 172.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 25.4 p -142.28 -156.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.331 -174.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' H ' ' HB ' ' A' ' 88' ' ' THR . 32.6 t70 63.86 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.615 0.766 . . . . 0.0 112.157 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.671 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -66.88 -41.55 87.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.32 -24.88 20.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.77 0.319 . . . . 0.0 111.056 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 89' ' ' ASP . 47.1 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.762 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 51.6 p90 -89.91 146.25 24.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.72 140.04 21.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.335 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.806 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 12.4 pt20 -104.43 150.12 24.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.613 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.59 ' HA ' HG21 ' A' ' 90' ' ' VAL . 9.2 p -154.48 155.56 35.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.356 0.598 . . . . 0.0 111.399 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 89' ' ' ASP . 0.7 OUTLIER -76.74 108.98 10.14 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.62 118.69 19.52 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.405 ' CD2' HD21 ' A' ' 24' ' ' ASN . 14.4 m-70 -88.41 126.4 35.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 1.1 tm? -99.87 121.21 40.96 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 130.01 54.02 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.554 0.692 . . . . 0.0 111.497 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -106.95 151.17 25.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.743 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.33 100.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.313 0.383 . . . . 0.0 110.16 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' ARG . . . 138.58 -51.69 0.76 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.941 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 7.5 tpp180 176.49 179.56 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.452 0.301 . . . . 0.0 110.249 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.665 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.6 t-80 -41.05 130.98 2.64 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.722 0.809 . . . . 0.0 111.966 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 39.4 t90 -104.61 -53.9 2.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.75 164.88 34.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.189 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.26 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.506 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.488 ' HB ' HG21 ' A' ' 45' ' ' VAL . 2.3 mp -115.65 132.38 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.67 98.74 4.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.78 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.24 148.95 43.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 110.407 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 51.3 mtpt -64.52 153.36 39.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.47 139.56 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.564 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.967 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 92.49 -38.85 3.09 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.023 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -66.58 125.39 25.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.5 122.58 22.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.51 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.4 p -109.39 147.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.085 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 134.35 40.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.354 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 27' ' ' LEU . 90.2 m-85 -122.05 127.3 50.05 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.7 147.98 30.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.596 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 9.4 pt-20 -86.94 130.36 34.49 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.913 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 47.5 mt-10 -108.23 102.29 11.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.266 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.856 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 34.4 mmtp -99.36 129.69 28.66 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.415 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 116.36 3.27 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.349 2.033 . . . . 0.0 112.265 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.65 90.42 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 53.8 mt-30 -125.71 157.36 68.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 C-N-CA 122.381 0.272 . . . . 0.0 110.343 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.26 160.69 48.13 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.393 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 55.1 mttt -103.55 136.64 42.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.337 -173.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -132.91 135.77 45.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.677 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.5 119.93 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.558 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 32.2 m -92.69 -27.01 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.466 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.699 ' HB1' ' SG ' ' A' ' 75' ' ' CYS . . . 177.7 144.25 0.1 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.727 0.642 . . . . 0.0 111.261 173.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.1 mp -102.93 111.93 34.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.7 m -116.96 146.49 42.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.932 0.396 . . . . 0.0 111.136 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.917 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.5 pttm -155.13 161.56 41.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 9.0 t30 -80.19 143.21 33.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.301 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.2 -57.04 3.14 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.062 0.852 . . . . 0.0 112.044 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.7 m -94.74 138.77 22.12 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.406 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.967 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.5 Cg_endo -82.98 23.52 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.143 2.562 . . . . 0.0 112.008 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 4.0 t -136.34 -73.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.68 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -85.13 159.92 20.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.13 125.71 48.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.985 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -123.64 -79.34 0.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.27 174.45 10.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 85' ' ' GLY . 50.1 mt -101.28 122.51 43.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.464 0.65 . . . . 0.0 111.381 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.778 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.6 mmpt? -93.59 106.91 18.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.356 172.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.699 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 8.1 t -121.58 166.1 14.71 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.298 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 t -159.94 162.19 34.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.073 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.3 m120 68.67 33.56 3.78 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.78 0.675 . . . . 0.0 110.256 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.892 HD22 ' HA ' ' A' ' 83' ' ' SER . 93.1 mt -59.86 139.58 57.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -97.55 65.09 1.87 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.0 111.484 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.84 -88.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.151 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.19 -21.8 77.38 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.898 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -88.43 109.66 20.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.937 0.398 . . . . 0.0 110.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.892 ' HA ' HD22 ' A' ' 78' ' ' LEU . 17.0 m -128.54 173.62 10.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.58 158.79 19.53 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.69 -0.631 . . . . 0.0 110.667 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -123.11 -151.14 8.22 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.19 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -84.15 -176.69 6.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.855 0.359 . . . . 0.0 110.186 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 39.1 m -120.72 142.94 49.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.7 p -139.55 -156.04 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.731 0.301 . . . . 0.0 111.75 -170.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.502 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 21.9 t70 63.61 -77.03 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.99 0.916 . . . . 0.0 112.547 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.5 m -68.08 -46.61 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 23' ' ' CYS . 3.8 pp -90.7 -41.35 11.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.712 0.291 . . . . 0.0 111.648 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.411 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 79.7 m-85 -76.37 134.21 39.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 69' ' ' HIS . 2.3 p -135.57 136.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.388 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.786 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 4.5 pp0? -101.99 141.54 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.627 ' HA ' HG21 ' A' ' 90' ' ' VAL . 7.1 p -144.09 148.86 35.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.416 0.627 . . . . 0.0 112.105 -170.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.872 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -74.77 106.61 6.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.169 175.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.51 121.74 21.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.2 130.81 37.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.29 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -100.2 124.13 45.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.409 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.98 125.65 49.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.253 0.549 . . . . 0.0 110.686 -176.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 50.9 t80 -113.32 151.27 31.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -53.34 100.92 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.715 0.634 . . . . 0.0 110.379 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -52.16 0.82 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.241 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 20.9 tpt180 -172.74 171.77 4.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.743 0.272 . . . . 0.0 110.822 -175.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.429 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 23.7 t-80 -46.31 121.38 3.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.325 0.65 . . . . 0.0 111.289 172.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 57.9 t90 -89.93 -56.14 3.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.99 170.8 34.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.563 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.6 t -154.42 143.92 21.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.09 0.445 . . . . 0.0 110.758 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.1 mp -127.11 130.23 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.637 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.2 mtm180 -82.32 117.83 22.7 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.362 0.601 . . . . 0.0 110.726 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG3' HG23 ' A' ' 45' ' ' VAL . 72.6 mmtt -142.52 152.61 42.82 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.3 mtpt -69.16 156.74 38.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.023 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 140.3 58.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.418 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.98 -25.1 12.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.228 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 49.8 m95 -83.13 130.05 35.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 0.0 110.634 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.916 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -79.03 123.38 27.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.705 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 39' ' ' LYS . 8.7 p -106.15 154.26 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.981 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.8 140.99 29.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.502 ' CG ' HD23 ' A' ' 27' ' ' LEU . 75.6 m-85 -131.33 123.68 28.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -142.14 149.85 40.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.933 0.397 . . . . 0.0 111.265 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 11.1 pt-20 -87.41 130.04 34.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.728 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 56' ' ' LYS . 29.8 mt-10 -114.04 101.91 9.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.152 0.501 . . . . 0.0 109.827 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 71.6 mmtt -82.9 134.74 46.24 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.896 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 52.3 Cg_exo -54.55 117.05 3.53 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.54 2.16 . . . . 0.0 112.358 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.06 80.55 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.482 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.797 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 31.3 mt-30 -115.67 162.04 27.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 122.498 0.319 . . . . 0.0 110.772 -175.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 54' ' ' GLN . 57.5 Cg_endo -70.95 159.2 53.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.88 2.387 . . . . 0.0 112.803 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.863 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.4 146.39 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 -178.182 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -137.63 131.65 31.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.49 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.22 119.6 7.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.012 0.434 . . . . 0.0 112.046 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.4 m -100.09 -15.71 7.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.396 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.32 135.77 0.58 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.581 0.705 . . . . 0.0 111.821 176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.74 112.29 39.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.77 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.1 t -131.53 149.72 52.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.728 -169.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.916 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 pttp -155.39 163.43 40.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.42 139.22 34.13 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.318 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.38 -55.71 4.78 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.818 0.698 . . . . 0.0 112.179 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.9 t -95.86 146.64 31.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.212 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 66' ' ' SER . 3.5 Cg_exo -82.45 -1.19 10.54 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.157 2.572 . . . . 0.0 111.972 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.7 t -103.96 -79.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.405 ' HA ' HG12 ' A' ' 21' ' ' VAL . 65.7 m80 -94.27 165.04 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.155 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.1 121.97 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -119.55 -85.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.275 0.56 . . . . 0.0 109.593 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -126.31 166.34 17.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.914 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.77 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 14.2 mt -102.99 123.39 46.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.0 110.638 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.713 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -98.88 104.65 16.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.808 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -112.84 146.1 39.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.427 . . . . 0.0 110.658 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -129.23 155.45 45.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.874 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.4 60.2 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.691 0.619 . . . . 0.0 110.37 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.3 mt -77.6 157.91 30.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.364 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -115.46 71.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.743 0.306 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.96 -92.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.171 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.16 55.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.994 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.6 m-85 -72.65 109.56 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.314 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.592 ' HA ' HD22 ' A' ' 78' ' ' LEU . 19.6 m -140.97 166.71 24.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.56 168.49 9.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.045 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -139.0 -171.49 12.19 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.049 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -69.16 169.77 11.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.463 0.649 . . . . 0.0 111.622 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.4 m -105.76 153.84 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.669 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.5 p -139.88 -156.44 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.047 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.872 ' HB3' HD21 ' A' ' 24' ' ' ASN . 4.1 t70 62.61 -80.17 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.643 HG23 HD23 ' A' ' 91' ' ' LEU . 1.3 m -66.06 -41.62 89.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.222 -175.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.643 HD23 HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.464 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.387 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 17.8 p90 -58.5 131.15 49.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.284 0.564 . . . . 0.0 110.589 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.35 139.78 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.92 -170.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.68 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -99.7 143.34 30.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.659 175.083 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.54 ' CB ' HD23 ' A' ' 91' ' ' LEU . 7.5 p -151.72 159.19 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.886 0.374 . . . . 0.0 111.463 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.6 OUTLIER -82.16 117.25 22.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.42 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 21.8 m170 -85.16 119.44 25.55 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.414 ' CD2' HD21 ' A' ' 24' ' ' ASN . 12.1 m170 -90.57 130.37 36.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.829 0.347 . . . . 0.0 111.206 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.532 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -98.1 126.1 43.39 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -110.02 116.53 31.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.575 0.703 . . . . 0.0 110.68 -175.405 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -94.95 135.12 36.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.8 101.92 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.446 0.641 . . . . 0.0 110.281 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.73 -56.29 0.61 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.607 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -175.4 161.69 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.492 0.317 . . . . 0.0 110.727 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -37.86 132.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.908 0.883 . . . . 0.0 112.195 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -100.79 -54.8 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.593 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.99 -179.33 40.49 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.338 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -153.83 147.7 25.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.031 0.416 . . . . 0.0 111.354 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.4 mp -134.02 136.6 53.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 46.0 mtm180 -77.71 130.17 36.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.294 0.568 . . . . 0.0 111.36 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -150.39 148.22 28.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.542 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.68 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 46.6 mtpt -73.97 149.94 41.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.069 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -61.6 138.92 58.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 93.75 -23.7 29.53 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.143 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -101.44 136.16 41.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.824 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -82.57 155.07 24.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.495 0.664 . . . . 0.0 111.117 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.6 p -126.92 150.19 32.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.585 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 135.77 33.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.421 . . . . 0.0 111.301 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.709 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.2 m-85 -125.9 128.27 47.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 169.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 49.9 p90 -146.18 153.75 40.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.396 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -100.04 136.64 39.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -115.68 110.85 19.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.567 0.699 . . . . 0.0 111.474 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.2 105.28 42.39 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -44.29 121.63 3.24 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.324 2.682 . . . . 0.0 112.683 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.27 -24.15 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.65 151.43 57.08 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.004 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.72 149.25 54.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.227 1.952 . . . . 0.0 111.049 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 51.8 mttt -77.24 119.0 20.29 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.823 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 19.5 tpp180 -94.1 133.77 37.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.356 -168.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.29 107.78 0.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.195 0.522 . . . . 0.0 110.28 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.2 m -91.56 -22.71 6.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.295 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -168.68 135.53 1.9 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 111.684 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.11 111.18 33.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.7 t -132.88 146.45 51.82 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.899 -168.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.824 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 29.6 pttt -145.25 164.92 29.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.955 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -78.27 136.81 37.83 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.799 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -48.67 -37.77 19.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.474 -171.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 22.1 t -105.62 140.74 21.48 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.06 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.568 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 4.2 Cg_exo -77.83 4.35 6.16 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.022 2.482 . . . . 0.0 111.943 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.1 t -121.4 -77.33 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.68 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' ' 66' ' ' SER . 52.8 m80 -94.06 163.75 13.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 p -96.7 125.38 41.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 50.6 m-20 -123.21 -87.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 33.9 m-85 -129.24 177.56 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.018 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.758 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.3 mt -103.17 125.12 49.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.153 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 14.1 mptt -106.85 106.26 16.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.034 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -115.56 150.44 36.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.022 -174.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -119.68 150.57 40.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 7.2 t30 64.74 103.84 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.705 0.628 . . . . 0.0 110.722 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.544 HD22 ' HA ' ' A' ' 83' ' ' SER . 98.1 mt -117.98 127.63 54.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -91.26 76.8 5.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.633 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.06 -88.52 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.456 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.36 -6.36 61.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.061 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.3 m-85 -94.24 115.84 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.893 0.378 . . . . 0.0 110.809 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.544 ' HA ' HD22 ' A' ' 78' ' ' LEU . 17.2 m -144.98 168.64 19.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.582 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -99.86 154.77 18.08 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -110.67 -58.97 0.49 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.603 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.26 -178.32 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.9 m -126.9 141.36 51.83 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.7 p -142.32 -155.96 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.16 0.505 . . . . 0.0 111.812 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.8 t70 66.95 -83.45 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.113 168.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 7.3 m -71.07 -33.36 51.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.843 0.354 . . . . 0.0 111.027 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.54 HD23 ' CB ' ' A' ' 23' ' ' CYS . 4.1 pp -88.73 -31.94 18.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 CA--C 1.532 0.287 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.84 -175.542 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 18.2 p90 -86.79 131.41 34.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.43 142.11 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.895 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 1.027 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 1.7 pp0? -100.28 147.53 25.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 10.6 p -149.49 147.91 28.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.454 0.645 . . . . 0.0 112.405 -175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.5 OUTLIER -72.39 110.66 6.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.769 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 5.4 m80 -75.85 107.28 7.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.802 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 12.3 m-70 -79.68 126.63 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.106 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.533 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -99.33 125.26 44.96 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -107.55 125.42 51.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.472 0.653 . . . . 0.0 110.978 -176.225 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -100.14 151.13 21.77 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -48.29 101.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.458 0.474 . . . . 0.0 111.009 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.5 -53.03 0.68 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.235 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -147.85 160.95 42.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.457 0.646 . . . . 0.0 112.67 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -48.78 133.05 17.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.177 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -102.91 -55.48 2.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.127 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -177.9 38.01 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.467 ' C ' HD12 ' A' ' 37' ' ' ILE . 5.6 t -153.92 141.44 19.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.204 0.502 . . . . 0.0 110.037 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.467 HD12 ' C ' ' A' ' 36' ' ' THR . 1.8 mp -116.31 123.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 6.1 tpp85 -75.84 99.4 4.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.841 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -145.02 145.76 31.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.133 0.492 . . . . 0.0 111.365 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 12.7 ptmt -64.69 151.82 43.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.002 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.93 142.57 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.866 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.872 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.62 -30.61 10.01 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.316 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.577 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 76.2 m95 -90.17 139.68 30.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.21 130.59 40.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.957 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.3 p -121.46 153.43 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.141 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.73 142.39 28.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 111.059 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.769 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 77.3 m-85 -127.89 133.81 49.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 170.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.591 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 45.6 p90 -148.92 151.05 33.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.706 0.289 . . . . 0.0 110.689 -175.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.29 143.78 27.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.611 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.942 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 11.3 pt-20 -126.67 102.02 6.89 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.933 0.873 . . . . 0.0 111.158 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.17 128.15 41.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.02 116.94 2.71 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.57 2.18 . . . . 0.0 112.487 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.53 -29.27 12.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.372 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -96.54 153.09 38.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.24 153.4 74.59 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.588 2.192 . . . . 0.0 111.732 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.942 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 21.1 mmtp -70.57 117.7 12.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.43 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -105.81 125.67 51.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.598 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mt -57.02 120.83 8.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 110.784 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.1 m -107.74 -17.74 7.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.35 138.41 0.94 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.48 0.657 . . . . 0.0 111.62 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.26 112.38 40.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -130.69 150.89 51.67 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.953 -168.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.1 ptpp? -151.28 162.74 40.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.44 144.61 31.27 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.43 -56.96 5.13 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.767 0.667 . . . . 0.0 111.918 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 15.0 m -97.05 143.06 25.48 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.585 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.872 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 Cg_endo -83.81 22.19 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.25 2.633 . . . . 0.0 112.343 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.0 t -136.03 -76.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -81.28 159.55 24.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.7 t -98.81 122.32 41.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.998 0.427 . . . . 0.0 109.957 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -112.09 -83.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.591 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -145.76 179.99 7.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.838 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.729 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 16.3 mt -101.75 121.78 42.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -100.6 104.87 16.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.013 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -116.57 149.22 40.0 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.91 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -128.17 156.32 43.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 63.74 59.34 1.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.752 0.658 . . . . 0.0 110.286 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.662 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.6 mt -77.84 131.63 37.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.428 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -90.33 66.65 6.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 111.538 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.2 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.107 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.47 -10.15 83.85 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.089 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.7 m-85 -96.43 114.14 25.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.662 ' HA ' HD22 ' A' ' 78' ' ' LEU . 38.6 m -143.98 172.82 12.34 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.714 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -106.98 162.64 13.66 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.55 -126.91 3.95 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.02 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 14.1 t -104.4 -176.37 3.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 3.9 p -132.52 141.82 48.93 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.442 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 28.8 p -142.67 -157.58 0.79 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.962 0.41 . . . . 0.0 111.967 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 21.1 t70 72.21 -62.43 0.46 Allowed 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.799 168.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.637 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 1.5 m -85.07 -31.89 7.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.481 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.515 HD23 ' HB3' ' A' ' 23' ' ' CYS . 4.1 pp -89.77 -34.66 16.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.667 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.1 p . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.37 -178.736 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.717 0.294 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 39.1 p90 -88.8 139.59 30.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -120.71 138.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.571 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 4.8 pp0? -98.71 142.36 30.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.689 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.624 ' HA ' HG21 ' A' ' 90' ' ' VAL . 7.6 p -155.68 159.45 39.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 111.613 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.984 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -80.38 111.78 17.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.099 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.406 ' O ' ' HA ' ' A' ' 36' ' ' THR . 45.1 m170 -81.82 115.95 21.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -87.85 129.65 35.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.562 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.5 tm? -98.6 127.78 44.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -103.64 121.72 43.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.71 -175.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.609 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 85.4 t80 -94.31 141.29 28.73 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -54.78 101.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 110.699 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.57 -42.9 1.39 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.361 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -168.86 153.09 5.62 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.018 0.437 . . . . 0.0 111.672 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -38.55 126.22 1.43 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.07 0.948 . . . . 0.0 112.538 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.6 t90 -94.25 -55.77 3.07 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.98 -175.07 37.42 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.781 -0.724 . . . . 0.0 111.899 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.6 t -154.39 147.89 25.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.055 0.428 . . . . 0.0 110.882 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' CE1' ' A' ' 47' ' ' PHE . 3.3 mp -124.4 126.22 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 2.9 tpp180 -77.84 93.7 4.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -127.7 144.54 51.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 36.4 mtpt -70.72 151.86 44.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.65 142.05 57.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.47 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 91.88 -27.94 9.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.157 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.465 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 27.1 m95 -84.52 128.28 34.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.08 135.07 46.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.475 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.3 p -121.56 142.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.841 0.353 . . . . 0.0 110.764 -176.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.14 141.81 28.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.706 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 73.9 m-85 -130.65 134.98 47.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.46 167.75 21.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.733 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 15.5 pt-20 -107.54 125.39 51.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.422 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' ' HZ2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -117.52 121.67 41.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -129.73 149.97 74.47 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.24 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.13 117.81 3.96 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.447 2.765 . . . . 0.0 112.737 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.29 -13.43 45.64 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.888 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.75 142.38 25.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.965 0.412 . . . . 0.0 111.549 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.1 155.49 67.95 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.834 2.356 . . . . 0.0 111.568 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.676 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.487 -176.208 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -130.52 144.16 51.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 58' ' ' LEU . 14.9 mt -60.54 130.85 48.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.465 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 49' ' ' GLU . 33.5 m -117.2 -20.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -166.73 137.67 3.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.433 0.635 . . . . 0.0 111.137 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.54 110.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.706 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.9 t -130.52 168.16 17.5 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.863 -167.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.712 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 19.5 pttp -174.45 163.83 3.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.606 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.1 133.42 44.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.568 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -45.59 -41.9 10.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 114.009 -1.451 . . . . 0.0 113.177 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.9 t -102.15 138.15 19.66 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.191 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.3 Cg_endo -75.89 1.43 8.16 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.642 2.228 . . . . 0.0 111.792 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.5 t -118.81 -78.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.555 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 66' ' ' SER . 45.7 m-70 -89.91 162.53 15.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.2 t -97.25 129.12 44.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.067 0.46 . . . . 0.0 110.446 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -125.49 -81.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -139.67 174.82 10.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.828 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.9 mt -103.6 120.57 41.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.721 0.296 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 5.6 mptp? -106.54 110.53 22.75 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m -112.81 149.78 32.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.357 -173.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -111.8 150.61 30.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 9.5 t30 59.62 90.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.675 0.61 . . . . 0.0 110.473 -174.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.0 117.4 34.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -84.21 61.74 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.046 0.451 . . . . 0.0 111.352 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.57 -91.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.265 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 5.31 84.73 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.41 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.6 m-85 -114.43 108.84 17.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 0.0 110.139 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 m -147.29 166.52 26.84 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.546 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.32 153.78 19.02 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.321 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.66 -63.82 0.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.486 -171.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 t -175.91 -169.94 0.36 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 m -129.09 143.39 50.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.0 p -140.23 -152.51 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.995 -0.093 . . . . 0.0 110.97 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.984 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.6 t70 63.0 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.962 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -69.12 -45.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.723 0.297 . . . . 0.0 111.778 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.02 -24.33 22.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 111.259 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.4 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -175.647 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.7 m-85 -47.82 130.01 14.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.309 0.576 . . . . 0.0 110.799 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.75 143.77 34.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.266 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.932 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 2.8 pp0? -99.3 142.43 30.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.14 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 6.0 p -148.84 146.21 27.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.512 . . . . 0.0 111.846 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.8 OUTLIER -77.27 115.52 17.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 110.302 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -81.4 124.49 29.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.281 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.531 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 10.8 m170 -94.25 126.27 39.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.92 0.39 . . . . 0.0 111.533 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.4 tm? -97.89 127.89 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -105.07 128.86 53.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.929 -175.139 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 73.3 t80 -104.26 148.22 26.6 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.05 99.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.0 109.756 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -49.83 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.626 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -173.99 175.35 2.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.526 0.203 . . . . 0.0 110.619 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.681 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 44.9 t-80 -54.3 139.14 37.36 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.794 0.438 . . . . 0.0 110.945 176.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 60.9 t90 -107.42 -56.01 2.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.736 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.78 167.45 33.16 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.035 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 26' ' ' HIS . 0.9 OUTLIER -151.89 136.78 17.2 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 120.99 0.424 . . . . 0.0 112.025 -176.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.5 mp -126.2 132.78 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.957 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 34.9 ttp180 -94.21 113.92 25.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' HG2' HG22 ' A' ' 37' ' ' ILE . 73.9 mmtt -138.1 153.95 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.298 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.932 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.9 mtpt -68.06 157.84 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 111.251 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -69.87 142.47 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.41 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.24 10.98 81.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.487 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -116.75 156.44 27.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . . . -90.55 120.44 31.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.407 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 62' ' ' CYS . 14.7 p -105.38 141.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.569 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 133.61 39.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.182 0.515 . . . . 0.0 110.671 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.488 ' CG ' HD23 ' A' ' 27' ' ' LEU . 66.5 m-85 -125.65 125.14 42.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.679 ' HB3' HD23 ' A' ' 58' ' ' LEU . 42.6 p90 -147.32 148.03 30.96 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.998 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.6 125.19 34.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.57 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.659 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 8.8 pt-20 -128.54 102.78 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.02 0.914 . . . . 0.0 110.019 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 29.2 mtmt -104.13 118.24 57.48 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.572 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 1.2 Cg_endo -42.92 117.34 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.694 2.929 . . . . 0.0 113.067 -172.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.18 -20.83 32.4 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.012 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 47.5 mt-30 -115.84 143.4 30.69 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.654 0.264 . . . . 0.0 110.91 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 24.4 Cg_exo -64.56 161.99 32.98 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.215 2.61 . . . . 0.0 111.93 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.659 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 27.9 mttm -90.93 143.43 26.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.116 -169.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.641 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -134.53 133.29 40.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.679 HD23 ' HB3' ' A' ' 48' ' ' TYR . 13.3 mt -64.09 126.67 28.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 0.0 111.052 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 20.5 m -113.02 -17.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -171.18 135.53 0.99 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.484 0.659 . . . . 0.0 111.799 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -113.17 112.13 39.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 167.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -120.56 146.12 46.64 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.356 -166.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 24.9 mmtm -120.01 164.67 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 70' ' ' CYS . 9.9 t30 -93.66 137.06 33.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.6 -55.28 1.89 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.115 0.884 . . . . 0.0 112.679 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.438 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 39.9 t -103.12 141.62 22.86 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.823 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.48 -10.55 13.3 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.591 2.194 . . . . 0.0 111.649 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 16.2 t -100.32 -59.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.497 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -104.96 164.52 11.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.407 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.431 ' HA ' HD21 ' A' ' 64' ' ' ASN . 5.9 p -100.87 122.02 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.302 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.87 -90.09 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.111 0.481 . . . . 0.0 110.709 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -131.37 176.52 8.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.448 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.801 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.7 mt -105.79 128.41 53.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -170.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -109.41 105.26 14.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.772 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.7 m -119.94 152.68 37.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.973 -171.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 t -124.45 174.1 8.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.18 34.49 21.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.636 0.585 . . . . 0.0 111.606 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -66.08 131.01 45.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.795 -176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -100.92 68.15 1.26 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.674 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.07 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.538 0.735 . . . . 0.0 112.821 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.12 -14.05 83.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.966 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.1 m-85 -96.92 111.42 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.994 0.426 . . . . 0.0 110.753 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 78' ' ' LEU . 45.1 m -148.51 168.53 22.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.772 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -112.1 154.61 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.872 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -106.31 -79.22 1.23 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.895 -171.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.402 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 13.4 t -161.1 -174.91 4.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 27.8 m -116.06 144.04 44.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.9 p -139.75 -155.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.103 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.501 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 20.9 t70 66.67 -81.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.593 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -65.23 -40.91 90.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.813 0.339 . . . . 0.0 111.591 -175.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.8 -30.24 19.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.668 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.661 -178.699 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HD1' ' H ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -85.32 125.81 33.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.065 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -132.93 139.44 49.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.865 -172.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.689 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 4.0 pp0? -101.51 142.15 33.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.947 ' HA ' HG21 ' A' ' 90' ' ' VAL . 26.1 p -143.69 150.14 38.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.316 -172.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' HB2' ' OG1' ' A' ' 36' ' ' THR . 0.8 OUTLIER -74.31 114.4 12.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 175.335 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.527 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -83.18 113.79 20.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.601 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -85.39 127.37 34.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.173 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.5 tm? -100.06 132.44 45.42 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -99.46 124.67 44.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.599 -178.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.932 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.8 t80 -93.61 150.0 20.78 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -53.74 99.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 110.309 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.85 -68.32 0.46 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.189 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -142.89 179.19 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 112.128 -171.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -47.71 133.85 13.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.801 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.932 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 83.8 t90 -103.15 -56.62 2.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.17 -178.57 42.49 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.022 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 13.3 t -153.11 138.7 17.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.631 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.2 mp -116.11 129.89 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.571 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.645 HH11 HG13 ' A' ' 90' ' ' VAL . 2.3 tpp180 -80.84 99.84 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.419 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.0 mmtm -140.9 152.95 45.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.224 0.535 . . . . 0.0 111.385 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.4 mtpt -67.18 154.97 39.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.826 -176.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 54.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.187 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 91.94 -26.63 12.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.177 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -81.14 134.73 35.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.007 0.432 . . . . 0.0 110.842 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -78.21 121.75 24.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.972 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.1 p -111.87 147.31 15.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 141.72 28.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 -176.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.75 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.0 m-85 -127.56 138.29 52.84 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 22.4 p90 -153.33 159.63 42.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 -172.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.48 137.37 44.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HG2' ' HG2' ' A' ' 56' ' ' LYS . 22.9 mt-10 -112.5 102.0 10.13 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -90.56 143.59 29.38 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.57 116.51 3.34 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.512 2.141 . . . . 0.0 111.788 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.07 -17.74 57.68 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.292 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.56 148.43 35.22 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.63 153.41 59.82 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 110.615 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.569 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 15.6 mttp -62.61 127.85 33.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.08 -173.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -103.82 119.97 40.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.89 115.53 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.638 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 25.9 m -96.88 -22.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.614 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 59' ' ' VAL . . . 176.27 144.61 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.612 0.57 . . . . 0.0 111.315 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.4 mp -101.73 116.98 46.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.75 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.6 t -128.63 149.42 50.66 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.321 -171.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.659 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.2 ptpt -144.26 162.29 36.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -85.71 133.69 34.0 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.166 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.29 -53.51 5.17 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.092 0.87 . . . . 0.0 112.959 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 33.2 t -93.46 139.59 22.93 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.318 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 71.7 Cg_endo -78.87 -3.51 13.28 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.594 2.196 . . . . 0.0 111.827 173.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -111.33 -69.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.423 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.436 ' O ' ' HB3' ' A' ' 66' ' ' SER . 35.6 m80 -94.79 161.8 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.004 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.0 p -98.51 121.17 40.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -121.41 -88.48 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 0.0 109.707 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.04 171.23 12.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.47 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.686 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 37.8 mt -103.71 119.93 39.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.869 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.9 mmpt? -96.05 104.47 16.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 30.7 m -100.87 152.88 20.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.033 0.444 . . . . 0.0 111.361 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -133.39 157.86 44.48 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.553 173.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.1 m120 59.43 49.57 8.56 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.469 0.481 . . . . 0.0 111.066 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 75' ' ' CYS . 97.2 mt -65.87 140.81 58.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.91 79.0 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.944 0.402 . . . . 0.0 110.76 -178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 67.67 -77.7 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.798 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.83 -13.1 6.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.955 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 50.6 m-85 -71.22 118.09 13.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -151.2 171.59 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.705 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -92.24 163.24 13.99 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.752 0.311 . . . . 0.0 110.56 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.24 -62.64 0.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.511 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.11 -171.44 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.8 m -129.83 143.18 50.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.6 p -141.66 -160.74 1.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.698 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.447 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 19.5 t70 64.51 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.388 171.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.947 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -62.25 -38.29 80.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.901 0.382 . . . . 0.0 111.206 -176.386 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.22 -37.91 15.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.733 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.53 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.03 -179.45 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.6 m-85 -53.32 141.22 24.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.941 0.4 . . . . 0.0 110.419 173.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.527 HG13 ' SG ' ' A' ' 70' ' ' CYS . 1.5 p -142.39 133.7 25.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.606 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 4.5 pp0? -96.52 145.66 25.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 21.6 p -150.23 149.1 29.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.486 0.66 . . . . 0.0 111.876 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.926 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.53 114.37 14.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.857 173.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.04 117.96 21.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -87.06 134.09 33.53 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.804 0.335 . . . . 0.0 111.895 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.587 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -99.55 123.59 43.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -105.78 122.29 45.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.475 0.655 . . . . 0.0 110.858 -176.502 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -95.35 146.66 24.22 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -60.8 100.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.0 -52.61 0.68 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.825 -174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 17.6 tpt180 -174.94 177.9 1.9 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.744 0.272 . . . . 0.0 111.428 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.529 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.5 t-80 -51.23 128.13 21.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.516 0.727 . . . . 0.0 111.631 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.705 ' HZ2' ' H ' ' A' ' 50' ' ' GLU . 57.2 t90 -95.65 -56.8 2.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.56 173.71 44.97 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 8.8 t -155.24 146.6 22.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.206 0.503 . . . . 0.0 111.497 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.81 133.85 66.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.405 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.621 HH11 ' HB3' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -76.09 113.55 13.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.156 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 11.9 tppt? -143.72 150.72 39.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 21.0 ttmt -83.25 147.42 28.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -53.86 139.59 33.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.966 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 98.2 -39.6 2.72 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.447 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -81.2 137.19 35.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 110.608 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -76.34 136.66 39.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.646 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 62' ' ' CYS . 10.0 p -118.39 148.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.708 ' HE ' ' HE1' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -89.01 143.32 26.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.407 . . . . 0.0 110.899 -177.382 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 55.0 m-85 -128.31 143.28 51.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.708 ' HE1' ' HE ' ' A' ' 46' ' ' ARG . 36.7 p90 -152.51 156.48 39.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.814 0.34 . . . . 0.0 110.58 -174.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 8.5 pt-20 -100.17 130.07 46.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.753 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -120.32 101.08 7.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.963 0.887 . . . . 0.0 110.497 175.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -85.19 141.53 37.38 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.816 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.19 116.39 2.22 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.847 2.365 . . . . 0.0 112.894 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.73 -30.52 6.48 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.171 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -83.15 153.33 66.27 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.719 0.295 . . . . 0.0 111.228 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 153.9 76.15 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 111.186 171.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.753 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 32.2 mttm -94.54 126.1 39.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.99 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 7.2 ttm-85 -94.58 123.53 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.261 -174.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -61.15 102.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.59 -19.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.79 146.92 0.35 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.158 0.504 . . . . 0.0 111.51 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.89 118.64 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.716 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 9.1 t -133.82 150.88 51.42 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.289 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.4 ptpt -146.32 162.75 37.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.21 138.65 36.87 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.439 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.93 -57.53 2.37 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.38 1.05 . . . . 0.0 112.677 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.7 t -93.54 138.3 23.0 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.156 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -76.25 -0.76 10.7 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.641 2.228 . . . . 0.0 111.879 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -115.34 -66.45 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.73 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' SER . 53.5 m-70 -98.21 163.89 12.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.527 ' SG ' HG13 ' A' ' 21' ' ' VAL . 97.9 m -99.23 122.33 42.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.398 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -125.04 -79.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.305 0.574 . . . . 0.0 110.218 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.53 174.18 10.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.827 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.706 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 28.3 mt -104.51 127.44 52.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.235 0.541 . . . . 0.0 111.387 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -104.69 105.66 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.35 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.727 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 5.9 m -106.14 163.64 12.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.244 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -144.22 157.91 44.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.3 46.61 5.9 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.664 0.603 . . . . 0.0 111.34 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.5 mt -67.28 147.89 52.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.691 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -107.57 69.85 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 111.465 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.22 -93.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.8 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.91 -5.87 88.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.184 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -98.71 112.98 24.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.233 0.539 . . . . 0.0 110.485 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' HD22 ' A' ' 78' ' ' LEU . 20.1 m -140.02 169.12 18.29 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.727 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -108.0 156.78 18.85 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.569 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -121.07 3.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.896 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -110.35 -169.6 1.49 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.616 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 18.9 p -125.24 142.74 51.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.2 p -140.4 -155.86 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.538 0.208 . . . . 0.0 111.046 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.926 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.3 t70 67.25 -72.9 0.08 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.828 0.851 . . . . 0.0 112.33 170.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 m -78.63 -42.76 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -89.51 -45.6 9.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.377 -178.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.449 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 15.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.579 0.228 . . . . 0.0 110.66 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.7 p90 -58.19 136.56 57.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.23 139.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.463 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.595 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -116.88 141.6 48.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 90' ' ' VAL . 20.5 p -147.33 164.12 34.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.111 0.481 . . . . 0.0 111.373 -171.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.556 ' HB2' ' OG1' ' A' ' 36' ' ' THR . 0.9 OUTLIER -79.35 115.61 19.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.585 176.302 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 36' ' ' THR . 49.6 m170 -83.22 121.53 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -89.53 138.69 31.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.477 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -109.65 130.32 55.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 170.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.537 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -100.43 123.5 44.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.385 0.612 . . . . 0.0 111.032 -178.029 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.964 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 21.4 t80 -95.72 151.63 19.19 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -57.44 100.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.079 0.466 . . . . 0.0 110.514 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.2 -57.28 0.69 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.62 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -147.38 178.47 8.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.193 0.52 . . . . 0.0 111.87 -171.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -62.5 133.7 55.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.044 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.964 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 84.3 t90 -101.25 -57.61 2.05 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.218 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.31 -179.5 40.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.118 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 12.1 t -154.68 148.75 25.82 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.65 0.262 . . . . 0.0 110.892 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.687 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.6 mp -128.15 125.54 64.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -75.97 99.5 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.952 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.687 ' HG2' HG22 ' A' ' 37' ' ' ILE . 67.5 mmtt -135.15 153.12 52.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.0 mtpt -72.11 153.0 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 142.39 58.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 90.96 -25.86 12.77 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 -178.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.562 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 86.0 m95 -86.02 133.7 33.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.605 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.665 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.91 135.64 48.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 62' ' ' CYS . 11.2 p -122.54 148.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.1 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -90.6 147.88 23.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.705 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 61.1 m-85 -136.38 137.28 40.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.0 p90 -145.55 154.29 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.515 0.198 . . . . 0.0 110.549 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.441 ' HB3' HG11 ' A' ' 59' ' ' VAL . 15.0 pt-20 -95.51 135.43 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.073 0.463 . . . . 0.0 110.577 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.62 ' HB2' ' HZ2' ' A' ' 34' ' ' TRP . 1.6 mm-40 -94.84 106.39 18.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.418 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.652 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 75.9 mmtt -106.81 123.46 38.48 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.48 117.26 3.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.848 2.366 . . . . 0.0 112.339 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.46 -6.68 75.91 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.479 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.652 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 28.3 mt-30 -113.25 158.63 37.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 122.664 0.385 . . . . 0.0 110.69 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.85 155.53 62.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.529 2.153 . . . . 0.0 111.944 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 56' ' ' LYS . 1.9 mptp? -80.82 130.01 34.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.299 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.563 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.4 tpm_? -108.19 124.09 49.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.354 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -61.0 106.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.077 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 49' ' ' GLU . 29.5 m -94.2 -17.06 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.927 -172.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.34 138.08 2.47 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.376 0.608 . . . . 0.0 112.238 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.81 111.93 38.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.6 t -130.93 155.11 47.33 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.193 -168.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.665 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.7 ptpt -157.59 158.56 35.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -77.95 131.09 37.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.659 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -55.2 -28.3 52.03 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.022 0.826 . . . . 0.0 112.958 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 34.0 t -104.64 131.65 21.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.683 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 77.6 Cg_endo -80.1 2.54 8.37 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.65 2.233 . . . . 0.0 112.415 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 13.2 t -121.31 -65.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.667 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.582 ' O ' ' HB3' ' A' ' 66' ' ' SER . 57.0 t-80 -97.94 160.37 14.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 110.025 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.3 p -100.94 128.62 46.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.071 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -129.13 -86.63 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.036 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -132.14 169.72 16.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.544 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.74 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 19.0 mt -102.76 120.1 39.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.157 0.503 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.659 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 4.1 mptp? -100.79 106.27 17.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.479 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.634 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.5 m -108.81 152.49 24.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.776 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -125.73 156.1 39.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.729 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 m120 61.9 47.45 6.0 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.611 0.57 . . . . 0.0 111.773 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 75' ' ' CYS . 81.2 mt -66.77 145.91 55.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -88.8 72.95 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.2 -93.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.15 -17.13 30.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 40.4 m-85 -72.38 109.37 6.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.166 0.507 . . . . 0.0 109.885 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' HD22 ' A' ' 78' ' ' LEU . 4.4 p -139.14 175.93 9.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.017 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.34 169.1 9.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.768 0.318 . . . . 0.0 110.652 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.82 -159.24 10.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.861 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 t -77.29 -178.09 4.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.475 ' HB2' HD21 ' A' ' 91' ' ' LEU . 41.2 m -116.8 144.75 44.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.5 p -139.67 -157.92 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.525 0.202 . . . . 0.0 111.335 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.491 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 27.9 t70 65.14 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.955 0.902 . . . . 0.0 112.43 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.6 m -71.4 -47.67 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.3 pp -88.97 -30.34 18.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.688 0.28 . . . . 0.0 111.079 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -176.574 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 41.1 p90 -58.81 142.06 51.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.93 0.395 . . . . 0.0 110.059 175.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.42 139.37 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.322 0.582 . . . . 0.0 111.802 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.745 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -113.71 140.93 47.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.577 173.583 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 7.7 p -148.44 151.58 35.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.951 0.405 . . . . 0.0 111.842 -171.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.937 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -73.01 102.63 3.55 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.414 0.626 . . . . 0.0 110.573 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.784 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 4.7 m80 -69.95 116.55 10.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.382 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.9 m-70 -93.57 128.98 39.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.439 . . . . 0.0 111.43 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.503 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.487 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -91.85 123.63 35.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.487 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.561 ' HB2' ' CB ' ' A' ' 34' ' ' TRP . 37.2 t80 -94.18 149.59 21.1 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -52.04 99.45 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.475 0.484 . . . . 0.0 110.038 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.14 -70.86 0.51 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.954 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -149.15 178.97 8.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.087 0.47 . . . . 0.0 112.031 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -53.62 132.7 41.05 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.856 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 29' ' ' TYR . 8.1 t-105 -128.34 -57.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.073 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 26' ' ' HIS . . . -98.93 150.62 19.34 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.314 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -151.39 108.07 3.51 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.73 113.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.835 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 21.9 ttp180 -77.87 93.56 4.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 109.768 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 15.6 tppt? -116.34 153.0 32.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.036 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.745 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.5 mtpt -79.94 149.33 30.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.673 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.05 137.31 56.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 97.08 -20.24 51.61 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.031 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.499 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 84.6 m95 -95.9 133.11 40.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.769 0.319 . . . . 0.0 110.223 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.48 130.42 40.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.162 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.569 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 14.8 p -116.09 143.18 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.906 0.384 . . . . 0.0 110.382 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -95.94 143.27 27.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.226 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.784 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 86.7 m-85 -120.93 137.96 54.35 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.8 p90 -144.51 157.96 43.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.399 0.619 . . . . 0.0 111.371 -173.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 21.8 pt-20 -97.78 126.42 43.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.939 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.789 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 7.7 pt-20 -121.93 102.09 7.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.715 0.769 . . . . 0.0 109.824 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -116.15 151.77 47.05 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.237 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.95 116.14 2.45 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.957 2.438 . . . . 0.0 112.759 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.57 50.07 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.312 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 68.9 mt-30 -102.14 143.81 27.35 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.196 0.522 . . . . 0.0 112.105 -173.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 13.3 Cg_exo -70.23 166.11 29.26 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.214 2.609 . . . . 0.0 110.429 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.789 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 50.3 mttt -94.16 110.67 22.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.36 -168.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 9.5 ttp180 -100.7 144.2 29.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.579 -174.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 46' ' ' ARG . 14.1 mt -64.94 125.35 24.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.137 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 29.8 m -111.3 -18.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.535 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -172.47 140.6 1.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.446 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -113.31 113.28 43.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.679 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -133.73 162.64 31.42 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.595 -169.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.3 ptpt -158.21 163.39 37.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.91 132.88 35.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.34 -54.7 3.66 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.155 0.909 . . . . 0.0 112.795 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -95.22 146.77 31.91 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.428 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 83.4 Cg_endo -86.57 10.99 3.42 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.769 2.313 . . . . 0.0 112.485 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 10.8 t -122.64 -73.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.638 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -95.58 163.47 13.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.1 t -98.08 125.91 43.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.07 -80.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.672 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -139.52 176.36 8.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.75 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.668 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.8 mt -106.72 120.43 41.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.828 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -100.22 104.02 15.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 22.1 m -105.62 150.32 25.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 112.074 -172.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 t -132.26 156.23 46.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.458 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.6 t30 57.14 77.7 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.758 0.661 . . . . 0.0 111.102 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.616 HD22 ' HA ' ' A' ' 83' ' ' SER . 92.0 mt -94.8 137.31 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.268 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.08 80.71 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 110.685 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.61 -94.26 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.686 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.99 -5.29 53.58 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.37 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 33.6 m-85 -83.39 113.58 20.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.988 0.423 . . . . 0.0 110.116 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.616 ' HA ' HD22 ' A' ' 78' ' ' LEU . 12.3 m -142.44 166.44 24.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -89.47 162.89 15.5 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.91 -63.28 0.24 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.884 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -175.85 -167.83 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 19.7 m -135.0 144.08 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.6 p -140.11 -152.15 0.4 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.937 ' HB3' HD21 ' A' ' 24' ' ' ASN . 27.8 t70 66.07 -70.11 0.1 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.018 0.927 . . . . 0.0 112.533 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 23' ' ' CYS . 4.5 m -80.14 -42.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.746 0.308 . . . . 0.0 111.651 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.4 pp -89.9 -33.2 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.745 0.307 . . . . 0.0 111.443 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 120.679 0.276 . . . . 0.0 110.716 -177.271 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.671 ' HD1' ' HA ' ' A' ' 68' ' ' VAL . 28.6 m-85 -53.89 131.32 39.81 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 110.301 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 t -111.14 130.99 63.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.135 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 1.5 pp0? -93.15 141.08 28.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.662 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 92.8 m -151.72 144.36 24.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.782 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.822 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -74.7 109.72 8.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.019 0.438 . . . . 0.0 109.861 176.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.69 12.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' THR . 9.8 m-70 -84.46 130.8 34.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.332 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.598 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -99.04 127.8 45.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -98.35 122.76 41.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.613 . . . . 0.0 110.846 -176.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.054 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 1.8 t80 -100.39 152.7 20.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.42 99.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.526 0.516 . . . . 0.0 111.857 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.96 -19.74 42.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.379 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -163.82 156.89 18.27 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.458 1.129 . . . . 0.0 112.909 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -48.54 119.34 3.0 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.704 171.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 1.054 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.5 t90 -87.71 -56.52 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.503 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.01 -177.92 42.63 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.2 t -156.0 146.53 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.086 0.443 . . . . 0.0 111.391 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.2 mp -125.15 126.73 71.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 16.1 mtm180 -75.94 122.1 23.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.656 0.741 . . . . 0.0 110.803 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.83 149.78 31.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.262 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 50.6 mtpt -69.92 155.1 41.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 110.858 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.43 142.3 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.445 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 88.44 -34.29 3.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.348 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 89.7 m95 -78.13 132.8 37.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.08 0.467 . . . . 0.0 110.451 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.661 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.44 141.59 52.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.741 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 62' ' ' CYS . 9.5 p -124.35 157.63 31.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.4 136.45 40.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.377 . . . . 0.0 111.484 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.598 ' CG ' HD23 ' A' ' 27' ' ' LEU . 67.8 m-85 -128.37 133.74 48.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -150.77 154.04 36.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 17.0 pt-20 -101.46 126.56 48.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.06 102.49 9.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.604 0.716 . . . . 0.0 109.905 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.76 131.41 35.75 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.975 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.83 116.46 3.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.569 2.179 . . . . 0.0 112.351 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.41 -10.18 57.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.123 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -122.05 154.69 61.5 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.406 0.282 . . . . 0.0 110.569 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.23 155.6 51.57 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.6 2.2 . . . . 0.0 111.359 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.707 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -72.33 140.09 48.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.216 0.531 . . . . 0.0 110.903 -177.171 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.33 129.8 55.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.464 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 58' ' ' LEU . 3.7 mm? -59.14 123.74 17.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 110.484 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -110.37 -18.27 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.1 134.87 1.29 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.623 0.725 . . . . 0.0 111.394 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.68 111.6 36.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.9 t -131.18 144.05 51.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.269 -167.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -144.8 161.13 40.02 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -80.53 141.79 34.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.825 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.83 -62.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.015 0.822 . . . . 0.0 112.258 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.7 t -90.23 138.53 27.21 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.249 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.699 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -78.23 -2.41 12.49 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.521 2.147 . . . . 0.0 111.632 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.671 ' HA ' ' HD1' ' A' ' 20' ' ' PHE . 12.5 t -105.04 -74.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.336 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.91 163.64 12.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.1 t -98.22 131.69 44.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.85 0.357 . . . . 0.0 110.298 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -132.54 -84.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.953 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -131.57 164.24 26.28 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.186 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.776 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 25.9 mt -103.54 122.94 45.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.988 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -102.78 106.21 16.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.698 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.8 m -110.01 146.56 35.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.599 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -124.16 157.48 34.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.708 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m120 60.54 55.84 3.28 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.609 0.568 . . . . 0.0 110.987 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 75' ' ' CYS . 92.1 mt -73.62 148.21 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.153 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -105.22 67.89 0.79 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.026 0.441 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.8 -91.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.258 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.04 60.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.008 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 90.2 m-85 -79.51 108.23 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.401 . . . . 0.0 110.74 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 m -149.68 163.31 38.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.67 159.98 14.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.34 -64.0 0.19 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.335 -170.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 11.6 t -160.16 -165.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.943 0.372 . . . . 0.0 110.423 -171.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.662 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 14.3 t -144.5 148.04 34.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.54 ' HB ' HG21 ' A' ' 95' ' ' THR . 73.8 p -140.01 -153.21 0.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.276 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.822 ' HB3' HD21 ' A' ' 24' ' ' ASN . 7.9 t70 61.34 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 173.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -69.28 -42.38 81.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.967 0.413 . . . . 0.0 111.31 -176.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.414 HD23 ' SG ' ' A' ' 23' ' ' CYS . 4.1 pp -89.68 -33.93 16.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.552 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t -94.67 -37.73 11.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.554 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 t 66.35 114.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.122 0.569 . . . . 0.0 111.694 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.9 66.12 1.32 Allowed Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.643 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.54 HG21 ' HB ' ' A' ' 88' ' ' THR . 11.6 p -144.42 160.02 41.77 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.708 -0.29 . . . . 0.0 110.758 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 m -82.14 79.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.887 0.851 . . . . 0.0 110.482 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.49 -86.04 1.81 Allowed Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.051 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.88 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.622 0.248 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.3 m-85 -81.24 140.67 34.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.85 140.18 48.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.816 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 4.7 pp0? -112.41 144.87 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.325 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HB3' HD11 ' A' ' 91' ' ' LEU . 19.8 p -153.49 157.05 39.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 0.0 111.54 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.643 ' HB2' ' OG1' ' A' ' 36' ' ' THR . 0.6 OUTLIER -78.11 112.52 15.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.602 174.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -81.97 115.3 21.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.651 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -83.94 129.01 34.93 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.017 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.3 tm? -101.36 132.57 46.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.542 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.31 122.57 44.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.374 0.607 . . . . 0.0 111.037 -178.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.828 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 56.7 t80 -106.09 143.99 33.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -53.07 104.96 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.039 0.447 . . . . 0.0 110.792 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 -50.59 0.88 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.964 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -172.75 167.37 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -36.3 131.37 0.63 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.985 0.914 . . . . 0.0 112.221 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.828 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 32.8 t-105 -99.56 -56.69 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.264 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -178.71 39.57 Favored Glycine 0 C--O 1.234 0.143 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.643 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 9.7 t -151.77 141.76 22.11 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.187 0.518 . . . . 0.0 111.664 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.88 130.04 58.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.827 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.489 HH11 HE22 ' A' ' 22' ' ' GLN . 29.7 mtm180 -87.68 124.78 33.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.325 0.583 . . . . 0.0 111.539 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.425 ' HE3' HG13 ' A' ' 45' ' ' VAL . 36.6 ttmt -153.53 152.35 30.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.575 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.816 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 47.1 mtpt -76.15 155.07 34.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.924 0.392 . . . . 0.0 111.044 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.78 142.45 55.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 104.65 -36.32 4.46 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.139 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -90.29 146.92 23.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.927 0.394 . . . . 0.0 110.614 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -85.63 131.37 34.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -101.12 152.54 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -94.43 140.12 30.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.88 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.476 ' O ' HD23 ' A' ' 58' ' ' LEU . 94.2 m-85 -136.54 132.5 35.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.5 p90 -147.62 157.76 43.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 0.0 111.377 -173.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 16.9 pt-20 -95.33 130.03 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.143 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.557 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 16.4 pt-20 -126.25 112.21 15.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.443 0.64 . . . . 0.0 109.96 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 49.2 mtmt -136.4 121.82 13.29 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.592 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 8.0 Cg_endo -48.58 116.88 2.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.686 2.924 . . . . 0.0 113.417 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.04 -19.26 12.02 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.274 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -126.67 149.26 67.76 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.807 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 162.33 42.44 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.822 2.348 . . . . 0.0 111.403 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.557 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 24.3 mttm -86.29 118.28 25.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.532 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -103.99 133.33 49.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.292 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -65.85 113.25 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.244 0.34 . . . . 0.0 110.172 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 33.2 m -92.76 -24.04 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.4 ' CB ' HD23 ' A' ' 78' ' ' LEU . . . 178.91 146.68 0.17 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.288 0.565 . . . . 0.0 111.29 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.408 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 4.7 mp -105.42 117.31 50.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 170.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 6.2 t -125.44 144.74 50.39 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.514 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.0 ptpt -143.1 163.0 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -84.59 136.35 33.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.261 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.43 -54.68 3.74 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.052 0.845 . . . . 0.0 112.322 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.507 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 34.5 t -89.33 141.03 28.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.294 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 3.5 Cg_exo -81.62 2.79 8.31 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.25 2.633 . . . . 0.0 112.107 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.2 t -122.99 -70.38 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.664 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -86.25 165.02 16.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.1 126.05 44.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.879 0.371 . . . . 0.0 110.223 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -124.16 -81.55 0.64 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.293 0.568 . . . . 0.0 110.016 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.44 168.91 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.69 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 24.0 mt -102.52 120.34 40.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.251 0.548 . . . . 0.0 110.784 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.67 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.9 mmpt? -102.26 105.65 16.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.809 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.666 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.7 m -104.58 149.77 25.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.956 0.408 . . . . 0.0 110.769 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -127.27 155.36 43.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.517 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.48 50.82 4.39 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.491 0.494 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 75' ' ' CYS . 87.7 mt -68.24 140.36 56.03 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.51 89.62 7.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.575 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.54 -88.16 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.01 0.82 11.77 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.993 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -82.42 126.17 31.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 m -146.81 -177.74 5.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.923 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.72 171.28 7.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.04 -140.79 5.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.256 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 178.85 5.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.844 0.354 . . . . 0.0 110.531 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 42.4 m -110.6 142.61 42.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 24.6 p -141.27 -159.32 0.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.594 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 22.2 t70 63.06 -82.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.948 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -70.97 -36.02 61.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.211 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 23' ' ' CYS . 12.9 mt -89.46 -55.32 3.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.23 0.538 . . . . 0.0 111.729 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -73.38 -76.99 0.11 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.62 -171.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 m -152.57 -61.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.262 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 89' ' ' ASP . . . -178.15 172.62 45.14 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.5 p -141.1 -87.31 0.17 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.831 0.824 . . . . 0.0 110.59 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.429 ' H ' ' H ' ' A' ' 97' ' ' GLY . 11.7 p 174.12 -15.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.171 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 96' ' ' VAL . . . 105.46 35.75 3.01 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.212 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.532 ' HA ' HG22 ' A' ' 36' ' ' THR . 31.0 t . . . . . 0 C--O 1.252 1.221 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -173.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.641 0.258 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.3 m-85 -64.39 113.99 4.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 69' ' ' HIS . 1.9 p -101.26 139.75 21.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.322 -172.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 1.01 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.0 pt20 -96.08 144.81 26.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HA ' HG21 ' A' ' 90' ' ' VAL . 10.8 p -150.07 142.43 24.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 111.796 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.887 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.6 OUTLIER -73.43 110.59 7.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.016 175.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.83 116.11 16.21 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.412 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 11.4 m-70 -86.62 131.18 34.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.873 0.368 . . . . 0.0 111.132 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.445 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -98.51 125.46 43.73 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -104.12 125.67 50.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.366 0.603 . . . . 0.0 111.235 -172.38 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -98.53 150.79 21.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -53.38 100.38 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.662 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.91 -58.85 0.58 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.684 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -142.58 170.81 15.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.369 0.604 . . . . 0.0 112.317 -171.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 134.48 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.866 172.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -101.59 -55.85 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.897 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.99 175.14 42.28 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.7 t -154.28 145.79 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.278 0.539 . . . . 0.0 111.424 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.507 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.0 mp -126.78 125.1 66.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 47.2 ttp180 -88.67 98.07 11.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.5 mmtp -126.05 153.8 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 1.01 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 32.9 mtpt -66.24 161.93 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.228 0.537 . . . . 0.0 111.482 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -59.92 142.78 53.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.763 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 89.78 -28.19 7.35 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.465 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.529 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 55.1 m95 -75.87 115.27 15.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.572 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.929 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.11 115.43 16.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.042 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.2 p -103.75 154.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.34 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.53 134.09 37.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 111.346 -177.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.72 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 88.7 m-85 -120.37 128.38 53.18 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HB3' HD23 ' A' ' 58' ' ' LEU . 36.7 p90 -143.78 152.1 40.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.299 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 7.1 pt-20 -94.72 137.53 33.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.354 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -126.78 100.37 6.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 31.8 mttp -95.66 154.08 39.26 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.02 116.36 3.12 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 121.994 1.796 . . . . 0.0 111.639 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 -11.59 66.39 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.873 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -110.12 126.34 29.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.769 -0.254 . . . . 0.0 110.474 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 31.7 Cg_exo -63.06 154.87 64.44 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.041 2.494 . . . . 0.0 112.765 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -62.11 126.92 29.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.181 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -130.39 142.74 50.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.816 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.785 HD13 HD11 ' A' ' 61' ' ' ILE . 16.6 mt -70.32 130.07 41.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 -175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.09 -18.0 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.393 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -176.63 138.29 0.28 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.514 0.673 . . . . 0.0 111.633 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -108.81 111.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.7 t -132.39 146.12 51.73 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.687 -168.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.929 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 27.5 pttt -145.6 164.56 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.651 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 9.0 t30 -77.33 134.37 38.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.75 -56.78 1.67 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.455 1.097 . . . . 0.0 112.706 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 40.6 t -92.0 136.75 25.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 69.3 Cg_endo -75.42 -1.52 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.404 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.9 t -112.42 -72.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 66' ' ' SER . 39.6 m80 -98.01 164.47 12.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.424 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.0 t -97.63 132.72 43.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -132.1 -81.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -138.26 175.7 9.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.498 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 31.3 mt -103.72 129.5 51.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.69 109.95 21.25 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m -114.44 149.15 36.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.53 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -124.76 159.99 29.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.174 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 68.36 40.13 2.1 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.407 0.442 . . . . 0.0 111.642 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' A' ' 75' ' ' CYS . 96.5 mt -66.73 126.69 29.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.887 0.375 . . . . 0.0 110.971 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -95.41 68.79 3.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.585 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.47 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.366 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.3 -16.32 64.77 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.971 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 99.2 m-85 -86.99 109.29 19.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.085 0.469 . . . . 0.0 110.39 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.4 m -147.72 168.29 22.48 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.611 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.76 161.53 13.6 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.472 -175.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.31 -79.28 0.76 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.218 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.9 t -155.77 -169.52 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 30.1 m -130.58 144.75 51.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.645 0.259 . . . . 0.0 110.309 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 58.3 p -138.34 -154.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.936 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.542 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 36.2 t70 63.58 -78.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.25 1.02 . . . . 0.0 112.548 173.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.9 OUTLIER -68.03 -42.84 85.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.793 0.33 . . . . 0.0 111.662 -175.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.0 pp -89.66 -31.39 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.597 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 t -87.44 -40.28 14.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.027 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.3 t 60.54 90.38 0.06 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.236 0.541 . . . . 0.0 111.061 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.56 43.66 0.53 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.184 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.426 HG21 ' HB ' ' A' ' 88' ' ' THR . 53.9 p -133.38 -179.34 5.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -118.41 134.5 61.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.967 172.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -100.56 -89.54 2.04 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.253 1.248 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.307 173.526 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.1 p90 -57.09 142.08 43.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.402 174.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.29 141.33 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.709 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.2 pt20 -94.39 143.0 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.709 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 20.0 p -147.53 145.5 29.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.037 0.446 . . . . 0.0 110.901 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.981 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.02 113.05 11.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 174.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.505 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 1.3 m80 -78.4 117.63 19.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -85.42 134.69 34.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.019 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -101.09 122.9 44.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.423 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -101.07 122.04 42.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.697 0.76 . . . . 0.0 110.862 -177.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 65.9 t80 -94.24 150.95 19.83 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.75 100.15 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.47 -58.45 0.71 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.255 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -159.71 179.96 8.4 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -52.44 131.51 33.66 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.764 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.808 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.4 t90 -101.57 -55.84 2.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.314 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.23 179.03 38.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.1 t -154.32 143.74 21.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.187 0.493 . . . . 0.0 111.164 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.586 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.5 mp -123.42 122.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 42.3 ttp180 -83.44 105.65 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.17 0.509 . . . . 0.0 110.741 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.586 ' HG2' HG22 ' A' ' 37' ' ' ILE . 70.1 mmtt -127.11 152.96 46.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.536 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 38.9 mtpt -80.22 149.97 30.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.631 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.09 136.18 57.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 111.297 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.47 -17.76 46.16 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -91.38 130.93 37.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.73 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.93 122.89 26.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.5 p -107.58 147.81 12.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.873 0.368 . . . . 0.0 110.483 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -98.44 135.95 39.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.0 111.154 -177.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CG ' HD23 ' A' ' 27' ' ' LEU . 74.8 m-85 -123.89 131.02 53.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.193 173.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HD2' ' HB3' ' A' ' 56' ' ' LYS . 36.0 p90 -143.74 149.64 37.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.194 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.4 ' HB3' HG11 ' A' ' 59' ' ' VAL . 9.0 pt-20 -95.21 142.97 27.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 10.4 pt-20 -130.07 102.2 6.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.726 0.774 . . . . 0.0 110.199 172.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.5 124.84 56.07 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.45 117.82 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.583 2.855 . . . . 0.0 113.303 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.77 22.51 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.377 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.49 148.32 34.37 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.592 0.357 . . . . 0.0 110.735 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.0 151.84 82.9 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.903 2.402 . . . . 0.0 112.153 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 26.9 mttm -76.63 136.06 39.17 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.899 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -123.89 135.92 54.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.613 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.82 118.8 12.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.2 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 16.1 m -104.7 -19.16 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.39 136.21 0.59 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.651 0.739 . . . . 0.0 112.349 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.28 112.87 42.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 166.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.8 t -132.14 150.46 52.15 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 -168.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -150.1 163.59 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.838 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 32.6 t30 -73.02 150.55 42.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.989 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.41 -52.5 28.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.542 0.526 . . . . 0.0 111.692 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -108.78 139.12 20.57 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.066 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.23 12.74 1.21 Allowed 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.772 2.315 . . . . 0.0 113.149 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.7 t -128.01 -78.8 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.762 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -90.59 156.94 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.838 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 31.5 t -97.74 137.03 37.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.854 0.359 . . . . 0.0 110.992 -172.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -133.49 -76.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -134.28 164.75 26.69 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.461 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.67 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.3 mt -103.82 124.32 48.7 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.13 105.75 16.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.17 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 19.0 m -102.93 155.18 18.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.816 -175.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.9 t -136.37 154.71 50.75 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.5 m120 65.81 46.35 2.33 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.736 0.648 . . . . 0.0 111.279 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.9 mt -64.3 155.62 31.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 111.425 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.193 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.39 -90.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.287 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.49 -15.1 78.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.769 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.1 m-85 -89.12 120.44 30.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 110.332 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.47 ' HA ' HD22 ' A' ' 78' ' ' LEU . 22.9 m -147.34 172.75 13.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.622 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -109.87 174.93 5.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.158 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -142.48 -175.35 15.64 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.068 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -66.57 172.45 4.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.0 111.495 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 15.5 p -110.33 144.0 39.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.71 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.5 p -140.7 -154.84 0.54 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 111.461 -174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.981 ' HB3' HD21 ' A' ' 24' ' ' ASN . 19.4 t70 69.9 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.032 169.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.64 -38.05 57.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.616 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.87 -30.03 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 p -94.73 -76.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.606 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 t -158.4 -54.54 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.669 0.271 . . . . 0.0 110.589 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 89' ' ' ASP . . . 173.4 138.66 2.69 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.47 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 89' ' ' ASP . 7.7 p -140.04 21.77 2.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.957 0.408 . . . . 0.0 110.492 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.6 t 68.48 -72.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.418 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.55 -131.64 4.92 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.874 178.043 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.479 0.181 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -79.05 140.58 37.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 70' ' ' CYS . 2.3 p -145.4 136.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.245 -175.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.667 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -100.87 155.14 18.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.516 175.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 16.9 p -154.85 152.44 29.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.212 0.53 . . . . 0.0 111.681 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -75.05 111.19 10.02 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 109.503 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.83 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 9.7 m80 -72.19 121.03 18.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.403 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -84.17 136.54 33.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.584 -174.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.596 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -109.89 122.98 48.78 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 165.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -106.02 122.08 45.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.287 0.565 . . . . 0.0 110.504 -176.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.13 143.94 26.17 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -50.43 101.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.537 0.523 . . . . 0.0 110.463 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.6 -53.34 0.81 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.146 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 22.8 tpt180 -165.09 160.02 18.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.085 0.442 . . . . 0.0 111.77 -175.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -42.83 127.83 4.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -99.51 -56.72 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.323 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.63 178.32 39.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.975 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 26' ' ' HIS . 5.8 t -153.8 138.41 16.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.951 0.375 . . . . 0.0 110.704 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.31 135.98 55.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.199 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.3 tpp85 -73.81 110.21 7.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.788 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 16.7 tppt? -143.89 128.57 18.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.563 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 18.6 ptmt -72.3 153.64 41.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.222 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -63.66 142.75 58.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 94.26 -17.27 59.23 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.645 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 44.3 m95 -105.36 142.91 34.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 0.0 110.66 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.64 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -80.17 140.63 36.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.63 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.788 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.9 p -126.89 148.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.85 0.357 . . . . 0.0 110.543 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.76 143.55 27.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.83 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 63.5 m-85 -128.35 135.88 50.19 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 53.0 p90 -151.1 156.49 41.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.869 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' ' 51' ' ' LYS . 14.9 pt-20 -107.38 134.93 49.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 168.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.0 102.25 10.74 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.229 0.537 . . . . 0.0 110.67 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HE2' ' OE1' ' A' ' 49' ' ' GLU . 67.6 mttm -85.23 125.48 69.96 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.672 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 86.9 Cg_exo -48.02 117.64 2.63 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.332 2.688 . . . . 0.0 113.573 -173.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.37 -14.24 62.37 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.559 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -113.05 158.11 38.85 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.543 0.211 . . . . 0.0 110.438 -176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.55 161.9 41.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.665 2.243 . . . . 0.0 111.118 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -74.71 138.38 42.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.056 0.455 . . . . 0.0 110.728 -176.115 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 20.4 tpp180 -99.52 123.55 43.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.069 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.34 107.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.997 0.427 . . . . 0.0 110.55 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -95.16 -18.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -173.57 138.7 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.505 0.669 . . . . 0.0 111.904 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.62 112.13 38.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.845 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 12.0 t -134.9 154.02 51.83 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.982 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -150.21 162.36 40.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -83.85 135.86 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.718 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.33 -51.9 6.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.079 0.862 . . . . 0.0 112.868 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 46.0 t -94.77 139.18 22.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.265 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 80.1 Cg_endo -79.13 2.69 8.08 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 111.744 173.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.2 -79.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.589 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' ' 66' ' ' SER . 67.5 m80 -89.65 165.38 14.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.472 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 21' ' ' VAL . 74.8 m -98.72 124.92 43.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.29 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 61.5 m-20 -124.22 -85.52 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 110.227 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 93.9 m-85 -130.43 174.14 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.949 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.845 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.6 mt -109.36 132.21 54.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.626 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -101.19 104.51 15.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.744 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.6 m -116.41 144.87 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.967 0.413 . . . . 0.0 110.597 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -126.46 159.63 32.8 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 6.2 t30 59.83 71.59 0.57 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 -175.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 83' ' ' SER . 96.4 mt -91.66 128.79 37.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -92.33 73.92 5.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.674 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.62 -93.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.468 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.07 0.85 73.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.923 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 96.5 m-85 -101.16 108.89 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 0.0 110.474 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 78' ' ' LEU . 41.7 m -138.39 169.35 17.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -101.24 163.76 12.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.283 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.83 -175.68 14.8 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.669 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 13.6 t -61.77 159.02 14.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.567 0.698 . . . . 0.0 111.234 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 7.0 p -91.17 144.67 25.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.479 -168.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.613 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 40.0 p -131.64 -158.45 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.803 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.474 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 25.2 t70 70.83 -85.04 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.411 1.084 . . . . 0.0 111.707 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 90' ' ' VAL . 1.7 m -67.45 -46.94 82.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.94 -27.8 20.7 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.725 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' A' ' 88' ' ' THR . 5.9 t -76.96 -54.03 7.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.069 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 t 68.12 115.0 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.422 0.63 . . . . 0.0 110.372 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.86 35.15 5.2 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -173.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -144.33 148.81 35.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.699 -0.75 . . . . 0.0 110.445 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.28 114.47 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 89' ' ' ASP . . . -136.21 178.31 18.88 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.851 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.793 178.561 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 82.5 m-85 -78.9 139.94 38.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.46 138.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.398 0.618 . . . . 0.0 111.819 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.821 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 3.8 pp0? -106.47 145.84 31.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.421 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.707 ' HA ' HG21 ' A' ' 90' ' ' VAL . 18.0 p -148.66 150.44 33.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.501 0.667 . . . . 0.0 112.314 -174.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.973 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -72.24 112.84 8.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.958 174.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.832 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 14.6 m80 -80.68 108.81 14.64 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.615 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.562 ' HD2' ' HA ' ' A' ' 87' ' ' SER . 43.5 m-70 -83.72 125.33 31.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.774 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.7 tm? -98.2 134.08 41.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.589 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -104.73 116.7 32.49 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.563 0.697 . . . . 0.0 110.903 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.728 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 71.6 t80 -95.19 145.42 25.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.954 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -57.75 99.76 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.856 0.36 . . . . 0.0 110.287 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.76 -43.57 1.26 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.68 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -175.06 166.06 3.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.092 0.446 . . . . 0.0 111.337 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -43.42 127.03 4.54 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.553 0.741 . . . . 0.0 111.596 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.728 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 48.9 t-105 -99.68 -57.65 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.636 -175.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.73 177.49 39.56 Favored Glycine 0 C--N 1.328 0.137 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.278 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -152.85 133.11 13.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.143 0.497 . . . . 0.0 111.328 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.6 mp -120.33 134.6 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.53 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -80.05 104.93 10.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.562 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 3.7 tppp? -138.85 145.01 39.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.821 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.5 mtpt -68.32 148.94 50.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.424 ' HB1' ' OD1' ' A' ' 64' ' ' ASN . . . -65.55 136.61 56.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.9 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.797 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 97.14 -26.18 23.85 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.068 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -89.19 130.83 35.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.924 0.392 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.736 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.99 126.64 30.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.201 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.2 p -116.41 145.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.41 145.21 30.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.148 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.832 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 76.7 m-85 -134.79 145.33 48.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 56' ' ' LYS . 31.5 p90 -148.61 163.39 37.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.199 0.523 . . . . 0.0 111.585 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.32 134.53 51.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.381 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' H ' ' HZ2' ' A' ' 34' ' ' TRP . 10.8 pt-20 -109.57 113.79 26.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.391 0.615 . . . . 0.0 110.399 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 33.6 mmtp -108.31 125.51 31.75 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.432 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.53 126.87 23.93 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.32 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.5 -9.56 64.35 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.297 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 40.8 mt-30 -122.38 159.12 53.87 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.365 0.266 . . . . 0.0 110.733 -175.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.25 156.65 58.79 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.765 2.31 . . . . 0.0 111.967 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . 9.7 pttp -88.21 138.86 31.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -117.45 123.63 46.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.929 -172.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.45 106.6 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.44 -30.08 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . . . -174.07 144.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.199 0.523 . . . . 0.0 111.338 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 4.6 mp -102.07 113.72 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.71 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -118.96 148.69 42.69 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.187 -171.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 13.9 pttp -157.1 164.32 38.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.341 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.64 HD22 ' H ' ' A' ' 71' ' ' ASN . 4.6 t-20 -81.83 152.02 27.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.408 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.23 -48.88 67.82 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.552 0.532 . . . . 0.0 111.362 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -105.57 137.54 19.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.818 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.797 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 78.1 Cg_endo -80.96 10.37 3.41 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.742 2.294 . . . . 0.0 112.518 175.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.0 t -113.98 -82.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.11 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -90.28 158.45 17.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.593 ' HA ' ' OD1' ' A' ' 64' ' ' ASN . 38.6 t -98.5 127.32 44.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.64 ' H ' HD22 ' A' ' 64' ' ' ASN . 31.5 m-80 -116.39 -87.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -134.53 171.79 13.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 39.2 mt -103.43 120.54 41.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.105 0.479 . . . . 0.0 112.056 -173.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -102.91 109.29 20.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.155 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.678 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.9 m -103.21 146.53 28.28 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.481 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -120.45 155.29 33.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.152 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 56.68 55.24 6.51 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.664 0.603 . . . . 0.0 110.184 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.6 mt -67.74 149.48 49.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.76 94.67 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.51 -85.56 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.628 0.58 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.45 4.64 6.26 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.02 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.88 120.71 25.06 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.9 t -151.84 178.17 9.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.469 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.71 159.84 14.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.199 -177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.55 -64.38 0.38 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.006 -171.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 t -164.91 -169.62 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.006 0.403 . . . . 0.0 110.586 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 5.0 p -143.73 144.25 31.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.263 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 37.6 p -139.61 -155.22 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.731 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.973 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.7 t70 64.61 -76.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.465 0.706 . . . . 0.0 112.377 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -70.94 -44.36 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.15 -23.34 22.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.095 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.5 t -84.53 -77.24 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.77 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.2 t 174.88 -60.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.97 131.33 2.45 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.526 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.0 p -144.73 124.9 13.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.629 0.215 . . . . 0.0 110.476 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.9 m -79.44 87.28 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.66 0.743 . . . . 0.0 110.546 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.06 -152.91 11.97 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.734 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.507 ' OXT' ' HB ' ' A' ' 36' ' ' THR . 11.5 p . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -64.18 149.14 48.44 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 69' ' ' HIS . 2.6 p -133.67 135.23 55.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.402 0.62 . . . . 0.0 111.488 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.767 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 3.3 pp0? -109.6 140.94 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.388 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 58.6 m -145.1 157.58 44.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.088 0.47 . . . . 0.0 111.994 -168.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.963 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -83.43 111.84 19.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 166.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -77.61 124.02 27.39 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.32 137.6 32.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.403 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -98.96 116.4 31.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 166.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.72 124.05 41.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.928 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -110.7 150.62 28.79 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -52.86 101.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.346 0.404 . . . . 0.0 110.492 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.17 -59.01 0.69 Allowed Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.32 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -162.58 166.76 24.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -49.87 119.58 3.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.767 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.538 ' HH2' ' H ' ' A' ' 50' ' ' GLU . 10.1 t90 -92.84 -55.57 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.968 0.413 . . . . 0.0 110.598 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.73 163.26 28.56 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.509 ' C ' HD12 ' A' ' 37' ' ' ILE . 6.0 t -154.26 140.22 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.224 0.512 . . . . 0.0 110.699 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 36' ' ' THR . 2.5 mp -124.39 126.97 72.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.745 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.9 mtm180 -79.13 110.31 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.502 . . . . 0.0 111.819 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HG3' HG22 ' A' ' 37' ' ' ILE . 62.2 mttm -146.52 137.29 24.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.155 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.0 ptmt -62.12 156.91 20.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.28 142.15 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.935 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.38 -40.7 2.33 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.523 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 56.9 m95 -75.14 141.94 43.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.137 0.494 . . . . 0.0 111.142 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.93 131.33 41.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.399 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.8 p -121.63 140.08 46.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.059 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.672 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -101.33 139.41 37.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.998 0.427 . . . . 0.0 110.541 -178.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.508 ' CG ' HD23 ' A' ' 27' ' ' LEU . 82.9 m-85 -120.43 139.08 53.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.301 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 30.5 p90 -147.44 154.04 40.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.934 0.397 . . . . 0.0 111.335 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -103.69 142.66 33.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.495 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.538 ' H ' ' HH2' ' A' ' 34' ' ' TRP . 7.6 pt-20 -93.89 104.16 16.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 73.1 mmtt -119.45 135.47 24.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.055 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 23.3 Cg_exo -63.9 117.51 4.5 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.028 2.485 . . . . 0.0 112.834 -175.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.45 64.76 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -107.69 149.96 39.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.942 0.401 . . . . 0.0 110.696 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.24 153.4 78.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.943 1.762 . . . . 0.0 109.323 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.594 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 34.7 mmtm -67.37 109.53 3.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.181 0.515 . . . . 0.0 109.899 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 18.7 tpp180 -80.67 126.11 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.817 -167.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 46' ' ' ARG . 11.1 mt -58.9 109.12 0.76 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.599 0.562 . . . . 0.0 110.649 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -93.78 -15.43 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.862 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.53 135.19 0.53 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.598 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.522 HD11 HD13 ' A' ' 58' ' ' LEU . 4.7 mp -107.7 113.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 166.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.2 t -133.63 159.54 40.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.998 -168.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.637 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -158.97 162.82 36.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 10.4 t30 -87.4 138.4 31.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.383 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -55.4 4.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.093 0.87 . . . . 0.0 112.655 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -99.89 146.41 31.84 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.049 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 94.7 Cg_endo -87.98 20.54 1.15 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.053 2.502 . . . . 0.0 112.714 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.57 -76.77 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.103 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.496 ' HA ' HG12 ' A' ' 21' ' ' VAL . 36.5 m-70 -92.22 164.28 13.61 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.54 122.43 44.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -116.51 -78.74 0.58 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.484 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.26 165.49 25.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.213 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.797 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.4 mt -105.03 124.74 50.06 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.457 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.57 105.37 15.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 2.1 m -111.54 151.46 28.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.364 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -128.95 161.74 29.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.521 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.39 41.09 5.98 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.567 0.542 . . . . 0.0 111.484 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -65.55 147.03 54.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.975 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -110.46 67.42 0.64 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.408 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.71 -89.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.859 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.85 -16.66 69.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.734 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.0 m-85 -85.17 107.05 17.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.234 0.54 . . . . 0.0 110.475 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.542 ' HA ' HD22 ' A' ' 78' ' ' LEU . 11.1 m -134.08 165.54 24.83 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.512 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -101.44 161.7 13.44 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.1 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 -164.04 9.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.846 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -69.34 -177.39 1.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.833 0.453 . . . . 0.0 111.338 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.61 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.2 p -122.03 151.75 40.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.928 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.566 ' HB ' ' CB ' ' A' ' 95' ' ' THR . 68.8 p -139.78 -157.4 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 110.739 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.963 ' HB3' HD21 ' A' ' 24' ' ' ASN . 35.3 t70 66.11 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.919 0.888 . . . . 0.0 112.111 172.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.83 -41.47 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -89.87 -40.97 12.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 88' ' ' THR . 9.3 m -77.13 -40.69 44.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -172.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.9 m 62.24 96.39 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.224 0.535 . . . . 0.0 111.145 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.13 36.65 2.29 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.566 ' CB ' ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -138.16 163.73 30.95 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.024 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.76 118.4 35.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.319 0.581 . . . . 0.0 111.231 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.88 85.75 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.338 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.978 -177.54 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 34.6 p90 -61.23 135.35 57.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.419 0.628 . . . . 0.0 110.921 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.4 142.71 40.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.869 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 1.6 pp0? -95.15 142.34 27.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 5.1 m -142.94 140.54 31.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.377 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.994 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -72.51 111.7 7.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 170.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 36' ' ' THR . 5.1 m80 -80.77 122.98 27.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.892 -177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -90.61 123.64 34.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.589 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.1 tm? -98.1 126.81 43.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.37 128.62 53.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.158 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.7 t80 -103.78 144.78 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -56.1 100.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.2 -56.6 0.63 Allowed Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.658 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.503 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 11.5 tpp180 -172.02 172.08 4.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.503 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 39.5 t-80 -47.62 135.92 10.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.194 0.598 . . . . 0.0 111.524 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.501 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 58.3 t90 -107.43 -55.76 2.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.119 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.12 164.02 30.76 Favored Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.282 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -146.53 130.69 17.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.984 0.421 . . . . 0.0 111.313 -177.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.7 mp -122.44 130.47 74.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.703 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 24.1 mtm180 -76.42 128.53 35.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.216 0.531 . . . . 0.0 110.671 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 45' ' ' VAL . 12.3 tppt? -148.86 152.15 35.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.654 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.5 mtpt -87.19 148.13 25.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.42 -174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.84 136.42 58.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.971 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.58 -20.9 47.47 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.992 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 65.1 m95 -101.63 137.51 39.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 110.227 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.608 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -81.21 145.6 30.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -112.9 156.3 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.0 177.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.25 130.23 50.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.138 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 97.5 m-85 -122.73 126.83 48.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -145.78 156.68 43.75 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.483 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.501 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 14.3 pt-20 -104.47 123.68 47.91 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.7 102.08 10.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.826 0.822 . . . . 0.0 109.937 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.3 121.64 52.8 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.666 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.82 116.38 2.13 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.029 2.486 . . . . 0.0 112.519 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.46 -28.13 14.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.21 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -107.92 148.78 38.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.85 152.49 77.22 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.382 2.055 . . . . 0.0 111.293 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.714 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -77.82 137.6 38.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.537 -175.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -112.93 137.49 51.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.989 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.82 109.07 5.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.456 0.473 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 15.7 m -94.05 -19.64 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.808 -176.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.28 142.18 0.59 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 112.139 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.91 112.35 40.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 165.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.795 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.3 t -130.78 150.02 52.15 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.955 -167.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 ptpt -145.03 163.03 35.47 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -77.1 138.22 39.39 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.557 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -40.62 -58.73 1.54 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.125 0.891 . . . . 0.0 112.628 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 30.0 t -94.04 138.2 22.72 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.201 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.2 -1.75 11.05 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.675 2.25 . . . . 0.0 111.701 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.3 t -103.37 -81.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.296 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 66' ' ' SER . 7.4 p80 -107.25 165.98 10.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.122 0.487 . . . . 0.0 111.204 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.405 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 1.6 p -94.27 124.24 38.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.099 -168.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -128.46 -83.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.092 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -130.44 173.82 10.47 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.202 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.795 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 29.0 mt -110.07 127.71 55.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.952 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.82 107.92 19.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.519 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -113.41 152.15 30.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -175.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -126.2 159.43 33.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.6 m120 62.46 40.32 10.98 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.935 0.494 . . . . 0.0 111.301 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.9 mt -62.04 135.12 57.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.859 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -92.68 41.81 1.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.227 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.31 -84.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.22 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.89 -18.6 76.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.758 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.859 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.9 m-85 -96.38 109.48 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' HD22 ' A' ' 78' ' ' LEU . 14.8 m -139.85 167.15 22.77 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.47 159.77 15.29 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.311 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.81 -95.08 1.85 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.929 -174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -138.97 -167.44 2.22 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 49.4 m -134.43 144.97 48.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.574 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 61.3 p -139.35 -157.03 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.815 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.994 ' HB3' HD21 ' A' ' 24' ' ' ASN . 31.9 t70 61.68 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.431 1.092 . . . . 0.0 112.277 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 90' ' ' VAL . 3.1 m -70.8 -20.91 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.745 0.307 . . . . 0.0 111.141 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.528 HD21 ' SG ' ' A' ' 23' ' ' CYS . 13.6 mt -89.1 -56.04 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.505 0.669 . . . . 0.0 111.201 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p -91.18 -32.07 15.94 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.418 -174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.3 m 69.37 -0.46 2.55 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.198 0.599 . . . . 0.0 112.045 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.58 23.35 20.23 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.574 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.7 OUTLIER -129.71 163.76 25.45 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.223 -0.489 . . . . 0.0 109.866 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.8 t -98.84 104.52 16.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.794 0.33 . . . . 0.0 110.83 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.92 144.75 43.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.958 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.784 -0.627 . . . . 0.0 110.291 -176.07 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 48.5 p90 -88.8 143.2 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.85 137.76 21.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.358 0.599 . . . . 0.0 111.798 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.844 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 8.6 pt20 -102.95 150.13 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.467 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.2 p -151.04 136.4 17.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.366 0.603 . . . . 0.0 111.936 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.854 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -76.63 106.28 8.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 172.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.41 ' CB ' ' HZ ' ' A' ' 47' ' ' PHE . 4.6 m80 -72.86 122.26 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.122 -174.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.404 ' HE2' ' C ' ' A' ' 98' ' ' SER . 19.6 m170 -82.21 126.46 32.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.037 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 27' ' ' LEU . 1.1 tm? -98.33 119.5 37.11 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.03 123.22 44.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.681 0.753 . . . . 0.0 111.425 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -101.63 148.38 25.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -57.27 99.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.26 0.35 . . . . 0.0 110.089 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.39 -57.58 0.59 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.484 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -168.84 170.62 9.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.153 0.477 . . . . 0.0 111.346 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -46.26 114.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.395 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.504 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 70.4 t90 -90.26 -55.92 3.41 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.825 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.24 169.67 36.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.669 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.59 HG21 ' HB2' ' A' ' 98' ' ' SER . 15.1 t -154.55 147.81 24.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 111.551 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.9 mp -127.08 128.13 70.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.854 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.9 ttp180 -87.62 116.0 25.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.705 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -150.29 149.04 29.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.844 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 40.4 mtpt -66.62 145.94 55.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.37 141.58 58.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 108.37 -28.03 12.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.832 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -96.42 145.98 25.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.011 0.434 . . . . 0.0 110.409 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -75.85 131.96 40.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -105.79 131.49 55.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 129.42 34.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.101 0.477 . . . . 0.0 110.199 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 87.8 m-85 -121.27 123.69 42.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.8 p90 -144.57 150.35 37.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.991 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 15.6 pt-20 -95.51 142.2 28.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.689 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 6.4 pt-20 -118.72 102.51 8.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.472 0.653 . . . . 0.0 110.451 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -110.23 122.73 37.88 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.93 116.72 2.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.78 2.32 . . . . 0.0 112.532 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.83 13.71 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.023 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -104.77 140.26 20.9 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 159.52 31.5 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.827 2.352 . . . . 0.0 111.602 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.65 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 24.8 mmtp -71.05 119.93 15.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.87 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -112.97 129.25 56.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.186 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.485 HD13 HD11 ' A' ' 61' ' ' ILE . 12.9 mt -62.49 126.63 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.974 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -113.46 -17.19 8.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.532 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.13 140.65 1.2 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.542 0.687 . . . . 0.0 111.873 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.485 HD11 HD13 ' A' ' 58' ' ' LEU . 4.7 mp -117.49 111.93 36.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 167.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.648 ' O ' HG23 ' A' ' 45' ' ' VAL . 6.8 t -129.03 147.52 50.9 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.552 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.9 ptpt -148.18 163.22 37.64 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.65 137.88 32.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.447 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -48.72 8.15 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.085 0.866 . . . . 0.0 112.538 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 38.5 t -97.45 140.69 22.16 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.751 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 98.5 Cg_endo -81.65 5.21 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.876 2.384 . . . . 0.0 112.532 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.2 t -123.94 -62.33 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.378 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 66' ' ' SER . 36.7 m-70 -95.29 156.29 16.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.812 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.7 t -99.03 121.55 41.11 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -119.13 -78.73 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -135.56 172.48 12.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.58 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 11.5 mt -102.93 120.56 40.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 0.0 110.532 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.2 mmpt? -100.87 103.67 14.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 8.4 m -106.51 155.51 19.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.67 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -142.57 165.91 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 55.22 45.71 25.25 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.763 0.664 . . . . 0.0 111.487 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 83' ' ' SER . 85.0 mt -68.19 144.98 54.73 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -99.18 58.53 1.11 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.931 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.3 -86.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.103 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.54 -22.89 68.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.632 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -86.29 112.02 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.51 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.1 m -136.97 169.2 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.635 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.19 167.58 9.73 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.003 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.16 -108.35 1.07 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.18 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -115.32 -169.04 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.633 0.254 . . . . 0.0 110.531 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.6 m -135.7 143.52 45.45 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.499 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 12.1 p -139.83 -144.06 0.17 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -172.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.48 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.201 1.0 . . . . 0.0 113.498 174.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.596 HG23 HD23 ' A' ' 91' ' ' LEU . 3.2 m -70.42 -45.08 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 HG23 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -89.84 -37.75 14.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.671 0.272 . . . . 0.0 111.33 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t -90.02 -55.81 3.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.898 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.6 t 70.14 153.54 0.11 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.594 0.559 . . . . 0.0 111.058 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.69 19.13 66.5 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.499 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 1.3 m -97.41 137.65 36.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.267 -0.467 . . . . 0.0 110.629 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.54 115.38 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.077 0.465 . . . . 0.0 110.209 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.88 -132.85 14.3 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.59 ' HB2' HG21 ' A' ' 36' ' ' THR . 19.4 m . . . . . 0 C--O 1.246 0.903 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 68' ' ' VAL . 15.4 m . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.579 0.228 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.7 m-85 -87.49 148.46 24.92 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.021 0.439 . . . . 0.0 110.247 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -144.75 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.819 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.765 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 3.5 pp0? -113.99 143.38 44.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.692 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.671 ' HA ' HG21 ' A' ' 90' ' ' VAL . 8.1 p -152.76 155.45 37.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.106 0.479 . . . . 0.0 112.091 -173.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -80.88 113.34 19.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.816 175.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.416 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 32.3 m170 -79.76 121.12 24.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.53 132.2 35.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.918 0.39 . . . . 0.0 111.492 -174.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -99.94 129.27 46.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.443 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -108.44 123.45 48.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.282 0.563 . . . . 0.0 110.543 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 29.9 t80 -102.2 149.78 23.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.59 100.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.69 -56.91 0.72 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.364 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -159.8 178.49 9.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 111.452 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -61.47 129.56 41.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.323 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.1 t90 -90.83 -55.75 3.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.88 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.21 -179.4 44.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.831 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.0 t -153.69 146.0 23.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.16 0.48 . . . . 0.0 111.348 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.484 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.7 mp -129.0 127.35 65.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.7 ttp180 -86.6 111.98 21.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.015 0.436 . . . . 0.0 110.413 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HG2' HG22 ' A' ' 37' ' ' ILE . 37.9 mmtm -141.02 153.76 45.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.792 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.765 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 50.3 mtpt -69.98 155.91 39.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.744 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.16 141.39 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.831 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.847 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 89.73 -22.14 26.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.964 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 92.1 m95 -91.86 130.71 37.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.461 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -68.11 130.66 43.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.8 p -113.8 151.04 15.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.351 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -104.67 137.38 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.195 0.522 . . . . 0.0 111.407 -175.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.11 120.76 32.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.609 ' HE2' ' HD3' ' A' ' 56' ' ' LYS . 49.3 p90 -151.19 146.12 25.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -87.0 129.0 35.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 109.973 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.792 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -106.3 132.67 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.501 177.022 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 32.9 mmtm -131.82 113.3 15.08 Favored Pre-proline 0 C--N 1.315 -0.932 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.03 117.52 3.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.177 2.585 . . . . 0.0 113.053 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.32 -4.21 86.23 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.453 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -118.88 158.32 48.05 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 122.666 0.387 . . . . 0.0 109.976 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.29 154.69 65.41 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.437 2.091 . . . . 0.0 112.342 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.792 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 74.9 mttt -106.55 150.61 25.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.471 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -130.4 137.17 49.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.529 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 61' ' ' ILE . 8.5 mt -69.85 115.44 9.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.529 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 20.8 m -85.7 -21.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.99 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.498 ' HB2' HD23 ' A' ' 78' ' ' LEU . . . 176.85 140.81 0.07 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-O 121.589 0.709 . . . . 0.0 111.794 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 58' ' ' LEU . 4.6 mp -102.07 115.37 43.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.5 t -131.93 152.76 50.88 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.388 -169.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.662 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.3 ptpp? -153.14 163.27 40.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -81.04 135.56 35.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.4 -59.25 2.2 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.048 0.843 . . . . 0.0 112.624 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.7 t -87.17 135.22 35.12 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.213 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.847 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 4.0 Cg_exo -78.78 2.12 8.49 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.385 2.723 . . . . 0.0 112.059 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.0 t -119.06 -64.48 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.035 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' SER . 44.1 m80 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.039 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t -100.01 128.29 46.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -123.06 -82.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.298 0.57 . . . . 0.0 109.689 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.35 178.26 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.005 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.746 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 26.7 mt -103.48 124.56 48.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.894 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -109.19 107.21 17.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.297 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -110.4 149.74 29.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.075 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -124.27 155.51 38.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.6 t30 60.74 53.53 3.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.526 0.679 . . . . 0.0 110.152 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 75' ' ' CYS . 85.1 mt -72.95 139.34 46.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.298 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.893 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -91.56 45.29 1.22 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.583 0.23 . . . . 0.0 110.946 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 56.77 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.666 0.786 . . . . 0.0 112.054 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.72 -15.29 61.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.137 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.893 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.5 m-85 -99.64 106.69 18.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.015 0.436 . . . . 0.0 110.253 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.504 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.8 m -129.02 167.03 18.07 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.624 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -108.33 154.56 21.64 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.198 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.09 -126.57 3.42 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.06 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 p -96.82 -168.41 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.391 0.615 . . . . 0.0 111.814 -174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 49.7 m -136.33 141.53 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.024 172.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 25.4 p -142.28 -156.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.331 -174.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' H ' ' HB ' ' A' ' 88' ' ' THR . 32.6 t70 63.86 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.615 0.766 . . . . 0.0 112.157 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.671 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -66.88 -41.55 87.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.32 -24.88 20.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.77 0.319 . . . . 0.0 111.056 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 89' ' ' ASP . 47.1 t -86.53 -77.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.762 -176.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.3 p -173.85 -69.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.147 0.499 . . . . 0.0 110.119 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.06 96.79 0.12 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p -120.62 33.45 5.58 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.388 -0.125 . . . . 0.0 111.297 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 t 61.0 70.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.762 0.791 . . . . 0.0 109.608 -173.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.0 146.68 18.35 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.246 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.06 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 51.6 p90 -89.91 146.25 24.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.72 140.04 21.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.335 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.806 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 12.4 pt20 -104.43 150.12 24.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.613 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.59 ' HA ' HG21 ' A' ' 90' ' ' VAL . 9.2 p -154.48 155.56 35.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.356 0.598 . . . . 0.0 111.399 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 89' ' ' ASP . 0.7 OUTLIER -76.74 108.98 10.14 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.62 118.69 19.52 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.405 ' CD2' HD21 ' A' ' 24' ' ' ASN . 14.4 m-70 -88.41 126.4 35.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 1.1 tm? -99.87 121.21 40.96 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 130.01 54.02 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.554 0.692 . . . . 0.0 111.497 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -106.95 151.17 25.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.743 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.33 100.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.313 0.383 . . . . 0.0 110.16 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' ARG . . . 138.58 -51.69 0.76 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.941 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 7.5 tpp180 176.49 179.56 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.452 0.301 . . . . 0.0 110.249 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.665 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.6 t-80 -41.05 130.98 2.64 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.722 0.809 . . . . 0.0 111.966 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 39.4 t90 -104.61 -53.9 2.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.75 164.88 34.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.189 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.26 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.506 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.488 ' HB ' HG21 ' A' ' 45' ' ' VAL . 2.3 mp -115.65 132.38 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.67 98.74 4.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.78 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.24 148.95 43.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 110.407 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 51.3 mtpt -64.52 153.36 39.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.47 139.56 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.564 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.967 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 92.49 -38.85 3.09 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.023 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -66.58 125.39 25.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.5 122.58 22.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.51 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.4 p -109.39 147.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.085 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 134.35 40.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.354 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 27' ' ' LEU . 90.2 m-85 -122.05 127.3 50.05 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.7 147.98 30.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.596 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 9.4 pt-20 -86.94 130.36 34.49 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.913 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 47.5 mt-10 -108.23 102.29 11.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.266 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.856 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 34.4 mmtp -99.36 129.69 28.66 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.415 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 116.36 3.27 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.349 2.033 . . . . 0.0 112.265 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.65 90.42 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 53.8 mt-30 -125.71 157.36 68.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 C-N-CA 122.381 0.272 . . . . 0.0 110.343 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.26 160.69 48.13 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.393 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 55.1 mttt -103.55 136.64 42.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.337 -173.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -132.91 135.77 45.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.677 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.5 119.93 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.558 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 32.2 m -92.69 -27.01 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.466 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.699 ' HB1' ' SG ' ' A' ' 75' ' ' CYS . . . 177.7 144.25 0.1 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.727 0.642 . . . . 0.0 111.261 173.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.1 mp -102.93 111.93 34.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.7 m -116.96 146.49 42.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.932 0.396 . . . . 0.0 111.136 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.917 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.5 pttm -155.13 161.56 41.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 9.0 t30 -80.19 143.21 33.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.301 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.2 -57.04 3.14 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.062 0.852 . . . . 0.0 112.044 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.7 m -94.74 138.77 22.12 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.406 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.967 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.5 Cg_endo -82.98 23.52 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.143 2.562 . . . . 0.0 112.008 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 4.0 t -136.34 -73.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.68 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -85.13 159.92 20.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.13 125.71 48.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.985 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -123.64 -79.34 0.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.27 174.45 10.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 85' ' ' GLY . 50.1 mt -101.28 122.51 43.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.464 0.65 . . . . 0.0 111.381 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.778 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.6 mmpt? -93.59 106.91 18.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.356 172.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.699 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 8.1 t -121.58 166.1 14.71 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.298 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.4 t -159.94 162.19 34.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.073 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.3 m120 68.67 33.56 3.78 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.78 0.675 . . . . 0.0 110.256 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.892 HD22 ' HA ' ' A' ' 83' ' ' SER . 93.1 mt -59.86 139.58 57.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -97.55 65.09 1.87 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.0 111.484 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.84 -88.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.151 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.19 -21.8 77.38 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.898 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -88.43 109.66 20.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.937 0.398 . . . . 0.0 110.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.892 ' HA ' HD22 ' A' ' 78' ' ' LEU . 17.0 m -128.54 173.62 10.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.58 158.79 19.53 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.69 -0.631 . . . . 0.0 110.667 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -123.11 -151.14 8.22 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.19 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -84.15 -176.69 6.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.855 0.359 . . . . 0.0 110.186 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 39.1 m -120.72 142.94 49.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.46 HG21 HG21 ' A' ' 95' ' ' THR . 66.7 p -139.55 -156.04 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.731 0.301 . . . . 0.0 111.75 -170.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.502 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 21.9 t70 63.61 -77.03 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.99 0.916 . . . . 0.0 112.547 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.5 m -68.08 -46.61 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 23' ' ' CYS . 3.8 pp -90.7 -41.35 11.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.712 0.291 . . . . 0.0 111.648 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.411 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 t -78.08 -42.8 31.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -174.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.2 t 60.94 88.56 0.08 Allowed 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.514 0.509 . . . . 0.0 110.441 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 141.12 53.75 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.161 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.46 HG21 HG21 ' A' ' 88' ' ' THR . 6.5 p -148.41 178.71 8.37 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.375 0.27 . . . . 0.0 110.277 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.0 t -70.71 -73.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.43 177.37 48.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.251 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.248 0.99 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.475 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 79.7 m-85 -76.37 134.21 39.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 69' ' ' HIS . 2.3 p -135.57 136.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.388 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.786 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 4.5 pp0? -101.99 141.54 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.627 ' HA ' HG21 ' A' ' 90' ' ' VAL . 7.1 p -144.09 148.86 35.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.416 0.627 . . . . 0.0 112.105 -170.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.872 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -74.77 106.61 6.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.169 175.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.51 121.74 21.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.2 130.81 37.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.29 -174.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -100.2 124.13 45.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.409 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.98 125.65 49.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.253 0.549 . . . . 0.0 110.686 -176.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 50.9 t80 -113.32 151.27 31.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -53.34 100.92 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.715 0.634 . . . . 0.0 110.379 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -52.16 0.82 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.241 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 20.9 tpt180 -172.74 171.77 4.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.743 0.272 . . . . 0.0 110.822 -175.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.429 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 23.7 t-80 -46.31 121.38 3.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.325 0.65 . . . . 0.0 111.289 172.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 57.9 t90 -89.93 -56.14 3.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.99 170.8 34.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.563 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.6 t -154.42 143.92 21.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.09 0.445 . . . . 0.0 110.758 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.1 mp -127.11 130.23 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.637 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.2 mtm180 -82.32 117.83 22.7 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.362 0.601 . . . . 0.0 110.726 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG3' HG23 ' A' ' 45' ' ' VAL . 72.6 mmtt -142.52 152.61 42.82 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.3 mtpt -69.16 156.74 38.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.023 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 140.3 58.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.418 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.98 -25.1 12.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.228 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 49.8 m95 -83.13 130.05 35.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 0.0 110.634 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.916 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -79.03 123.38 27.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.705 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 39' ' ' LYS . 8.7 p -106.15 154.26 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.981 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.8 140.99 29.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.502 ' CG ' HD23 ' A' ' 27' ' ' LEU . 75.6 m-85 -131.33 123.68 28.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -142.14 149.85 40.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.933 0.397 . . . . 0.0 111.265 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 11.1 pt-20 -87.41 130.04 34.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.728 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 56' ' ' LYS . 29.8 mt-10 -114.04 101.91 9.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.152 0.501 . . . . 0.0 109.827 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 71.6 mmtt -82.9 134.74 46.24 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.896 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 52.3 Cg_exo -54.55 117.05 3.53 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.54 2.16 . . . . 0.0 112.358 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.06 80.55 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.482 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.797 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 31.3 mt-30 -115.67 162.04 27.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 122.498 0.319 . . . . 0.0 110.772 -175.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 54' ' ' GLN . 57.5 Cg_endo -70.95 159.2 53.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.88 2.387 . . . . 0.0 112.803 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.863 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.4 146.39 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 -178.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -137.63 131.65 31.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.49 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.22 119.6 7.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.012 0.434 . . . . 0.0 112.046 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.4 m -100.09 -15.71 7.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.396 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.32 135.77 0.58 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.581 0.705 . . . . 0.0 111.821 176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.74 112.29 39.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.77 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.1 t -131.53 149.72 52.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.728 -169.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.916 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 pttp -155.39 163.43 40.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.42 139.22 34.13 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.318 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.38 -55.71 4.78 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.818 0.698 . . . . 0.0 112.179 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.9 t -95.86 146.64 31.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.212 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 66' ' ' SER . 3.5 Cg_exo -82.45 -1.19 10.54 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.157 2.572 . . . . 0.0 111.972 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.7 t -103.96 -79.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.405 ' HA ' HG12 ' A' ' 21' ' ' VAL . 65.7 m80 -94.27 165.04 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.155 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.1 121.97 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -119.55 -85.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.275 0.56 . . . . 0.0 109.593 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -126.31 166.34 17.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.914 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.77 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 14.2 mt -102.99 123.39 46.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.0 110.638 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.713 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -98.88 104.65 16.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.808 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -112.84 146.1 39.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.427 . . . . 0.0 110.658 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -129.23 155.45 45.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.874 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.4 60.2 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.691 0.619 . . . . 0.0 110.37 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.3 mt -77.6 157.91 30.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.364 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -115.46 71.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.743 0.306 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.96 -92.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.171 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.16 55.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.994 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.6 m-85 -72.65 109.56 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.314 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.592 ' HA ' HD22 ' A' ' 78' ' ' LEU . 19.6 m -140.97 166.71 24.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.56 168.49 9.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.045 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -139.0 -171.49 12.19 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.049 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -69.16 169.77 11.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.463 0.649 . . . . 0.0 111.622 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.4 m -105.76 153.84 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.669 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.5 p -139.88 -156.44 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.047 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.872 ' HB3' HD21 ' A' ' 24' ' ' ASN . 4.1 t70 62.61 -80.17 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.643 HG23 HD23 ' A' ' 91' ' ' LEU . 1.3 m -66.06 -41.62 89.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.222 -175.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.643 HD23 HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.464 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m -95.53 -77.46 0.47 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.8 t -159.29 -59.31 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 110.824 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.55 ' N ' ' HA ' ' A' ' 89' ' ' ASP . . . 167.68 136.17 2.0 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.0 p -135.58 137.71 42.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.916 0.358 . . . . 0.0 111.21 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.38 164.75 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.003 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.89 -41.03 1.49 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.608 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.168 177.707 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 17.8 p90 -58.5 131.15 49.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.284 0.564 . . . . 0.0 110.589 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.35 139.78 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.92 -170.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.68 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -99.7 143.34 30.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.659 175.083 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.54 ' CB ' HD23 ' A' ' 91' ' ' LEU . 7.5 p -151.72 159.19 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.886 0.374 . . . . 0.0 111.463 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.6 OUTLIER -82.16 117.25 22.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.42 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 21.8 m170 -85.16 119.44 25.55 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.414 ' CD2' HD21 ' A' ' 24' ' ' ASN . 12.1 m170 -90.57 130.37 36.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.829 0.347 . . . . 0.0 111.206 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.532 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -98.1 126.1 43.39 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -110.02 116.53 31.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.575 0.703 . . . . 0.0 110.68 -175.405 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -94.95 135.12 36.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.8 101.92 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.446 0.641 . . . . 0.0 110.281 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.73 -56.29 0.61 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.607 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -175.4 161.69 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.492 0.317 . . . . 0.0 110.727 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -37.86 132.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.908 0.883 . . . . 0.0 112.195 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -100.79 -54.8 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.593 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.99 -179.33 40.49 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.338 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -153.83 147.7 25.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.031 0.416 . . . . 0.0 111.354 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.4 mp -134.02 136.6 53.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 46.0 mtm180 -77.71 130.17 36.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.294 0.568 . . . . 0.0 111.36 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -150.39 148.22 28.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.542 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.68 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 46.6 mtpt -73.97 149.94 41.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.069 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -61.6 138.92 58.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 93.75 -23.7 29.53 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.143 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -101.44 136.16 41.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.824 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -82.57 155.07 24.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.495 0.664 . . . . 0.0 111.117 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.6 p -126.92 150.19 32.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.585 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 135.77 33.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.421 . . . . 0.0 111.301 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.709 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.2 m-85 -125.9 128.27 47.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 169.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 49.9 p90 -146.18 153.75 40.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.396 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -100.04 136.64 39.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -115.68 110.85 19.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.567 0.699 . . . . 0.0 111.474 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.2 105.28 42.39 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -44.29 121.63 3.24 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.324 2.682 . . . . 0.0 112.683 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.27 -24.15 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.65 151.43 57.08 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.004 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.72 149.25 54.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.227 1.952 . . . . 0.0 111.049 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 51.8 mttt -77.24 119.0 20.29 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.823 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 19.5 tpp180 -94.1 133.77 37.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.356 -168.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.29 107.78 0.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.195 0.522 . . . . 0.0 110.28 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.2 m -91.56 -22.71 6.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.295 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -168.68 135.53 1.9 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 111.684 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.11 111.18 33.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.7 t -132.88 146.45 51.82 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.899 -168.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.824 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 29.6 pttt -145.25 164.92 29.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.955 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -78.27 136.81 37.83 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.799 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -48.67 -37.77 19.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.474 -171.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 22.1 t -105.62 140.74 21.48 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.06 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.568 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 4.2 Cg_exo -77.83 4.35 6.16 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.022 2.482 . . . . 0.0 111.943 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.1 t -121.4 -77.33 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.68 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' ' 66' ' ' SER . 52.8 m80 -94.06 163.75 13.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 p -96.7 125.38 41.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 50.6 m-20 -123.21 -87.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 33.9 m-85 -129.24 177.56 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.018 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.758 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.3 mt -103.17 125.12 49.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.153 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 14.1 mptt -106.85 106.26 16.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.034 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -115.56 150.44 36.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.022 -174.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -119.68 150.57 40.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 7.2 t30 64.74 103.84 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.705 0.628 . . . . 0.0 110.722 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.544 HD22 ' HA ' ' A' ' 83' ' ' SER . 98.1 mt -117.98 127.63 54.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -91.26 76.8 5.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.633 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.06 -88.52 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.456 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.36 -6.36 61.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.061 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.3 m-85 -94.24 115.84 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.893 0.378 . . . . 0.0 110.809 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.544 ' HA ' HD22 ' A' ' 78' ' ' LEU . 17.2 m -144.98 168.64 19.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.582 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -99.86 154.77 18.08 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -110.67 -58.97 0.49 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.603 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.26 -178.32 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.9 m -126.9 141.36 51.83 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.7 p -142.32 -155.96 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.16 0.505 . . . . 0.0 111.812 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.513 ' HB2' ' OG1' ' A' ' 95' ' ' THR . 26.8 t70 66.95 -83.45 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.113 168.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 7.3 m -71.07 -33.36 51.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.843 0.354 . . . . 0.0 111.027 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.54 HD23 ' CB ' ' A' ' 23' ' ' CYS . 4.1 pp -88.73 -31.94 18.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.4 t -95.27 -77.56 0.47 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.84 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -159.64 -59.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.995 0.426 . . . . 0.0 110.417 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.71 141.37 5.61 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.25 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 89' ' ' ASP . 7.2 p -137.41 167.3 21.89 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m -61.92 129.96 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.092 0.472 . . . . 0.0 110.512 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.74 106.91 2.59 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.829 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.4 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.951 176.428 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 18.2 p90 -86.79 131.41 34.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.43 142.11 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.895 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 1.027 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 1.7 pp0? -100.28 147.53 25.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 10.6 p -149.49 147.91 28.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.454 0.645 . . . . 0.0 112.405 -175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.5 OUTLIER -72.39 110.66 6.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.769 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 5.4 m80 -75.85 107.28 7.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.802 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 12.3 m-70 -79.68 126.63 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.106 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.533 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -99.33 125.26 44.96 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -107.55 125.42 51.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.472 0.653 . . . . 0.0 110.978 -176.225 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -100.14 151.13 21.77 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -48.29 101.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.458 0.474 . . . . 0.0 111.009 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.5 -53.03 0.68 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.235 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -147.85 160.95 42.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.457 0.646 . . . . 0.0 112.67 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -48.78 133.05 17.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.177 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -102.91 -55.48 2.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.127 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -177.9 38.01 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.467 ' C ' HD12 ' A' ' 37' ' ' ILE . 5.6 t -153.92 141.44 19.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.204 0.502 . . . . 0.0 110.037 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.467 HD12 ' C ' ' A' ' 36' ' ' THR . 1.8 mp -116.31 123.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.54 HH21 ' HA ' ' A' ' 98' ' ' SER . 6.1 tpp85 -75.84 99.4 4.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.841 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -145.02 145.76 31.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.133 0.492 . . . . 0.0 111.365 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 12.7 ptmt -64.69 151.82 43.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.002 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.93 142.57 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.866 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.872 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.62 -30.61 10.01 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.316 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.577 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 76.2 m95 -90.17 139.68 30.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.21 130.59 40.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.957 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.3 p -121.46 153.43 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.141 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.73 142.39 28.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 111.059 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.769 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 77.3 m-85 -127.89 133.81 49.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 170.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.591 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 45.6 p90 -148.92 151.05 33.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.706 0.289 . . . . 0.0 110.689 -175.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.29 143.78 27.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.611 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.942 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 11.3 pt-20 -126.67 102.02 6.89 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.933 0.873 . . . . 0.0 111.158 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.17 128.15 41.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.02 116.94 2.71 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.57 2.18 . . . . 0.0 112.487 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.53 -29.27 12.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.372 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -96.54 153.09 38.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.24 153.4 74.59 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.588 2.192 . . . . 0.0 111.732 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.942 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 21.1 mmtp -70.57 117.7 12.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.43 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -105.81 125.67 51.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.598 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mt -57.02 120.83 8.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 110.784 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.1 m -107.74 -17.74 7.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.35 138.41 0.94 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.48 0.657 . . . . 0.0 111.62 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.26 112.38 40.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -130.69 150.89 51.67 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.953 -168.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.1 ptpp? -151.28 162.74 40.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.44 144.61 31.27 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.43 -56.96 5.13 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.767 0.667 . . . . 0.0 111.918 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 15.0 m -97.05 143.06 25.48 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.585 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.872 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 Cg_endo -83.81 22.19 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.25 2.633 . . . . 0.0 112.343 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.0 t -136.03 -76.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -81.28 159.55 24.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.7 t -98.81 122.32 41.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.998 0.427 . . . . 0.0 109.957 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -112.09 -83.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.591 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -145.76 179.99 7.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.838 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.729 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 16.3 mt -101.75 121.78 42.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -100.6 104.87 16.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.013 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -116.57 149.22 40.0 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.91 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -128.17 156.32 43.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 63.74 59.34 1.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.752 0.658 . . . . 0.0 110.286 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.662 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.6 mt -77.84 131.63 37.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.428 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -90.33 66.65 6.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 111.538 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.2 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.107 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.47 -10.15 83.85 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.089 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.7 m-85 -96.43 114.14 25.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.662 ' HA ' HD22 ' A' ' 78' ' ' LEU . 38.6 m -143.98 172.82 12.34 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.714 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -106.98 162.64 13.66 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.55 -126.91 3.95 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.02 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 14.1 t -104.4 -176.37 3.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 3.9 p -132.52 141.82 48.93 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.505 ' HB ' HG21 ' A' ' 95' ' ' THR . 28.8 p -142.67 -157.58 0.79 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.962 0.41 . . . . 0.0 111.967 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 21.1 t70 72.21 -62.43 0.46 Allowed 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.799 168.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.637 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 1.5 m -85.07 -31.89 7.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.481 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.515 HD23 ' HB3' ' A' ' 23' ' ' CYS . 4.1 pp -89.77 -34.66 16.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.667 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.1 p -99.97 -14.96 18.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.37 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 5.3 t 82.2 86.67 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.074 171.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.9 94.72 0.89 Allowed Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.63 -0.714 . . . . 0.0 114.046 173.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.505 HG21 ' HB ' ' A' ' 88' ' ' THR . 41.6 p -137.64 -127.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.662 0.268 . . . . 0.0 110.977 174.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.2 m -123.61 149.46 27.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.632 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.5 162.3 21.51 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.274 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.54 ' HA ' HH21 ' A' ' 38' ' ' ARG . 20.7 t . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.355 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.717 0.294 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 39.1 p90 -88.8 139.59 30.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -120.71 138.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.571 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 4.8 pp0? -98.71 142.36 30.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.689 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.624 ' HA ' HG21 ' A' ' 90' ' ' VAL . 7.6 p -155.68 159.45 39.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 111.613 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.984 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -80.38 111.78 17.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.099 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.406 ' O ' ' HA ' ' A' ' 36' ' ' THR . 45.1 m170 -81.82 115.95 21.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -87.85 129.65 35.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.562 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.5 tm? -98.6 127.78 44.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -103.64 121.72 43.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.71 -175.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.609 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 85.4 t80 -94.31 141.29 28.73 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -54.78 101.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 110.699 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.57 -42.9 1.39 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.361 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -168.86 153.09 5.62 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.018 0.437 . . . . 0.0 111.672 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -38.55 126.22 1.43 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.07 0.948 . . . . 0.0 112.538 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.6 t90 -94.25 -55.77 3.07 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.98 -175.07 37.42 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.781 -0.724 . . . . 0.0 111.899 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.484 HG22 ' HB2' ' A' ' 98' ' ' SER . 6.6 t -154.39 147.89 25.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.055 0.428 . . . . 0.0 110.882 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' CE1' ' A' ' 47' ' ' PHE . 3.3 mp -124.4 126.22 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 2.9 tpp180 -77.84 93.7 4.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -127.7 144.54 51.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 36.4 mtpt -70.72 151.86 44.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.65 142.05 57.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.47 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 91.88 -27.94 9.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.157 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.465 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 27.1 m95 -84.52 128.28 34.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.08 135.07 46.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.475 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.3 p -121.56 142.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.841 0.353 . . . . 0.0 110.764 -176.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.14 141.81 28.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.706 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 73.9 m-85 -130.65 134.98 47.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.46 167.75 21.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.733 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 15.5 pt-20 -107.54 125.39 51.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.422 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' ' HZ2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -117.52 121.67 41.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -129.73 149.97 74.47 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.24 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.13 117.81 3.96 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.447 2.765 . . . . 0.0 112.737 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.29 -13.43 45.64 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.888 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.75 142.38 25.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.965 0.412 . . . . 0.0 111.549 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.1 155.49 67.95 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.834 2.356 . . . . 0.0 111.568 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.676 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.487 -176.208 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -130.52 144.16 51.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 58' ' ' LEU . 14.9 mt -60.54 130.85 48.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.465 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 49' ' ' GLU . 33.5 m -117.2 -20.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -166.73 137.67 3.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.433 0.635 . . . . 0.0 111.137 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.54 110.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.706 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.9 t -130.52 168.16 17.5 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.863 -167.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.712 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 19.5 pttp -174.45 163.83 3.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.606 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.1 133.42 44.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.568 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -45.59 -41.9 10.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 114.009 -1.451 . . . . 0.0 113.177 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.9 t -102.15 138.15 19.66 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.191 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.3 Cg_endo -75.89 1.43 8.16 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.642 2.228 . . . . 0.0 111.792 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.5 t -118.81 -78.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.555 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 66' ' ' SER . 45.7 m-70 -89.91 162.53 15.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.2 t -97.25 129.12 44.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.067 0.46 . . . . 0.0 110.446 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -125.49 -81.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -139.67 174.82 10.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.828 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.9 mt -103.6 120.57 41.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.721 0.296 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 5.6 mptp? -106.54 110.53 22.75 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m -112.81 149.78 32.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.357 -173.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -111.8 150.61 30.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 9.5 t30 59.62 90.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.675 0.61 . . . . 0.0 110.473 -174.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.0 117.4 34.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -84.21 61.74 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.046 0.451 . . . . 0.0 111.352 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.57 -91.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.265 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 5.31 84.73 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.41 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.6 m-85 -114.43 108.84 17.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 0.0 110.139 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 m -147.29 166.52 26.84 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.546 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.32 153.78 19.02 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.321 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.66 -63.82 0.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.486 -171.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 t -175.91 -169.94 0.36 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 m -129.09 143.39 50.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.0 p -140.23 -152.51 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.995 -0.093 . . . . 0.0 110.97 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.984 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.6 t70 63.0 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.962 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -69.12 -45.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.723 0.297 . . . . 0.0 111.778 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.02 -24.33 22.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 111.259 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.4 t -88.04 -71.68 0.57 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.7 p 179.8 -68.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.527 0.68 . . . . 0.0 109.663 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.05 -53.55 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p 50.44 -157.42 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.631 0.772 . . . . 0.0 112.34 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.23 148.33 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.83 -154.91 6.54 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.425 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 36' ' ' THR . 15.9 m . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.338 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.7 m-85 -47.82 130.01 14.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.309 0.576 . . . . 0.0 110.799 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.75 143.77 34.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.266 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.932 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 2.8 pp0? -99.3 142.43 30.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.14 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 6.0 p -148.84 146.21 27.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.512 . . . . 0.0 111.846 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.8 OUTLIER -77.27 115.52 17.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 110.302 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -81.4 124.49 29.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.281 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.531 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 10.8 m170 -94.25 126.27 39.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.92 0.39 . . . . 0.0 111.533 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.4 tm? -97.89 127.89 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -105.07 128.86 53.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.929 -175.139 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 73.3 t80 -104.26 148.22 26.6 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.05 99.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.0 109.756 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -49.83 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.626 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -173.99 175.35 2.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.526 0.203 . . . . 0.0 110.619 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.76 ' HE1' ' HA ' ' A' ' 98' ' ' SER . 44.9 t-80 -54.3 139.14 37.36 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.794 0.438 . . . . 0.0 110.945 176.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 60.9 t90 -107.42 -56.01 2.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.736 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.78 167.45 33.16 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.035 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 26' ' ' HIS . 0.9 OUTLIER -151.89 136.78 17.2 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 120.99 0.424 . . . . 0.0 112.025 -176.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.5 mp -126.2 132.78 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.957 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 34.9 ttp180 -94.21 113.92 25.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' HG2' HG22 ' A' ' 37' ' ' ILE . 73.9 mmtt -138.1 153.95 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.298 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.932 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.9 mtpt -68.06 157.84 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 111.251 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -69.87 142.47 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.41 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.24 10.98 81.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.487 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -116.75 156.44 27.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . . . -90.55 120.44 31.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.407 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 62' ' ' CYS . 14.7 p -105.38 141.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.569 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 133.61 39.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.182 0.515 . . . . 0.0 110.671 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.488 ' CG ' HD23 ' A' ' 27' ' ' LEU . 66.5 m-85 -125.65 125.14 42.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.679 ' HB3' HD23 ' A' ' 58' ' ' LEU . 42.6 p90 -147.32 148.03 30.96 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.998 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.6 125.19 34.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.57 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.659 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 8.8 pt-20 -128.54 102.78 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.02 0.914 . . . . 0.0 110.019 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 29.2 mtmt -104.13 118.24 57.48 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.572 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 1.2 Cg_endo -42.92 117.34 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.694 2.929 . . . . 0.0 113.067 -172.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.18 -20.83 32.4 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.012 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 47.5 mt-30 -115.84 143.4 30.69 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.654 0.264 . . . . 0.0 110.91 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 24.4 Cg_exo -64.56 161.99 32.98 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.215 2.61 . . . . 0.0 111.93 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.659 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 27.9 mttm -90.93 143.43 26.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.116 -169.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.641 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -134.53 133.29 40.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.679 HD23 ' HB3' ' A' ' 48' ' ' TYR . 13.3 mt -64.09 126.67 28.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 0.0 111.052 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 20.5 m -113.02 -17.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -171.18 135.53 0.99 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.484 0.659 . . . . 0.0 111.799 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -113.17 112.13 39.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 167.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -120.56 146.12 46.64 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.356 -166.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 24.9 mmtm -120.01 164.67 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 70' ' ' CYS . 9.9 t30 -93.66 137.06 33.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.6 -55.28 1.89 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.115 0.884 . . . . 0.0 112.679 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.438 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 39.9 t -103.12 141.62 22.86 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.823 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.48 -10.55 13.3 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.591 2.194 . . . . 0.0 111.649 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 16.2 t -100.32 -59.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.497 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -104.96 164.52 11.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.407 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.431 ' HA ' HD21 ' A' ' 64' ' ' ASN . 5.9 p -100.87 122.02 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.302 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.87 -90.09 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.111 0.481 . . . . 0.0 110.709 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -131.37 176.52 8.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.448 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.801 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.7 mt -105.79 128.41 53.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -170.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -109.41 105.26 14.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.772 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.7 m -119.94 152.68 37.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.973 -171.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 t -124.45 174.1 8.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.18 34.49 21.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.636 0.585 . . . . 0.0 111.606 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -66.08 131.01 45.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.795 -176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -100.92 68.15 1.26 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.674 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.07 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.538 0.735 . . . . 0.0 112.821 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.12 -14.05 83.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.966 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.1 m-85 -96.92 111.42 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.994 0.426 . . . . 0.0 110.753 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 78' ' ' LEU . 45.1 m -148.51 168.53 22.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.772 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -112.1 154.61 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.872 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -106.31 -79.22 1.23 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.895 -171.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.402 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 13.4 t -161.1 -174.91 4.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 27.8 m -116.06 144.04 44.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.409 ' OG1' HG21 ' A' ' 95' ' ' THR . 39.9 p -139.75 -155.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.103 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.661 ' HB2' ' OG1' ' A' ' 95' ' ' THR . 20.9 t70 66.67 -81.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.593 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -65.23 -40.91 90.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.813 0.339 . . . . 0.0 111.591 -175.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.8 -30.24 19.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.668 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -86.29 -75.55 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.661 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.4 t -166.95 -58.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.636 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.39 142.46 5.74 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.363 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.661 ' OG1' ' HB2' ' A' ' 89' ' ' ASP . 31.4 p -136.38 -170.87 2.76 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.89 26.92 3.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.903 0.382 . . . . 0.0 111.398 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.0 -115.04 6.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.085 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.76 ' HA ' ' HE1' ' A' ' 33' ' ' HIS . 50.1 m . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.839 -0.601 . . . . 0.0 110.199 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HD1' ' H ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -85.32 125.81 33.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.065 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -132.93 139.44 49.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.865 -172.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.689 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 4.0 pp0? -101.51 142.15 33.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.947 ' HA ' HG21 ' A' ' 90' ' ' VAL . 26.1 p -143.69 150.14 38.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.316 -172.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' HB2' ' OG1' ' A' ' 36' ' ' THR . 0.8 OUTLIER -74.31 114.4 12.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 175.335 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.527 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -83.18 113.79 20.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.601 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -85.39 127.37 34.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.173 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.5 tm? -100.06 132.44 45.42 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -99.46 124.67 44.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.599 -178.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.932 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.8 t80 -93.61 150.0 20.78 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -53.74 99.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 110.309 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.85 -68.32 0.46 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.189 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -142.89 179.19 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 112.128 -171.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -47.71 133.85 13.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.801 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.932 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 83.8 t90 -103.15 -56.62 2.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.17 -178.57 42.49 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.022 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 13.3 t -153.11 138.7 17.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.631 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.2 mp -116.11 129.89 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.571 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.645 HH11 HG13 ' A' ' 90' ' ' VAL . 2.3 tpp180 -80.84 99.84 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.419 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.0 mmtm -140.9 152.95 45.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.224 0.535 . . . . 0.0 111.385 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.4 mtpt -67.18 154.97 39.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.826 -176.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 54.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.187 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 91.94 -26.63 12.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.177 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -81.14 134.73 35.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.007 0.432 . . . . 0.0 110.842 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -78.21 121.75 24.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.972 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.1 p -111.87 147.31 15.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 141.72 28.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 -176.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.75 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.0 m-85 -127.56 138.29 52.84 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 22.4 p90 -153.33 159.63 42.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 -172.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.48 137.37 44.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HG2' ' HG2' ' A' ' 56' ' ' LYS . 22.9 mt-10 -112.5 102.0 10.13 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -90.56 143.59 29.38 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.57 116.51 3.34 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.512 2.141 . . . . 0.0 111.788 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.07 -17.74 57.68 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.292 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.56 148.43 35.22 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.63 153.41 59.82 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 110.615 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.569 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 15.6 mttp -62.61 127.85 33.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.08 -173.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -103.82 119.97 40.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.89 115.53 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.638 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 25.9 m -96.88 -22.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.614 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 59' ' ' VAL . . . 176.27 144.61 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.612 0.57 . . . . 0.0 111.315 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.4 mp -101.73 116.98 46.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.75 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.6 t -128.63 149.42 50.66 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.321 -171.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.659 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.2 ptpt -144.26 162.29 36.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -85.71 133.69 34.0 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.166 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.29 -53.51 5.17 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.092 0.87 . . . . 0.0 112.959 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 33.2 t -93.46 139.59 22.93 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.318 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 71.7 Cg_endo -78.87 -3.51 13.28 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.594 2.196 . . . . 0.0 111.827 173.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -111.33 -69.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.423 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.436 ' O ' ' HB3' ' A' ' 66' ' ' SER . 35.6 m80 -94.79 161.8 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.004 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.0 p -98.51 121.17 40.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -121.41 -88.48 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 0.0 109.707 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.04 171.23 12.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.47 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.686 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 37.8 mt -103.71 119.93 39.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.869 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.9 mmpt? -96.05 104.47 16.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 30.7 m -100.87 152.88 20.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.033 0.444 . . . . 0.0 111.361 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -133.39 157.86 44.48 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.553 173.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.1 m120 59.43 49.57 8.56 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.469 0.481 . . . . 0.0 111.066 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 75' ' ' CYS . 97.2 mt -65.87 140.81 58.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.91 79.0 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.944 0.402 . . . . 0.0 110.76 -178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 67.67 -77.7 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.798 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.83 -13.1 6.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.955 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 50.6 m-85 -71.22 118.09 13.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -151.2 171.59 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.705 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -92.24 163.24 13.99 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.752 0.311 . . . . 0.0 110.56 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.24 -62.64 0.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.511 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.11 -171.44 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.8 m -129.83 143.18 50.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.6 p -141.66 -160.74 1.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.698 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.447 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 19.5 t70 64.51 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.388 171.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.947 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -62.25 -38.29 80.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.901 0.382 . . . . 0.0 111.206 -176.386 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.22 -37.91 15.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.733 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m -87.96 -77.06 0.36 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.03 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.5 t -162.43 -66.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.37 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' HA2' ' OD1' ' A' ' 89' ' ' ASP . . . -170.58 137.49 4.47 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.131 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.5 p -136.44 123.69 21.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.718 0.259 . . . . 0.0 111.287 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.5 m -86.26 129.02 38.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.94 -57.82 0.17 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.589 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.555 -1.212 . . . . 0.0 109.623 -178.785 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.6 m-85 -53.32 141.22 24.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.941 0.4 . . . . 0.0 110.419 173.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.527 HG13 ' SG ' ' A' ' 70' ' ' CYS . 1.5 p -142.39 133.7 25.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.606 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 4.5 pp0? -96.52 145.66 25.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 21.6 p -150.23 149.1 29.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.486 0.66 . . . . 0.0 111.876 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.926 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.53 114.37 14.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.857 173.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.04 117.96 21.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' CE1' ' HA3' ' A' ' 97' ' ' GLY . 11.5 m170 -87.06 134.09 33.53 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.804 0.335 . . . . 0.0 111.895 -174.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.587 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -99.55 123.59 43.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -105.78 122.29 45.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.475 0.655 . . . . 0.0 110.858 -176.502 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -95.35 146.66 24.22 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -60.8 100.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.0 -52.61 0.68 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.825 -174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 17.6 tpt180 -174.94 177.9 1.9 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.744 0.272 . . . . 0.0 111.428 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.529 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.5 t-80 -51.23 128.13 21.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.516 0.727 . . . . 0.0 111.631 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' HZ2' ' H ' ' A' ' 50' ' ' GLU . 57.2 t90 -95.65 -56.8 2.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.56 173.71 44.97 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 8.8 t -155.24 146.6 22.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.206 0.503 . . . . 0.0 111.497 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.81 133.85 66.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.405 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.621 HH11 ' HB3' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -76.09 113.55 13.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.156 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 11.9 tppt? -143.72 150.72 39.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 21.0 ttmt -83.25 147.42 28.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -53.86 139.59 33.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.966 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 98.2 -39.6 2.72 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.447 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -81.2 137.19 35.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 110.608 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -76.34 136.66 39.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.646 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 62' ' ' CYS . 10.0 p -118.39 148.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.708 ' HE ' ' HE1' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -89.01 143.32 26.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.407 . . . . 0.0 110.899 -177.382 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 55.0 m-85 -128.31 143.28 51.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.708 ' HE1' ' HE ' ' A' ' 46' ' ' ARG . 36.7 p90 -152.51 156.48 39.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.814 0.34 . . . . 0.0 110.58 -174.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 8.5 pt-20 -100.17 130.07 46.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.753 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -120.32 101.08 7.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.963 0.887 . . . . 0.0 110.497 175.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -85.19 141.53 37.38 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.816 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.19 116.39 2.22 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.847 2.365 . . . . 0.0 112.894 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.73 -30.52 6.48 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.171 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -83.15 153.33 66.27 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.719 0.295 . . . . 0.0 111.228 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 153.9 76.15 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 111.186 171.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.753 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 32.2 mttm -94.54 126.1 39.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.99 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 7.2 ttm-85 -94.58 123.53 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.261 -174.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -61.15 102.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.59 -19.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.79 146.92 0.35 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.158 0.504 . . . . 0.0 111.51 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.89 118.64 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.716 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 9.1 t -133.82 150.88 51.42 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.289 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.4 ptpt -146.32 162.75 37.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.21 138.65 36.87 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.439 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.93 -57.53 2.37 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.38 1.05 . . . . 0.0 112.677 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.7 t -93.54 138.3 23.0 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.156 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -76.25 -0.76 10.7 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.641 2.228 . . . . 0.0 111.879 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -115.34 -66.45 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.73 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' SER . 53.5 m-70 -98.21 163.89 12.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.527 ' SG ' HG13 ' A' ' 21' ' ' VAL . 97.9 m -99.23 122.33 42.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.398 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -125.04 -79.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.305 0.574 . . . . 0.0 110.218 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.53 174.18 10.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.827 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.706 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 28.3 mt -104.51 127.44 52.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.235 0.541 . . . . 0.0 111.387 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -104.69 105.66 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.35 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.727 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 5.9 m -106.14 163.64 12.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.244 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -144.22 157.91 44.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.3 46.61 5.9 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.664 0.603 . . . . 0.0 111.34 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.5 mt -67.28 147.89 52.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.691 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -107.57 69.85 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 111.465 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.22 -93.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.8 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.91 -5.87 88.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.184 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -98.71 112.98 24.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.233 0.539 . . . . 0.0 110.485 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' HD22 ' A' ' 78' ' ' LEU . 20.1 m -140.02 169.12 18.29 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.727 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -108.0 156.78 18.85 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.569 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -121.07 3.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.896 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -110.35 -169.6 1.49 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.616 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 18.9 p -125.24 142.74 51.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.523 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 75.2 p -140.4 -155.86 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.538 0.208 . . . . 0.0 111.046 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.926 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.3 t70 67.25 -72.9 0.08 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.828 0.851 . . . . 0.0 112.33 170.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 m -78.63 -42.76 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -89.51 -45.6 9.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.377 -178.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.449 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 15.2 t -83.82 -16.74 43.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.579 0.228 . . . . 0.0 110.66 -175.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 62.9 m 62.74 -82.44 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.324 0.649 . . . . 0.0 112.409 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -71.7 74.89 0.73 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.339 -0.457 . . . . 0.0 112.817 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.523 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -154.58 152.37 29.95 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 122.665 0.386 . . . . 0.0 110.427 -177.367 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.86 102.64 14.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' A' ' 26' ' ' HIS . . . -159.17 101.06 0.2 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.891 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 18.6 t . . . . . 0 C--O 1.254 1.303 0 CA-C-O 117.89 -1.052 . . . . 0.0 108.422 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.7 p90 -58.19 136.56 57.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.23 139.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.463 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.595 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -116.88 141.6 48.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 90' ' ' VAL . 20.5 p -147.33 164.12 34.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.111 0.481 . . . . 0.0 111.373 -171.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.556 ' HB2' ' OG1' ' A' ' 36' ' ' THR . 0.9 OUTLIER -79.35 115.61 19.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.585 176.302 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 36' ' ' THR . 49.6 m170 -83.22 121.53 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -89.53 138.69 31.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.477 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -109.65 130.32 55.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 170.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.537 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -100.43 123.5 44.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.385 0.612 . . . . 0.0 111.032 -178.029 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.964 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 21.4 t80 -95.72 151.63 19.19 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -57.44 100.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.079 0.466 . . . . 0.0 110.514 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.2 -57.28 0.69 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.62 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -147.38 178.47 8.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.193 0.52 . . . . 0.0 111.87 -171.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -62.5 133.7 55.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.044 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.964 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 84.3 t90 -101.25 -57.61 2.05 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.218 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.31 -179.5 40.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.118 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 12.1 t -154.68 148.75 25.82 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.65 0.262 . . . . 0.0 110.892 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.687 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.6 mp -128.15 125.54 64.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.55 HH12 ' HA ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -75.97 99.5 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.952 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.687 ' HG2' HG22 ' A' ' 37' ' ' ILE . 67.5 mmtt -135.15 153.12 52.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.0 mtpt -72.11 153.0 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 142.39 58.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 90.96 -25.86 12.77 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 -178.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.562 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 86.0 m95 -86.02 133.7 33.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.605 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.665 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.91 135.64 48.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 62' ' ' CYS . 11.2 p -122.54 148.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.1 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -90.6 147.88 23.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.705 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 61.1 m-85 -136.38 137.28 40.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.0 p90 -145.55 154.29 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.515 0.198 . . . . 0.0 110.549 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.441 ' HB3' HG11 ' A' ' 59' ' ' VAL . 15.0 pt-20 -95.51 135.43 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.073 0.463 . . . . 0.0 110.577 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.62 ' HB2' ' HZ2' ' A' ' 34' ' ' TRP . 1.6 mm-40 -94.84 106.39 18.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.418 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.652 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 75.9 mmtt -106.81 123.46 38.48 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.48 117.26 3.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.848 2.366 . . . . 0.0 112.339 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.46 -6.68 75.91 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.479 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.652 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 28.3 mt-30 -113.25 158.63 37.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 122.664 0.385 . . . . 0.0 110.69 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.85 155.53 62.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.529 2.153 . . . . 0.0 111.944 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 56' ' ' LYS . 1.9 mptp? -80.82 130.01 34.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.299 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.563 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.4 tpm_? -108.19 124.09 49.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.354 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -61.0 106.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.077 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 49' ' ' GLU . 29.5 m -94.2 -17.06 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.927 -172.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.34 138.08 2.47 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.376 0.608 . . . . 0.0 112.238 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.81 111.93 38.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.6 t -130.93 155.11 47.33 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.193 -168.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.665 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.7 ptpt -157.59 158.56 35.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -77.95 131.09 37.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.659 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -55.2 -28.3 52.03 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.022 0.826 . . . . 0.0 112.958 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 34.0 t -104.64 131.65 21.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.683 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 77.6 Cg_endo -80.1 2.54 8.37 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.65 2.233 . . . . 0.0 112.415 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 13.2 t -121.31 -65.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.667 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.582 ' O ' ' HB3' ' A' ' 66' ' ' SER . 57.0 t-80 -97.94 160.37 14.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 110.025 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.3 p -100.94 128.62 46.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.071 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -129.13 -86.63 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.036 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -132.14 169.72 16.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.544 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.74 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 19.0 mt -102.76 120.1 39.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.157 0.503 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.659 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 4.1 mptp? -100.79 106.27 17.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.479 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.634 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.5 m -108.81 152.49 24.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.776 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -125.73 156.1 39.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.729 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 m120 61.9 47.45 6.0 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.611 0.57 . . . . 0.0 111.773 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 75' ' ' CYS . 81.2 mt -66.77 145.91 55.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -88.8 72.95 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.2 -93.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.15 -17.13 30.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 40.4 m-85 -72.38 109.37 6.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.166 0.507 . . . . 0.0 109.885 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' HD22 ' A' ' 78' ' ' LEU . 4.4 p -139.14 175.93 9.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.017 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.34 169.1 9.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.768 0.318 . . . . 0.0 110.652 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.82 -159.24 10.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.861 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 t -77.29 -178.09 4.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.475 ' HB2' HD21 ' A' ' 91' ' ' LEU . 41.2 m -116.8 144.75 44.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.603 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 69.5 p -139.67 -157.92 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.525 0.202 . . . . 0.0 111.335 -173.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.491 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 27.9 t70 65.14 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.955 0.902 . . . . 0.0 112.43 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.6 m -71.4 -47.67 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.3 pp -88.97 -30.34 18.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.688 0.28 . . . . 0.0 111.079 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.6 t -85.03 -58.67 2.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.7 t 69.47 133.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.32 0.581 . . . . 0.0 110.03 -171.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.4 -1.37 72.65 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.603 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.8 OUTLIER -116.36 155.87 27.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.726 -0.737 . . . . 0.0 109.979 177.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.6 m -97.56 144.03 11.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.925 0.393 . . . . 0.0 110.609 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.65 172.11 39.42 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.772 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.55 ' HA ' HH12 ' A' ' 38' ' ' ARG . 22.1 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.57 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 41.1 p90 -58.81 142.06 51.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.93 0.395 . . . . 0.0 110.059 175.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.42 139.37 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.322 0.582 . . . . 0.0 111.802 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.745 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -113.71 140.93 47.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.577 173.583 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 7.7 p -148.44 151.58 35.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.951 0.405 . . . . 0.0 111.842 -171.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.937 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -73.01 102.63 3.55 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.414 0.626 . . . . 0.0 110.573 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.784 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 4.7 m80 -69.95 116.55 10.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.382 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.9 m-70 -93.57 128.98 39.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.439 . . . . 0.0 111.43 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.503 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.487 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -91.85 123.63 35.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.487 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.561 ' HB2' ' CB ' ' A' ' 34' ' ' TRP . 37.2 t80 -94.18 149.59 21.1 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -52.04 99.45 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.475 0.484 . . . . 0.0 110.038 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.14 -70.86 0.51 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.954 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -149.15 178.97 8.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.087 0.47 . . . . 0.0 112.031 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -53.62 132.7 41.05 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.856 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 29' ' ' TYR . 8.1 t-105 -128.34 -57.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.073 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 26' ' ' HIS . . . -98.93 150.62 19.34 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.314 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -151.39 108.07 3.51 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.73 113.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.835 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 21.9 ttp180 -77.87 93.56 4.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 109.768 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 15.6 tppt? -116.34 153.0 32.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.036 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.745 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.5 mtpt -79.94 149.33 30.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.673 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.05 137.31 56.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 97.08 -20.24 51.61 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.031 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.499 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 84.6 m95 -95.9 133.11 40.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.769 0.319 . . . . 0.0 110.223 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.48 130.42 40.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.162 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.569 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 14.8 p -116.09 143.18 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.906 0.384 . . . . 0.0 110.382 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -95.94 143.27 27.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.226 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.784 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 86.7 m-85 -120.93 137.96 54.35 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.8 p90 -144.51 157.96 43.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.399 0.619 . . . . 0.0 111.371 -173.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 21.8 pt-20 -97.78 126.42 43.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.939 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.789 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 7.7 pt-20 -121.93 102.09 7.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.715 0.769 . . . . 0.0 109.824 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -116.15 151.77 47.05 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.237 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.95 116.14 2.45 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.957 2.438 . . . . 0.0 112.759 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.57 50.07 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.312 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 68.9 mt-30 -102.14 143.81 27.35 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.196 0.522 . . . . 0.0 112.105 -173.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 13.3 Cg_exo -70.23 166.11 29.26 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.214 2.609 . . . . 0.0 110.429 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.789 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 50.3 mttt -94.16 110.67 22.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.36 -168.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 9.5 ttp180 -100.7 144.2 29.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.579 -174.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 46' ' ' ARG . 14.1 mt -64.94 125.35 24.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.137 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 29.8 m -111.3 -18.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.535 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -172.47 140.6 1.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.446 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -113.31 113.28 43.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.679 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -133.73 162.64 31.42 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.595 -169.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.3 ptpt -158.21 163.39 37.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.91 132.88 35.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.34 -54.7 3.66 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.155 0.909 . . . . 0.0 112.795 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -95.22 146.77 31.91 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.428 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 83.4 Cg_endo -86.57 10.99 3.42 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.769 2.313 . . . . 0.0 112.485 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 10.8 t -122.64 -73.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.638 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -95.58 163.47 13.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.1 t -98.08 125.91 43.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.07 -80.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.672 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -139.52 176.36 8.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.75 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.668 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.8 mt -106.72 120.43 41.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.828 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -100.22 104.02 15.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 22.1 m -105.62 150.32 25.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 112.074 -172.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 t -132.26 156.23 46.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.458 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.6 t30 57.14 77.7 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.758 0.661 . . . . 0.0 111.102 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.616 HD22 ' HA ' ' A' ' 83' ' ' SER . 92.0 mt -94.8 137.31 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.268 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.08 80.71 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 110.685 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.61 -94.26 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.686 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.99 -5.29 53.58 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.37 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 33.6 m-85 -83.39 113.58 20.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.988 0.423 . . . . 0.0 110.116 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.616 ' HA ' HD22 ' A' ' 78' ' ' LEU . 12.3 m -142.44 166.44 24.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -89.47 162.89 15.5 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.91 -63.28 0.24 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.884 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -175.85 -167.83 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 19.7 m -135.0 144.08 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.482 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 62.6 p -140.11 -152.15 0.4 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.937 ' HB3' HD21 ' A' ' 24' ' ' ASN . 27.8 t70 66.07 -70.11 0.1 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.018 0.927 . . . . 0.0 112.533 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 23' ' ' CYS . 4.5 m -80.14 -42.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.746 0.308 . . . . 0.0 111.651 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.4 pp -89.9 -33.2 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.745 0.307 . . . . 0.0 111.443 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -93.44 -16.13 24.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.679 0.276 . . . . 0.0 110.716 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 t 68.01 -81.19 0.03 OUTLIER 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.24 66.97 3.7 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.521 -176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.482 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -141.38 138.35 32.94 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.911 -0.17 . . . . 0.0 110.592 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.8 t -72.74 119.14 18.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.029 0.442 . . . . 0.0 110.494 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.33 -155.49 13.35 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.641 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.246 0.898 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.071 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.671 ' HD1' ' HA ' ' A' ' 68' ' ' VAL . 28.6 m-85 -53.89 131.32 39.81 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 110.301 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 t -111.14 130.99 63.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.135 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -93.15 141.08 28.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.662 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 92.8 m -151.72 144.36 24.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.782 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.822 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -74.7 109.72 8.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.019 0.438 . . . . 0.0 109.861 176.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.69 12.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' THR . 9.8 m-70 -84.46 130.8 34.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.332 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.598 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -99.04 127.8 45.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -98.35 122.76 41.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.613 . . . . 0.0 110.846 -176.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.054 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 1.8 t80 -100.39 152.7 20.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.42 99.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.526 0.516 . . . . 0.0 111.857 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.96 -19.74 42.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.379 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -163.82 156.89 18.27 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.458 1.129 . . . . 0.0 112.909 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -48.54 119.34 3.0 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.704 171.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 1.054 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.5 t90 -87.71 -56.52 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.503 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.01 -177.92 42.63 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.2 t -156.0 146.53 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.086 0.443 . . . . 0.0 111.391 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.2 mp -125.15 126.73 71.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 16.1 mtm180 -75.94 122.1 23.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.656 0.741 . . . . 0.0 110.803 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.83 149.78 31.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.262 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 50.6 mtpt -69.92 155.1 41.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 110.858 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.43 142.3 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.445 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 88.44 -34.29 3.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.348 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 89.7 m95 -78.13 132.8 37.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.08 0.467 . . . . 0.0 110.451 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.661 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.44 141.59 52.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.741 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 62' ' ' CYS . 9.5 p -124.35 157.63 31.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.4 136.45 40.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.377 . . . . 0.0 111.484 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.598 ' CG ' HD23 ' A' ' 27' ' ' LEU . 67.8 m-85 -128.37 133.74 48.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -150.77 154.04 36.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 17.0 pt-20 -101.46 126.56 48.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.06 102.49 9.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.604 0.716 . . . . 0.0 109.905 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.76 131.41 35.75 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.975 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.83 116.46 3.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.569 2.179 . . . . 0.0 112.351 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.41 -10.18 57.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.123 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -122.05 154.69 61.5 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.406 0.282 . . . . 0.0 110.569 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.23 155.6 51.57 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.6 2.2 . . . . 0.0 111.359 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.707 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -72.33 140.09 48.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.216 0.531 . . . . 0.0 110.903 -177.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.33 129.8 55.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.464 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 58' ' ' LEU . 3.7 mm? -59.14 123.74 17.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 110.484 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -110.37 -18.27 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.1 134.87 1.29 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.623 0.725 . . . . 0.0 111.394 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.68 111.6 36.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.9 t -131.18 144.05 51.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.269 -167.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -144.8 161.13 40.02 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -80.53 141.79 34.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.825 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.83 -62.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.015 0.822 . . . . 0.0 112.258 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.7 t -90.23 138.53 27.21 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.249 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.699 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -78.23 -2.41 12.49 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.521 2.147 . . . . 0.0 111.632 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.671 ' HA ' ' HD1' ' A' ' 20' ' ' PHE . 12.5 t -105.04 -74.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.336 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.91 163.64 12.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.1 t -98.22 131.69 44.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.85 0.357 . . . . 0.0 110.298 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -132.54 -84.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.953 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -131.57 164.24 26.28 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.186 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.776 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 25.9 mt -103.54 122.94 45.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.988 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -102.78 106.21 16.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.698 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.8 m -110.01 146.56 35.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.599 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.434 HG23 HD22 ' A' ' 77' ' ' ASN . 13.6 t -124.16 157.48 34.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.708 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.434 HD22 HG23 ' A' ' 76' ' ' THR . 43.5 m-80 60.54 55.84 3.28 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.609 0.568 . . . . 0.0 110.987 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 75' ' ' CYS . 92.1 mt -73.62 148.21 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.153 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -105.22 67.89 0.79 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.026 0.441 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.8 -91.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.258 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.04 60.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.008 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 90.2 m-85 -79.51 108.23 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.401 . . . . 0.0 110.74 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 m -149.68 163.31 38.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.67 159.98 14.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.34 -64.0 0.19 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.335 -170.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 11.6 t -160.16 -165.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.943 0.372 . . . . 0.0 110.423 -171.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.662 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 14.3 t -144.5 148.04 34.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.8 p -140.01 -153.21 0.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.276 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.822 ' HB3' HD21 ' A' ' 24' ' ' ASN . 7.9 t70 61.34 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 173.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -69.28 -42.38 81.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.967 0.413 . . . . 0.0 111.31 -176.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.414 HD23 ' SG ' ' A' ' 23' ' ' CYS . 4.1 pp -89.68 -33.93 16.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.552 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.554 -172.612 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.622 0.248 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.3 m-85 -81.24 140.67 34.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.85 140.18 48.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.863 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -112.41 144.87 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.325 176.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HB3' HD11 ' A' ' 91' ' ' LEU . 19.8 p -153.49 157.05 39.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 0.0 111.54 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.026 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -78.11 112.52 15.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.602 174.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -81.97 115.3 21.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.651 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -83.94 129.01 34.93 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.017 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.3 tm? -101.36 132.57 46.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.542 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.31 122.57 44.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.374 0.607 . . . . 0.0 111.037 -178.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.828 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 56.7 t80 -106.09 143.99 33.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -53.07 104.96 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.039 0.447 . . . . 0.0 110.792 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 -50.59 0.88 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.964 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -172.75 167.37 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -36.3 131.37 0.63 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.985 0.914 . . . . 0.0 112.221 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.828 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 32.8 t-105 -99.56 -56.69 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.264 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -178.71 39.57 Favored Glycine 0 C--O 1.234 0.143 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.643 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 9.7 t -151.77 141.76 22.11 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.187 0.518 . . . . 0.0 111.664 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.88 130.04 58.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.827 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.863 ' HD2' HE22 ' A' ' 22' ' ' GLN . 29.7 mtm180 -87.68 124.78 33.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.325 0.583 . . . . 0.0 111.539 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.425 ' HE3' HG13 ' A' ' 45' ' ' VAL . 36.6 ttmt -153.53 152.35 30.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.575 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.816 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 47.1 mtpt -76.15 155.07 34.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.924 0.392 . . . . 0.0 111.044 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.78 142.45 55.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 104.65 -36.32 4.46 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.139 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -90.29 146.92 23.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.927 0.394 . . . . 0.0 110.614 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -85.63 131.37 34.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -101.12 152.54 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -94.43 140.12 30.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.88 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.476 ' O ' HD23 ' A' ' 58' ' ' LEU . 94.2 m-85 -136.54 132.5 35.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.5 p90 -147.62 157.76 43.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 0.0 111.377 -173.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 16.9 pt-20 -95.33 130.03 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.143 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.557 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 16.4 pt-20 -126.25 112.21 15.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.443 0.64 . . . . 0.0 109.96 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 49.2 mtmt -136.4 121.82 13.29 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.592 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 8.0 Cg_endo -48.58 116.88 2.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.686 2.924 . . . . 0.0 113.417 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.04 -19.26 12.02 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.274 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -126.67 149.26 67.76 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.807 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 162.33 42.44 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.822 2.348 . . . . 0.0 111.403 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.557 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 24.3 mttm -86.29 118.28 25.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.532 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -103.99 133.33 49.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.292 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -65.85 113.25 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.244 0.34 . . . . 0.0 110.172 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 33.2 m -92.76 -24.04 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.4 ' CB ' HD23 ' A' ' 78' ' ' LEU . . . 178.91 146.68 0.17 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.288 0.565 . . . . 0.0 111.29 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.408 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 4.7 mp -105.42 117.31 50.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 170.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 6.2 t -125.44 144.74 50.39 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.514 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.0 ptpt -143.1 163.0 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -84.59 136.35 33.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.261 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.43 -54.68 3.74 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.052 0.845 . . . . 0.0 112.322 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.507 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 34.5 t -89.33 141.03 28.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.294 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 3.5 Cg_exo -81.62 2.79 8.31 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.25 2.633 . . . . 0.0 112.107 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.2 t -122.99 -70.38 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.664 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -86.25 165.02 16.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.1 126.05 44.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.879 0.371 . . . . 0.0 110.223 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -124.16 -81.55 0.64 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.293 0.568 . . . . 0.0 110.016 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.44 168.91 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.69 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 24.0 mt -102.52 120.34 40.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.251 0.548 . . . . 0.0 110.784 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.67 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.9 mmpt? -102.26 105.65 16.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.809 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.666 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.7 m -104.58 149.77 25.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.956 0.408 . . . . 0.0 110.769 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -127.27 155.36 43.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.517 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.48 50.82 4.39 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.491 0.494 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 75' ' ' CYS . 87.7 mt -68.24 140.36 56.03 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.51 89.62 7.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.575 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.54 -88.16 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.01 0.82 11.77 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.993 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -82.42 126.17 31.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 m -146.81 -177.74 5.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.923 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.499 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.72 171.28 7.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.04 -140.79 5.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.256 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 178.85 5.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.844 0.354 . . . . 0.0 110.531 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 42.4 m -110.6 142.61 42.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 24.6 p -141.27 -159.32 0.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 1.026 ' HB3' HD21 ' A' ' 24' ' ' ASN . 22.2 t70 63.06 -82.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.948 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -70.97 -36.02 61.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.211 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 23' ' ' CYS . 12.9 mt -89.46 -55.32 3.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.23 0.538 . . . . 0.0 111.729 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.62 -171.329 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.641 0.258 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.3 m-85 -64.39 113.99 4.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 69' ' ' HIS . 1.9 p -101.26 139.75 21.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.322 -172.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 1.01 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.0 pt20 -96.08 144.81 26.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HA ' HG21 ' A' ' 90' ' ' VAL . 10.8 p -150.07 142.43 24.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 111.796 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.994 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -73.43 110.59 7.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.016 175.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.83 116.11 16.21 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.412 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 11.4 m-70 -86.62 131.18 34.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.873 0.368 . . . . 0.0 111.132 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -98.51 125.46 43.73 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -104.12 125.67 50.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.366 0.603 . . . . 0.0 111.235 -172.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -98.53 150.79 21.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -53.38 100.38 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.662 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.91 -58.85 0.58 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.684 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -142.58 170.81 15.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.369 0.604 . . . . 0.0 112.317 -171.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 134.48 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.866 172.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -101.59 -55.85 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.897 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.99 175.14 42.28 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.7 t -154.28 145.79 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.278 0.539 . . . . 0.0 111.424 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.507 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.0 mp -126.78 125.1 66.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 47.2 ttp180 -88.67 98.07 11.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.5 mmtp -126.05 153.8 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 1.01 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 32.9 mtpt -66.24 161.93 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.228 0.537 . . . . 0.0 111.482 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -59.92 142.78 53.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.763 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 89.78 -28.19 7.35 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.465 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.529 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 55.1 m95 -75.87 115.27 15.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.572 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.929 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.11 115.43 16.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.042 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.2 p -103.75 154.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.34 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.53 134.09 37.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 111.346 -177.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.72 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 88.7 m-85 -120.37 128.38 53.18 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HB3' HD23 ' A' ' 58' ' ' LEU . 36.7 p90 -143.78 152.1 40.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.299 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 7.1 pt-20 -94.72 137.53 33.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.354 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -126.78 100.37 6.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 31.8 mttp -95.66 154.08 39.26 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.02 116.36 3.12 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 121.994 1.796 . . . . 0.0 111.639 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 -11.59 66.39 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.873 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -110.12 126.34 29.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.769 -0.254 . . . . 0.0 110.474 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 31.7 Cg_exo -63.06 154.87 64.44 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.041 2.494 . . . . 0.0 112.765 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -62.11 126.92 29.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.181 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -130.39 142.74 50.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.816 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.785 HD13 HD11 ' A' ' 61' ' ' ILE . 16.6 mt -70.32 130.07 41.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 -175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.09 -18.0 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.393 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -176.63 138.29 0.28 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.514 0.673 . . . . 0.0 111.633 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -108.81 111.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.7 t -132.39 146.12 51.73 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.687 -168.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.929 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 27.5 pttt -145.6 164.56 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.651 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 9.0 t30 -77.33 134.37 38.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.75 -56.78 1.67 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.455 1.097 . . . . 0.0 112.706 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 40.6 t -92.0 136.75 25.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 69.3 Cg_endo -75.42 -1.52 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.404 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.9 t -112.42 -72.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 66' ' ' SER . 39.6 m80 -98.01 164.47 12.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.424 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.0 t -97.63 132.72 43.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -132.1 -81.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -138.26 175.7 9.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.498 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 31.3 mt -103.72 129.5 51.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.69 109.95 21.25 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m -114.44 149.15 36.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.53 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -124.76 159.99 29.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.174 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 68.36 40.13 2.1 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.407 0.442 . . . . 0.0 111.642 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' A' ' 75' ' ' CYS . 96.5 mt -66.73 126.69 29.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.887 0.375 . . . . 0.0 110.971 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -95.41 68.79 3.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.585 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.47 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.366 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.3 -16.32 64.77 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.971 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 99.2 m-85 -86.99 109.29 19.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.085 0.469 . . . . 0.0 110.39 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.4 m -147.72 168.29 22.48 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.611 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.76 161.53 13.6 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.472 -175.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.31 -79.28 0.76 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.218 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.9 t -155.77 -169.52 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 30.1 m -130.58 144.75 51.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.645 0.259 . . . . 0.0 110.309 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 58.3 p -138.34 -154.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.936 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.994 ' HB3' HD21 ' A' ' 24' ' ' ASN . 36.2 t70 63.58 -78.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.25 1.02 . . . . 0.0 112.548 173.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.9 OUTLIER -68.03 -42.84 85.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.793 0.33 . . . . 0.0 111.662 -175.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.0 pp -89.66 -31.39 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.597 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.027 -175.249 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.1 p90 -57.09 142.08 43.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.402 174.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.29 141.33 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.709 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.2 pt20 -94.39 143.0 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.709 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 20.0 p -147.53 145.5 29.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.037 0.446 . . . . 0.0 110.901 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.981 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.02 113.05 11.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 174.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.505 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 1.3 m80 -78.4 117.63 19.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -85.42 134.69 34.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.019 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -101.09 122.9 44.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -101.07 122.04 42.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.697 0.76 . . . . 0.0 110.862 -177.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 65.9 t80 -94.24 150.95 19.83 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.75 100.15 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.47 -58.45 0.71 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.255 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -159.71 179.96 8.4 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -52.44 131.51 33.66 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.764 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.808 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.4 t90 -101.57 -55.84 2.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.314 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.23 179.03 38.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.1 t -154.32 143.74 21.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.187 0.493 . . . . 0.0 111.164 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.586 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.5 mp -123.42 122.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 42.3 ttp180 -83.44 105.65 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.17 0.509 . . . . 0.0 110.741 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.586 ' HG2' HG22 ' A' ' 37' ' ' ILE . 70.1 mmtt -127.11 152.96 46.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.536 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 38.9 mtpt -80.22 149.97 30.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.631 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.09 136.18 57.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 111.297 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.47 -17.76 46.16 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -91.38 130.93 37.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.73 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.93 122.89 26.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.5 p -107.58 147.81 12.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.873 0.368 . . . . 0.0 110.483 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -98.44 135.95 39.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.0 111.154 -177.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CG ' HD23 ' A' ' 27' ' ' LEU . 74.8 m-85 -123.89 131.02 53.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.193 173.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HD2' ' HB3' ' A' ' 56' ' ' LYS . 36.0 p90 -143.74 149.64 37.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.194 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.4 ' HB3' HG11 ' A' ' 59' ' ' VAL . 9.0 pt-20 -95.21 142.97 27.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 10.4 pt-20 -130.07 102.2 6.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.726 0.774 . . . . 0.0 110.199 172.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.5 124.84 56.07 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.45 117.82 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.583 2.855 . . . . 0.0 113.303 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.77 22.51 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.377 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.49 148.32 34.37 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.592 0.357 . . . . 0.0 110.735 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.0 151.84 82.9 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.903 2.402 . . . . 0.0 112.153 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 26.9 mttm -76.63 136.06 39.17 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.899 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -123.89 135.92 54.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.613 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.82 118.8 12.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.2 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 16.1 m -104.7 -19.16 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.39 136.21 0.59 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.651 0.739 . . . . 0.0 112.349 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.61 HD13 HD22 ' A' ' 77' ' ' ASN . 4.6 mp -108.28 112.87 42.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.8 t -132.14 150.46 52.15 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 -168.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -150.1 163.59 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.838 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 32.6 t30 -73.02 150.55 42.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.989 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.41 -52.5 28.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.542 0.526 . . . . 0.0 111.692 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -108.78 139.12 20.57 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.066 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.23 12.74 1.21 Allowed 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.772 2.315 . . . . 0.0 113.149 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.7 t -128.01 -78.8 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.762 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -90.59 156.94 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.838 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 31.5 t -97.74 137.03 37.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.854 0.359 . . . . 0.0 110.992 -172.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -133.49 -76.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -134.28 164.75 26.69 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.461 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.67 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.3 mt -103.82 124.32 48.7 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.13 105.75 16.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.17 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 19.0 m -102.93 155.18 18.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.816 -175.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.9 t -136.37 154.71 50.75 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.61 HD22 HD13 ' A' ' 61' ' ' ILE . 90.8 m-20 65.81 46.35 2.33 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.736 0.648 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.9 mt -64.3 155.62 31.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 111.425 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.193 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.39 -90.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.287 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.49 -15.1 78.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.769 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.1 m-85 -89.12 120.44 30.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 110.332 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.47 ' HA ' HD22 ' A' ' 78' ' ' LEU . 22.9 m -147.34 172.75 13.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.622 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -109.87 174.93 5.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.158 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -142.48 -175.35 15.64 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.068 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -66.57 172.45 4.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.0 111.495 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 15.5 p -110.33 144.0 39.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.71 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.5 p -140.7 -154.84 0.54 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 111.461 -174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.981 ' HB3' HD21 ' A' ' 24' ' ' ASN . 19.4 t70 69.9 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.032 169.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.64 -38.05 57.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.616 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.87 -30.03 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 p . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.606 -179.228 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.479 0.181 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -79.05 140.58 37.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 70' ' ' CYS . 2.3 p -145.4 136.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.245 -175.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.667 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.87 155.14 18.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.516 175.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 16.9 p -154.85 152.44 29.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.212 0.53 . . . . 0.0 111.681 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -75.05 111.19 10.02 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 109.503 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.83 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 9.7 m80 -72.19 121.03 18.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.403 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -84.17 136.54 33.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.584 -174.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.596 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -109.89 122.98 48.78 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 165.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -106.02 122.08 45.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.287 0.565 . . . . 0.0 110.504 -176.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.13 143.94 26.17 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -50.43 101.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.537 0.523 . . . . 0.0 110.463 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.6 -53.34 0.81 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.146 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 22.8 tpt180 -165.09 160.02 18.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.085 0.442 . . . . 0.0 111.77 -175.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -42.83 127.83 4.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -99.51 -56.72 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.323 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.63 178.32 39.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.975 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 26' ' ' HIS . 5.8 t -153.8 138.41 16.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.951 0.375 . . . . 0.0 110.704 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.31 135.98 55.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.199 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.665 ' HD2' HE22 ' A' ' 22' ' ' GLN . 3.3 tpp85 -73.81 110.21 7.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.788 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 16.7 tppt? -143.89 128.57 18.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.563 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 18.6 ptmt -72.3 153.64 41.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.222 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -63.66 142.75 58.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 94.26 -17.27 59.23 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.645 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 44.3 m95 -105.36 142.91 34.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 0.0 110.66 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.64 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -80.17 140.63 36.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.63 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.788 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.9 p -126.89 148.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.85 0.357 . . . . 0.0 110.543 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.76 143.55 27.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.83 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 63.5 m-85 -128.35 135.88 50.19 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 53.0 p90 -151.1 156.49 41.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.869 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' ' 51' ' ' LYS . 14.9 pt-20 -107.38 134.93 49.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 168.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.0 102.25 10.74 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.229 0.537 . . . . 0.0 110.67 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HE2' ' OE1' ' A' ' 49' ' ' GLU . 67.6 mttm -85.23 125.48 69.96 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.672 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 86.9 Cg_exo -48.02 117.64 2.63 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.332 2.688 . . . . 0.0 113.573 -173.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.37 -14.24 62.37 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.559 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -113.05 158.11 38.85 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.543 0.211 . . . . 0.0 110.438 -176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.55 161.9 41.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.665 2.243 . . . . 0.0 111.118 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -74.71 138.38 42.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.056 0.455 . . . . 0.0 110.728 -176.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 20.4 tpp180 -99.52 123.55 43.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.069 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.34 107.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.997 0.427 . . . . 0.0 110.55 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -95.16 -18.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -173.57 138.7 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.505 0.669 . . . . 0.0 111.904 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.62 112.13 38.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.845 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 12.0 t -134.9 154.02 51.83 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.982 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -150.21 162.36 40.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -83.85 135.86 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.718 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.33 -51.9 6.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.079 0.862 . . . . 0.0 112.868 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 46.0 t -94.77 139.18 22.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.265 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 80.1 Cg_endo -79.13 2.69 8.08 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 111.744 173.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.2 -79.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.589 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' ' 66' ' ' SER . 67.5 m80 -89.65 165.38 14.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.472 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 21' ' ' VAL . 74.8 m -98.72 124.92 43.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.29 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 61.5 m-20 -124.22 -85.52 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 110.227 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 93.9 m-85 -130.43 174.14 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.949 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.845 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.6 mt -109.36 132.21 54.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.626 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -101.19 104.51 15.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.744 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.6 m -116.41 144.87 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.967 0.413 . . . . 0.0 110.597 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -126.46 159.63 32.8 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 6.2 t30 59.83 71.59 0.57 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 -175.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 83' ' ' SER . 96.4 mt -91.66 128.79 37.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -92.33 73.92 5.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.674 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.62 -93.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.468 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.07 0.85 73.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.923 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 96.5 m-85 -101.16 108.89 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 0.0 110.474 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 78' ' ' LEU . 41.7 m -138.39 169.35 17.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -101.24 163.76 12.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.283 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.83 -175.68 14.8 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.669 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 13.6 t -61.77 159.02 14.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.567 0.698 . . . . 0.0 111.234 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 7.0 p -91.17 144.67 25.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.479 -168.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.613 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 40.0 p -131.64 -158.45 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.803 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 88' ' ' THR . 25.2 t70 70.83 -85.04 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.411 1.084 . . . . 0.0 111.707 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 90' ' ' VAL . 1.7 m -67.45 -46.94 82.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.94 -27.8 20.7 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.725 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' A' ' 88' ' ' THR . 5.9 t . . . . . 0 C--N 1.329 -0.284 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.069 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 82.5 m-85 -78.9 139.94 38.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.46 138.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.398 0.618 . . . . 0.0 111.819 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.821 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.47 145.84 31.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.421 176.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.707 ' HA ' HG21 ' A' ' 90' ' ' VAL . 18.0 p -148.66 150.44 33.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.501 0.667 . . . . 0.0 112.314 -174.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.973 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -72.24 112.84 8.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.958 174.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.832 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 14.6 m80 -80.68 108.81 14.64 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.615 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.562 ' HD2' ' HA ' ' A' ' 87' ' ' SER . 43.5 m-70 -83.72 125.33 31.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.774 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.7 tm? -98.2 134.08 41.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.589 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -104.73 116.7 32.49 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.563 0.697 . . . . 0.0 110.903 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.728 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 71.6 t80 -95.19 145.42 25.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.954 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -57.75 99.76 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.856 0.36 . . . . 0.0 110.287 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.76 -43.57 1.26 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.68 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -175.06 166.06 3.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.092 0.446 . . . . 0.0 111.337 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -43.42 127.03 4.54 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.553 0.741 . . . . 0.0 111.596 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.728 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 48.9 t-105 -99.68 -57.65 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.636 -175.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.73 177.49 39.56 Favored Glycine 0 C--N 1.328 0.137 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.278 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -152.85 133.11 13.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.143 0.497 . . . . 0.0 111.328 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.6 mp -120.33 134.6 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.53 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -80.05 104.93 10.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.562 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 3.7 tppp? -138.85 145.01 39.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.821 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.5 mtpt -68.32 148.94 50.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.939 ' HB1' HD22 ' A' ' 64' ' ' ASN . . . -65.55 136.61 56.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.9 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.797 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 97.14 -26.18 23.85 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.068 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -89.19 130.83 35.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.924 0.392 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.736 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.99 126.64 30.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.201 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.2 p -116.41 145.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.41 145.21 30.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.148 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.832 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 76.7 m-85 -134.79 145.33 48.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 56' ' ' LYS . 31.5 p90 -148.61 163.39 37.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.199 0.523 . . . . 0.0 111.585 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.32 134.53 51.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.381 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' H ' ' HZ2' ' A' ' 34' ' ' TRP . 10.8 pt-20 -109.57 113.79 26.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.391 0.615 . . . . 0.0 110.399 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 33.6 mmtp -108.31 125.51 31.75 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.432 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.53 126.87 23.93 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.32 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.5 -9.56 64.35 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.297 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 40.8 mt-30 -122.38 159.12 53.87 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.365 0.266 . . . . 0.0 110.733 -175.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.25 156.65 58.79 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.765 2.31 . . . . 0.0 111.967 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . 9.7 pttp -88.21 138.86 31.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -117.45 123.63 46.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.929 -172.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.45 106.6 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.44 -30.08 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . . . -174.07 144.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.199 0.523 . . . . 0.0 111.338 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.413 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 4.6 mp -102.07 113.72 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.71 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -118.96 148.69 42.69 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.187 -171.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 13.9 pttp -157.1 164.32 38.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.341 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.939 HD22 ' HB1' ' A' ' 41' ' ' ALA . 30.7 t30 -81.83 152.02 27.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.408 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.23 -48.88 67.82 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.552 0.532 . . . . 0.0 111.362 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -105.57 137.54 19.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.818 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.797 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 78.1 Cg_endo -80.96 10.37 3.41 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.742 2.294 . . . . 0.0 112.518 175.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.0 t -113.98 -82.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.11 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -90.28 158.45 17.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.743 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.6 t -98.5 127.32 44.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -116.39 -87.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -134.53 171.79 13.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 39.2 mt -103.43 120.54 41.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.105 0.479 . . . . 0.0 112.056 -173.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -102.91 109.29 20.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.155 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.678 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.9 m -103.21 146.53 28.28 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.481 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -120.45 155.29 33.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.152 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 56.68 55.24 6.51 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.664 0.603 . . . . 0.0 110.184 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.6 mt -67.74 149.48 49.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.76 94.67 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.51 -85.56 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.628 0.58 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.45 4.64 6.26 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.02 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.88 120.71 25.06 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.9 t -151.84 178.17 9.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.469 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.71 159.84 14.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.199 -177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.55 -64.38 0.38 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.006 -171.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 t -164.91 -169.62 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.006 0.403 . . . . 0.0 110.586 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 5.0 p -143.73 144.25 31.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.263 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 37.6 p -139.61 -155.22 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.731 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.973 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.7 t70 64.61 -76.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.465 0.706 . . . . 0.0 112.377 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -70.94 -44.36 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.15 -23.34 22.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.095 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.77 179.593 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -64.18 149.14 48.44 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 69' ' ' HIS . 2.6 p -133.67 135.23 55.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.402 0.62 . . . . 0.0 111.488 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.767 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -109.6 140.94 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.388 176.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 58.6 m -145.1 157.58 44.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.088 0.47 . . . . 0.0 111.994 -168.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.963 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -83.43 111.84 19.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 166.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -77.61 124.02 27.39 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.32 137.6 32.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.403 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -98.96 116.4 31.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 166.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.72 124.05 41.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.928 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -110.7 150.62 28.79 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -52.86 101.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.346 0.404 . . . . 0.0 110.492 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.17 -59.01 0.69 Allowed Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.32 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -162.58 166.76 24.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -49.87 119.58 3.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.767 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.538 ' HH2' ' H ' ' A' ' 50' ' ' GLU . 10.1 t90 -92.84 -55.57 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.968 0.413 . . . . 0.0 110.598 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.73 163.26 28.56 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.509 ' C ' HD12 ' A' ' 37' ' ' ILE . 6.0 t -154.26 140.22 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.224 0.512 . . . . 0.0 110.699 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 36' ' ' THR . 2.5 mp -124.39 126.97 72.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.745 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.9 mtm180 -79.13 110.31 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.502 . . . . 0.0 111.819 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HG3' HG22 ' A' ' 37' ' ' ILE . 62.2 mttm -146.52 137.29 24.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.155 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.0 ptmt -62.12 156.91 20.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.28 142.15 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.935 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.38 -40.7 2.33 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.523 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 56.9 m95 -75.14 141.94 43.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.137 0.494 . . . . 0.0 111.142 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.93 131.33 41.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.399 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.8 p -121.63 140.08 46.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.059 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.672 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -101.33 139.41 37.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.998 0.427 . . . . 0.0 110.541 -178.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.508 ' CG ' HD23 ' A' ' 27' ' ' LEU . 82.9 m-85 -120.43 139.08 53.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.301 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 30.5 p90 -147.44 154.04 40.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.934 0.397 . . . . 0.0 111.335 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -103.69 142.66 33.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.495 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.538 ' H ' ' HH2' ' A' ' 34' ' ' TRP . 7.6 pt-20 -93.89 104.16 16.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 73.1 mmtt -119.45 135.47 24.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.055 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 23.3 Cg_exo -63.9 117.51 4.5 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.028 2.485 . . . . 0.0 112.834 -175.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.45 64.76 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -107.69 149.96 39.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.942 0.401 . . . . 0.0 110.696 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.24 153.4 78.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.943 1.762 . . . . 0.0 109.323 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.594 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 34.7 mmtm -67.37 109.53 3.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.181 0.515 . . . . 0.0 109.899 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 18.7 tpp180 -80.67 126.11 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.817 -167.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 46' ' ' ARG . 11.1 mt -58.9 109.12 0.76 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.599 0.562 . . . . 0.0 110.649 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -93.78 -15.43 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.862 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.53 135.19 0.53 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.598 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.522 HD11 HD13 ' A' ' 58' ' ' LEU . 4.7 mp -107.7 113.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 166.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.2 t -133.63 159.54 40.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.998 -168.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.637 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -158.97 162.82 36.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 10.4 t30 -87.4 138.4 31.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.383 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -55.4 4.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.093 0.87 . . . . 0.0 112.655 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -99.89 146.41 31.84 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.049 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 94.7 Cg_endo -87.98 20.54 1.15 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.053 2.502 . . . . 0.0 112.714 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.57 -76.77 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.103 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.496 ' HA ' HG12 ' A' ' 21' ' ' VAL . 36.5 m-70 -92.22 164.28 13.61 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.54 122.43 44.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -116.51 -78.74 0.58 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.484 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.26 165.49 25.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.213 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.797 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.4 mt -105.03 124.74 50.06 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.457 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.57 105.37 15.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 2.1 m -111.54 151.46 28.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.364 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -128.95 161.74 29.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.521 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.39 41.09 5.98 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.567 0.542 . . . . 0.0 111.484 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -65.55 147.03 54.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.975 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -110.46 67.42 0.64 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.408 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.71 -89.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.859 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.85 -16.66 69.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.734 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.0 m-85 -85.17 107.05 17.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.234 0.54 . . . . 0.0 110.475 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.542 ' HA ' HD22 ' A' ' 78' ' ' LEU . 11.1 m -134.08 165.54 24.83 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.512 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -101.44 161.7 13.44 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.1 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 -164.04 9.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.846 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -69.34 -177.39 1.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.833 0.453 . . . . 0.0 111.338 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.61 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.2 p -122.03 151.75 40.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.928 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.528 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 68.8 p -139.78 -157.4 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 110.739 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.963 ' HB3' HD21 ' A' ' 24' ' ' ASN . 35.3 t70 66.11 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.919 0.888 . . . . 0.0 112.111 172.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.83 -41.47 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -89.87 -40.97 12.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 88' ' ' THR . 9.3 m . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -172.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 34.6 p90 -61.23 135.35 57.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.419 0.628 . . . . 0.0 110.921 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.4 142.71 40.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.869 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.876 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -95.15 142.34 27.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 5.1 m -142.94 140.54 31.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.377 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.994 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -72.51 111.7 7.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 170.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 36' ' ' THR . 5.1 m80 -80.77 122.98 27.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.892 -177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -90.61 123.64 34.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.589 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.1 tm? -98.1 126.81 43.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.37 128.62 53.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.158 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.7 t80 -103.78 144.78 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -56.1 100.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.2 -56.6 0.63 Allowed Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.658 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.503 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 11.5 tpp180 -172.02 172.08 4.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.503 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 39.5 t-80 -47.62 135.92 10.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.194 0.598 . . . . 0.0 111.524 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.501 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 58.3 t90 -107.43 -55.76 2.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.119 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.12 164.02 30.76 Favored Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.282 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -146.53 130.69 17.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.984 0.421 . . . . 0.0 111.313 -177.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.7 mp -122.44 130.47 74.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.876 ' HD2' HE22 ' A' ' 22' ' ' GLN . 24.1 mtm180 -76.42 128.53 35.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.216 0.531 . . . . 0.0 110.671 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 45' ' ' VAL . 12.3 tppt? -148.86 152.15 35.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.654 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.5 mtpt -87.19 148.13 25.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.42 -174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.84 136.42 58.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.971 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.58 -20.9 47.47 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.992 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 65.1 m95 -101.63 137.51 39.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 110.227 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.608 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -81.21 145.6 30.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -112.9 156.3 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.0 177.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.25 130.23 50.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.138 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 97.5 m-85 -122.73 126.83 48.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -145.78 156.68 43.75 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.483 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.501 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 14.3 pt-20 -104.47 123.68 47.91 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.7 102.08 10.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.826 0.822 . . . . 0.0 109.937 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.3 121.64 52.8 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.666 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.82 116.38 2.13 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.029 2.486 . . . . 0.0 112.519 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.46 -28.13 14.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.21 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -107.92 148.78 38.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.85 152.49 77.22 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.382 2.055 . . . . 0.0 111.293 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.714 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -77.82 137.6 38.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.537 -175.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -112.93 137.49 51.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.989 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.82 109.07 5.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.456 0.473 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 15.7 m -94.05 -19.64 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.808 -176.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.28 142.18 0.59 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 112.139 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.91 112.35 40.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 165.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.795 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.3 t -130.78 150.02 52.15 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.955 -167.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 ptpt -145.03 163.03 35.47 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -77.1 138.22 39.39 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.557 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -40.62 -58.73 1.54 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.125 0.891 . . . . 0.0 112.628 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 30.0 t -94.04 138.2 22.72 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.201 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.2 -1.75 11.05 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.675 2.25 . . . . 0.0 111.701 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.3 t -103.37 -81.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.296 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 66' ' ' SER . 7.4 p80 -107.25 165.98 10.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.122 0.487 . . . . 0.0 111.204 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.405 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 1.6 p -94.27 124.24 38.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.099 -168.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -128.46 -83.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.092 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -130.44 173.82 10.47 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.202 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.795 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 29.0 mt -110.07 127.71 55.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.952 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.82 107.92 19.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.519 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -113.41 152.15 30.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -175.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.402 HG23 HD22 ' A' ' 77' ' ' ASN . 12.5 t -126.2 159.43 33.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.402 HD22 HG23 ' A' ' 76' ' ' THR . 40.8 m-80 62.46 40.32 10.98 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.935 0.494 . . . . 0.0 111.301 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.9 mt -62.04 135.12 57.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.859 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -92.68 41.81 1.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.227 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.31 -84.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.22 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.89 -18.6 76.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.758 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.859 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.9 m-85 -96.38 109.48 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' HD22 ' A' ' 78' ' ' LEU . 14.8 m -139.85 167.15 22.77 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.47 159.77 15.29 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.311 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.81 -95.08 1.85 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.929 -174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -138.97 -167.44 2.22 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 49.4 m -134.43 144.97 48.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 61.3 p -139.35 -157.03 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.815 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.994 ' HB3' HD21 ' A' ' 24' ' ' ASN . 31.9 t70 61.68 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.431 1.092 . . . . 0.0 112.277 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 90' ' ' VAL . 3.1 m -70.8 -20.91 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.745 0.307 . . . . 0.0 111.141 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.528 HD21 ' SG ' ' A' ' 23' ' ' CYS . 13.6 mt -89.1 -56.04 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.505 0.669 . . . . 0.0 111.201 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.317 -0.831 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.418 -174.139 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 48.5 p90 -88.8 143.2 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.85 137.76 21.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.358 0.599 . . . . 0.0 111.798 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.844 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 8.6 pt20 -102.95 150.13 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.467 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.2 p -151.04 136.4 17.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.366 0.603 . . . . 0.0 111.936 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.854 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -76.63 106.28 8.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 172.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.41 ' CB ' ' HZ ' ' A' ' 47' ' ' PHE . 4.6 m80 -72.86 122.26 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.122 -174.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -82.21 126.46 32.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.037 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 27' ' ' LEU . 1.1 tm? -98.33 119.5 37.11 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.03 123.22 44.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.681 0.753 . . . . 0.0 111.425 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -101.63 148.38 25.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -57.27 99.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.26 0.35 . . . . 0.0 110.089 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.39 -57.58 0.59 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.484 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -168.84 170.62 9.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.153 0.477 . . . . 0.0 111.346 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -46.26 114.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.395 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.504 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 70.4 t90 -90.26 -55.92 3.41 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.825 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.24 169.67 36.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.669 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 t -154.55 147.81 24.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 111.551 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.9 mp -127.08 128.13 70.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.854 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.9 ttp180 -87.62 116.0 25.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.705 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -150.29 149.04 29.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.844 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 40.4 mtpt -66.62 145.94 55.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.37 141.58 58.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 108.37 -28.03 12.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.832 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -96.42 145.98 25.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.011 0.434 . . . . 0.0 110.409 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -75.85 131.96 40.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -105.79 131.49 55.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 129.42 34.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.101 0.477 . . . . 0.0 110.199 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 87.8 m-85 -121.27 123.69 42.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.8 p90 -144.57 150.35 37.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.991 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 15.6 pt-20 -95.51 142.2 28.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.689 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 6.4 pt-20 -118.72 102.51 8.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.472 0.653 . . . . 0.0 110.451 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -110.23 122.73 37.88 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.93 116.72 2.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.78 2.32 . . . . 0.0 112.532 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.83 13.71 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.023 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.77 140.26 20.9 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 159.52 31.5 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.827 2.352 . . . . 0.0 111.602 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.65 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 24.8 mmtp -71.05 119.93 15.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.87 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -112.97 129.25 56.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.186 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.485 HD13 HD11 ' A' ' 61' ' ' ILE . 12.9 mt -62.49 126.63 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.974 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -113.46 -17.19 8.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.532 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.13 140.65 1.2 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.542 0.687 . . . . 0.0 111.873 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.485 HD11 HD13 ' A' ' 58' ' ' LEU . 4.7 mp -117.49 111.93 36.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 167.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.648 ' O ' HG23 ' A' ' 45' ' ' VAL . 6.8 t -129.03 147.52 50.9 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.552 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.9 ptpt -148.18 163.22 37.64 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.65 137.88 32.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.447 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -48.72 8.15 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.085 0.866 . . . . 0.0 112.538 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 38.5 t -97.45 140.69 22.16 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.751 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 98.5 Cg_endo -81.65 5.21 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.876 2.384 . . . . 0.0 112.532 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.2 t -123.94 -62.33 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.378 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 66' ' ' SER . 36.7 m-70 -95.29 156.29 16.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.812 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.7 t -99.03 121.55 41.11 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -119.13 -78.73 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -135.56 172.48 12.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.58 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 11.5 mt -102.93 120.56 40.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 0.0 110.532 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.2 mmpt? -100.87 103.67 14.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 8.4 m -106.51 155.51 19.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.67 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -142.57 165.91 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 55.22 45.71 25.25 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.763 0.664 . . . . 0.0 111.487 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 83' ' ' SER . 85.0 mt -68.19 144.98 54.73 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -99.18 58.53 1.11 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.931 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.3 -86.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.103 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.54 -22.89 68.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.632 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -86.29 112.02 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.51 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.1 m -136.97 169.2 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.635 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.19 167.58 9.73 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.003 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.16 -108.35 1.07 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.18 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -115.32 -169.04 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.633 0.254 . . . . 0.0 110.531 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.6 m -135.7 143.52 45.45 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.1 p -139.83 -144.06 0.17 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.591 ' HB3' HD21 ' A' ' 24' ' ' ASN . 33.0 t70 53.48 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.201 1.0 . . . . 0.0 113.498 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.596 HG23 HD23 ' A' ' 91' ' ' LEU . 3.2 m -70.42 -45.08 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 HG23 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -89.84 -37.75 14.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.671 0.272 . . . . 0.0 111.33 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.898 -175.138 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 68' ' ' VAL . 15.4 m . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.579 0.228 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.7 m-85 -87.49 148.46 24.92 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.021 0.439 . . . . 0.0 110.247 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -144.75 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.819 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.765 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.99 143.38 44.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.692 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.671 ' HA ' HG21 ' A' ' 90' ' ' VAL . 8.1 p -152.76 155.45 37.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.106 0.479 . . . . 0.0 112.091 -173.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -80.88 113.34 19.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.816 175.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -79.76 121.12 24.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.53 132.2 35.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.918 0.39 . . . . 0.0 111.492 -174.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -99.94 129.27 46.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.443 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -108.44 123.45 48.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.282 0.563 . . . . 0.0 110.543 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 29.9 t80 -102.2 149.78 23.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.59 100.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.69 -56.91 0.72 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.364 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -159.8 178.49 9.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 111.452 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -61.47 129.56 41.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.323 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.1 t90 -90.83 -55.75 3.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.88 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.21 -179.4 44.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.831 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.0 t -153.69 146.0 23.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.16 0.48 . . . . 0.0 111.348 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.484 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.7 mp -129.0 127.35 65.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.7 ttp180 -86.6 111.98 21.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.015 0.436 . . . . 0.0 110.413 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HG2' HG22 ' A' ' 37' ' ' ILE . 37.9 mmtm -141.02 153.76 45.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.792 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.765 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 50.3 mtpt -69.98 155.91 39.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.744 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.16 141.39 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.831 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.847 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 89.73 -22.14 26.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.964 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 92.1 m95 -91.86 130.71 37.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.461 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -68.11 130.66 43.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.8 p -113.8 151.04 15.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.351 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -104.67 137.38 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.195 0.522 . . . . 0.0 111.407 -175.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.11 120.76 32.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.609 ' HE2' ' HD3' ' A' ' 56' ' ' LYS . 49.3 p90 -151.19 146.12 25.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -87.0 129.0 35.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 109.973 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.792 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -106.3 132.67 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.501 177.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 32.9 mmtm -131.82 113.3 15.08 Favored Pre-proline 0 C--N 1.315 -0.932 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.03 117.52 3.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.177 2.585 . . . . 0.0 113.053 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.32 -4.21 86.23 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.453 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -118.88 158.32 48.05 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 122.666 0.387 . . . . 0.0 109.976 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.29 154.69 65.41 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.437 2.091 . . . . 0.0 112.342 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.792 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 74.9 mttt -106.55 150.61 25.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.471 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -130.4 137.17 49.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.529 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 61' ' ' ILE . 8.5 mt -69.85 115.44 9.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.529 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 20.8 m -85.7 -21.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.99 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.498 ' HB2' HD23 ' A' ' 78' ' ' LEU . . . 176.85 140.81 0.07 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-O 121.589 0.709 . . . . 0.0 111.794 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 58' ' ' LEU . 4.6 mp -102.07 115.37 43.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.5 t -131.93 152.76 50.88 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.388 -169.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.662 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.3 ptpp? -153.14 163.27 40.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -81.04 135.56 35.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.4 -59.25 2.2 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.048 0.843 . . . . 0.0 112.624 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.7 t -87.17 135.22 35.12 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.213 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.847 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 4.0 Cg_exo -78.78 2.12 8.49 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.385 2.723 . . . . 0.0 112.059 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.0 t -119.06 -64.48 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.035 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' SER . 44.1 m80 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.039 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t -100.01 128.29 46.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -123.06 -82.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.298 0.57 . . . . 0.0 109.689 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.35 178.26 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.005 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.746 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 26.7 mt -103.48 124.56 48.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.894 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -109.19 107.21 17.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.297 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -110.4 149.74 29.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.075 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -124.27 155.51 38.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.6 t30 60.74 53.53 3.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.526 0.679 . . . . 0.0 110.152 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 75' ' ' CYS . 85.1 mt -72.95 139.34 46.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.298 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.893 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -91.56 45.29 1.22 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.583 0.23 . . . . 0.0 110.946 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 56.77 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.666 0.786 . . . . 0.0 112.054 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.72 -15.29 61.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.137 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.893 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.5 m-85 -99.64 106.69 18.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.015 0.436 . . . . 0.0 110.253 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.504 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.8 m -129.02 167.03 18.07 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.624 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -108.33 154.56 21.64 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.198 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.09 -126.57 3.42 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.06 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 p -96.82 -168.41 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.391 0.615 . . . . 0.0 111.814 -174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 49.7 m -136.33 141.53 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.024 172.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 25.4 p -142.28 -156.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.331 -174.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.824 ' HB3' HD21 ' A' ' 24' ' ' ASN . 32.6 t70 63.86 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.615 0.766 . . . . 0.0 112.157 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.671 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -66.88 -41.55 87.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.32 -24.88 20.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.77 0.319 . . . . 0.0 111.056 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 89' ' ' ASP . 47.1 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.762 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 51.6 p90 -89.91 146.25 24.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.72 140.04 21.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.335 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.806 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 12.4 pt20 -104.43 150.12 24.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.613 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.59 ' HA ' HG21 ' A' ' 90' ' ' VAL . 9.2 p -154.48 155.56 35.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.356 0.598 . . . . 0.0 111.399 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.98 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -76.74 108.98 10.14 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.62 118.69 19.52 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 14.4 m-70 -88.41 126.4 35.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 1.1 tm? -99.87 121.21 40.96 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 130.01 54.02 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.554 0.692 . . . . 0.0 111.497 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -106.95 151.17 25.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.743 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.33 100.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.313 0.383 . . . . 0.0 110.16 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' ARG . . . 138.58 -51.69 0.76 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.941 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 7.5 tpp180 176.49 179.56 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.452 0.301 . . . . 0.0 110.249 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.665 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.6 t-80 -41.05 130.98 2.64 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.722 0.809 . . . . 0.0 111.966 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 39.4 t90 -104.61 -53.9 2.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.75 164.88 34.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.189 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.26 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.506 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.488 ' HB ' HG21 ' A' ' 45' ' ' VAL . 2.3 mp -115.65 132.38 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.67 98.74 4.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.78 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.24 148.95 43.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 110.407 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 51.3 mtpt -64.52 153.36 39.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.47 139.56 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.564 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.967 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 92.49 -38.85 3.09 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.023 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -66.58 125.39 25.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.5 122.58 22.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.51 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.4 p -109.39 147.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.085 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 134.35 40.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.354 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 27' ' ' LEU . 90.2 m-85 -122.05 127.3 50.05 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.7 147.98 30.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.596 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 9.4 pt-20 -86.94 130.36 34.49 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.913 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 47.5 mt-10 -108.23 102.29 11.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.266 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.856 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 34.4 mmtp -99.36 129.69 28.66 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.415 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 116.36 3.27 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.349 2.033 . . . . 0.0 112.265 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.65 90.42 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 53.8 mt-30 -125.71 157.36 68.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 C-N-CA 122.381 0.272 . . . . 0.0 110.343 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.26 160.69 48.13 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.393 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 55.1 mttt -103.55 136.64 42.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.337 -173.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -132.91 135.77 45.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.677 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.5 119.93 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.558 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 32.2 m -92.69 -27.01 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.466 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.699 ' HB1' ' SG ' ' A' ' 75' ' ' CYS . . . 177.7 144.25 0.1 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.727 0.642 . . . . 0.0 111.261 173.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.1 mp -102.93 111.93 34.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.7 m -116.96 146.49 42.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.932 0.396 . . . . 0.0 111.136 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.917 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.5 pttm -155.13 161.56 41.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 9.0 t30 -80.19 143.21 33.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.301 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.2 -57.04 3.14 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.062 0.852 . . . . 0.0 112.044 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.7 m -94.74 138.77 22.12 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.406 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.967 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.5 Cg_endo -82.98 23.52 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.143 2.562 . . . . 0.0 112.008 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 4.0 t -136.34 -73.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.68 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -85.13 159.92 20.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.13 125.71 48.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.985 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -123.64 -79.34 0.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.27 174.45 10.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 85' ' ' GLY . 50.1 mt -101.28 122.51 43.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.464 0.65 . . . . 0.0 111.381 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.778 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.6 mmpt? -93.59 106.91 18.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.356 172.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.699 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 8.1 t -121.58 166.1 14.71 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.298 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.615 HG23 HD22 ' A' ' 77' ' ' ASN . 11.4 t -159.94 162.19 34.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.073 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.615 HD22 HG23 ' A' ' 76' ' ' THR . 50.3 m-80 68.67 33.56 3.78 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.78 0.675 . . . . 0.0 110.256 -176.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.892 HD22 ' HA ' ' A' ' 83' ' ' SER . 93.1 mt -59.86 139.58 57.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -97.55 65.09 1.87 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.0 111.484 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.84 -88.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.151 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.19 -21.8 77.38 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.898 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -88.43 109.66 20.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.937 0.398 . . . . 0.0 110.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.892 ' HA ' HD22 ' A' ' 78' ' ' LEU . 17.0 m -128.54 173.62 10.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.58 158.79 19.53 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.69 -0.631 . . . . 0.0 110.667 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -123.11 -151.14 8.22 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.19 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -84.15 -176.69 6.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.855 0.359 . . . . 0.0 110.186 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 39.1 m -120.72 142.94 49.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.7 p -139.55 -156.04 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.731 0.301 . . . . 0.0 111.75 -170.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.98 ' HB3' HD21 ' A' ' 24' ' ' ASN . 21.9 t70 63.61 -77.03 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.99 0.916 . . . . 0.0 112.547 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.5 m -68.08 -46.61 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 23' ' ' CYS . 3.8 pp -90.7 -41.35 11.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.712 0.291 . . . . 0.0 111.648 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.411 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 79.7 m-85 -76.37 134.21 39.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 69' ' ' HIS . 2.3 p -135.57 136.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.388 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.786 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -101.99 141.54 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.627 ' HA ' HG21 ' A' ' 90' ' ' VAL . 7.1 p -144.09 148.86 35.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.416 0.627 . . . . 0.0 112.105 -170.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.872 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -74.77 106.61 6.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.169 175.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.51 121.74 21.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.2 130.81 37.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.29 -174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -100.2 124.13 45.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.98 125.65 49.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.253 0.549 . . . . 0.0 110.686 -176.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 50.9 t80 -113.32 151.27 31.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -53.34 100.92 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.715 0.634 . . . . 0.0 110.379 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -52.16 0.82 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.241 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 20.9 tpt180 -172.74 171.77 4.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.743 0.272 . . . . 0.0 110.822 -175.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.429 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 23.7 t-80 -46.31 121.38 3.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.325 0.65 . . . . 0.0 111.289 172.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 57.9 t90 -89.93 -56.14 3.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.99 170.8 34.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.563 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.6 t -154.42 143.92 21.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.09 0.445 . . . . 0.0 110.758 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.1 mp -127.11 130.23 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.637 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.2 mtm180 -82.32 117.83 22.7 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.362 0.601 . . . . 0.0 110.726 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG3' HG23 ' A' ' 45' ' ' VAL . 72.6 mmtt -142.52 152.61 42.82 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.3 mtpt -69.16 156.74 38.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.023 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 140.3 58.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.418 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.98 -25.1 12.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.228 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 49.8 m95 -83.13 130.05 35.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 0.0 110.634 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.916 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -79.03 123.38 27.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.705 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 39' ' ' LYS . 8.7 p -106.15 154.26 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.981 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.8 140.99 29.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.502 ' CG ' HD23 ' A' ' 27' ' ' LEU . 75.6 m-85 -131.33 123.68 28.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -142.14 149.85 40.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.933 0.397 . . . . 0.0 111.265 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 11.1 pt-20 -87.41 130.04 34.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.728 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 56' ' ' LYS . 29.8 mt-10 -114.04 101.91 9.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.152 0.501 . . . . 0.0 109.827 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 71.6 mmtt -82.9 134.74 46.24 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.896 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 52.3 Cg_exo -54.55 117.05 3.53 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.54 2.16 . . . . 0.0 112.358 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.06 80.55 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.482 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.797 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 33.3 mt-30 -115.67 162.04 27.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 122.498 0.319 . . . . 0.0 110.772 -175.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 54' ' ' GLN . 57.5 Cg_endo -70.95 159.2 53.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.88 2.387 . . . . 0.0 112.803 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.863 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.4 146.39 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 -178.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -137.63 131.65 31.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.49 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.22 119.6 7.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.012 0.434 . . . . 0.0 112.046 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.4 m -100.09 -15.71 7.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.396 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.32 135.77 0.58 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.581 0.705 . . . . 0.0 111.821 176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.74 112.29 39.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.77 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.1 t -131.53 149.72 52.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.728 -169.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.916 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 pttp -155.39 163.43 40.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.42 139.22 34.13 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.318 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.38 -55.71 4.78 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.818 0.698 . . . . 0.0 112.179 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.9 t -95.86 146.64 31.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.212 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 66' ' ' SER . 3.5 Cg_exo -82.45 -1.19 10.54 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.157 2.572 . . . . 0.0 111.972 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.7 t -103.96 -79.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.405 ' HA ' HG12 ' A' ' 21' ' ' VAL . 65.7 m80 -94.27 165.04 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.155 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.1 121.97 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -119.55 -85.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.275 0.56 . . . . 0.0 109.593 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -126.31 166.34 17.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.914 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.77 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 14.2 mt -102.99 123.39 46.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.0 110.638 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.713 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -98.88 104.65 16.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.808 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -112.84 146.1 39.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.427 . . . . 0.0 110.658 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -129.23 155.45 45.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.874 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.4 60.2 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.691 0.619 . . . . 0.0 110.37 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.3 mt -77.6 157.91 30.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.364 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -115.46 71.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.743 0.306 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.96 -92.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.171 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.16 55.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.994 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.6 m-85 -72.65 109.56 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.314 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.592 ' HA ' HD22 ' A' ' 78' ' ' LEU . 19.6 m -140.97 166.71 24.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.56 168.49 9.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.045 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -139.0 -171.49 12.19 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.049 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -69.16 169.77 11.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.463 0.649 . . . . 0.0 111.622 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.4 m -105.76 153.84 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.669 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.5 p -139.88 -156.44 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.047 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.872 ' HB3' HD21 ' A' ' 24' ' ' ASN . 4.1 t70 62.61 -80.17 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.643 HG23 HD23 ' A' ' 91' ' ' LEU . 1.3 m -66.06 -41.62 89.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.222 -175.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.643 HD23 HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.464 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.387 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 17.8 p90 -58.5 131.15 49.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.284 0.564 . . . . 0.0 110.589 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.35 139.78 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.92 -170.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.68 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -99.7 143.34 30.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.659 175.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.54 ' CB ' HD23 ' A' ' 91' ' ' LEU . 7.5 p -151.72 159.19 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.886 0.374 . . . . 0.0 111.463 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.837 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -82.16 117.25 22.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -85.16 119.44 25.55 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -90.57 130.37 36.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.829 0.347 . . . . 0.0 111.206 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.532 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -98.1 126.1 43.39 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -110.02 116.53 31.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.575 0.703 . . . . 0.0 110.68 -175.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -94.95 135.12 36.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.8 101.92 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.446 0.641 . . . . 0.0 110.281 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.73 -56.29 0.61 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.607 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -175.4 161.69 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.492 0.317 . . . . 0.0 110.727 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -37.86 132.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.908 0.883 . . . . 0.0 112.195 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -100.79 -54.8 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.593 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.99 -179.33 40.49 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.338 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -153.83 147.7 25.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.031 0.416 . . . . 0.0 111.354 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.4 mp -134.02 136.6 53.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 46.0 mtm180 -77.71 130.17 36.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.294 0.568 . . . . 0.0 111.36 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -150.39 148.22 28.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.542 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.68 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 46.6 mtpt -73.97 149.94 41.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.069 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -61.6 138.92 58.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 93.75 -23.7 29.53 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.143 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -101.44 136.16 41.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.824 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -82.57 155.07 24.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.495 0.664 . . . . 0.0 111.117 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.6 p -126.92 150.19 32.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.585 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 135.77 33.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.421 . . . . 0.0 111.301 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.709 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.2 m-85 -125.9 128.27 47.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 169.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 49.9 p90 -146.18 153.75 40.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.396 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -100.04 136.64 39.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -115.68 110.85 19.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.567 0.699 . . . . 0.0 111.474 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.2 105.28 42.39 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -44.29 121.63 3.24 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.324 2.682 . . . . 0.0 112.683 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.27 -24.15 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.65 151.43 57.08 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.004 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.72 149.25 54.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.227 1.952 . . . . 0.0 111.049 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 51.8 mttt -77.24 119.0 20.29 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.823 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 19.5 tpp180 -94.1 133.77 37.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.356 -168.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.29 107.78 0.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.195 0.522 . . . . 0.0 110.28 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.2 m -91.56 -22.71 6.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.295 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -168.68 135.53 1.9 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 111.684 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.11 111.18 33.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.7 t -132.88 146.45 51.82 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.899 -168.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.824 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 29.6 pttt -145.25 164.92 29.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.955 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -78.27 136.81 37.83 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.799 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -48.67 -37.77 19.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.474 -171.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 22.1 t -105.62 140.74 21.48 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.06 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.568 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 4.2 Cg_exo -77.83 4.35 6.16 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.022 2.482 . . . . 0.0 111.943 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.1 t -121.4 -77.33 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.68 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' ' 66' ' ' SER . 52.8 m80 -94.06 163.75 13.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 p -96.7 125.38 41.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 50.6 m-20 -123.21 -87.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 33.9 m-85 -129.24 177.56 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.018 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.758 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.3 mt -103.17 125.12 49.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.153 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 14.1 mptt -106.85 106.26 16.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.034 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -115.56 150.44 36.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.022 -174.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -119.68 150.57 40.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 7.2 t30 64.74 103.84 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.705 0.628 . . . . 0.0 110.722 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.544 HD22 ' HA ' ' A' ' 83' ' ' SER . 98.1 mt -117.98 127.63 54.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -91.26 76.8 5.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.633 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.06 -88.52 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.456 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.36 -6.36 61.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.061 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.3 m-85 -94.24 115.84 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.893 0.378 . . . . 0.0 110.809 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.544 ' HA ' HD22 ' A' ' 78' ' ' LEU . 17.2 m -144.98 168.64 19.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.582 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -99.86 154.77 18.08 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -110.67 -58.97 0.49 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.603 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.26 -178.32 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.9 m -126.9 141.36 51.83 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.7 p -142.32 -155.96 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.16 0.505 . . . . 0.0 111.812 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.837 ' HB3' HD21 ' A' ' 24' ' ' ASN . 26.8 t70 66.95 -83.45 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.113 168.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 7.3 m -71.07 -33.36 51.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.843 0.354 . . . . 0.0 111.027 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.54 HD23 ' CB ' ' A' ' 23' ' ' CYS . 4.1 pp -88.73 -31.94 18.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 CA--C 1.532 0.287 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.84 -175.542 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 18.2 p90 -86.79 131.41 34.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.43 142.11 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.895 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 1.027 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.28 147.53 25.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 10.6 p -149.49 147.91 28.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.454 0.645 . . . . 0.0 112.405 -175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 1.071 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -72.39 110.66 6.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.769 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 5.4 m80 -75.85 107.28 7.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.802 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 12.3 m-70 -79.68 126.63 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.106 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.533 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -99.33 125.26 44.96 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -107.55 125.42 51.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.472 0.653 . . . . 0.0 110.978 -176.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -100.14 151.13 21.77 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -48.29 101.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.458 0.474 . . . . 0.0 111.009 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.5 -53.03 0.68 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.235 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -147.85 160.95 42.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.457 0.646 . . . . 0.0 112.67 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -48.78 133.05 17.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.177 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -102.91 -55.48 2.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.127 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -177.9 38.01 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.467 ' C ' HD12 ' A' ' 37' ' ' ILE . 5.6 t -153.92 141.44 19.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.204 0.502 . . . . 0.0 110.037 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.467 HD12 ' C ' ' A' ' 36' ' ' THR . 1.8 mp -116.31 123.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 6.1 tpp85 -75.84 99.4 4.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.841 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -145.02 145.76 31.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.133 0.492 . . . . 0.0 111.365 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 12.7 ptmt -64.69 151.82 43.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.002 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.93 142.57 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.866 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.872 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.62 -30.61 10.01 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.316 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.577 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 76.2 m95 -90.17 139.68 30.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.21 130.59 40.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.957 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.3 p -121.46 153.43 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.141 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.73 142.39 28.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 111.059 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.769 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 77.3 m-85 -127.89 133.81 49.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 170.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.591 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 45.6 p90 -148.92 151.05 33.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.706 0.289 . . . . 0.0 110.689 -175.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.29 143.78 27.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.611 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.942 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 11.3 pt-20 -126.67 102.02 6.89 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.933 0.873 . . . . 0.0 111.158 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.17 128.15 41.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.02 116.94 2.71 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.57 2.18 . . . . 0.0 112.487 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.53 -29.27 12.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.372 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -96.54 153.09 38.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.24 153.4 74.59 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.588 2.192 . . . . 0.0 111.732 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.942 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 21.1 mmtp -70.57 117.7 12.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.43 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -105.81 125.67 51.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.598 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mt -57.02 120.83 8.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 110.784 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.1 m -107.74 -17.74 7.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.35 138.41 0.94 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.48 0.657 . . . . 0.0 111.62 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.26 112.38 40.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -130.69 150.89 51.67 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.953 -168.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.1 ptpp? -151.28 162.74 40.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.44 144.61 31.27 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.43 -56.96 5.13 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.767 0.667 . . . . 0.0 111.918 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 15.0 m -97.05 143.06 25.48 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.585 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.872 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 Cg_endo -83.81 22.19 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.25 2.633 . . . . 0.0 112.343 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.0 t -136.03 -76.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -81.28 159.55 24.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.7 t -98.81 122.32 41.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.998 0.427 . . . . 0.0 109.957 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -112.09 -83.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.591 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -145.76 179.99 7.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.838 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.729 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 16.3 mt -101.75 121.78 42.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -100.6 104.87 16.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.013 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -116.57 149.22 40.0 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.91 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -128.17 156.32 43.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 63.74 59.34 1.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.752 0.658 . . . . 0.0 110.286 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.662 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.6 mt -77.84 131.63 37.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.428 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -90.33 66.65 6.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 111.538 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.2 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.107 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.47 -10.15 83.85 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.089 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.7 m-85 -96.43 114.14 25.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.662 ' HA ' HD22 ' A' ' 78' ' ' LEU . 38.6 m -143.98 172.82 12.34 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.714 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -106.98 162.64 13.66 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.55 -126.91 3.95 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.02 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 14.1 t -104.4 -176.37 3.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 3.9 p -132.52 141.82 48.93 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.442 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 28.8 p -142.67 -157.58 0.79 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.962 0.41 . . . . 0.0 111.967 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 1.071 ' HB3' HD21 ' A' ' 24' ' ' ASN . 21.1 t70 72.21 -62.43 0.46 Allowed 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.799 168.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.637 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 1.5 m -85.07 -31.89 7.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.481 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.515 HD23 ' HB3' ' A' ' 23' ' ' CYS . 4.1 pp -89.77 -34.66 16.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.667 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.1 p . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.37 -178.736 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.717 0.294 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 39.1 p90 -88.8 139.59 30.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -120.71 138.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.571 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -98.71 142.36 30.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.689 175.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.624 ' HA ' HG21 ' A' ' 90' ' ' VAL . 7.6 p -155.68 159.45 39.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 111.613 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.984 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -80.38 111.78 17.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.099 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.621 ' HD2' HG11 ' A' ' 45' ' ' VAL . 3.3 m-70 -81.82 115.95 21.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -87.85 129.65 35.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.562 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.5 tm? -98.6 127.78 44.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -103.64 121.72 43.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.71 -175.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.609 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 85.4 t80 -94.31 141.29 28.73 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -54.78 101.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 110.699 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.57 -42.9 1.39 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.361 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -168.86 153.09 5.62 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.018 0.437 . . . . 0.0 111.672 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -38.55 126.22 1.43 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.07 0.948 . . . . 0.0 112.538 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.6 t90 -94.25 -55.77 3.07 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.98 -175.07 37.42 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.781 -0.724 . . . . 0.0 111.899 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.6 t -154.39 147.89 25.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.055 0.428 . . . . 0.0 110.882 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' CE1' ' A' ' 47' ' ' PHE . 3.3 mp -124.4 126.22 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 2.9 tpp180 -77.84 93.7 4.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -127.7 144.54 51.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 36.4 mtpt -70.72 151.86 44.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.65 142.05 57.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.47 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 91.88 -27.94 9.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.157 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.465 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 27.1 m95 -84.52 128.28 34.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.08 135.07 46.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.475 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.621 HG11 ' HD2' ' A' ' 25' ' ' HIS . 7.3 p -121.56 142.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.841 0.353 . . . . 0.0 110.764 -176.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.14 141.81 28.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.706 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 73.9 m-85 -130.65 134.98 47.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.46 167.75 21.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.733 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 15.5 pt-20 -107.54 125.39 51.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.422 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' ' HZ2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -117.52 121.67 41.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -129.73 149.97 74.47 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.24 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.13 117.81 3.96 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.447 2.765 . . . . 0.0 112.737 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.29 -13.43 45.64 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.888 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.75 142.38 25.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.965 0.412 . . . . 0.0 111.549 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.1 155.49 67.95 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.834 2.356 . . . . 0.0 111.568 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.676 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.487 -176.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -130.52 144.16 51.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 58' ' ' LEU . 14.9 mt -60.54 130.85 48.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.465 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 49' ' ' GLU . 33.5 m -117.2 -20.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -166.73 137.67 3.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.433 0.635 . . . . 0.0 111.137 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.54 110.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.706 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.9 t -130.52 168.16 17.5 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.863 -167.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.712 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 19.5 pttp -174.45 163.83 3.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.606 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.1 133.42 44.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.568 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -45.59 -41.9 10.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 114.009 -1.451 . . . . 0.0 113.177 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.9 t -102.15 138.15 19.66 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.191 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.3 Cg_endo -75.89 1.43 8.16 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.642 2.228 . . . . 0.0 111.792 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.5 t -118.81 -78.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.555 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 66' ' ' SER . 45.7 m-70 -89.91 162.53 15.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.2 t -97.25 129.12 44.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.067 0.46 . . . . 0.0 110.446 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -125.49 -81.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -139.67 174.82 10.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.828 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.9 mt -103.6 120.57 41.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.721 0.296 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 5.6 mptp? -106.54 110.53 22.75 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m -112.81 149.78 32.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.357 -173.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -111.8 150.61 30.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 9.5 t30 59.62 90.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.675 0.61 . . . . 0.0 110.473 -174.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.0 117.4 34.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -84.21 61.74 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.046 0.451 . . . . 0.0 111.352 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.57 -91.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.265 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 5.31 84.73 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.41 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.6 m-85 -114.43 108.84 17.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 0.0 110.139 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 m -147.29 166.52 26.84 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.546 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.32 153.78 19.02 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.321 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.66 -63.82 0.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.486 -171.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 t -175.91 -169.94 0.36 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 m -129.09 143.39 50.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.0 p -140.23 -152.51 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.995 -0.093 . . . . 0.0 110.97 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.984 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.6 t70 63.0 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.962 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -69.12 -45.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.723 0.297 . . . . 0.0 111.778 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.02 -24.33 22.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 111.259 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.4 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -175.647 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.7 m-85 -47.82 130.01 14.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.309 0.576 . . . . 0.0 110.799 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.75 143.77 34.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.266 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.932 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -99.3 142.43 30.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.14 177.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 6.0 p -148.84 146.21 27.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.512 . . . . 0.0 111.846 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.985 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -77.27 115.52 17.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 110.302 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.4 124.49 29.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.281 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.531 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 10.8 m170 -94.25 126.27 39.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.92 0.39 . . . . 0.0 111.533 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.4 tm? -97.89 127.89 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -105.07 128.86 53.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.929 -175.139 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 73.3 t80 -104.26 148.22 26.6 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.05 99.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.0 109.756 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -49.83 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.626 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -173.99 175.35 2.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.526 0.203 . . . . 0.0 110.619 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.681 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 44.9 t-80 -54.3 139.14 37.36 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.794 0.438 . . . . 0.0 110.945 176.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 60.9 t90 -107.42 -56.01 2.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.736 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.78 167.45 33.16 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.035 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 26' ' ' HIS . 0.9 OUTLIER -151.89 136.78 17.2 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 120.99 0.424 . . . . 0.0 112.025 -176.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.5 mp -126.2 132.78 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.957 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 34.9 ttp180 -94.21 113.92 25.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' HG2' HG22 ' A' ' 37' ' ' ILE . 73.9 mmtt -138.1 153.95 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.298 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.932 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.9 mtpt -68.06 157.84 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 111.251 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -69.87 142.47 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.41 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.24 10.98 81.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.487 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -116.75 156.44 27.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . . . -90.55 120.44 31.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.407 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 62' ' ' CYS . 14.7 p -105.38 141.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.569 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 133.61 39.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.182 0.515 . . . . 0.0 110.671 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.488 ' CG ' HD23 ' A' ' 27' ' ' LEU . 66.5 m-85 -125.65 125.14 42.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.679 ' HB3' HD23 ' A' ' 58' ' ' LEU . 42.6 p90 -147.32 148.03 30.96 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.998 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.6 125.19 34.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.57 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.659 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 8.8 pt-20 -128.54 102.78 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.02 0.914 . . . . 0.0 110.019 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 29.2 mtmt -104.13 118.24 57.48 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.572 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 1.2 Cg_endo -42.92 117.34 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.694 2.929 . . . . 0.0 113.067 -172.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.18 -20.83 32.4 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.012 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 47.5 mt-30 -115.84 143.4 30.69 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.654 0.264 . . . . 0.0 110.91 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 24.4 Cg_exo -64.56 161.99 32.98 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.215 2.61 . . . . 0.0 111.93 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.659 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 27.9 mttm -90.93 143.43 26.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.116 -169.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.641 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -134.53 133.29 40.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.679 HD23 ' HB3' ' A' ' 48' ' ' TYR . 13.3 mt -64.09 126.67 28.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 0.0 111.052 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 20.5 m -113.02 -17.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -171.18 135.53 0.99 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.484 0.659 . . . . 0.0 111.799 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -113.17 112.13 39.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 167.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -120.56 146.12 46.64 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.356 -166.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 24.9 mmtm -120.01 164.67 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 70' ' ' CYS . 9.9 t30 -93.66 137.06 33.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.6 -55.28 1.89 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.115 0.884 . . . . 0.0 112.679 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.438 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 39.9 t -103.12 141.62 22.86 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.823 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.48 -10.55 13.3 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.591 2.194 . . . . 0.0 111.649 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 16.2 t -100.32 -59.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.497 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -104.96 164.52 11.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.407 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.431 ' HA ' HD21 ' A' ' 64' ' ' ASN . 5.9 p -100.87 122.02 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.302 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.87 -90.09 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.111 0.481 . . . . 0.0 110.709 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -131.37 176.52 8.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.448 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.801 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.7 mt -105.79 128.41 53.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -170.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -109.41 105.26 14.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.772 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.7 m -119.94 152.68 37.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.973 -171.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 t -124.45 174.1 8.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.18 34.49 21.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.636 0.585 . . . . 0.0 111.606 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -66.08 131.01 45.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.795 -176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -100.92 68.15 1.26 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.674 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.07 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.538 0.735 . . . . 0.0 112.821 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.12 -14.05 83.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.966 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.1 m-85 -96.92 111.42 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.994 0.426 . . . . 0.0 110.753 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 78' ' ' LEU . 45.1 m -148.51 168.53 22.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.772 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -112.1 154.61 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.872 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -106.31 -79.22 1.23 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.895 -171.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.402 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 13.4 t -161.1 -174.91 4.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 27.8 m -116.06 144.04 44.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.9 p -139.75 -155.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.103 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.985 ' HB3' HD21 ' A' ' 24' ' ' ASN . 20.9 t70 66.67 -81.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.593 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -65.23 -40.91 90.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.813 0.339 . . . . 0.0 111.591 -175.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.8 -30.24 19.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.668 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.661 -178.699 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HD1' ' H ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -85.32 125.81 33.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -132.93 139.44 49.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.865 -172.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.689 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -101.51 142.15 33.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.947 ' HA ' HG21 ' A' ' 90' ' ' VAL . 26.1 p -143.69 150.14 38.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.316 -172.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.957 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -74.31 114.4 12.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 175.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.527 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -83.18 113.79 20.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.601 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -85.39 127.37 34.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.173 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.5 tm? -100.06 132.44 45.42 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -99.46 124.67 44.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.599 -178.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.932 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.8 t80 -93.61 150.0 20.78 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -53.74 99.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 110.309 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.85 -68.32 0.46 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.189 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -142.89 179.19 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 112.128 -171.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -47.71 133.85 13.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.801 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.932 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 83.8 t90 -103.15 -56.62 2.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.17 -178.57 42.49 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.022 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 13.3 t -153.11 138.7 17.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.631 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.2 mp -116.11 129.89 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.571 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.645 HH11 HG13 ' A' ' 90' ' ' VAL . 2.3 tpp180 -80.84 99.84 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.419 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.0 mmtm -140.9 152.95 45.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.224 0.535 . . . . 0.0 111.385 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.4 mtpt -67.18 154.97 39.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.826 -176.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 54.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.187 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 91.94 -26.63 12.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.177 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -81.14 134.73 35.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.007 0.432 . . . . 0.0 110.842 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -78.21 121.75 24.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.972 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.1 p -111.87 147.31 15.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 141.72 28.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 -176.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.75 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.0 m-85 -127.56 138.29 52.84 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 22.4 p90 -153.33 159.63 42.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 -172.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.48 137.37 44.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HG2' ' HG2' ' A' ' 56' ' ' LYS . 22.9 mt-10 -112.5 102.0 10.13 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -90.56 143.59 29.38 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.57 116.51 3.34 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.512 2.141 . . . . 0.0 111.788 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.07 -17.74 57.68 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.292 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -101.56 148.43 35.22 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.63 153.41 59.82 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 110.615 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.569 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 15.6 mttp -62.61 127.85 33.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.08 -173.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -103.82 119.97 40.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.89 115.53 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.638 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 25.9 m -96.88 -22.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.614 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 59' ' ' VAL . . . 176.27 144.61 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.612 0.57 . . . . 0.0 111.315 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.504 HD13 HD22 ' A' ' 77' ' ' ASN . 4.4 mp -101.73 116.98 46.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.75 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.6 t -128.63 149.42 50.66 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.321 -171.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.659 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.2 ptpt -144.26 162.29 36.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -85.71 133.69 34.0 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.166 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.29 -53.51 5.17 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.092 0.87 . . . . 0.0 112.959 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 33.2 t -93.46 139.59 22.93 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.318 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 71.7 Cg_endo -78.87 -3.51 13.28 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.594 2.196 . . . . 0.0 111.827 173.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -111.33 -69.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.423 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.436 ' O ' ' HB3' ' A' ' 66' ' ' SER . 35.6 m80 -94.79 161.8 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.004 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.0 p -98.51 121.17 40.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -121.41 -88.48 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 0.0 109.707 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.04 171.23 12.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.47 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.686 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 37.8 mt -103.71 119.93 39.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.869 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.9 mmpt? -96.05 104.47 16.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 30.7 m -100.87 152.88 20.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.033 0.444 . . . . 0.0 111.361 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -133.39 157.86 44.48 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.553 173.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.504 HD22 HD13 ' A' ' 61' ' ' ILE . 90.6 m-20 59.43 49.57 8.56 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.469 0.481 . . . . 0.0 111.066 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 75' ' ' CYS . 97.2 mt -65.87 140.81 58.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.91 79.0 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.944 0.402 . . . . 0.0 110.76 -178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 67.67 -77.7 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.798 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.83 -13.1 6.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.955 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 50.6 m-85 -71.22 118.09 13.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -151.2 171.59 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.705 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -92.24 163.24 13.99 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.752 0.311 . . . . 0.0 110.56 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.24 -62.64 0.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.511 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.11 -171.44 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.8 m -129.83 143.18 50.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.6 p -141.66 -160.74 1.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.698 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.957 ' HB3' HD21 ' A' ' 24' ' ' ASN . 19.5 t70 64.51 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.388 171.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.947 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -62.25 -38.29 80.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.901 0.382 . . . . 0.0 111.206 -176.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.22 -37.91 15.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.733 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.53 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.03 -179.45 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.6 m-85 -53.32 141.22 24.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.941 0.4 . . . . 0.0 110.419 173.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.527 HG13 ' SG ' ' A' ' 70' ' ' CYS . 1.5 p -142.39 133.7 25.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.606 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -96.52 145.66 25.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 21.6 p -150.23 149.1 29.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.486 0.66 . . . . 0.0 111.876 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.926 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.53 114.37 14.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.857 173.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.04 117.96 21.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -87.06 134.09 33.53 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.804 0.335 . . . . 0.0 111.895 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.587 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -99.55 123.59 43.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -105.78 122.29 45.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.475 0.655 . . . . 0.0 110.858 -176.502 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -95.35 146.66 24.22 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -60.8 100.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.0 -52.61 0.68 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.825 -174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 17.6 tpt180 -174.94 177.9 1.9 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.744 0.272 . . . . 0.0 111.428 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.529 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.5 t-80 -51.23 128.13 21.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.516 0.727 . . . . 0.0 111.631 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.705 ' HZ2' ' H ' ' A' ' 50' ' ' GLU . 57.2 t90 -95.65 -56.8 2.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.56 173.71 44.97 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 8.8 t -155.24 146.6 22.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.206 0.503 . . . . 0.0 111.497 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.81 133.85 66.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.405 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.621 HH11 ' HB3' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -76.09 113.55 13.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 11.9 tppt? -143.72 150.72 39.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 21.0 ttmt -83.25 147.42 28.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -53.86 139.59 33.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.966 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 98.2 -39.6 2.72 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.447 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -81.2 137.19 35.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 110.608 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -76.34 136.66 39.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.646 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 62' ' ' CYS . 10.0 p -118.39 148.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.708 ' HE ' ' HE1' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -89.01 143.32 26.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.407 . . . . 0.0 110.899 -177.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 55.0 m-85 -128.31 143.28 51.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.708 ' HE1' ' HE ' ' A' ' 46' ' ' ARG . 36.7 p90 -152.51 156.48 39.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.814 0.34 . . . . 0.0 110.58 -174.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 8.5 pt-20 -100.17 130.07 46.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.753 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -120.32 101.08 7.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.963 0.887 . . . . 0.0 110.497 175.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -85.19 141.53 37.38 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.816 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.19 116.39 2.22 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.847 2.365 . . . . 0.0 112.894 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.73 -30.52 6.48 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.171 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -83.15 153.33 66.27 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.719 0.295 . . . . 0.0 111.228 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 153.9 76.15 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 111.186 171.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.753 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 32.2 mttm -94.54 126.1 39.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.99 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 7.2 ttm-85 -94.58 123.53 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.261 -174.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -61.15 102.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.59 -19.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.79 146.92 0.35 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.158 0.504 . . . . 0.0 111.51 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.89 118.64 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.716 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 9.1 t -133.82 150.88 51.42 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.289 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.4 ptpt -146.32 162.75 37.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.21 138.65 36.87 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.439 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.93 -57.53 2.37 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.38 1.05 . . . . 0.0 112.677 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.7 t -93.54 138.3 23.0 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.156 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -76.25 -0.76 10.7 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.641 2.228 . . . . 0.0 111.879 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -115.34 -66.45 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.73 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' SER . 53.5 m-70 -98.21 163.89 12.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.527 ' SG ' HG13 ' A' ' 21' ' ' VAL . 97.9 m -99.23 122.33 42.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.398 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -125.04 -79.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.305 0.574 . . . . 0.0 110.218 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.53 174.18 10.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.827 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.706 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 28.3 mt -104.51 127.44 52.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.235 0.541 . . . . 0.0 111.387 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -104.69 105.66 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.35 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.727 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 5.9 m -106.14 163.64 12.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.244 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -144.22 157.91 44.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.3 46.61 5.9 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.664 0.603 . . . . 0.0 111.34 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.5 mt -67.28 147.89 52.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.691 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -107.57 69.85 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 111.465 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.22 -93.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.8 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.91 -5.87 88.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.184 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -98.71 112.98 24.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.233 0.539 . . . . 0.0 110.485 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' HD22 ' A' ' 78' ' ' LEU . 20.1 m -140.02 169.12 18.29 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.727 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -108.0 156.78 18.85 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.569 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -121.07 3.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.896 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -110.35 -169.6 1.49 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.616 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 18.9 p -125.24 142.74 51.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.2 p -140.4 -155.86 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.538 0.208 . . . . 0.0 111.046 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.926 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.3 t70 67.25 -72.9 0.08 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.828 0.851 . . . . 0.0 112.33 170.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 m -78.63 -42.76 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -89.51 -45.6 9.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.377 -178.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.449 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 15.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.579 0.228 . . . . 0.0 110.66 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.7 p90 -58.19 136.56 57.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.23 139.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.463 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.595 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -116.88 141.6 48.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 90' ' ' VAL . 20.5 p -147.33 164.12 34.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.111 0.481 . . . . 0.0 111.373 -171.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.898 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.3 p30 -79.35 115.61 19.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.585 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m-70 -83.22 121.53 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -89.53 138.69 31.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.477 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -109.65 130.32 55.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 170.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.537 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -100.43 123.5 44.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.385 0.612 . . . . 0.0 111.032 -178.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.964 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 21.4 t80 -95.72 151.63 19.19 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 30' ' ' ASN . 10.0 m120 -57.44 100.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.079 0.466 . . . . 0.0 110.514 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.2 -57.28 0.69 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.62 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -147.38 178.47 8.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.193 0.52 . . . . 0.0 111.87 -171.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -62.5 133.7 55.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.044 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.964 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 84.3 t90 -101.25 -57.61 2.05 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.218 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.31 -179.5 40.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.118 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 12.1 t -154.68 148.75 25.82 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.65 0.262 . . . . 0.0 110.892 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.687 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.6 mp -128.15 125.54 64.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -75.97 99.5 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.952 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.687 ' HG2' HG22 ' A' ' 37' ' ' ILE . 67.5 mmtt -135.15 153.12 52.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.0 mtpt -72.11 153.0 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 142.39 58.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 90.96 -25.86 12.77 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 -178.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.562 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 86.0 m95 -86.02 133.7 33.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.605 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.665 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.91 135.64 48.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 62' ' ' CYS . 11.2 p -122.54 148.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.1 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -90.6 147.88 23.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.705 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 61.1 m-85 -136.38 137.28 40.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.0 p90 -145.55 154.29 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.515 0.198 . . . . 0.0 110.549 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.441 ' HB3' HG11 ' A' ' 59' ' ' VAL . 15.0 pt-20 -95.51 135.43 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.073 0.463 . . . . 0.0 110.577 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.62 ' HB2' ' HZ2' ' A' ' 34' ' ' TRP . 1.6 mm-40 -94.84 106.39 18.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.418 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.652 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 75.9 mmtt -106.81 123.46 38.48 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.48 117.26 3.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.848 2.366 . . . . 0.0 112.339 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.46 -6.68 75.91 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.479 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.652 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 28.3 mt-30 -113.25 158.63 37.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 122.664 0.385 . . . . 0.0 110.69 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.85 155.53 62.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.529 2.153 . . . . 0.0 111.944 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 56' ' ' LYS . 1.9 mptp? -80.82 130.01 34.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.299 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.563 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.4 tpm_? -108.19 124.09 49.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.354 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -61.0 106.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.077 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 49' ' ' GLU . 29.5 m -94.2 -17.06 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.927 -172.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.34 138.08 2.47 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.376 0.608 . . . . 0.0 112.238 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.81 111.93 38.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.6 t -130.93 155.11 47.33 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.193 -168.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.665 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.7 ptpt -157.59 158.56 35.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -77.95 131.09 37.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.659 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -55.2 -28.3 52.03 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.022 0.826 . . . . 0.0 112.958 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 34.0 t -104.64 131.65 21.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.683 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 77.6 Cg_endo -80.1 2.54 8.37 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.65 2.233 . . . . 0.0 112.415 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 13.2 t -121.31 -65.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.667 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.582 ' O ' ' HB3' ' A' ' 66' ' ' SER . 69.5 t60 -97.94 160.37 14.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 110.025 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.3 p -100.94 128.62 46.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.071 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -129.13 -86.63 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.036 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -132.14 169.72 16.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.544 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.74 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 19.0 mt -102.76 120.1 39.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.157 0.503 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.659 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 4.1 mptp? -100.79 106.27 17.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.479 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.634 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.5 m -108.81 152.49 24.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.776 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -125.73 156.1 39.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.729 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 61.9 47.45 6.0 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.611 0.57 . . . . 0.0 111.773 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 75' ' ' CYS . 81.2 mt -66.77 145.91 55.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -88.8 72.95 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.2 -93.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.15 -17.13 30.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 40.4 m-85 -72.38 109.37 6.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.166 0.507 . . . . 0.0 109.885 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' HD22 ' A' ' 78' ' ' LEU . 4.4 p -139.14 175.93 9.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.017 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.34 169.1 9.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.768 0.318 . . . . 0.0 110.652 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.82 -159.24 10.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.861 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 t -77.29 -178.09 4.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.475 ' HB2' HD21 ' A' ' 91' ' ' LEU . 41.2 m -116.8 144.75 44.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.5 p -139.67 -157.92 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.525 0.202 . . . . 0.0 111.335 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.898 ' HB3' HD21 ' A' ' 24' ' ' ASN . 27.9 t70 65.14 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.955 0.902 . . . . 0.0 112.43 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.6 m -71.4 -47.67 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.3 pp -88.97 -30.34 18.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.688 0.28 . . . . 0.0 111.079 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.6 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -176.574 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 41.1 p90 -58.81 142.06 51.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.93 0.395 . . . . 0.0 110.059 175.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.42 139.37 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.322 0.582 . . . . 0.0 111.802 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.745 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.71 140.93 47.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.577 173.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 7.7 p -148.44 151.58 35.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.951 0.405 . . . . 0.0 111.842 -171.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.937 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -73.01 102.63 3.55 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.414 0.626 . . . . 0.0 110.573 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.784 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 4.7 m80 -69.95 116.55 10.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.382 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.9 m-70 -93.57 128.98 39.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.439 . . . . 0.0 111.43 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.503 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.487 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -91.85 123.63 35.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.487 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.561 ' HB2' ' CB ' ' A' ' 34' ' ' TRP . 37.2 t80 -94.18 149.59 21.1 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -52.04 99.45 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.475 0.484 . . . . 0.0 110.038 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.14 -70.86 0.51 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.954 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -149.15 178.97 8.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.087 0.47 . . . . 0.0 112.031 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -53.62 132.7 41.05 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.856 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 29' ' ' TYR . 8.1 t-105 -128.34 -57.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.073 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 26' ' ' HIS . . . -98.93 150.62 19.34 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.314 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -151.39 108.07 3.51 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.73 113.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.835 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 21.9 ttp180 -77.87 93.56 4.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 109.768 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 15.6 tppt? -116.34 153.0 32.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.036 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.745 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.5 mtpt -79.94 149.33 30.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.673 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.05 137.31 56.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 97.08 -20.24 51.61 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.031 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.499 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 84.6 m95 -95.9 133.11 40.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.769 0.319 . . . . 0.0 110.223 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.48 130.42 40.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.162 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.569 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 14.8 p -116.09 143.18 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.906 0.384 . . . . 0.0 110.382 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -95.94 143.27 27.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.226 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.784 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 86.7 m-85 -120.93 137.96 54.35 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.8 p90 -144.51 157.96 43.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.399 0.619 . . . . 0.0 111.371 -173.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 21.8 pt-20 -97.78 126.42 43.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.939 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.789 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 7.7 pt-20 -121.93 102.09 7.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.715 0.769 . . . . 0.0 109.824 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -116.15 151.77 47.05 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.237 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.95 116.14 2.45 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.957 2.438 . . . . 0.0 112.759 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.57 50.07 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.312 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.452 HE21 ' HB3' ' A' ' 54' ' ' GLN . 18.5 mt-30 -102.14 143.81 27.35 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.196 0.522 . . . . 0.0 112.105 -173.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 13.3 Cg_exo -70.23 166.11 29.26 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.214 2.609 . . . . 0.0 110.429 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.789 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 50.3 mttt -94.16 110.67 22.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.36 -168.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 9.5 ttp180 -100.7 144.2 29.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.579 -174.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 46' ' ' ARG . 14.1 mt -64.94 125.35 24.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.137 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 29.8 m -111.3 -18.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.535 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -172.47 140.6 1.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.446 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -113.31 113.28 43.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.679 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -133.73 162.64 31.42 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.595 -169.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.3 ptpt -158.21 163.39 37.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.91 132.88 35.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.34 -54.7 3.66 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.155 0.909 . . . . 0.0 112.795 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -95.22 146.77 31.91 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.428 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 83.4 Cg_endo -86.57 10.99 3.42 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.769 2.313 . . . . 0.0 112.485 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 10.8 t -122.64 -73.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.638 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -95.58 163.47 13.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.1 t -98.08 125.91 43.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -120.07 -80.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.672 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -139.52 176.36 8.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.75 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.668 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.8 mt -106.72 120.43 41.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.828 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -100.22 104.02 15.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 22.1 m -105.62 150.32 25.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 112.074 -172.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 t -132.26 156.23 46.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.458 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.6 t30 57.14 77.7 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.758 0.661 . . . . 0.0 111.102 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.616 HD22 ' HA ' ' A' ' 83' ' ' SER . 92.0 mt -94.8 137.31 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.268 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.08 80.71 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 110.685 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.61 -94.26 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.686 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.99 -5.29 53.58 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.37 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 33.6 m-85 -83.39 113.58 20.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.988 0.423 . . . . 0.0 110.116 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.616 ' HA ' HD22 ' A' ' 78' ' ' LEU . 12.3 m -142.44 166.44 24.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -89.47 162.89 15.5 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.91 -63.28 0.24 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.884 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -175.85 -167.83 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 19.7 m -135.0 144.08 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.6 p -140.11 -152.15 0.4 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.937 ' HB3' HD21 ' A' ' 24' ' ' ASN . 27.8 t70 66.07 -70.11 0.1 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.018 0.927 . . . . 0.0 112.533 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 23' ' ' CYS . 4.5 m -80.14 -42.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.746 0.308 . . . . 0.0 111.651 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.4 pp -89.9 -33.2 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.745 0.307 . . . . 0.0 111.443 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 120.679 0.276 . . . . 0.0 110.716 -177.271 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.671 ' HD1' ' HA ' ' A' ' 68' ' ' VAL . 28.6 m-85 -53.89 131.32 39.81 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 110.301 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 t -111.14 130.99 63.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.135 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -93.15 141.08 28.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.662 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 92.8 m -151.72 144.36 24.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.782 -173.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.822 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -74.7 109.72 8.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.019 0.438 . . . . 0.0 109.861 176.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.93 113.69 12.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' THR . 9.8 m-70 -84.46 130.8 34.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.332 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.598 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -99.04 127.8 45.05 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -98.35 122.76 41.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.386 0.613 . . . . 0.0 110.846 -176.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.054 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 1.8 t80 -100.39 152.7 20.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.42 99.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.526 0.516 . . . . 0.0 111.857 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.96 -19.74 42.94 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.379 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -163.82 156.89 18.27 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.458 1.129 . . . . 0.0 112.909 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -48.54 119.34 3.0 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.704 171.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 1.054 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.5 t90 -87.71 -56.52 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.503 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -173.01 -177.92 42.63 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.2 t -156.0 146.53 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.086 0.443 . . . . 0.0 111.391 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.2 mp -125.15 126.73 71.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 16.1 mtm180 -75.94 122.1 23.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.656 0.741 . . . . 0.0 110.803 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -148.83 149.78 31.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.262 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.855 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 50.6 mtpt -69.92 155.1 41.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 110.858 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.43 142.3 58.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.445 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.699 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 88.44 -34.29 3.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.348 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 89.7 m95 -78.13 132.8 37.82 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.08 0.467 . . . . 0.0 110.451 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.661 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.44 141.59 52.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.741 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 62' ' ' CYS . 9.5 p -124.35 157.63 31.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.4 136.45 40.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.893 0.377 . . . . 0.0 111.484 -175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.598 ' CG ' HD23 ' A' ' 27' ' ' LEU . 67.8 m-85 -128.37 133.74 48.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -150.77 154.04 36.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 17.0 pt-20 -101.46 126.56 48.26 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -115.06 102.49 9.98 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.604 0.716 . . . . 0.0 109.905 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.76 131.41 35.75 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.975 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.83 116.46 3.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.569 2.179 . . . . 0.0 112.351 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.41 -10.18 57.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.123 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -122.05 154.69 61.5 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.406 0.282 . . . . 0.0 110.569 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.23 155.6 51.57 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.6 2.2 . . . . 0.0 111.359 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.707 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -72.33 140.09 48.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.216 0.531 . . . . 0.0 110.903 -177.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -118.33 129.8 55.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.464 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 58' ' ' LEU . 3.7 mm? -59.14 123.74 17.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 110.484 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -110.37 -18.27 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.1 134.87 1.29 Allowed 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.623 0.725 . . . . 0.0 111.394 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.68 111.6 36.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.776 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.9 t -131.18 144.05 51.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.269 -167.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -144.8 161.13 40.02 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -80.53 141.79 34.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.825 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.83 -62.21 0.95 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.015 0.822 . . . . 0.0 112.258 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.7 t -90.23 138.53 27.21 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.249 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.699 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -78.23 -2.41 12.49 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.521 2.147 . . . . 0.0 111.632 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.671 ' HA ' ' HD1' ' A' ' 20' ' ' PHE . 12.5 t -105.04 -74.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.336 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.91 163.64 12.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.1 t -98.22 131.69 44.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.85 0.357 . . . . 0.0 110.298 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -132.54 -84.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.953 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -131.57 164.24 26.28 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.186 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.776 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 25.9 mt -103.54 122.94 45.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.988 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -102.78 106.21 16.78 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.698 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.8 m -110.01 146.56 35.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.599 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.434 HG23 HD22 ' A' ' 77' ' ' ASN . 13.6 t -124.16 157.48 34.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.708 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.434 HD22 HG23 ' A' ' 76' ' ' THR . 43.5 m-80 60.54 55.84 3.28 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.609 0.568 . . . . 0.0 110.987 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 75' ' ' CYS . 92.1 mt -73.62 148.21 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.153 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -105.22 67.89 0.79 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.026 0.441 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.8 -91.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.258 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.79 -18.04 60.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.008 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 90.2 m-85 -79.51 108.23 12.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.401 . . . . 0.0 110.74 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.5 m -149.68 163.31 38.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.509 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.67 159.98 14.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -176.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.34 -64.0 0.19 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.335 -170.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 11.6 t -160.16 -165.68 1.52 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.943 0.372 . . . . 0.0 110.423 -171.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.662 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 14.3 t -144.5 148.04 34.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.54 ' HB ' HG21 ' A' ' 95' ' ' THR . 73.8 p -140.01 -153.21 0.45 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.276 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.822 ' HB3' HD21 ' A' ' 24' ' ' ASN . 7.9 t70 61.34 -76.49 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 173.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -69.28 -42.38 81.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.967 0.413 . . . . 0.0 111.31 -176.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.414 HD23 ' SG ' ' A' ' 23' ' ' CYS . 4.1 pp -89.68 -33.93 16.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.552 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t -94.67 -37.73 11.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.554 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 t 66.35 114.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.122 0.569 . . . . 0.0 111.694 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.9 66.12 1.32 Allowed Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.643 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.54 HG21 ' HB ' ' A' ' 88' ' ' THR . 11.6 p -144.42 160.02 41.77 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 122.708 -0.29 . . . . 0.0 110.758 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 m -82.14 79.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.887 0.851 . . . . 0.0 110.482 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.49 -86.04 1.81 Allowed Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.051 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.88 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.622 0.248 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.3 m-85 -81.24 140.67 34.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.215 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.85 140.18 48.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.863 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -112.41 144.87 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.325 176.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HB3' HD11 ' A' ' 91' ' ' LEU . 19.8 p -153.49 157.05 39.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.037 0.446 . . . . 0.0 111.54 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.026 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -78.11 112.52 15.14 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.602 174.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -81.97 115.3 21.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.651 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -83.94 129.01 34.93 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.017 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.3 tm? -101.36 132.57 46.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.542 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.31 122.57 44.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.374 0.607 . . . . 0.0 111.037 -178.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.828 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 56.7 t80 -106.09 143.99 33.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -53.07 104.96 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.039 0.447 . . . . 0.0 110.792 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 -50.59 0.88 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.964 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -172.75 167.37 5.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -36.3 131.37 0.63 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.985 0.914 . . . . 0.0 112.221 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.828 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 32.8 t-105 -99.56 -56.69 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.264 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -178.71 39.57 Favored Glycine 0 C--O 1.234 0.143 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.643 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 9.7 t -151.77 141.76 22.11 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.187 0.518 . . . . 0.0 111.664 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.88 130.04 58.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.827 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.863 ' HD2' HE22 ' A' ' 22' ' ' GLN . 29.7 mtm180 -87.68 124.78 33.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.325 0.583 . . . . 0.0 111.539 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.425 ' HE3' HG13 ' A' ' 45' ' ' VAL . 36.6 ttmt -153.53 152.35 30.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.575 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.816 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 47.1 mtpt -76.15 155.07 34.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.924 0.392 . . . . 0.0 111.044 -178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.78 142.45 55.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.796 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 104.65 -36.32 4.46 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.139 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -90.29 146.92 23.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.927 0.394 . . . . 0.0 110.614 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -85.63 131.37 34.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.673 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -101.12 152.54 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.289 . . . . 0.0 110.403 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -94.43 140.12 30.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.88 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.476 ' O ' HD23 ' A' ' 58' ' ' LEU . 94.2 m-85 -136.54 132.5 35.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.5 p90 -147.62 157.76 43.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.229 0.538 . . . . 0.0 111.377 -173.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 16.9 pt-20 -95.33 130.03 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.143 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.557 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 16.4 pt-20 -126.25 112.21 15.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.443 0.64 . . . . 0.0 109.96 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 49.2 mtmt -136.4 121.82 13.29 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.592 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 8.0 Cg_endo -48.58 116.88 2.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.686 2.924 . . . . 0.0 113.417 -172.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.04 -19.26 12.02 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.274 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -126.67 149.26 67.76 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.312 . . . . 0.0 110.807 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 162.33 42.44 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.822 2.348 . . . . 0.0 111.403 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.557 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 24.3 mttm -86.29 118.28 25.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.532 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -103.99 133.33 49.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.292 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -65.85 113.25 4.22 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.244 0.34 . . . . 0.0 110.172 179.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.477 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 33.2 m -92.76 -24.04 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.241 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.4 ' CB ' HD23 ' A' ' 78' ' ' LEU . . . 178.91 146.68 0.17 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.288 0.565 . . . . 0.0 111.29 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.408 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 4.7 mp -105.42 117.31 50.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 170.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 6.2 t -125.44 144.74 50.39 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.514 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.0 ptpt -143.1 163.0 34.05 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -84.59 136.35 33.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.261 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.43 -54.68 3.74 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.052 0.845 . . . . 0.0 112.322 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.507 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 34.5 t -89.33 141.03 28.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.294 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 3.5 Cg_exo -81.62 2.79 8.31 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.25 2.633 . . . . 0.0 112.107 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.2 t -122.99 -70.38 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.664 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -86.25 165.02 16.82 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.1 126.05 44.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.879 0.371 . . . . 0.0 110.223 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -124.16 -81.55 0.64 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.293 0.568 . . . . 0.0 110.016 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -137.44 168.91 18.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.69 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 24.0 mt -102.52 120.34 40.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.251 0.548 . . . . 0.0 110.784 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.67 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.9 mmpt? -102.26 105.65 16.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.809 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.666 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.7 m -104.58 149.77 25.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.956 0.408 . . . . 0.0 110.769 -176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -127.27 155.36 43.61 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.517 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 61.48 50.82 4.39 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.491 0.494 . . . . 0.0 111.092 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 75' ' ' CYS . 87.7 mt -68.24 140.36 56.03 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.252 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.51 89.62 7.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.575 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.54 -88.16 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.283 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.01 0.82 11.77 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.993 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -82.42 126.17 31.9 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 m -146.81 -177.74 5.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.923 -175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.499 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.72 171.28 7.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.782 0.325 . . . . 0.0 110.471 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.04 -140.79 5.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.256 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.5 t -93.25 178.85 5.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.844 0.354 . . . . 0.0 110.531 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 42.4 m -110.6 142.61 42.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 24.6 p -141.27 -159.32 0.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 1.026 ' HB3' HD21 ' A' ' 24' ' ' ASN . 22.2 t70 63.06 -82.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.948 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -70.97 -36.02 61.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.211 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 23' ' ' CYS . 12.9 mt -89.46 -55.32 3.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.23 0.538 . . . . 0.0 111.729 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.2 t -73.38 -76.99 0.11 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.62 -171.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 m -152.57 -61.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.262 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 89' ' ' ASP . . . -178.15 172.62 45.14 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.5 p -141.1 -87.31 0.17 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.831 0.824 . . . . 0.0 110.59 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.429 ' H ' ' H ' ' A' ' 97' ' ' GLY . 11.7 p 174.12 -15.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.171 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 96' ' ' VAL . . . 105.46 35.75 3.01 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.212 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.532 ' HA ' HG22 ' A' ' 36' ' ' THR . 31.0 t . . . . . 0 C--O 1.252 1.221 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -173.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.641 0.258 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.3 m-85 -64.39 113.99 4.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 69' ' ' HIS . 1.9 p -101.26 139.75 21.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.322 -172.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 1.01 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.0 pt20 -96.08 144.81 26.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 176.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HA ' HG21 ' A' ' 90' ' ' VAL . 10.8 p -150.07 142.43 24.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.301 0.572 . . . . 0.0 111.796 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.994 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -73.43 110.59 7.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.016 175.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.83 116.11 16.21 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.412 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 11.4 m-70 -86.62 131.18 34.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.873 0.368 . . . . 0.0 111.132 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.445 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -98.51 125.46 43.73 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -104.12 125.67 50.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.366 0.603 . . . . 0.0 111.235 -172.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -98.53 150.79 21.32 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -53.38 100.38 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.829 0.347 . . . . 0.0 110.662 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.91 -58.85 0.58 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.684 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -142.58 170.81 15.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.369 0.604 . . . . 0.0 112.317 -171.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 134.48 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.866 172.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -101.59 -55.85 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.897 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.99 175.14 42.28 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.7 t -154.28 145.79 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.278 0.539 . . . . 0.0 111.424 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.507 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.0 mp -126.78 125.1 66.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 47.2 ttp180 -88.67 98.07 11.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.124 0.488 . . . . 0.0 111.275 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.5 mmtp -126.05 153.8 43.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 1.01 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 32.9 mtpt -66.24 161.93 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.228 0.537 . . . . 0.0 111.482 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -59.92 142.78 53.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.763 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 89.78 -28.19 7.35 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.465 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.529 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 55.1 m95 -75.87 115.27 15.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.572 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.929 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.11 115.43 16.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.042 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.2 p -103.75 154.41 5.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.34 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -94.53 134.09 37.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 111.346 -177.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.72 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 88.7 m-85 -120.37 128.38 53.18 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HB3' HD23 ' A' ' 58' ' ' LEU . 36.7 p90 -143.78 152.1 40.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.299 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 7.1 pt-20 -94.72 137.53 33.7 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.354 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -126.78 100.37 6.15 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 31.8 mttp -95.66 154.08 39.26 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.02 116.36 3.12 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 121.994 1.796 . . . . 0.0 111.639 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 -11.59 66.39 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.873 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -110.12 126.34 29.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 122.769 -0.254 . . . . 0.0 110.474 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 31.7 Cg_exo -63.06 154.87 64.44 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.041 2.494 . . . . 0.0 112.765 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -62.11 126.92 29.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.181 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -130.39 142.74 50.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.816 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.785 HD13 HD11 ' A' ' 61' ' ' ILE . 16.6 mt -70.32 130.07 41.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 -175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.09 -18.0 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.393 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -176.63 138.29 0.28 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.514 0.673 . . . . 0.0 111.633 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -108.81 111.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 166.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.7 t -132.39 146.12 51.73 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.687 -168.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.929 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 27.5 pttt -145.6 164.56 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.651 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 9.0 t30 -77.33 134.37 38.51 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.75 -56.78 1.67 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.455 1.097 . . . . 0.0 112.706 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 40.6 t -92.0 136.75 25.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 69.3 Cg_endo -75.42 -1.52 11.42 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.404 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.9 t -112.42 -72.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.769 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 66' ' ' SER . 39.6 m80 -98.01 164.47 12.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.424 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.0 t -97.63 132.72 43.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -132.1 -81.46 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -138.26 175.7 9.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.498 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.789 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 31.3 mt -103.72 129.5 51.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.102 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -108.69 109.95 21.25 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m -114.44 149.15 36.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.53 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -124.76 159.99 29.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.174 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 68.36 40.13 2.1 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.407 0.442 . . . . 0.0 111.642 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' A' ' 75' ' ' CYS . 96.5 mt -66.73 126.69 29.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.887 0.375 . . . . 0.0 110.971 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -95.41 68.79 3.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 111.585 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.47 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.366 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.3 -16.32 64.77 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.971 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 99.2 m-85 -86.99 109.29 19.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.085 0.469 . . . . 0.0 110.39 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.4 m -147.72 168.29 22.48 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.611 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.76 161.53 13.6 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.472 -175.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.31 -79.28 0.76 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.218 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.9 t -155.77 -169.52 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.631 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 30.1 m -130.58 144.75 51.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.645 0.259 . . . . 0.0 110.309 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 58.3 p -138.34 -154.73 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.936 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.994 ' HB3' HD21 ' A' ' 24' ' ' ASN . 36.2 t70 63.58 -78.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.25 1.02 . . . . 0.0 112.548 173.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.9 OUTLIER -68.03 -42.84 85.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.793 0.33 . . . . 0.0 111.662 -175.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.0 pp -89.66 -31.39 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.597 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.8 t -87.44 -40.28 14.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.027 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.3 t 60.54 90.38 0.06 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.236 0.541 . . . . 0.0 111.061 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 118.56 43.66 0.53 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.184 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.426 HG21 ' HB ' ' A' ' 88' ' ' THR . 53.9 p -133.38 -179.34 5.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -118.41 134.5 61.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.967 172.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -100.56 -89.54 2.04 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.253 1.248 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.307 173.526 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.1 p90 -57.09 142.08 43.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.402 174.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.29 141.33 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.709 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 19.2 pt20 -94.39 143.0 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.709 175.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 20.0 p -147.53 145.5 29.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.037 0.446 . . . . 0.0 110.901 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.981 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.02 113.05 11.88 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 174.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.505 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 1.3 m80 -78.4 117.63 19.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -85.42 134.69 34.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.019 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -101.09 122.9 44.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.423 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -101.07 122.04 42.86 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.697 0.76 . . . . 0.0 110.862 -177.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.808 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 65.9 t80 -94.24 150.95 19.83 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.75 100.15 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.47 -58.45 0.71 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.255 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -159.71 179.96 8.4 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -52.44 131.51 33.66 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.764 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.808 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.4 t90 -101.57 -55.84 2.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.314 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.23 179.03 38.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.1 t -154.32 143.74 21.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.187 0.493 . . . . 0.0 111.164 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.586 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.5 mp -123.42 122.14 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 42.3 ttp180 -83.44 105.65 14.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.17 0.509 . . . . 0.0 110.741 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.586 ' HG2' HG22 ' A' ' 37' ' ' ILE . 70.1 mmtt -127.11 152.96 46.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.536 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.824 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 38.9 mtpt -80.22 149.97 30.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.631 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.09 136.18 57.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 111.297 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.47 -17.76 46.16 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -91.38 130.93 37.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.815 0.34 . . . . 0.0 110.73 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -77.93 122.89 26.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.5 p -107.58 147.81 12.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.873 0.368 . . . . 0.0 110.483 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' NH1' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -98.44 135.95 39.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.0 111.154 -177.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.576 ' CG ' HD23 ' A' ' 27' ' ' LEU . 74.8 m-85 -123.89 131.02 53.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.193 173.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HD2' ' HB3' ' A' ' 56' ' ' LYS . 36.0 p90 -143.74 149.64 37.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.821 0.343 . . . . 0.0 110.194 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.4 ' HB3' HG11 ' A' ' 59' ' ' VAL . 9.0 pt-20 -95.21 142.97 27.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 10.4 pt-20 -130.07 102.2 6.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.726 0.774 . . . . 0.0 110.199 172.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.5 124.84 56.07 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.45 117.82 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.583 2.855 . . . . 0.0 113.303 -174.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.77 22.51 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.377 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.49 148.32 34.37 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.592 0.357 . . . . 0.0 110.735 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.0 151.84 82.9 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.903 2.402 . . . . 0.0 112.153 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 26.9 mttm -76.63 136.06 39.17 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.899 -175.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -123.89 135.92 54.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.613 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 mt -68.82 118.8 12.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.2 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 16.1 m -104.7 -19.16 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.095 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.39 136.21 0.59 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.651 0.739 . . . . 0.0 112.349 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.61 HD13 HD22 ' A' ' 77' ' ' ASN . 4.6 mp -108.28 112.87 42.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 5.8 t -132.14 150.46 52.15 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 -168.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.8 ptpt -150.1 163.59 37.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.838 ' ND2' ' HA ' ' A' ' 70' ' ' CYS . 32.6 t30 -73.02 150.55 42.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.989 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.41 -52.5 28.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.542 0.526 . . . . 0.0 111.692 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -108.78 139.12 20.57 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.066 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.23 12.74 1.21 Allowed 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.772 2.315 . . . . 0.0 113.149 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.7 t -128.01 -78.8 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.233 . . . . 0.0 110.762 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -90.59 156.94 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.838 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 31.5 t -97.74 137.03 37.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.854 0.359 . . . . 0.0 110.992 -172.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -133.49 -76.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -134.28 164.75 26.69 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.461 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.67 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.3 mt -103.82 124.32 48.7 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -102.13 105.75 16.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.17 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 19.0 m -102.93 155.18 18.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.816 -175.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.9 t -136.37 154.71 50.75 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.372 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.61 HD22 HD13 ' A' ' 61' ' ' ILE . 90.8 m-20 65.81 46.35 2.33 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.736 0.648 . . . . 0.0 111.279 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.9 mt -64.3 155.62 31.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 111.425 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.193 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.39 -90.08 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.287 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.49 -15.1 78.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.769 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.1 m-85 -89.12 120.44 30.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 110.332 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.47 ' HA ' HD22 ' A' ' 78' ' ' LEU . 22.9 m -147.34 172.75 13.39 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.622 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -109.87 174.93 5.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.158 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -142.48 -175.35 15.64 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.068 -177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -66.57 172.45 4.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.0 111.495 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 15.5 p -110.33 144.0 39.7 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.71 -176.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 32.5 p -140.7 -154.84 0.54 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.803 0.335 . . . . 0.0 111.461 -174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.981 ' HB3' HD21 ' A' ' 24' ' ' ASN . 19.4 t70 69.9 -78.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.032 169.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.64 -38.05 57.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.616 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 pp -89.87 -30.03 18.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.0 p -94.73 -76.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.606 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 t -158.4 -54.54 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.669 0.271 . . . . 0.0 110.589 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 89' ' ' ASP . . . 173.4 138.66 2.69 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.47 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 89' ' ' ASP . 7.7 p -140.04 21.77 2.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.957 0.408 . . . . 0.0 110.492 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.6 t 68.48 -72.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.418 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.55 -131.64 4.92 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.874 178.043 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.479 0.181 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -79.05 140.58 37.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 70' ' ' CYS . 2.3 p -145.4 136.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.245 -175.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.667 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.87 155.14 18.11 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.516 175.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 16.9 p -154.85 152.44 29.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.212 0.53 . . . . 0.0 111.681 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -75.05 111.19 10.02 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 109.503 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.83 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 9.7 m80 -72.19 121.03 18.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.403 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -84.17 136.54 33.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.584 -174.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.596 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.2 tm? -109.89 122.98 48.78 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 165.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -106.02 122.08 45.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.287 0.565 . . . . 0.0 110.504 -176.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -95.13 143.94 26.17 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -50.43 101.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.537 0.523 . . . . 0.0 110.463 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.6 -53.34 0.81 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.146 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 32' ' ' ARG . 22.8 tpt180 -165.09 160.02 18.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.085 0.442 . . . . 0.0 111.77 -175.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -42.83 127.83 4.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.994 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -99.51 -56.72 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.323 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.63 178.32 39.87 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.975 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 26' ' ' HIS . 5.8 t -153.8 138.41 16.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.951 0.375 . . . . 0.0 110.704 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -117.31 135.98 55.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.199 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.665 ' HD2' HE22 ' A' ' 22' ' ' GLN . 3.3 tpp85 -73.81 110.21 7.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.788 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 16.7 tppt? -143.89 128.57 18.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.563 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 18.6 ptmt -72.3 153.64 41.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.222 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -63.66 142.75 58.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.319 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 94.26 -17.27 59.23 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.645 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 44.3 m95 -105.36 142.91 34.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 0.0 110.66 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.64 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -80.17 140.63 36.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.63 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.788 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.9 p -126.89 148.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.85 0.357 . . . . 0.0 110.543 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -86.76 143.55 27.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.751 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.83 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 63.5 m-85 -128.35 135.88 50.19 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 170.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 53.0 p90 -151.1 156.49 41.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.871 0.367 . . . . 0.0 111.869 -172.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' ' 51' ' ' LYS . 14.9 pt-20 -107.38 134.93 49.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 168.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.0 102.25 10.74 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.229 0.537 . . . . 0.0 110.67 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HE2' ' OE1' ' A' ' 49' ' ' GLU . 67.6 mttm -85.23 125.48 69.96 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.672 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 86.9 Cg_exo -48.02 117.64 2.63 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 123.332 2.688 . . . . 0.0 113.573 -173.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.37 -14.24 62.37 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.559 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -113.05 158.11 38.85 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 120.543 0.211 . . . . 0.0 110.438 -176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.55 161.9 41.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.665 2.243 . . . . 0.0 111.118 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -74.71 138.38 42.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.056 0.455 . . . . 0.0 110.728 -176.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 20.4 tpp180 -99.52 123.55 43.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.069 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.34 107.2 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.997 0.427 . . . . 0.0 110.55 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -95.16 -18.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -173.57 138.7 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.505 0.669 . . . . 0.0 111.904 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.62 112.13 38.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 167.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.845 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 12.0 t -134.9 154.02 51.83 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.982 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -150.21 162.36 40.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -83.85 135.86 34.34 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.122 -0.231 . . . . 0.0 110.718 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.33 -51.9 6.1 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.079 0.862 . . . . 0.0 112.868 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 46.0 t -94.77 139.18 22.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.265 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 80.1 Cg_endo -79.13 2.69 8.08 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.72 2.28 . . . . 0.0 111.744 173.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.2 -79.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.589 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' ' 66' ' ' SER . 67.5 m80 -89.65 165.38 14.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.472 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 21' ' ' VAL . 74.8 m -98.72 124.92 43.86 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.29 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 61.5 m-20 -124.22 -85.52 0.64 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 110.227 -176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 93.9 m-85 -130.43 174.14 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.949 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.845 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.6 mt -109.36 132.21 54.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.626 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -101.19 104.51 15.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.744 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.6 m -116.41 144.87 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.967 0.413 . . . . 0.0 110.597 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -126.46 159.63 32.8 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 6.2 t30 59.83 71.59 0.57 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 -175.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 83' ' ' SER . 96.4 mt -91.66 128.79 37.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -92.33 73.92 5.31 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.674 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.62 -93.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.468 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.07 0.85 73.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.923 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CB ' ' HB ' ' A' ' 59' ' ' VAL . 96.5 m-85 -101.16 108.89 20.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 0.0 110.474 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 78' ' ' LEU . 41.7 m -138.39 169.35 17.95 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -101.24 163.76 12.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.283 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.83 -175.68 14.8 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.669 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 13.6 t -61.77 159.02 14.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.567 0.698 . . . . 0.0 111.234 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 7.0 p -91.17 144.67 25.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.479 -168.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.613 ' HA ' ' HB2' ' A' ' 92' ' ' SER . 40.0 p -131.64 -158.45 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.803 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.474 ' HB2' ' HA3' ' A' ' 97' ' ' GLY . 25.2 t70 70.83 -85.04 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.411 1.084 . . . . 0.0 111.707 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 90' ' ' VAL . 1.7 m -67.45 -46.94 82.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -173.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.94 -27.8 20.7 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.725 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' A' ' 88' ' ' THR . 5.9 t -76.96 -54.03 7.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.069 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.8 t 68.12 115.0 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.422 0.63 . . . . 0.0 110.372 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.86 35.15 5.2 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -173.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -144.33 148.81 35.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.699 -0.75 . . . . 0.0 110.445 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.28 114.47 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 89' ' ' ASP . . . -136.21 178.31 18.88 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.851 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.709 -0.663 . . . . 0.0 109.793 178.561 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 82.5 m-85 -78.9 139.94 38.19 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.46 138.55 36.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.398 0.618 . . . . 0.0 111.819 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.821 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -106.47 145.84 31.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.421 176.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.707 ' HA ' HG21 ' A' ' 90' ' ' VAL . 18.0 p -148.66 150.44 33.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.501 0.667 . . . . 0.0 112.314 -174.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.973 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -72.24 112.84 8.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.958 174.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.832 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 14.6 m80 -80.68 108.81 14.64 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.615 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.562 ' HD2' ' HA ' ' A' ' 87' ' ' SER . 43.5 m-70 -83.72 125.33 31.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.796 0.332 . . . . 0.0 110.774 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.7 tm? -98.2 134.08 41.75 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.589 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -104.73 116.7 32.49 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.563 0.697 . . . . 0.0 110.903 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.728 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 71.6 t80 -95.19 145.42 25.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.603 -1.181 . . . . 0.0 107.954 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -57.75 99.76 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.856 0.36 . . . . 0.0 110.287 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.76 -43.57 1.26 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.68 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -175.06 166.06 3.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.092 0.446 . . . . 0.0 111.337 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -43.42 127.03 4.54 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.553 0.741 . . . . 0.0 111.596 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.728 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 48.9 t-105 -99.68 -57.65 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.636 -175.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.73 177.49 39.56 Favored Glycine 0 C--N 1.328 0.137 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.278 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -152.85 133.11 13.56 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.143 0.497 . . . . 0.0 111.328 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.6 mp -120.33 134.6 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.53 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -80.05 104.93 10.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.562 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 3.7 tppp? -138.85 145.01 39.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.821 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.5 mtpt -68.32 148.94 50.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.939 ' HB1' HD22 ' A' ' 64' ' ' ASN . . . -65.55 136.61 56.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.9 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.797 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 97.14 -26.18 23.85 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.068 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -89.19 130.83 35.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.924 0.392 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.736 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.99 126.64 30.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.201 -177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 10.2 p -116.41 145.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.563 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.41 145.21 30.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.148 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.832 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 76.7 m-85 -134.79 145.33 48.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 56' ' ' LYS . 31.5 p90 -148.61 163.39 37.4 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.199 0.523 . . . . 0.0 111.585 -173.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.32 134.53 51.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.381 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' H ' ' HZ2' ' A' ' 34' ' ' TRP . 10.8 pt-20 -109.57 113.79 26.87 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.391 0.615 . . . . 0.0 110.399 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 33.6 mmtp -108.31 125.51 31.75 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.432 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.53 126.87 23.93 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.65 2.234 . . . . 0.0 112.32 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.5 -9.56 64.35 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.297 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 40.8 mt-30 -122.38 159.12 53.87 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.365 0.266 . . . . 0.0 110.733 -175.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.25 156.65 58.79 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.765 2.31 . . . . 0.0 111.967 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . 9.7 pttp -88.21 138.86 31.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.495 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -117.45 123.63 46.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.929 -172.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.45 106.6 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.44 -30.08 12.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . . . -174.07 144.02 0.96 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.199 0.523 . . . . 0.0 111.338 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' CG2' ' HB1' ' A' ' 44' ' ' ALA . 4.6 mp -102.07 113.72 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.71 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -118.96 148.69 42.69 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.187 -171.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 13.9 pttp -157.1 164.32 38.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.341 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.939 HD22 ' HB1' ' A' ' 41' ' ' ALA . 30.7 t30 -81.83 152.02 27.09 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.408 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.23 -48.88 67.82 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.552 0.532 . . . . 0.0 111.362 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -105.57 137.54 19.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.818 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.797 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 78.1 Cg_endo -80.96 10.37 3.41 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.742 2.294 . . . . 0.0 112.518 175.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.0 t -113.98 -82.76 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.11 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -90.28 158.45 17.17 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.743 ' HA ' ' ND2' ' A' ' 64' ' ' ASN . 38.6 t -98.5 127.32 44.38 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.515 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -116.39 -87.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -134.53 171.79 13.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 39.2 mt -103.43 120.54 41.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.105 0.479 . . . . 0.0 112.056 -173.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -102.91 109.29 20.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.155 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.678 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.9 m -103.21 146.53 28.28 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.481 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -120.45 155.29 33.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.152 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 56.68 55.24 6.51 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.664 0.603 . . . . 0.0 110.184 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.6 mt -67.74 149.48 49.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.935 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.76 94.67 5.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.51 -85.56 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.628 0.58 . . . . 0.0 111.309 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.45 4.64 6.26 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.02 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.88 120.71 25.06 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.9 t -151.84 178.17 9.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.469 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.71 159.84 14.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.199 -177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.55 -64.38 0.38 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.006 -171.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 t -164.91 -169.62 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.006 0.403 . . . . 0.0 110.586 -173.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 5.0 p -143.73 144.25 31.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.263 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.439 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 37.6 p -139.61 -155.22 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.731 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.973 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.7 t70 64.61 -76.06 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.465 0.706 . . . . 0.0 112.377 174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.707 HG21 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -70.94 -44.36 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -176.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.15 -23.34 22.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.095 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.5 t -84.53 -77.24 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.77 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.2 t 174.88 -60.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.97 131.33 2.45 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.526 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.0 p -144.73 124.9 13.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.629 0.215 . . . . 0.0 110.476 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.9 m -79.44 87.28 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.66 0.743 . . . . 0.0 110.546 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.06 -152.91 11.97 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.734 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.507 ' OXT' ' HB ' ' A' ' 36' ' ' THR . 11.5 p . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -64.18 149.14 48.44 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 69' ' ' HIS . 2.6 p -133.67 135.23 55.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.402 0.62 . . . . 0.0 111.488 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.767 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -109.6 140.94 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.388 176.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 58.6 m -145.1 157.58 44.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.088 0.47 . . . . 0.0 111.994 -168.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.963 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -83.43 111.84 19.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 166.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -77.61 124.02 27.39 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.32 137.6 32.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.403 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.1 tm? -98.96 116.4 31.11 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 166.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.72 124.05 41.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.928 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -110.7 150.62 28.79 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -52.86 101.83 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.346 0.404 . . . . 0.0 110.492 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.17 -59.01 0.69 Allowed Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.32 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -162.58 166.76 24.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -49.87 119.58 3.65 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.767 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.538 ' HH2' ' H ' ' A' ' 50' ' ' GLU . 10.1 t90 -92.84 -55.57 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.968 0.413 . . . . 0.0 110.598 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.73 163.26 28.56 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.509 ' C ' HD12 ' A' ' 37' ' ' ILE . 6.0 t -154.26 140.22 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.224 0.512 . . . . 0.0 110.699 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 36' ' ' THR . 2.5 mp -124.39 126.97 72.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.745 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.9 mtm180 -79.13 110.31 14.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.502 . . . . 0.0 111.819 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HG3' HG22 ' A' ' 37' ' ' ILE . 62.2 mttm -146.52 137.29 24.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.155 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.0 ptmt -62.12 156.91 20.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.361 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.28 142.15 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.935 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.38 -40.7 2.33 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.523 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.495 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 56.9 m95 -75.14 141.94 43.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.137 0.494 . . . . 0.0 111.142 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.93 131.33 41.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.399 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.8 p -121.63 140.08 46.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.059 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.672 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -101.33 139.41 37.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.998 0.427 . . . . 0.0 110.541 -178.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.508 ' CG ' HD23 ' A' ' 27' ' ' LEU . 82.9 m-85 -120.43 139.08 53.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.301 174.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.594 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 30.5 p90 -147.44 154.04 40.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.934 0.397 . . . . 0.0 111.335 -174.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -103.69 142.66 33.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.495 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.538 ' H ' ' HH2' ' A' ' 34' ' ' TRP . 7.6 pt-20 -93.89 104.16 16.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.682 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 73.1 mmtt -119.45 135.47 24.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.055 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 23.3 Cg_exo -63.9 117.51 4.5 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.028 2.485 . . . . 0.0 112.834 -175.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.45 64.76 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.172 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -107.69 149.96 39.59 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 120.942 0.401 . . . . 0.0 110.696 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.24 153.4 78.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.943 1.762 . . . . 0.0 109.323 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.594 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 34.7 mmtm -67.37 109.53 3.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.181 0.515 . . . . 0.0 109.899 -173.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 18.7 tpp180 -80.67 126.11 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.817 -167.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 46' ' ' ARG . 11.1 mt -58.9 109.12 0.76 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.599 0.562 . . . . 0.0 110.649 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -93.78 -15.43 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.862 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.53 135.19 0.53 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.598 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.522 HD11 HD13 ' A' ' 58' ' ' LEU . 4.7 mp -107.7 113.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 166.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.2 t -133.63 159.54 40.2 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.998 -168.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.637 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 11.2 ptpp? -158.97 162.82 36.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 10.4 t30 -87.4 138.4 31.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.383 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -55.4 4.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.093 0.87 . . . . 0.0 112.655 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -99.89 146.41 31.84 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.049 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 94.7 Cg_endo -87.98 20.54 1.15 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.053 2.502 . . . . 0.0 112.714 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.57 -76.77 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.103 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.496 ' HA ' HG12 ' A' ' 21' ' ' VAL . 36.5 m-70 -92.22 164.28 13.61 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.54 122.43 44.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.478 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -116.51 -78.74 0.58 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.484 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.26 165.49 25.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.213 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.797 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 20.4 mt -105.03 124.74 50.06 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.457 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -102.57 105.37 15.87 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 2.1 m -111.54 151.46 28.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.364 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -128.95 161.74 29.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.521 175.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.39 41.09 5.98 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.567 0.542 . . . . 0.0 111.484 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -65.55 147.03 54.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.975 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -110.46 67.42 0.64 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.408 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.71 -89.92 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.859 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.85 -16.66 69.64 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.119 -0.563 . . . . 0.0 111.734 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.0 m-85 -85.17 107.05 17.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.234 0.54 . . . . 0.0 110.475 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.542 ' HA ' HD22 ' A' ' 78' ' ' LEU . 11.1 m -134.08 165.54 24.83 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.512 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -101.44 161.7 13.44 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.1 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 -164.04 9.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.846 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -69.34 -177.39 1.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.833 0.453 . . . . 0.0 111.338 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.61 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.2 p -122.03 151.75 40.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.928 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.566 ' HB ' ' CB ' ' A' ' 95' ' ' THR . 68.8 p -139.78 -157.4 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 110.739 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.963 ' HB3' HD21 ' A' ' 24' ' ' ASN . 35.3 t70 66.11 -80.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.919 0.888 . . . . 0.0 112.111 172.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.83 -41.47 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -89.87 -40.97 12.08 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 88' ' ' THR . 9.3 m -77.13 -40.69 44.78 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -172.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.9 m 62.24 96.39 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.224 0.535 . . . . 0.0 111.145 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.13 36.65 2.29 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.566 ' CB ' ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -138.16 163.73 30.95 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.5 m -90.76 118.4 35.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.319 0.581 . . . . 0.0 111.231 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.88 85.75 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.338 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.978 -177.54 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.046 -0.354 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.676 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 34.6 p90 -61.23 135.35 57.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.419 0.628 . . . . 0.0 110.921 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.4 142.71 40.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.869 -173.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.876 HE22 ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -95.15 142.34 27.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 5.1 m -142.94 140.54 31.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.377 -174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.994 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -72.51 111.7 7.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 170.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 36' ' ' THR . 5.1 m80 -80.77 122.98 27.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.892 -177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -90.61 123.64 34.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.589 -178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.1 tm? -98.1 126.81 43.71 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.37 128.62 53.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.158 -173.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.454 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.7 t80 -103.78 144.78 31.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -56.1 100.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.2 -56.6 0.63 Allowed Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.658 -173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.503 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 11.5 tpp180 -172.02 172.08 4.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.503 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 39.5 t-80 -47.62 135.92 10.88 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.194 0.598 . . . . 0.0 111.524 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.501 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 58.3 t90 -107.43 -55.76 2.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.119 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.12 164.02 30.76 Favored Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.282 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -146.53 130.69 17.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.984 0.421 . . . . 0.0 111.313 -177.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.7 mp -122.44 130.47 74.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.876 ' HD2' HE22 ' A' ' 22' ' ' GLN . 24.1 mtm180 -76.42 128.53 35.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.216 0.531 . . . . 0.0 110.671 176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 45' ' ' VAL . 12.3 tppt? -148.86 152.15 35.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.654 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.5 mtpt -87.19 148.13 25.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.42 -174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.84 136.42 58.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.999 0.428 . . . . 0.0 110.971 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.58 -20.9 47.47 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.992 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 65.1 m95 -101.63 137.51 39.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 110.227 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.608 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -81.21 145.6 30.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -112.9 156.3 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.0 177.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.25 130.23 50.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 110.138 176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 97.5 m-85 -122.73 126.83 48.3 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -145.78 156.68 43.75 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.483 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.501 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 14.3 pt-20 -104.47 123.68 47.91 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.7 102.08 10.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.826 0.822 . . . . 0.0 109.937 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -100.3 121.64 52.8 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.666 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.82 116.38 2.13 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.029 2.486 . . . . 0.0 112.519 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.46 -28.13 14.5 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.21 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -107.92 148.78 38.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.85 152.49 77.22 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.382 2.055 . . . . 0.0 111.293 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.714 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -77.82 137.6 38.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.537 -175.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -112.93 137.49 51.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.989 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.82 109.07 5.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.456 0.473 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 15.7 m -94.05 -19.64 6.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.808 -176.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -175.28 142.18 0.59 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 112.139 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.91 112.35 40.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 165.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.795 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.3 t -130.78 150.02 52.15 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.955 -167.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 ptpt -145.03 163.03 35.47 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -77.1 138.22 39.39 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.557 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -40.62 -58.73 1.54 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.125 0.891 . . . . 0.0 112.628 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 30.0 t -94.04 138.2 22.72 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.201 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.2 -1.75 11.05 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.675 2.25 . . . . 0.0 111.701 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 15.3 t -103.37 -81.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.296 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 66' ' ' SER . 7.4 p80 -107.25 165.98 10.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.122 0.487 . . . . 0.0 111.204 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.405 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 1.6 p -94.27 124.24 38.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.099 -168.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -128.46 -83.64 0.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.092 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -130.44 173.82 10.47 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.202 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.795 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 29.0 mt -110.07 127.71 55.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.952 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -103.82 107.92 19.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.519 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -113.41 152.15 30.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -175.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.402 HG23 HD22 ' A' ' 77' ' ' ASN . 12.5 t -126.2 159.43 33.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.402 HD22 HG23 ' A' ' 76' ' ' THR . 40.8 m-80 62.46 40.32 10.98 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.935 0.494 . . . . 0.0 111.301 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 75' ' ' CYS . 94.9 mt -62.04 135.12 57.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.895 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.859 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -92.68 41.81 1.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.227 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.31 -84.86 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.22 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.89 -18.6 76.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.758 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.859 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.9 m-85 -96.38 109.48 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.502 ' HA ' HD22 ' A' ' 78' ' ' LEU . 14.8 m -139.85 167.15 22.77 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.47 159.77 15.29 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.311 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.81 -95.08 1.85 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.929 -174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -138.97 -167.44 2.22 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 49.4 m -134.43 144.97 48.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.574 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 61.3 p -139.35 -157.03 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.815 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.994 ' HB3' HD21 ' A' ' 24' ' ' ASN . 31.9 t70 61.68 -78.7 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.431 1.092 . . . . 0.0 112.277 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 90' ' ' VAL . 3.1 m -70.8 -20.91 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.745 0.307 . . . . 0.0 111.141 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.528 HD21 ' SG ' ' A' ' 23' ' ' CYS . 13.6 mt -89.1 -56.04 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.505 0.669 . . . . 0.0 111.201 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p -91.18 -32.07 15.94 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.418 -174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.3 m 69.37 -0.46 2.55 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.198 0.599 . . . . 0.0 112.045 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.58 23.35 20.23 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.574 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.7 OUTLIER -129.71 163.76 25.45 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.223 -0.489 . . . . 0.0 109.866 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.8 t -98.84 104.52 16.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.794 0.33 . . . . 0.0 110.83 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.92 144.75 43.87 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.958 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.784 -0.627 . . . . 0.0 110.291 -176.07 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 48.5 p90 -88.8 143.2 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.85 137.76 21.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.358 0.599 . . . . 0.0 111.798 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.844 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 8.6 pt20 -102.95 150.13 23.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.467 174.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 2.2 p -151.04 136.4 17.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.366 0.603 . . . . 0.0 111.936 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.854 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -76.63 106.28 8.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 172.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.41 ' CB ' ' HZ ' ' A' ' 47' ' ' PHE . 4.6 m80 -72.86 122.26 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.122 -174.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.404 ' HE2' ' C ' ' A' ' 98' ' ' SER . 19.6 m170 -82.21 126.46 32.11 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.037 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 27' ' ' LEU . 1.1 tm? -98.33 119.5 37.11 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.03 123.22 44.87 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.681 0.753 . . . . 0.0 111.425 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -101.63 148.38 25.31 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -57.27 99.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.26 0.35 . . . . 0.0 110.089 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.39 -57.58 0.59 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.484 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -168.84 170.62 9.04 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.153 0.477 . . . . 0.0 111.346 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -46.26 114.11 0.74 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.395 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.504 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 70.4 t90 -90.26 -55.92 3.41 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.825 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.24 169.67 36.14 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.669 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.59 HG21 ' HB2' ' A' ' 98' ' ' SER . 15.1 t -154.55 147.81 24.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 111.551 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.9 mp -127.08 128.13 70.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.854 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.9 ttp180 -87.62 116.0 25.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.705 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -150.29 149.04 29.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.844 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 40.4 mtpt -66.62 145.94 55.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.624 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.37 141.58 58.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.269 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.751 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 108.37 -28.03 12.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.135 -0.555 . . . . 0.0 111.832 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -96.42 145.98 25.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.011 0.434 . . . . 0.0 110.409 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -75.85 131.96 40.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.75 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -105.79 131.49 55.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.1 129.42 34.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.101 0.477 . . . . 0.0 110.199 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 87.8 m-85 -121.27 123.69 42.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.8 p90 -144.57 150.35 37.34 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.991 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 15.6 pt-20 -95.51 142.2 28.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.689 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 6.4 pt-20 -118.72 102.51 8.89 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.472 0.653 . . . . 0.0 110.451 173.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -110.23 122.73 37.88 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.93 116.72 2.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.78 2.32 . . . . 0.0 112.532 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.83 13.71 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.023 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -104.77 140.26 20.9 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 159.52 31.5 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.827 2.352 . . . . 0.0 111.602 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.65 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 24.8 mmtp -71.05 119.93 15.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.87 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -112.97 129.25 56.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.186 -172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.485 HD13 HD11 ' A' ' 61' ' ' ILE . 12.9 mt -62.49 126.63 27.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.974 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 19.1 m -113.46 -17.19 8.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.532 -177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.13 140.65 1.2 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.542 0.687 . . . . 0.0 111.873 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.485 HD11 HD13 ' A' ' 58' ' ' LEU . 4.7 mp -117.49 111.93 36.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 167.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.648 ' O ' HG23 ' A' ' 45' ' ' VAL . 6.8 t -129.03 147.52 50.9 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.552 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 14.9 ptpt -148.18 163.22 37.64 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.65 137.88 32.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.447 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.78 -48.72 8.15 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.085 0.866 . . . . 0.0 112.538 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 38.5 t -97.45 140.69 22.16 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.751 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 98.5 Cg_endo -81.65 5.21 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.876 2.384 . . . . 0.0 112.532 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.2 t -123.94 -62.33 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.378 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 66' ' ' SER . 36.7 m-70 -95.29 156.29 16.38 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.812 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.7 t -99.03 121.55 41.11 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 -119.13 -78.73 0.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -135.56 172.48 12.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.58 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 11.5 mt -102.93 120.56 40.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.898 0.38 . . . . 0.0 110.532 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.2 mmpt? -100.87 103.67 14.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 8.4 m -106.51 155.51 19.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.67 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -142.57 165.91 26.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 55.22 45.71 25.25 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.763 0.664 . . . . 0.0 111.487 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 83' ' ' SER . 85.0 mt -68.19 144.98 54.73 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -99.18 58.53 1.11 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.931 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.3 -86.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.103 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.54 -22.89 68.89 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.632 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -86.29 112.02 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.51 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.1 m -136.97 169.2 18.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.635 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.19 167.58 9.73 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.003 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.16 -108.35 1.07 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.468 -0.873 . . . . 0.0 113.18 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 t -115.32 -169.04 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.633 0.254 . . . . 0.0 110.531 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.6 m -135.7 143.52 45.45 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.499 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 12.1 p -139.83 -144.06 0.17 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -172.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.591 ' HB3' HD21 ' A' ' 24' ' ' ASN . 33.0 t70 53.48 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.201 1.0 . . . . 0.0 113.498 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.596 HG23 HD23 ' A' ' 91' ' ' LEU . 3.2 m -70.42 -45.08 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.787 0.327 . . . . 0.0 111.596 -175.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 HG23 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -89.84 -37.75 14.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.671 0.272 . . . . 0.0 111.33 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 t -90.02 -55.81 3.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.898 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.6 t 70.14 153.54 0.11 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.594 0.559 . . . . 0.0 111.058 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.69 19.13 66.5 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.499 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 1.3 m -97.41 137.65 36.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.267 -0.467 . . . . 0.0 110.629 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.54 115.38 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.077 0.465 . . . . 0.0 110.209 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.88 -132.85 14.3 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.59 ' HB2' HG21 ' A' ' 36' ' ' THR . 19.4 m . . . . . 0 C--O 1.246 0.903 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 68' ' ' VAL . 15.4 m . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.579 0.228 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.7 m-85 -87.49 148.46 24.92 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.021 0.439 . . . . 0.0 110.247 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -144.75 138.23 22.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.819 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.765 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.99 143.38 44.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.692 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.671 ' HA ' HG21 ' A' ' 90' ' ' VAL . 8.1 p -152.76 155.45 37.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.106 0.479 . . . . 0.0 112.091 -173.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.856 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -80.88 113.34 19.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.816 175.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -79.76 121.12 24.96 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -90.53 132.2 35.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.918 0.39 . . . . 0.0 111.492 -174.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -99.94 129.27 46.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.443 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -108.44 123.45 48.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.282 0.563 . . . . 0.0 110.543 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 29.9 t80 -102.2 149.78 23.96 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.59 100.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.69 -56.91 0.72 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.364 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -159.8 178.49 9.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 111.452 -173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -61.47 129.56 41.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.323 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 62.1 t90 -90.83 -55.75 3.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.88 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.21 -179.4 44.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.831 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.0 t -153.69 146.0 23.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.16 0.48 . . . . 0.0 111.348 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.484 HG22 ' HG2' ' A' ' 39' ' ' LYS . 3.7 mp -129.0 127.35 65.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 43.7 ttp180 -86.6 111.98 21.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.015 0.436 . . . . 0.0 110.413 -176.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HG2' HG22 ' A' ' 37' ' ' ILE . 37.9 mmtm -141.02 153.76 45.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.792 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.765 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 50.3 mtpt -69.98 155.91 39.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.744 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.16 141.39 58.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.831 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.847 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 89.73 -22.14 26.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.964 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 92.1 m95 -91.86 130.71 37.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.461 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -68.11 130.66 43.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.8 p -113.8 151.04 15.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.351 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -104.67 137.38 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.195 0.522 . . . . 0.0 111.407 -175.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.11 120.76 32.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.609 ' HE2' ' HD3' ' A' ' 56' ' ' LYS . 49.3 p90 -151.19 146.12 25.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -87.0 129.0 35.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.056 0.455 . . . . 0.0 109.973 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.792 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -106.3 132.67 52.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.501 177.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 32.9 mmtm -131.82 113.3 15.08 Favored Pre-proline 0 C--N 1.315 -0.932 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -50.03 117.52 3.16 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.177 2.585 . . . . 0.0 113.053 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.32 -4.21 86.23 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.453 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 70.0 mt-30 -118.88 158.32 48.05 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 122.666 0.387 . . . . 0.0 109.976 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.29 154.69 65.41 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.437 2.091 . . . . 0.0 112.342 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.792 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 74.9 mttt -106.55 150.61 25.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.471 -175.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -130.4 137.17 49.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.529 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 61' ' ' ILE . 8.5 mt -69.85 115.44 9.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.529 175.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 20.8 m -85.7 -21.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.99 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.498 ' HB2' HD23 ' A' ' 78' ' ' LEU . . . 176.85 140.81 0.07 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-O 121.589 0.709 . . . . 0.0 111.794 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 58' ' ' LEU . 4.6 mp -102.07 115.37 43.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.5 t -131.93 152.76 50.88 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.388 -169.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.662 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.3 ptpp? -153.14 163.27 40.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -81.04 135.56 35.85 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.086 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.4 -59.25 2.2 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.048 0.843 . . . . 0.0 112.624 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.7 t -87.17 135.22 35.12 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.213 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.847 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 4.0 Cg_exo -78.78 2.12 8.49 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.385 2.723 . . . . 0.0 112.059 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 6.0 t -119.06 -64.48 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.035 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' SER . 44.1 m80 -94.93 163.41 13.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.039 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.6 t -100.01 128.29 46.12 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -123.06 -82.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.298 0.57 . . . . 0.0 109.689 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.35 178.26 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.005 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.746 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 26.7 mt -103.48 124.56 48.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.139 0.495 . . . . 0.0 110.894 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -109.19 107.21 17.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.297 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -110.4 149.74 29.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.075 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.4 t -124.27 155.51 38.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.6 t30 60.74 53.53 3.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.526 0.679 . . . . 0.0 110.152 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 75' ' ' CYS . 85.1 mt -72.95 139.34 46.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.298 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.893 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -91.56 45.29 1.22 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.583 0.23 . . . . 0.0 110.946 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 56.77 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.666 0.786 . . . . 0.0 112.054 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.72 -15.29 61.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.137 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.893 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.5 m-85 -99.64 106.69 18.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.015 0.436 . . . . 0.0 110.253 174.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.504 ' HA ' HD22 ' A' ' 78' ' ' LEU . 15.8 m -129.02 167.03 18.07 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.624 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -108.33 154.56 21.64 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.198 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.09 -126.57 3.42 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.06 -172.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.9 p -96.82 -168.41 1.71 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.391 0.615 . . . . 0.0 111.814 -174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 49.7 m -136.33 141.53 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.024 172.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 89' ' ' ASP . 25.4 p -142.28 -156.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.815 -0.175 . . . . 0.0 111.331 -174.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.824 ' HB3' HD21 ' A' ' 24' ' ' ASN . 32.6 t70 63.86 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.615 0.766 . . . . 0.0 112.157 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.671 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -66.88 -41.55 87.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -90.32 -24.88 20.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.77 0.319 . . . . 0.0 111.056 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 89' ' ' ASP . 47.1 t -86.53 -77.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.762 -176.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.3 p -173.85 -69.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.147 0.499 . . . . 0.0 110.119 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.06 96.79 0.12 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.1 p -120.62 33.45 5.58 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 121.388 -0.125 . . . . 0.0 111.297 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 t 61.0 70.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.762 0.791 . . . . 0.0 109.608 -173.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -96.0 146.68 18.35 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.246 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.742 -0.647 . . . . 0.0 110.06 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 51.6 p90 -89.91 146.25 24.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.72 140.04 21.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.335 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.806 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 12.4 pt20 -104.43 150.12 24.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.613 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.59 ' HA ' HG21 ' A' ' 90' ' ' VAL . 9.2 p -154.48 155.56 35.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.356 0.598 . . . . 0.0 111.399 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.98 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -76.74 108.98 10.14 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.62 118.69 19.52 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 14.4 m-70 -88.41 126.4 35.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.892 0.377 . . . . 0.0 111.52 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 47' ' ' PHE . 1.1 tm? -99.87 121.21 40.96 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 169.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 130.01 54.02 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.554 0.692 . . . . 0.0 111.497 -174.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -106.95 151.17 25.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.743 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -55.33 100.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.313 0.383 . . . . 0.0 110.16 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' ARG . . . 138.58 -51.69 0.76 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.941 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 7.5 tpp180 176.49 179.56 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.452 0.301 . . . . 0.0 110.249 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.665 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.6 t-80 -41.05 130.98 2.64 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.722 0.809 . . . . 0.0 111.966 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 49' ' ' GLU . 39.4 t90 -104.61 -53.9 2.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.75 164.88 34.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.189 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.26 15.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.915 0.388 . . . . 0.0 110.506 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.488 ' HB ' HG21 ' A' ' 45' ' ' VAL . 2.3 mp -115.65 132.38 65.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.67 98.74 4.14 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.78 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.24 148.95 43.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 110.407 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 51.3 mtpt -64.52 153.36 39.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.588 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.47 139.56 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.564 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.967 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 92.49 -38.85 3.09 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.023 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -66.58 125.39 25.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.5 122.58 22.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.51 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.4 p -109.39 147.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.085 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 134.35 40.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.26 0.552 . . . . 0.0 111.354 -175.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 27' ' ' LEU . 90.2 m-85 -122.05 127.3 50.05 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.7 147.98 30.53 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.596 ' HA ' ' CH2' ' A' ' 34' ' ' TRP . 9.4 pt-20 -86.94 130.36 34.49 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.913 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 47.5 mt-10 -108.23 102.29 11.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.266 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.856 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 34.4 mmtp -99.36 129.69 28.66 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.415 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.15 116.36 3.27 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.349 2.033 . . . . 0.0 112.265 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.65 90.42 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.48 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 53.8 mt-30 -125.71 157.36 68.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 C-N-CA 122.381 0.272 . . . . 0.0 110.343 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.26 160.69 48.13 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.393 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 55.1 mttt -103.55 136.64 42.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.337 -173.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -132.91 135.77 45.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.677 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.5 119.93 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.558 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 60' ' ' ALA . 32.2 m -92.69 -27.01 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.466 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.699 ' HB1' ' SG ' ' A' ' 75' ' ' CYS . . . 177.7 144.25 0.1 Allowed 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.727 0.642 . . . . 0.0 111.261 173.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.1 mp -102.93 111.93 34.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 45' ' ' VAL . 9.7 m -116.96 146.49 42.97 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 120.932 0.396 . . . . 0.0 111.136 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.917 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.5 pttm -155.13 161.56 41.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 42' ' ' GLY . 9.0 t30 -80.19 143.21 33.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.301 -174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.2 -57.04 3.14 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.062 0.852 . . . . 0.0 112.044 -176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.7 m -94.74 138.77 22.12 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.406 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.967 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.5 Cg_endo -82.98 23.52 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.143 2.562 . . . . 0.0 112.008 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 4.0 t -136.34 -73.85 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.68 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -85.13 159.92 20.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.13 125.71 48.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.985 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -123.64 -79.34 0.61 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.27 174.45 10.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 85' ' ' GLY . 50.1 mt -101.28 122.51 43.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.464 0.65 . . . . 0.0 111.381 -175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.778 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.6 mmpt? -93.59 106.91 18.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.356 172.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.699 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 8.1 t -121.58 166.1 14.71 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.298 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.615 HG23 HD22 ' A' ' 77' ' ' ASN . 11.4 t -159.94 162.19 34.39 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.073 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.615 HD22 HG23 ' A' ' 76' ' ' THR . 50.3 m-80 68.67 33.56 3.78 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.78 0.675 . . . . 0.0 110.256 -176.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.892 HD22 ' HA ' ' A' ' 83' ' ' SER . 93.1 mt -59.86 139.58 57.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -97.55 65.09 1.87 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.0 111.484 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.84 -88.88 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.151 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.19 -21.8 77.38 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.898 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -88.43 109.66 20.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.937 0.398 . . . . 0.0 110.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.892 ' HA ' HD22 ' A' ' 78' ' ' LEU . 17.0 m -128.54 173.62 10.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -112.58 158.79 19.53 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 121.69 -0.631 . . . . 0.0 110.667 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -123.11 -151.14 8.22 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.19 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -84.15 -176.69 6.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.855 0.359 . . . . 0.0 110.186 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 39.1 m -120.72 142.94 49.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.46 HG21 HG21 ' A' ' 95' ' ' THR . 66.7 p -139.55 -156.04 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.731 0.301 . . . . 0.0 111.75 -170.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.98 ' HB3' HD21 ' A' ' 24' ' ' ASN . 21.9 t70 63.61 -77.03 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.99 0.916 . . . . 0.0 112.547 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.5 m -68.08 -46.61 81.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 23' ' ' CYS . 3.8 pp -90.7 -41.35 11.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.712 0.291 . . . . 0.0 111.648 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.411 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 t -78.08 -42.8 31.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -174.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.2 t 60.94 88.56 0.08 Allowed 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.514 0.509 . . . . 0.0 110.441 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 141.12 53.75 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.161 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.46 HG21 HG21 ' A' ' 88' ' ' THR . 6.5 p -148.41 178.71 8.37 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.375 0.27 . . . . 0.0 110.277 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.0 t -70.71 -73.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.43 177.37 48.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.251 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.248 0.99 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.475 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 79.7 m-85 -76.37 134.21 39.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 69' ' ' HIS . 2.3 p -135.57 136.84 50.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.388 -173.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.786 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -101.99 141.54 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.627 ' HA ' HG21 ' A' ' 90' ' ' VAL . 7.1 p -144.09 148.86 35.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.416 0.627 . . . . 0.0 112.105 -170.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.872 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.6 OUTLIER -74.77 106.61 6.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.169 175.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.51 121.74 21.07 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -92.2 130.81 37.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.29 -174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -100.2 124.13 45.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -102.98 125.65 49.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.253 0.549 . . . . 0.0 110.686 -176.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 50.9 t80 -113.32 151.27 31.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -53.34 100.92 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.715 0.634 . . . . 0.0 110.379 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.81 -52.16 0.82 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.241 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 20.9 tpt180 -172.74 171.77 4.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.743 0.272 . . . . 0.0 110.822 -175.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.429 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 23.7 t-80 -46.31 121.38 3.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.325 0.65 . . . . 0.0 111.289 172.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 57.9 t90 -89.93 -56.14 3.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.761 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.99 170.8 34.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.563 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 6.6 t -154.42 143.92 21.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.09 0.445 . . . . 0.0 110.758 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.1 mp -127.11 130.23 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.637 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 10.2 mtm180 -82.32 117.83 22.7 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.362 0.601 . . . . 0.0 110.726 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG3' HG23 ' A' ' 45' ' ' VAL . 72.6 mmtt -142.52 152.61 42.82 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 44.3 mtpt -69.16 156.74 38.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.023 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.86 140.3 58.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.418 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.98 -25.1 12.69 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.228 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 49.8 m95 -83.13 130.05 35.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 0.0 110.634 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.916 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -79.03 123.38 27.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.705 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 39' ' ' LYS . 8.7 p -106.15 154.26 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.981 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.8 140.99 29.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.502 ' CG ' HD23 ' A' ' 27' ' ' LEU . 75.6 m-85 -131.33 123.68 28.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -142.14 149.85 40.32 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.933 0.397 . . . . 0.0 111.265 -177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 11.1 pt-20 -87.41 130.04 34.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.728 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 56' ' ' LYS . 29.8 mt-10 -114.04 101.91 9.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.152 0.501 . . . . 0.0 109.827 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 71.6 mmtt -82.9 134.74 46.24 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.896 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 52.3 Cg_exo -54.55 117.05 3.53 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.54 2.16 . . . . 0.0 112.358 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.02 -6.06 80.55 Favored Glycine 0 C--N 1.33 0.206 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.482 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.797 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 33.3 mt-30 -115.67 162.04 27.25 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 122.498 0.319 . . . . 0.0 110.772 -175.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 54' ' ' GLN . 57.5 Cg_endo -70.95 159.2 53.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.88 2.387 . . . . 0.0 112.803 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.863 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.4 146.39 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 -178.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -137.63 131.65 31.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.49 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.22 119.6 7.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.012 0.434 . . . . 0.0 112.046 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.4 m -100.09 -15.71 7.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.396 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -173.32 135.77 0.58 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.581 0.705 . . . . 0.0 111.821 176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -107.74 112.29 39.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.77 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.1 t -131.53 149.72 52.41 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.728 -169.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.916 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.6 pttp -155.39 163.43 40.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.074 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.42 139.22 34.13 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.318 -173.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.38 -55.71 4.78 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.818 0.698 . . . . 0.0 112.179 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 30.9 t -95.86 146.64 31.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.212 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 66' ' ' SER . 3.5 Cg_exo -82.45 -1.19 10.54 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.157 2.572 . . . . 0.0 111.972 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.7 t -103.96 -79.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.815 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.405 ' HA ' HG12 ' A' ' 21' ' ' VAL . 65.7 m80 -94.27 165.04 12.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.155 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.1 121.97 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -119.55 -85.14 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.275 0.56 . . . . 0.0 109.593 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -126.31 166.34 17.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.914 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.77 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 14.2 mt -102.99 123.39 46.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.308 0.575 . . . . 0.0 110.638 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.713 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -98.88 104.65 16.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.808 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -112.84 146.1 39.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.998 0.427 . . . . 0.0 110.658 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -129.23 155.45 45.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.874 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.7 t30 62.4 60.2 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.691 0.619 . . . . 0.0 110.37 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.3 mt -77.6 157.91 30.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.364 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -115.46 71.9 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.743 0.306 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.96 -92.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.171 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.16 55.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.068 -0.586 . . . . 0.0 111.994 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.6 m-85 -72.65 109.56 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.314 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.592 ' HA ' HD22 ' A' ' 78' ' ' LEU . 19.6 m -140.97 166.71 24.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -103.56 168.49 9.12 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.045 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 73' ' ' LEU . . . -139.0 -171.49 12.19 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.049 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -69.16 169.77 11.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.463 0.649 . . . . 0.0 111.622 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.4 m -105.76 153.84 21.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.669 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.5 p -139.88 -156.44 0.68 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.047 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.872 ' HB3' HD21 ' A' ' 24' ' ' ASN . 4.1 t70 62.61 -80.17 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.643 HG23 HD23 ' A' ' 91' ' ' LEU . 1.3 m -66.06 -41.62 89.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.222 -175.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.643 HD23 HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -89.4 -33.25 16.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.464 176.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 m -95.53 -77.46 0.47 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.8 t -159.29 -59.31 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 110.824 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.55 ' N ' ' HA ' ' A' ' 89' ' ' ASP . . . 167.68 136.17 2.0 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.0 p -135.58 137.71 42.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.916 0.358 . . . . 0.0 111.21 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.38 164.75 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.003 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.89 -41.03 1.49 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.608 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.168 177.707 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 17.8 p90 -58.5 131.15 49.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.284 0.564 . . . . 0.0 110.589 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.35 139.78 48.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.92 -170.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.68 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -99.7 143.34 30.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.659 175.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.54 ' CB ' HD23 ' A' ' 91' ' ' LEU . 7.5 p -151.72 159.19 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.886 0.374 . . . . 0.0 111.463 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.837 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -82.16 117.25 22.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 176.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -85.16 119.44 25.55 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -90.57 130.37 36.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.829 0.347 . . . . 0.0 111.206 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.532 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -98.1 126.1 43.39 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -110.02 116.53 31.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.575 0.703 . . . . 0.0 110.68 -175.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -94.95 135.12 36.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -53.8 101.92 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.446 0.641 . . . . 0.0 110.281 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.73 -56.29 0.61 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.607 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -175.4 161.69 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.492 0.317 . . . . 0.0 110.727 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -37.86 132.12 0.97 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.908 0.883 . . . . 0.0 112.195 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -100.79 -54.8 2.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.593 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.99 -179.33 40.49 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.338 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -153.83 147.7 25.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.031 0.416 . . . . 0.0 111.354 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 45' ' ' VAL . 4.4 mp -134.02 136.6 53.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 46.0 mtm180 -77.71 130.17 36.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.294 0.568 . . . . 0.0 111.36 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -150.39 148.22 28.53 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.542 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.68 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 46.6 mtpt -73.97 149.94 41.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.069 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -61.6 138.92 58.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 93.75 -23.7 29.53 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.143 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -101.44 136.16 41.74 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.824 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -82.57 155.07 24.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.495 0.664 . . . . 0.0 111.117 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.6 p -126.92 150.19 32.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.585 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 135.77 33.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.985 0.421 . . . . 0.0 111.301 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.709 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.2 m-85 -125.9 128.27 47.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 169.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 49.9 p90 -146.18 153.75 40.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.396 -175.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -100.04 136.64 39.63 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -115.68 110.85 19.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.567 0.699 . . . . 0.0 111.474 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -120.2 105.28 42.39 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -44.29 121.63 3.24 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.324 2.682 . . . . 0.0 112.683 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.27 -24.15 14.69 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -121.65 151.43 57.08 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.004 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.72 149.25 54.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.227 1.952 . . . . 0.0 111.049 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 51.8 mttt -77.24 119.0 20.29 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.823 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 19.5 tpp180 -94.1 133.77 37.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.356 -168.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.29 107.78 0.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.195 0.522 . . . . 0.0 110.28 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.2 m -91.56 -22.71 6.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.295 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -168.68 135.53 1.9 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.44 0.638 . . . . 0.0 111.684 175.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.11 111.18 33.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 10.7 t -132.88 146.45 51.82 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.899 -168.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.824 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 29.6 pttt -145.25 164.92 29.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.955 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -78.27 136.81 37.83 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.799 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -48.67 -37.77 19.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.474 -171.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.472 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 22.1 t -105.62 140.74 21.48 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.06 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.568 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 4.2 Cg_exo -77.83 4.35 6.16 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.022 2.482 . . . . 0.0 111.943 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 5.1 t -121.4 -77.33 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.68 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' ' 66' ' ' SER . 52.8 m80 -94.06 163.75 13.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.868 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 5.8 p -96.7 125.38 41.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HB2' ' H ' ' A' ' 72' ' ' TYR . 50.6 m-20 -123.21 -87.11 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' H ' ' HB2' ' A' ' 71' ' ' ASN . 33.9 m-85 -129.24 177.56 7.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.018 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.758 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.3 mt -103.17 125.12 49.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.153 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 14.1 mptt -106.85 106.26 16.7 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.034 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 0.5 OUTLIER -115.56 150.44 36.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.022 -174.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -119.68 150.57 40.13 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 7.2 t30 64.74 103.84 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.705 0.628 . . . . 0.0 110.722 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.544 HD22 ' HA ' ' A' ' 83' ' ' SER . 98.1 mt -117.98 127.63 54.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -91.26 76.8 5.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.633 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.06 -88.52 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.456 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.36 -6.36 61.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.061 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.3 m-85 -94.24 115.84 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.893 0.378 . . . . 0.0 110.809 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.544 ' HA ' HD22 ' A' ' 78' ' ' LEU . 17.2 m -144.98 168.64 19.78 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.582 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -99.86 154.77 18.08 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.178 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -110.67 -58.97 0.49 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.603 -171.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.26 -178.32 1.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.9 m -126.9 141.36 51.83 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.7 p -142.32 -155.96 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.16 0.505 . . . . 0.0 111.812 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.837 ' HB3' HD21 ' A' ' 24' ' ' ASN . 26.8 t70 66.95 -83.45 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 114.46 -1.246 . . . . 0.0 112.113 168.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 7.3 m -71.07 -33.36 51.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.843 0.354 . . . . 0.0 111.027 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.54 HD23 ' CB ' ' A' ' 23' ' ' CYS . 4.1 pp -88.73 -31.94 18.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.4 t -95.27 -77.56 0.47 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.84 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -159.64 -59.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.995 0.426 . . . . 0.0 110.417 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.71 141.37 5.61 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.25 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 89' ' ' ASP . 7.2 p -137.41 167.3 21.89 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 175.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m -61.92 129.96 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.092 0.472 . . . . 0.0 110.512 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -80.74 106.91 2.59 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.829 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.4 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.951 176.428 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 18.2 p90 -86.79 131.41 34.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 p -121.43 142.11 39.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.895 -168.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 1.027 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.28 147.53 25.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 10.6 p -149.49 147.91 28.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.454 0.645 . . . . 0.0 112.405 -175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 1.071 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.5 OUTLIER -72.39 110.66 6.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 173.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.769 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 5.4 m80 -75.85 107.28 7.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.802 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 24' ' ' ASN . 12.3 m-70 -79.68 126.63 31.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.106 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.533 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -99.33 125.26 44.96 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 173.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -107.55 125.42 51.27 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.472 0.653 . . . . 0.0 110.978 -176.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -100.14 151.13 21.77 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -48.29 101.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 123.458 0.474 . . . . 0.0 111.009 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.5 -53.03 0.68 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.235 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -147.85 160.95 42.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.457 0.646 . . . . 0.0 112.67 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -48.78 133.05 17.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.177 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -102.91 -55.48 2.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.127 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -177.9 38.01 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.467 ' C ' HD12 ' A' ' 37' ' ' ILE . 5.6 t -153.92 141.44 19.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.204 0.502 . . . . 0.0 110.037 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.467 HD12 ' C ' ' A' ' 36' ' ' THR . 1.8 mp -116.31 123.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.54 HH21 ' HA ' ' A' ' 98' ' ' SER . 6.1 tpp85 -75.84 99.4 4.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.841 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -145.02 145.76 31.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.133 0.492 . . . . 0.0 111.365 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 1.027 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 12.7 ptmt -64.69 151.82 43.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.002 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.93 142.57 52.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.866 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.872 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 101.62 -30.61 10.01 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.316 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.577 ' CD1' ' HG3' ' A' ' 40' ' ' LYS . 76.2 m95 -90.17 139.68 30.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.516 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -73.21 130.59 40.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.957 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 62' ' ' CYS . 8.3 p -121.46 153.43 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.141 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.73 142.39 28.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 111.059 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.769 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 77.3 m-85 -127.89 133.81 49.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 170.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.591 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 45.6 p90 -148.92 151.05 33.96 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.706 0.289 . . . . 0.0 110.689 -175.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.29 143.78 27.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.611 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.942 ' HB3' ' HD2' ' A' ' 56' ' ' LYS . 11.3 pt-20 -126.67 102.02 6.89 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.933 0.873 . . . . 0.0 111.158 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.17 128.15 41.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.02 116.94 2.71 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.57 2.18 . . . . 0.0 112.487 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.53 -29.27 12.18 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.372 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -96.54 153.09 38.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.715 0.293 . . . . 0.0 110.608 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.24 153.4 74.59 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.588 2.192 . . . . 0.0 111.732 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.942 ' HD2' ' HB3' ' A' ' 50' ' ' GLU . 21.1 mmtp -70.57 117.7 12.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.43 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -105.81 125.67 51.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.598 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mt -57.02 120.83 8.67 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.875 0.369 . . . . 0.0 110.784 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 22.1 m -107.74 -17.74 7.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -172.35 138.41 0.94 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.48 0.657 . . . . 0.0 111.62 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mp -108.26 112.38 40.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -130.69 150.89 51.67 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.953 -168.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 10.1 ptpp? -151.28 162.74 40.36 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.44 144.61 31.27 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -46.43 -56.96 5.13 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.767 0.667 . . . . 0.0 111.918 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 15.0 m -97.05 143.06 25.48 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.585 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.872 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 1.7 Cg_endo -83.81 22.19 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.25 2.633 . . . . 0.0 112.343 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 12.0 t -136.03 -76.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -81.28 159.55 24.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.7 t -98.81 122.32 41.89 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.998 0.427 . . . . 0.0 109.957 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -112.09 -83.47 0.58 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.591 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -145.76 179.99 7.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.838 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.729 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 16.3 mt -101.75 121.78 42.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.058 0.456 . . . . 0.0 111.102 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -100.6 104.87 16.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.013 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.8 m -116.57 149.22 40.0 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.91 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -128.17 156.32 43.08 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 63.74 59.34 1.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.752 0.658 . . . . 0.0 110.286 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.662 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.6 mt -77.84 131.63 37.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.428 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -90.33 66.65 6.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 111.538 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 59.2 -90.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.107 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.47 -10.15 83.85 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.089 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.7 m-85 -96.43 114.14 25.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.662 ' HA ' HD22 ' A' ' 78' ' ' LEU . 38.6 m -143.98 172.82 12.34 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.714 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -106.98 162.64 13.66 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.55 -126.91 3.95 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.02 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 14.1 t -104.4 -176.37 3.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 3.9 p -132.52 141.82 48.93 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.505 ' HB ' HG21 ' A' ' 95' ' ' THR . 28.8 p -142.67 -157.58 0.79 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.962 0.41 . . . . 0.0 111.967 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 1.071 ' HB3' HD21 ' A' ' 24' ' ' ASN . 21.1 t70 72.21 -62.43 0.46 Allowed 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.799 168.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.637 ' CG2' ' HA ' ' A' ' 23' ' ' CYS . 1.5 m -85.07 -31.89 7.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.481 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.515 HD23 ' HB3' ' A' ' 23' ' ' CYS . 4.1 pp -89.77 -34.66 16.1 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.667 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.1 p -99.97 -14.96 18.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.37 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 5.3 t 82.2 86.67 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.074 171.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.9 94.72 0.89 Allowed Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.63 -0.714 . . . . 0.0 114.046 173.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.505 HG21 ' HB ' ' A' ' 88' ' ' THR . 41.6 p -137.64 -127.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.662 0.268 . . . . 0.0 110.977 174.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.2 m -123.61 149.46 27.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.632 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.5 162.3 21.51 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.274 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.54 ' HA ' HH21 ' A' ' 38' ' ' ARG . 20.7 t . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.355 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.717 0.294 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 39.1 p90 -88.8 139.59 30.31 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 p -120.71 138.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.571 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -98.71 142.36 30.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.689 175.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.624 ' HA ' HG21 ' A' ' 90' ' ' VAL . 7.6 p -155.68 159.45 39.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 111.613 -175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.984 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.1 p30 -80.38 111.78 17.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.099 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.621 ' HD2' HG11 ' A' ' 45' ' ' VAL . 3.3 m-70 -81.82 115.95 21.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -87.85 129.65 35.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.364 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.562 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.5 tm? -98.6 127.78 44.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -103.64 121.72 43.52 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.71 -175.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.609 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 85.4 t80 -94.31 141.29 28.73 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -54.78 101.16 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 110.699 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.57 -42.9 1.39 Allowed Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.361 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -168.86 153.09 5.62 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.018 0.437 . . . . 0.0 111.672 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -38.55 126.22 1.43 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.07 0.948 . . . . 0.0 112.538 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 87.6 t90 -94.25 -55.77 3.07 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.98 -175.07 37.42 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.781 -0.724 . . . . 0.0 111.899 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.484 HG22 ' HB2' ' A' ' 98' ' ' SER . 6.6 t -154.39 147.89 25.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.055 0.428 . . . . 0.0 110.882 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' CE1' ' A' ' 47' ' ' PHE . 3.3 mp -124.4 126.22 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 2.9 tpp180 -77.84 93.7 4.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -127.7 144.54 51.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.982 0.42 . . . . 0.0 110.553 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 36.4 mtpt -70.72 151.86 44.43 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.348 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.65 142.05 57.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.47 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 91.88 -27.94 9.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.157 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.465 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 27.1 m95 -84.52 128.28 34.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 110.376 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.08 135.07 46.15 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.475 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.621 HG11 ' HD2' ' A' ' 25' ' ' HIS . 7.3 p -121.56 142.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.841 0.353 . . . . 0.0 110.764 -176.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.14 141.81 28.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.706 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 73.9 m-85 -130.65 134.98 47.4 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 172.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -141.46 167.75 21.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.733 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 15.5 pt-20 -107.54 125.39 51.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.422 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' ' HZ2' ' A' ' 34' ' ' TRP . 13.5 pt-20 -117.52 121.67 41.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -129.73 149.97 74.47 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.24 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.13 117.81 3.96 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.447 2.765 . . . . 0.0 112.737 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.29 -13.43 45.64 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.888 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.75 142.38 25.09 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.965 0.412 . . . . 0.0 111.549 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.1 155.49 67.95 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.834 2.356 . . . . 0.0 111.568 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.676 ' HD3' ' H ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -83.49 136.07 34.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.487 -176.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -130.52 144.16 51.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.369 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 58' ' ' LEU . 14.9 mt -60.54 130.85 48.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.465 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 49' ' ' GLU . 33.5 m -117.2 -20.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -166.73 137.67 3.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.433 0.635 . . . . 0.0 111.137 176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.54 110.58 32.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.706 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.9 t -130.52 168.16 17.5 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.863 -167.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.712 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 19.5 pttp -174.45 163.83 3.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.606 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.1 133.42 44.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.462 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.568 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -45.59 -41.9 10.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 114.009 -1.451 . . . . 0.0 113.177 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.9 t -102.15 138.15 19.66 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.191 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.3 Cg_endo -75.89 1.43 8.16 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.642 2.228 . . . . 0.0 111.792 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.5 t -118.81 -78.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.555 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 66' ' ' SER . 45.7 m-70 -89.91 162.53 15.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.2 t -97.25 129.12 44.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.067 0.46 . . . . 0.0 110.446 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -125.49 -81.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.925 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -139.67 174.82 10.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.828 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.9 mt -103.6 120.57 41.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.721 0.296 . . . . 0.0 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 5.6 mptp? -106.54 110.53 22.75 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.9 m -112.81 149.78 32.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.357 -173.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -111.8 150.61 30.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 9.5 t30 59.62 90.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.675 0.61 . . . . 0.0 110.473 -174.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.0 117.4 34.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -84.21 61.74 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.046 0.451 . . . . 0.0 111.352 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.57 -91.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.265 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.32 5.31 84.73 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.41 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.6 m-85 -114.43 108.84 17.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.918 0.39 . . . . 0.0 110.139 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 m -147.29 166.52 26.84 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.546 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -100.32 153.78 19.02 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.321 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -109.66 -63.82 0.53 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.486 -171.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.4 t -175.91 -169.94 0.36 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 m -129.09 143.39 50.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.0 p -140.23 -152.51 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.995 -0.093 . . . . 0.0 110.97 -174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.984 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.6 t70 63.0 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.541 0.736 . . . . 0.0 111.962 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 23' ' ' CYS . 1.0 OUTLIER -69.12 -45.49 79.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.723 0.297 . . . . 0.0 111.778 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.02 -24.33 22.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 111.259 -178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.4 t -88.04 -71.68 0.57 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.7 p 179.8 -68.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.527 0.68 . . . . 0.0 109.663 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -152.05 -53.55 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.8 p 50.44 -157.42 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.631 0.772 . . . . 0.0 112.34 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.23 148.33 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.83 -154.91 6.54 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.425 -176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 36' ' ' THR . 15.9 m . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.338 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 4.7 m-85 -47.82 130.01 14.55 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.309 0.576 . . . . 0.0 110.799 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.75 143.77 34.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.266 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.932 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -99.3 142.43 30.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.14 177.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 6.0 p -148.84 146.21 27.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.512 . . . . 0.0 111.846 -173.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.985 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -77.27 115.52 17.12 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 110.302 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.4 124.49 29.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.281 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.531 ' HA ' ' OG1' ' A' ' 36' ' ' THR . 10.8 m170 -94.25 126.27 39.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.92 0.39 . . . . 0.0 111.533 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.4 tm? -97.89 127.89 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -105.07 128.86 53.54 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.929 -175.139 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 73.3 t80 -104.26 148.22 26.6 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.05 99.91 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.142 0.496 . . . . 0.0 109.756 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -49.83 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.626 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -173.99 175.35 2.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.526 0.203 . . . . 0.0 110.619 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.76 ' HE1' ' HA ' ' A' ' 98' ' ' SER . 44.9 t-80 -54.3 139.14 37.36 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 122.794 0.438 . . . . 0.0 110.945 176.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.635 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 60.9 t90 -107.42 -56.01 2.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.736 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.78 167.45 33.16 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.035 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.531 ' OG1' ' HA ' ' A' ' 26' ' ' HIS . 0.9 OUTLIER -151.89 136.78 17.2 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 120.99 0.424 . . . . 0.0 112.025 -176.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.424 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.5 mp -126.2 132.78 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.957 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 34.9 ttp180 -94.21 113.92 25.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 -176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' HG2' HG22 ' A' ' 37' ' ' ILE . 73.9 mmtt -138.1 153.95 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.298 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.932 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.9 mtpt -68.06 157.84 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 111.251 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -69.87 142.47 53.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.41 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.24 10.98 81.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.487 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -116.75 156.44 27.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . . . -90.55 120.44 31.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.407 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 62' ' ' CYS . 14.7 p -105.38 141.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.569 177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.58 133.61 39.41 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.182 0.515 . . . . 0.0 110.671 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.488 ' CG ' HD23 ' A' ' 27' ' ' LEU . 66.5 m-85 -125.65 125.14 42.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.679 ' HB3' HD23 ' A' ' 58' ' ' LEU . 42.6 p90 -147.32 148.03 30.96 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.998 -177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.6 125.19 34.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.57 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.659 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 8.8 pt-20 -128.54 102.78 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 122.02 0.914 . . . . 0.0 110.019 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 29.2 mtmt -104.13 118.24 57.48 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.572 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 1.2 Cg_endo -42.92 117.34 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.694 2.929 . . . . 0.0 113.067 -172.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.18 -20.83 32.4 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.012 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 47.5 mt-30 -115.84 143.4 30.69 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.654 0.264 . . . . 0.0 110.91 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 24.4 Cg_exo -64.56 161.99 32.98 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.215 2.61 . . . . 0.0 111.93 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.659 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 27.9 mttm -90.93 143.43 26.73 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.116 -169.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.641 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -134.53 133.29 40.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.679 HD23 ' HB3' ' A' ' 48' ' ' TYR . 13.3 mt -64.09 126.67 28.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.021 0.439 . . . . 0.0 111.052 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 82' ' ' PHE . 20.5 m -113.02 -17.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.712 -177.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -171.18 135.53 0.99 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.484 0.659 . . . . 0.0 111.799 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -113.17 112.13 39.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 167.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 8.9 t -120.56 146.12 46.64 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.356 -166.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 24.9 mmtm -120.01 164.67 15.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 70' ' ' CYS . 9.9 t30 -93.66 137.06 33.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.6 -55.28 1.89 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.115 0.884 . . . . 0.0 112.679 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.438 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 39.9 t -103.12 141.62 22.86 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.823 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.48 -10.55 13.3 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.591 2.194 . . . . 0.0 111.649 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 16.2 t -100.32 -59.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.497 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -104.96 164.52 11.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.407 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.431 ' HA ' HD21 ' A' ' 64' ' ' ASN . 5.9 p -100.87 122.02 42.72 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.302 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.87 -90.09 0.54 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.111 0.481 . . . . 0.0 110.709 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -131.37 176.52 8.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.448 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.801 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 22.7 mt -105.79 128.41 53.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -170.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -109.41 105.26 14.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.772 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 1.7 m -119.94 152.68 37.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.973 -171.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 t -124.45 174.1 8.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.18 34.49 21.08 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.636 0.585 . . . . 0.0 111.606 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 83' ' ' SER . 94.0 mt -66.08 131.01 45.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.795 -176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -100.92 68.15 1.26 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.674 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.07 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.538 0.735 . . . . 0.0 112.821 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.12 -14.05 83.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.966 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 98.1 m-85 -96.92 111.42 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.994 0.426 . . . . 0.0 110.753 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 78' ' ' LEU . 45.1 m -148.51 168.53 22.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.772 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -112.1 154.61 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.872 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -106.31 -79.22 1.23 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.895 -171.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.402 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 13.4 t -161.1 -174.91 4.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 27.8 m -116.06 144.04 44.65 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.409 ' OG1' HG21 ' A' ' 95' ' ' THR . 39.9 p -139.75 -155.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.103 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.985 ' HB3' HD21 ' A' ' 24' ' ' ASN . 20.9 t70 66.67 -81.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.593 175.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.9 m -65.23 -40.91 90.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.813 0.339 . . . . 0.0 111.591 -175.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.8 -30.24 19.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.668 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -86.29 -75.55 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.661 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.4 t -166.95 -58.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.636 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.39 142.46 5.74 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.363 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.661 ' OG1' ' HB2' ' A' ' 89' ' ' ASP . 31.4 p -136.38 -170.87 2.76 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.89 26.92 3.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.903 0.382 . . . . 0.0 111.398 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.0 -115.04 6.54 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.085 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.76 ' HA ' ' HE1' ' A' ' 33' ' ' HIS . 50.1 m . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.839 -0.601 . . . . 0.0 110.199 178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.678 ' HD1' ' H ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -85.32 125.81 33.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -132.93 139.44 49.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.865 -172.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.689 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -101.51 142.15 33.31 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.947 ' HA ' HG21 ' A' ' 90' ' ' VAL . 26.1 p -143.69 150.14 38.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.514 0.673 . . . . 0.0 112.316 -172.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.957 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -74.31 114.4 12.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.868 175.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.527 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -83.18 113.79 20.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.601 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -85.39 127.37 34.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.173 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 28' ' ' LEU . 1.5 tm? -100.06 132.44 45.42 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -99.46 124.67 44.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.599 -178.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.932 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 80.8 t80 -93.61 150.0 20.78 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -53.74 99.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 110.309 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.85 -68.32 0.46 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.189 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -142.89 179.19 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 112.128 -171.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -47.71 133.85 13.32 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.801 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.932 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 83.8 t90 -103.15 -56.62 2.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.17 -178.57 42.49 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.022 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 13.3 t -153.11 138.7 17.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 110.631 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.2 mp -116.11 129.89 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.571 -178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.645 HH11 HG13 ' A' ' 90' ' ' VAL . 2.3 tpp180 -80.84 99.84 8.51 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.419 ' HG2' HG22 ' A' ' 37' ' ' ILE . 31.0 mmtm -140.9 152.95 45.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.224 0.535 . . . . 0.0 111.385 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.4 mtpt -67.18 154.97 39.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.826 -176.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.12 141.36 54.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.187 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 91.94 -26.63 12.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.177 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -81.14 134.73 35.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.007 0.432 . . . . 0.0 110.842 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -78.21 121.75 24.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.972 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 62' ' ' CYS . 7.1 p -111.87 147.31 15.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 141.72 28.42 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.77 -176.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.75 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 65.0 m-85 -127.56 138.29 52.84 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 22.4 p90 -153.33 159.63 42.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.914 -172.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.48 137.37 44.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HG2' ' HG2' ' A' ' 56' ' ' LYS . 22.9 mt-10 -112.5 102.0 10.13 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.21 0.529 . . . . 0.0 110.212 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -90.56 143.59 29.38 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.57 116.51 3.34 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.512 2.141 . . . . 0.0 111.788 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.07 -17.74 57.68 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.292 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -101.56 148.43 35.22 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.904 0.383 . . . . 0.0 111.269 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.63 153.41 59.82 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.56 2.173 . . . . 0.0 110.615 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.569 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 15.6 mttp -62.61 127.85 33.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.08 -173.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -103.82 119.97 40.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.89 115.53 3.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.638 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 25.9 m -96.88 -22.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.614 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 59' ' ' VAL . . . 176.27 144.61 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 123.612 0.57 . . . . 0.0 111.315 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.504 HD13 HD22 ' A' ' 77' ' ' ASN . 4.4 mp -101.73 116.98 46.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.75 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 4.6 t -128.63 149.42 50.66 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.321 -171.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.659 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.2 ptpt -144.26 162.29 36.76 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -85.71 133.69 34.0 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.166 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.29 -53.51 5.17 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.092 0.87 . . . . 0.0 112.959 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 33.2 t -93.46 139.59 22.93 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.318 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 71.7 Cg_endo -78.87 -3.51 13.28 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.594 2.196 . . . . 0.0 111.827 173.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -111.33 -69.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.423 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.436 ' O ' ' HB3' ' A' ' 66' ' ' SER . 35.6 m80 -94.79 161.8 14.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.004 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.0 p -98.51 121.17 40.1 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -121.41 -88.48 0.62 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.19 0.519 . . . . 0.0 109.707 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.04 171.23 12.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.47 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.686 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 37.8 mt -103.71 119.93 39.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.869 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.657 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.9 mmpt? -96.05 104.47 16.42 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 30.7 m -100.87 152.88 20.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.033 0.444 . . . . 0.0 111.361 -174.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -133.39 157.86 44.48 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.553 173.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.504 HD22 HD13 ' A' ' 61' ' ' ILE . 90.6 m-20 59.43 49.57 8.56 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.469 0.481 . . . . 0.0 111.066 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 75' ' ' CYS . 97.2 mt -65.87 140.81 58.39 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.271 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.91 79.0 2.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.944 0.402 . . . . 0.0 110.76 -178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 67.67 -77.7 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.798 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.83 -13.1 6.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.955 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 50.6 m-85 -71.22 118.09 13.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 p -151.2 171.59 17.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.705 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -92.24 163.24 13.99 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.752 0.311 . . . . 0.0 110.56 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.24 -62.64 0.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.511 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -175.11 -171.44 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 24.8 m -129.83 143.18 50.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.6 p -141.66 -160.74 1.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.698 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.957 ' HB3' HD21 ' A' ' 24' ' ' ASN . 19.5 t70 64.51 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.388 171.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.947 HG21 ' HA ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -62.25 -38.29 80.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.901 0.382 . . . . 0.0 111.206 -176.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.22 -37.91 15.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.733 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m -87.96 -77.06 0.36 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.03 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.5 t -162.43 -66.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.37 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' HA2' ' OD1' ' A' ' 89' ' ' ASP . . . -170.58 137.49 4.47 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.131 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.5 p -136.44 123.69 21.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.718 0.259 . . . . 0.0 111.287 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.5 m -86.26 129.02 38.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.94 -57.82 0.17 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.589 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.555 -1.212 . . . . 0.0 109.623 -178.785 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 92.6 m-85 -53.32 141.22 24.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.941 0.4 . . . . 0.0 110.419 173.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.527 HG13 ' SG ' ' A' ' 70' ' ' CYS . 1.5 p -142.39 133.7 25.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.606 -177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -96.52 145.66 25.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.095 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 21.6 p -150.23 149.1 29.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.486 0.66 . . . . 0.0 111.876 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.926 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.8 OUTLIER -75.53 114.37 14.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.857 173.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.04 117.96 21.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' CE1' ' HA3' ' A' ' 97' ' ' GLY . 11.5 m170 -87.06 134.09 33.53 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.804 0.335 . . . . 0.0 111.895 -174.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.587 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -99.55 123.59 43.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -105.78 122.29 45.79 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.475 0.655 . . . . 0.0 110.858 -176.502 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -95.35 146.66 24.22 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -60.8 100.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.0 -52.61 0.68 Allowed Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.825 -174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG3' ' H ' ' A' ' 33' ' ' HIS . 17.6 tpt180 -174.94 177.9 1.9 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.744 0.272 . . . . 0.0 111.428 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.529 ' H ' ' HG3' ' A' ' 32' ' ' ARG . 3.5 t-80 -51.23 128.13 21.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.516 0.727 . . . . 0.0 111.631 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' HZ2' ' H ' ' A' ' 50' ' ' GLU . 57.2 t90 -95.65 -56.8 2.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.56 173.71 44.97 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 8.8 t -155.24 146.6 22.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.206 0.503 . . . . 0.0 111.497 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.81 133.85 66.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.405 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.621 HH11 ' HB3' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -76.09 113.55 13.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 11.9 tppt? -143.72 150.72 39.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 21.0 ttmt -83.25 147.42 28.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 66' ' ' SER . . . -53.86 139.59 33.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.966 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.551 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 98.2 -39.6 2.72 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.447 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -81.2 137.19 35.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.008 0.432 . . . . 0.0 110.608 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -76.34 136.66 39.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.646 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 62' ' ' CYS . 10.0 p -118.39 148.84 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.708 ' HE ' ' HE1' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -89.01 143.32 26.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.407 . . . . 0.0 110.899 -177.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 55.0 m-85 -128.31 143.28 51.0 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.708 ' HE1' ' HE ' ' A' ' 46' ' ' ARG . 36.7 p90 -152.51 156.48 39.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.814 0.34 . . . . 0.0 110.58 -174.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 57' ' ' ARG . 8.5 pt-20 -100.17 130.07 46.26 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.753 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 6.7 pt-20 -120.32 101.08 7.56 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.963 0.887 . . . . 0.0 110.497 175.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -85.19 141.53 37.38 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.816 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.19 116.39 2.22 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.847 2.365 . . . . 0.0 112.894 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.73 -30.52 6.48 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.171 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -83.15 153.33 66.27 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.719 0.295 . . . . 0.0 111.228 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.61 153.9 76.15 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 111.186 171.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.753 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 32.2 mttm -94.54 126.1 39.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.99 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.535 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 7.2 ttm-85 -94.58 123.53 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.261 -174.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -61.15 102.95 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.59 -19.65 7.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -178.79 146.92 0.35 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.158 0.504 . . . . 0.0 111.51 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.6 mp -107.89 118.64 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.716 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 9.1 t -133.82 150.88 51.42 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.289 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 16.4 ptpt -146.32 162.75 37.47 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.21 138.65 36.87 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.439 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.93 -57.53 2.37 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.38 1.05 . . . . 0.0 112.677 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 42.7 t -93.54 138.3 23.0 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.156 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 73.2 Cg_endo -76.25 -0.76 10.7 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.641 2.228 . . . . 0.0 111.879 173.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 11.8 t -115.34 -66.45 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.73 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 66' ' ' SER . 53.5 m-70 -98.21 163.89 12.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.527 ' SG ' HG13 ' A' ' 21' ' ' VAL . 97.9 m -99.23 122.33 42.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.398 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -125.04 -79.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.305 0.574 . . . . 0.0 110.218 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -138.53 174.18 10.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.827 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.706 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 28.3 mt -104.51 127.44 52.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.235 0.541 . . . . 0.0 111.387 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -104.69 105.66 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.35 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.727 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 5.9 m -106.14 163.64 12.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.244 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -144.22 157.91 44.03 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.646 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.3 46.61 5.9 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.664 0.603 . . . . 0.0 111.34 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 83' ' ' SER . 91.5 mt -67.28 147.89 52.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.691 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -107.57 69.85 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 111.465 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.22 -93.54 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.8 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.91 -5.87 88.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.184 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 97.8 m-85 -98.71 112.98 24.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.233 0.539 . . . . 0.0 110.485 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' HD22 ' A' ' 78' ' ' LEU . 20.1 m -140.02 169.12 18.29 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.727 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -108.0 156.78 18.85 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.569 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -115.85 -121.07 3.34 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.896 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.6 t -110.35 -169.6 1.49 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.616 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 18.9 p -125.24 142.74 51.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.523 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 75.2 p -140.4 -155.86 0.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.538 0.208 . . . . 0.0 111.046 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.926 ' HB3' HD21 ' A' ' 24' ' ' ASN . 16.3 t70 67.25 -72.9 0.08 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.828 0.851 . . . . 0.0 112.33 170.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 m -78.63 -42.76 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -89.51 -45.6 9.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.377 -178.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.449 ' N ' ' HG ' ' A' ' 91' ' ' LEU . 15.2 t -83.82 -16.74 43.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.579 0.228 . . . . 0.0 110.66 -175.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 89' ' ' ASP . 62.9 m 62.74 -82.44 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.324 0.649 . . . . 0.0 112.409 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -71.7 74.89 0.73 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.339 -0.457 . . . . 0.0 112.817 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.523 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -154.58 152.37 29.95 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 122.665 0.386 . . . . 0.0 110.427 -177.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.86 102.64 14.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' A' ' 26' ' ' HIS . . . -159.17 101.06 0.2 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.891 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 18.6 t . . . . . 0 C--O 1.254 1.303 0 CA-C-O 117.89 -1.052 . . . . 0.0 108.422 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 31.7 p90 -58.19 136.56 57.29 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 110.221 175.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.23 139.32 44.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.463 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.595 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -116.88 141.6 48.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HA ' HG21 ' A' ' 90' ' ' VAL . 20.5 p -147.33 164.12 34.27 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.111 0.481 . . . . 0.0 111.373 -171.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.898 HD21 ' HB3' ' A' ' 89' ' ' ASP . 1.3 p30 -79.35 115.61 19.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.585 176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m-70 -83.22 121.53 27.21 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -89.53 138.69 31.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.477 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.4 tm? -109.65 130.32 55.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 170.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.537 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -100.43 123.5 44.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.385 0.612 . . . . 0.0 111.032 -178.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.964 ' HB2' ' HB2' ' A' ' 34' ' ' TRP . 21.4 t80 -95.72 151.63 19.19 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 30' ' ' ASN . 10.0 m120 -57.44 100.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.079 0.466 . . . . 0.0 110.514 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.2 -57.28 0.69 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.62 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -147.38 178.47 8.4 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.193 0.52 . . . . 0.0 111.87 -171.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -62.5 133.7 55.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.044 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.964 ' HB2' ' HB2' ' A' ' 29' ' ' TYR . 84.3 t90 -101.25 -57.61 2.05 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.218 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.31 -179.5 40.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.118 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 24' ' ' ASN . 12.1 t -154.68 148.75 25.82 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 120.65 0.262 . . . . 0.0 110.892 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.687 HG22 ' HG2' ' A' ' 39' ' ' LYS . 4.6 mp -128.15 125.54 64.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.55 HH12 ' HA ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -75.97 99.5 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.952 -178.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.687 ' HG2' HG22 ' A' ' 37' ' ' ILE . 67.5 mmtt -135.15 153.12 52.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.595 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 53.0 mtpt -72.11 153.0 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.97 142.39 58.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 67' ' ' PRO . . . 90.96 -25.86 12.77 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 -178.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.562 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 86.0 m95 -86.02 133.7 33.89 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.605 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.665 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -70.91 135.64 48.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.804 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 62' ' ' CYS . 11.2 p -122.54 148.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.1 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -90.6 147.88 23.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.705 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HE2' ' HB3' ' A' ' 62' ' ' CYS . 61.1 m-85 -136.38 137.28 40.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 172.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 39.0 p90 -145.55 154.29 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.515 0.198 . . . . 0.0 110.549 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.441 ' HB3' HG11 ' A' ' 59' ' ' VAL . 15.0 pt-20 -95.51 135.43 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.073 0.463 . . . . 0.0 110.577 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.62 ' HB2' ' HZ2' ' A' ' 34' ' ' TRP . 1.6 mm-40 -94.84 106.39 18.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.418 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.652 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 75.9 mmtt -106.81 123.46 38.48 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.48 117.26 3.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.848 2.366 . . . . 0.0 112.339 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.46 -6.68 75.91 Favored Glycine 0 C--N 1.33 0.199 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.479 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.652 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 28.3 mt-30 -113.25 158.63 37.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 C-N-CA 122.664 0.385 . . . . 0.0 110.69 -175.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.85 155.53 62.17 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.529 2.153 . . . . 0.0 111.944 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 56' ' ' LYS . 1.9 mptp? -80.82 130.01 34.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.299 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.563 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.4 tpm_? -108.19 124.09 49.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.354 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -61.0 106.57 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.077 176.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 49' ' ' GLU . 29.5 m -94.2 -17.06 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.927 -172.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -168.34 138.08 2.47 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.376 0.608 . . . . 0.0 112.238 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mp -108.81 111.93 38.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 7.6 t -130.93 155.11 47.33 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.193 -168.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.665 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 18.7 ptpt -157.59 158.56 35.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -77.95 131.09 37.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.659 ' HB2' ' HD3' ' A' ' 74' ' ' LYS . . . -55.2 -28.3 52.03 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 124.022 0.826 . . . . 0.0 112.958 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 69' ' ' HIS . 34.0 t -104.64 131.65 21.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.683 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . 77.6 Cg_endo -80.1 2.54 8.37 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.65 2.233 . . . . 0.0 112.415 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 13.2 t -121.31 -65.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.667 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.582 ' O ' ' HB3' ' A' ' 66' ' ' SER . 69.5 t60 -97.94 160.37 14.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.31 0.576 . . . . 0.0 110.025 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.3 p -100.94 128.62 46.9 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.071 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -129.13 -86.63 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.036 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -132.14 169.72 16.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.544 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.74 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 19.0 mt -102.76 120.1 39.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.157 0.503 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.659 ' HD3' ' HB2' ' A' ' 65' ' ' ALA . 4.1 mptp? -100.79 106.27 17.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.479 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.634 ' HB2' HD21 ' A' ' 78' ' ' LEU . 2.5 m -108.81 152.49 24.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.776 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -125.73 156.1 39.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.729 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 61.9 47.45 6.0 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.611 0.57 . . . . 0.0 111.773 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 75' ' ' CYS . 81.2 mt -66.77 145.91 55.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 82' ' ' PHE . . . -88.8 72.95 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.2 -93.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.555 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.15 -17.13 30.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 40.4 m-85 -72.38 109.37 6.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.166 0.507 . . . . 0.0 109.885 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' HD22 ' A' ' 78' ' ' LEU . 4.4 p -139.14 175.93 9.14 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.017 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -98.34 169.1 9.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.768 0.318 . . . . 0.0 110.652 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.82 -159.24 10.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.861 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 t -77.29 -178.09 4.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.9 0.381 . . . . 0.0 111.085 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.475 ' HB2' HD21 ' A' ' 91' ' ' LEU . 41.2 m -116.8 144.75 44.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.603 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 69.5 p -139.67 -157.92 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.525 0.202 . . . . 0.0 111.335 -173.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.898 ' HB3' HD21 ' A' ' 24' ' ' ASN . 27.9 t70 65.14 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.955 0.902 . . . . 0.0 112.43 171.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 23' ' ' CYS . 2.6 m -71.4 -47.67 57.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.3 pp -88.97 -30.34 18.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.688 0.28 . . . . 0.0 111.079 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.6 t -85.03 -58.67 2.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.592 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.7 t 69.47 133.0 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.32 0.581 . . . . 0.0 110.03 -171.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.4 -1.37 72.65 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.603 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.8 OUTLIER -116.36 155.87 27.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.726 -0.737 . . . . 0.0 109.979 177.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.6 m -97.56 144.03 11.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.925 0.393 . . . . 0.0 110.609 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 174.65 172.11 39.42 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.772 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.55 ' HA ' HH12 ' A' ' 38' ' ' ARG . 22.1 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.57 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 41.1 p90 -58.81 142.06 51.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.93 0.395 . . . . 0.0 110.059 175.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.42 139.37 41.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.322 0.582 . . . . 0.0 111.802 -171.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.745 ' HB3' ' HG2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -113.71 140.93 47.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.577 173.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 7.7 p -148.44 151.58 35.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.951 0.405 . . . . 0.0 111.842 -171.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.937 HD21 ' HB3' ' A' ' 89' ' ' ASP . 0.4 OUTLIER -73.01 102.63 3.55 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.414 0.626 . . . . 0.0 110.573 179.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.784 ' HB3' ' HZ ' ' A' ' 47' ' ' PHE . 4.7 m80 -69.95 116.55 10.45 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.382 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 45.9 m-70 -93.57 128.98 39.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.439 . . . . 0.0 111.43 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.503 HD23 ' CG ' ' A' ' 47' ' ' PHE . 1.3 tm? -98.92 129.75 45.27 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.487 ' N ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -91.85 123.63 35.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.487 -177.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.561 ' HB2' ' CB ' ' A' ' 34' ' ' TRP . 37.2 t80 -94.18 149.59 21.1 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -52.04 99.45 0.02 OUTLIER 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.475 0.484 . . . . 0.0 110.038 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.14 -70.86 0.51 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.954 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -149.15 178.97 8.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.087 0.47 . . . . 0.0 112.031 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -53.62 132.7 41.05 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.856 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 29' ' ' TYR . 8.1 t-105 -128.34 -57.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.073 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 26' ' ' HIS . . . -98.93 150.62 19.34 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.314 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -151.39 108.07 3.51 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.73 113.35 37.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.835 ' HA ' ' HA ' ' A' ' 24' ' ' ASN . 21.9 ttp180 -77.87 93.56 4.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.419 0.628 . . . . 0.0 109.768 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HG2' ' HB ' ' A' ' 45' ' ' VAL . 15.6 tppt? -116.34 153.0 32.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.036 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.745 ' HG2' ' HB3' ' A' ' 22' ' ' GLN . 48.5 mtpt -79.94 149.33 30.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.673 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.05 137.31 56.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.718 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.428 ' CA ' ' HA ' ' A' ' 67' ' ' PRO . . . 97.08 -20.24 51.61 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.031 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.499 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 84.6 m95 -95.9 133.11 40.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.769 0.319 . . . . 0.0 110.223 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . . . -72.48 130.42 40.62 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.162 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.569 ' HB ' ' HG2' ' A' ' 39' ' ' LYS . 14.8 p -116.09 143.18 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.906 0.384 . . . . 0.0 110.382 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -95.94 143.27 27.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.226 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.784 ' HZ ' ' HB3' ' A' ' 25' ' ' HIS . 86.7 m-85 -120.93 137.96 54.35 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 56' ' ' LYS . 32.8 p90 -144.51 157.96 43.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.399 0.619 . . . . 0.0 111.371 -173.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 21.8 pt-20 -97.78 126.42 43.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.939 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.789 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 7.7 pt-20 -121.93 102.09 7.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.715 0.769 . . . . 0.0 109.824 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -116.15 151.77 47.05 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.237 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.95 116.14 2.45 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.957 2.438 . . . . 0.0 112.759 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.71 -20.57 50.07 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.312 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.452 HE21 ' HB3' ' A' ' 54' ' ' GLN . 18.5 mt-30 -102.14 143.81 27.35 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.196 0.522 . . . . 0.0 112.105 -173.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 54' ' ' GLN . 13.3 Cg_exo -70.23 166.11 29.26 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 123.214 2.609 . . . . 0.0 110.429 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.789 ' HG2' ' HB3' ' A' ' 50' ' ' GLU . 50.3 mttt -94.16 110.67 22.38 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.36 -168.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 9.5 ttp180 -100.7 144.2 29.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.579 -174.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 46' ' ' ARG . 14.1 mt -64.94 125.35 24.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.137 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . 29.8 m -111.3 -18.68 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.535 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 77' ' ' ASN . . . -172.47 140.6 1.09 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.446 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 61' ' ' ILE . 4.5 mp -113.31 113.28 43.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.679 ' HB3' ' HE2' ' A' ' 47' ' ' PHE . 5.3 t -133.73 162.64 31.42 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.595 -169.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 44' ' ' ALA . 17.3 ptpt -158.21 163.39 37.53 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -81.91 132.88 35.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -42.34 -54.7 3.66 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 124.155 0.909 . . . . 0.0 112.795 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -95.22 146.77 31.91 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.428 ' HA ' ' CA ' ' A' ' 42' ' ' GLY . 83.4 Cg_endo -86.57 10.99 3.42 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.769 2.313 . . . . 0.0 112.485 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 10.8 t -122.64 -73.37 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.638 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -95.58 163.47 13.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.1 t -98.08 125.91 43.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.987 0.422 . . . . 0.0 110.199 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -120.07 -80.07 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.672 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -139.52 176.36 8.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.75 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.668 ' HB3' ' SG ' ' A' ' 62' ' ' CYS . 21.8 mt -106.72 120.43 41.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.828 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 11.0 mmpt? -100.22 104.02 15.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 22.1 m -105.62 150.32 25.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 112.074 -172.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 t -132.26 156.23 46.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.458 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 60' ' ' ALA . 57.6 t30 57.14 77.7 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.758 0.661 . . . . 0.0 111.102 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.616 HD22 ' HA ' ' A' ' 83' ' ' SER . 92.0 mt -94.8 137.31 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.268 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.08 80.71 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 110.685 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.61 -94.26 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.686 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.99 -5.29 53.58 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.37 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 33.6 m-85 -83.39 113.58 20.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.988 0.423 . . . . 0.0 110.116 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.616 ' HA ' HD22 ' A' ' 78' ' ' LEU . 12.3 m -142.44 166.44 24.66 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 75' ' ' CYS . . . -89.47 162.89 15.5 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.616 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.91 -63.28 0.24 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.884 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.2 t -175.85 -167.83 0.25 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 19.7 m -135.0 144.08 47.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.482 ' HB ' ' OG1' ' A' ' 95' ' ' THR . 62.6 p -140.11 -152.15 0.4 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.937 ' HB3' HD21 ' A' ' 24' ' ' ASN . 27.8 t70 66.07 -70.11 0.1 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.018 0.927 . . . . 0.0 112.533 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 23' ' ' CYS . 4.5 m -80.14 -42.13 21.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.746 0.308 . . . . 0.0 111.651 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 87' ' ' SER . 4.4 pp -89.9 -33.2 16.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.745 0.307 . . . . 0.0 111.443 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -93.44 -16.13 24.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.679 0.276 . . . . 0.0 110.716 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 t 68.01 -81.19 0.03 OUTLIER 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.24 66.97 3.7 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.521 -176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.482 ' OG1' ' HB ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -141.38 138.35 32.94 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.911 -0.17 . . . . 0.0 110.592 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.8 t -72.74 119.14 18.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.029 0.442 . . . . 0.0 110.494 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.33 -155.49 13.35 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.641 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.246 0.898 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.071 -179.699 . . . . . . . . 0 0 . 1 stop_ save_